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Abstract 
Although the many cells within a mammal share the same DNA sequence, 
their gene expression programmes are highly heterogeneous, and their functions 
correspondingly diverse. This heterogeneity within an isogenic population of cells 
arises in part from the ability of each cell to respond to its immediate surroundings 
via a network of signalling pathways. However, this is not sufficient to explain many 
of the transcriptional and functional differences between cells, particularly those that 
are more stable, or, indeed, differences in expression between parental alleles within 
the same cell. This conundrum lead to the emergence of the field of epigenetics - the 
study of heritable changes in gene expression independent of DNA sequence. Such 
changes are dependent on “epigenetic modifications”, of which DNA methylation is 
one of the best characterised, and is associated with gene silencing. The 
establishment of correct DNA methylation patterns is particularly important during 
early development, leading to cell type specific and parental allele specific gene 
regulation. Besides DNA methyltransferases, various other proteins have recently 
been implicated in DNA methylation. The absence of these proteins leads to defects 
in DNA methylation and development that can be even more severe than those in 
DNA methyltransferase knockouts themselves. In this study I focus on three such 
accessory proteins: LSH (a putative chromatin remodelling ATPase), G9a (a histone 
lysine methyltransferase) and SmcHD1 (a structural maintenance of chromosomes 
protein). To compare DNA methylation between WT cells and cells knocked out for 
each of these proteins, I used whole genome methylated DNA affinity purification 
and subsequent hybridization to promoter microarrays. This enabled me to compare 
the requirement for each protein in DNA methylation at specific genomic regions. 
                11
The absence of LSH in mouse embryonic fibroblasts (MEFs) resulted in the 
loss of DNA methylation at 20% of usually methylated promoters, and the 
misregulation of associated protein coding genes. This revealed a requirement for 
LSH in the establishment of DNA methylation at promoters normally methylated 
during pre-implantation as well as post-implantation development.  
Secondly, I identified hypomethylation at 26% of normally methylated 
promoters in G9a-/- compared to WT ES cells. Strikingly, this revealed that G9a is 
required for maintenance of DNA methylation at maternal as well as paternal 
imprinting control regions (ICRs). This is accompanied by expression defects of 
imprinted genes regulated by these ICRs.  
Finally, in collaboration with the Brockdorff lab at the University of Oxford I 
identified a role for SmcHD1 in establishing DNA methylation at promoters on the X 
chromosome normally methylated slowly during X chromosome inactivation. 
Interestingly, SmcHD1 was also required for DNA methylation at autosomal gene 
promoters, contrary to previous reports that it is mainly involved in X chromosome 
methylation.  
I conclude that different accessory proteins are required to facilitate correct 
DNA methylation and gene repression at distinct regions of the genome, as well as at 
different times during development. This function of accessory proteins may be in 
part dependent on the prior establishment of specific chromatin signatures and 
developmental signals, together comprising a precisely regulated system to establish 
and maintain appropriate DNA methylation throughout development. 
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Chapter 1 - Introduction 
1.1 Epigenetics 
Since the completion of various genome projects, a wealth of insight has been 
gained into the evolutionary origins of different organisms as well as their functional 
divergence. In the case of unicellular organisms this enables extensive genome 
function characterization throughout their lifecycle. Multicellular organisms provide 
us with yet widely unanswered questions, despite the availability of genome 
sequences.  Multicellular organisms arise from a series of lineage commitments 
commencing in the first cell divisions upon fertilization of a single cell. Lineage 
commitment results in subsets of cells with different functions, despite containing 
largely the same DNA sequence. Most functional differences between cells occur 
through the presence of pools of different proteins and non-coding RNAs within the 
cells. Therefore the question arises: How can cells regulate which products of the 
genome they contain?  
In some early lineage commitment processes it has become apparent, that 
cells with different cytoplasmic properties can arise through accumulation of 
different proteins at each cell pole, followed by cell divisions. This leads to 
temporary differences in protein composition (Plusa et al, 2005; Smith et al, 2006; 
Xin et al, 2003). However, most differences in protein and RNA composition of cells 
originate from differential regulation of gene expression. Some differences can arise 
through topological properties of the early embryo: specific cell-cell contacts have 
been found to initiate signalling pathways, leading to differential activation or 
repression of genes. The Hippo signalling pathway in the mouse for example is 
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initiated in cells in the centre of the developing embryo destined to become part of 
embryonic tissues, whereas cells on the periphery, destined to become part of the 
extraembryonic tissues, do not undergo this activation. Activation of the Hippo 
pathway enables the continued repression of trophectoderm markers such as Cdx2, in 
cells destined to become part of the embryonic tissues (Avner & Heard, 2001; Heard 
et al, 2001).   
The wealth of cell types with different gene expression profiles suggests the 
presence of a more complex gene regulatory system. Indeed throughout the years, 
other gene expression phenomena have become apparent which challenged our 
understanding of gene regulation. These involve heritable differences in regulation of 
genomic regions with the same DNA sequence in different cells or even in the same 
cell. This is now known as epigenetics (‘above’ genetics). Major phenomena 
highlighting the importance of epigenetic regulation mechanisms of genome function 
are genomic imprinting and X chromosome inactivation.  
1.1.1 Genomic Imprinting 
Genomic imprinting is the parental allele specific differential expression of 
genes. Both alleles have the same DNA sequence but are differentially expressed 
within the same cell. Initial evidence for this phenomenon came from studies of 
embryos derived from only maternal or paternal chromosomes, which failed to 
develop normally, displaying placental and embryonic defects (McGrath & Solter, 
1984; Surani et al, 1984). Several hypotheses have been proposed to explain this 
phenomenon, but a parental conflict model is the most developed and has received 
most support (Haig & Graham, 1991; Morton et al, 2011; Myant & Sansom, 2011). 
This model hypothesizes, that the maternal genome strives to reserve resources for 
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future offspring, whereas the paternal genome strives to provide his current offspring 
with as many resources as required. Evidence for the existence of such a conflict 
between parental genomes comes from studies into functions of imprinted genes.  
Firstly, many imprinted gene functions support this model, with paternally expressed 
genes supporting growth and maternal genes expressing growth inhibitors. An 
example occurs in the Igf2 gene cluster, which encodes a paternally expressed 
growth factor (IGF2) and a maternally expressed growth suppressor (IGF2R), which 
targets IGF2 for degradation (Dean et al, 1998; Myant et al, 2011; Zvetkova et al, 
2005). Interestingly, all imprinted genes analysed are expressed in placental tissue 
(Reik et al, 2003). The placenta is important in regulation of embryonic growth and 
development. Imprinted genes in the placenta therefore regulate the supply of 
nutrients to the developing embryo. In foetal tissues on the other hand they regulate 
the demand for resources through regulation of growth.  
Secondly, a role of imprinted genes in metabolic processes has also been 
found. The Gnas imprinted locus is a good example of this function. Defects in the 
maternal allele of the Gnas locus lead to obesity, whereas paternal defects lead to 
lean phenotypes, supporting the parent conflict model outlined above (Blewitt et al, 
2008; Gibbons et al, 2000; Yu et al, 2001). The Igf2 locus has also been shown to 
function in metabolism, with paternal disruption of Igf2 causing weight reduction 
(Smith et al, 2006). 
Finally, studies have highlighted requirement of imprinted genes for correct 
development of behavioural traits. Female mice inheriting a paternal mutation of the 
Peg3 imprinted gene display altered behaviour towards her litter (making nest, 
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gathering pups, keeping them warm), frequently resulting in death of offspring (Li et 
al, 1999). Additionally to these observations, many well studied imprinting disorders 
are accompanied by neurological and psychiatric impairments (e.g. Prader-Willi 
Syndrome and Angelman Syndrome) (Ohta et al, 1999).  
The above analysis of genomic imprinting highlights the importance of this 
phenomenon in a plethora of functions during early development as well as in adult 
life. 
1.1.2 X chromosome inactivation 
X inactivation is another phenomenon which involves non DNA sequence 
dependent distinction between chromosomes. This process ensures equal dosage of X 
linked gene expression between XY males and XX females and is achieved by 
inactivation of most genes one X chromosome in female mammals, either on the 
paternal chromosome in extraembryonic tissues or at random in the embryos (Avner 
& Heard, 2001).  
The above examples epitomize epigenetics. Epigenetic mechanisms utilize chemical 
modifications of DNA, as well as associated proteins and structural changes to 
DNA/protein complexes to cause alterations in gene expression or other functions. 
DNA methylation is the most well studied epigenetic mark.  
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1.2 DNA methylation 
1.2.1 Origins of DNA methylation 
DNA methylation originates from a genomic immune system to silence 
invading transposable elements in the bacterial genome (Lee et al, 1999). This use of 
DNA methylation to protect the genome from genomic instability has passed on to 
fungi and plants during evolution (Zemach & Zilberman, 2010). Most fungal 
methylation is to date still located within transposable elements (Zemach & 
Zilberman, 2010). Transposable element methylation was lost and regained 
independently during evolution of vertebrates (Zemach & Zilberman, 2010). During 
the evolution of animals and plants, gene body methylation arose, with vertebrates 
and seeded plants showing most genome wide DNA methylation. Methylation is 
seen at promoters of repressed genes and often within exons of transcribed genes. In 
invertebrates on the other hand there is little evidence for the silencing function of 
DNA methylation (Zemach & Zilberman, 2010). 
During evolution, DNA methylation enzyme gene families also became 
extinct at various stages, mainly remaining in vertebrates and plants only (Zemach & 
Zilberman, 2010). Why has this divergence occurred in the use of DNA methylation 
within eukaryotic genomes? One factor could be that multicellular organisms require 
more regulatory mechanisms to generate a diverse range of tissues and cell types. 
Another idea is that DNA methylation may have evolved alongside the evolution of 
sexual reproduction. Sexual reproduction brings about the continued requirement for 
DNA methylation to silence transposable elements, as these can be passed on 
through generations even without selective advantage. Therefore DNA methylation 
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may have been maintained in these organisms, allowing evolution of new functions 
(Zemach & Zilberman, 2010). 
1.2.2 DNA methylation 
In vertebrates the most prevalent type of DNA methylation is CpG 
methylation, although non-CpG methylation has been demonstrated to occur widely 
in ES cells and tissue such as human spleen (Ramsahoye et al, 2000). Non-CpG 
methylation in mammals has not been well characterized yet, but similarly to CpG 
methylation it has been proposed to function in gene silencing (Franchina & Kay, 
2000; Malone et al, 2001). CpG methylation involves the covalent attachment of a 
methyl group to the carbon five position of cytosine (Bird, 1986). Strand symmetry 
of CpG methylation allows it to be faithfully passed on during cell division due to the 
semi-conservative nature of DNA replication (Bird, 2002). Most CpGs in the genome 
(60-90% of CpGs) are methylated. This has caused the genome to be relatively 
depleted of CpG dinucleotides due to the frequent spontaneous deamination of 5 
methyl cytosines into thymidines (Bird, 1980; Coulondre & Miller, 1978; Coulondre 
et al, 1978). Exception to the highly methylated regions of the genome are regions 
called CpG islands (CGIs), which are usually unmethylated (Figure 1.1A). These 
regions display relatively high GC content as well as less CpG depletion, probably 
due to the lack of DNA methylation(Bird et al, 1985; Cross et al, 1994). 
Approximately 60% of annotated gene promoters are CpG islands, which points to 
their function in gene regulation (Larsen et al, 1992; Saxonov et al, 2006; Zhu et al, 
2008). DNA methylation of CGIs leads to stable silencing of associated promoters 
and is implicated in developmental gene regulation (Figure 1.1A) (Deaton & Bird, 
2011).  



























A  Distribution of methylcytosine
PB
Figure 1.1 DNA methylation
A: Distribution of 5meC. Methylated and unmethylated CpG dinucleotides are 
indicated by black and white lollipops respectively. Most of the genome is 
methylated at CG dinucleotides (intergenic and intragenic CG dinucleotides). This 
has resulted in depleted levels of CG dinucleotides due to frequent spontaneous 
deamination of 5meC to thymidines. Exception to this are CpG islands (CpG rich 
regions) which are usually located at promoter regions. CpG islands are usually 
unmethylated, unless they are involved in developmental regulation of gene activity. 
CpG islands have been recently found to occur outwith annotated gene promoters 
(orphan CpG islands). These could be indicators for novel promoters. B: Murine 
DNA methyltransferases. Domain annotation (to scale) of maintenance DNA 
methyltransferase DNMT1, de novo DNA methyltransferasese DNMT3A and 
DNMT3B, catalytically inactive family members DNMT3L and DNMT2. PB: 
PCNA binding domain; CXXC: DNA binding domain; BAH: bromo-adjacent 
homology domain required for protein-protein interactions; GK: Glycine-Lysine 
repeats may be required for targeting of DNMT1 to DNA close to replication forks; 
PWWP: required for chromatin targeting; ADD: ATRX-DNMT3-DNMT3L cysteine 
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CpG islands which do not overlap with annotated gene promoters have been termed 
orphan CpG islands (Figure 1.1A). A lot of these orphan CpG islands have now been 
shown (through co-localization with RNA Polymerase II and RNA sequencing data) 
to be unidentified transcription initiation sites (Illingworth et al, 2010). 
Substantiating the presence of orphan CGIs at promoters, is the presence of bound 
RNA polymerase II (RNA PolII)  as well as RNAs initiating at these orphan CGIs 
(Guttman et al, 2009; Illingworth et al, 2010).  
In addition to CGI promoters, 40-50% of all promoters do not overlap with 
CpG islands. This class of promoters has been less studied but recent work has 
confirmed similar effect of DNA methylation at non-CGI promoters as at CGI 
promoters (Han et al, 2011).  
Gene bodies, unlike promoter regions often display high levels of DNA 
methylation, especially within highly transcribed regions (Figure 1.1A). This 
methylation may function to prevent aberrant transcription initiation within the gene 
body or aid in mRNA splicing (Figure 1.1A) (Laurent et al, 2010).  
1.2.3 DNA methyltransferases 
Members of the DNA methyltransferase enzyme (DNMT) family establish 
and maintain DNA methylation. The first member of the family identified was 
DNMT1, closely followed by DNMT2, DNMT3A, DNMT3B and DNMT3L (Bestor 
et al, 1988; Gruenbaum et al, 1982; Okano et al, 1998b; Van den Wyngaert et al, 
1998; Yoder & Bestor, 1998) (Figure 1.1B). With the exception of DNMT3L, all 
these enzymes, contain C-terminal conserved catalytic domains which have been 
shown to be essential for their activity as methyltransferases (Cheng, 1995; Cheng & 
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Blumenthal, 2008; Jeltsch, 2002; Jurkowska et al, 2011). The catalytic domain 
contains six conserved motifs with I and X involved in cofactor binding and IV, VI, 
VIII in catalytic activity. A non-conserved region in the middle of the catalytic 
motifs is involved in ensuring target specificity (Cheng, 1995; Cheng & Blumenthal, 
2008; Jeltsch, 2002).The N terminal regions of DNMTs are responsible for protein-
protein interactions, targeting and regulation of these enzymes (Jurkowska et al, 
2011). 
Maintenance DNA methyltransferase - DNMT1 
The first identified DNA methyltransferase preferentially binds 
hemimethylated DNA and shows reduced specificity to unmethylated DNA (Fatemi 
et al, 2001). It has been suggested that unmethylated DNA binding to the N terminal 
portion of DNMT1 may lead to an allosteric inhibitory effect on enzymatic activity 
(Bacolla et al, 1999). Interaction between the N- and C-termini of the enzyme leads 
to allosteric activation (Fatemi et al, 2001).  
The major function of DNMT1 is in maintaining DNA methylation during 
cell division, but involvement in de novo methylation has also been demonstrated in 
conjunction with de novo methyltransferase DNMT3A (Bestor et al, 1988; Fatemi et 
al, 2002; Gowher et al, 2005b; Pradhan et al, 1999).Consistent with its role in 
maintenance methylation DNMT1 localizes diffusely during most of the cell cycle, 
but to replication foci in S phase and interacts with Proliferating Cell Nuclear 
Antigen (PCNA) at replication forks (Iida et al, 2002; Leonhardt et al, 1992; Margot 
et al, 2001). In addition to this, it localizes to centromeric heterochromatin, even after 
S phase, indicating a replication independent role of DNMT1 (Easwaran et al, 2004).  
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Expression patterns of DNMT1 reflect its DNA maintenance methylation 
role. It is highly expressed in proliferating cells and tissues (Robertson et al, 1999) 
and expression levels of Dnmt1 reach maximum levels during S phase of the cell 
cycle (Robertson et al, 2000; Szyf, 2001). Additionally, different isoforms of 
DNMT1 exist and are tissue specifically expressed. DNMT1O is the more stable 
oocyte specific form of the enzyme (Ding & Chaillet, 2002). Both maternal and 
zygotic DNMT1 seem to be required for imprinting maintenance in the embryo 
(Hirasawa et al, 2008).  
Disruption of DNMT1 leads to gradual demethylation of the genome, loss of 
imprinting, defects in X chromosome inactivation and early embryonic lethality 
(Beard et al, 1995; Howell et al, 2001; Li et al, 1993; Li et al, 1992). Additionally, 
DNMT1 has been linked to tumorigenesis, playing a role in proliferation and survival 
of cancer cells (Chen et al, 2007). ES cells on the other hand are viable but die upon 
differentiation (Li et al, 1992; Tsumura et al, 2006). This may point to a mechanism 
in ES cells to maintain stable heterochromatin in absence of DNA methylation.  
De novo DNA methyltransferases DNMT3A/3B 
DNMT3A and DNMT3B are similar in structure to each other, with 
DNMT3B having a shorter N terminal domain (Figure 1.1B). DNMT3A and 
DNMT3B are the major de novo DNA methyltransferases but have also been 
implicated in maintenance methylation of repetitive elements in co-operation with 
DNMT1 (Liang et al, 2002). Consistently, unlike DNMT1, neither of these enzymes 
show preference for unmethylated or hemimethylated DNA (Okano et al, 1998a).  
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Initially thought to be redundant in function, DNMT3A and DNMT3B also 
have non overlapping functions. These are illustrated by differences in phenotypic 
effects of knockout in embryos and ES cells (Okano et al, 1999). DNMT3A 
knockout embryos develop to term, but die shortly after birth. DNMT3B knockout 
embryos on the other hand die at embryonic day 9.5 (E9.5). Knockout ES cells are 
viable, suggesting DNA methylation is not required for self-renewal properties of ES 
cells (Tsumura et al, 2006). Additionally, DNMT3A but not DNMT3B knockout 
shows germ line specific defects in imprinting in the male and female germ line 
(Kaneda et al, 2004).  
Expression patterns of DNMT3A and DNMT3B enzymes reflect their roles 
in de novo methylation. They are both expressed highly in embryos and 
undifferentiated ES cells, at which time a lot of de novo DNA methylation events 
occur, and less expressed in somatic cells (Okano et al, 1998a). Similarly to DNMT1, 
different isoforms of DNMT3A and DNMT3B exist. Especially in the case of 
DNMT3B the full length enzyme (DNMT3B1) is expressed at higher levels in ES 
cells whereas isoforms lacking several exons are expressed in somatic cells (Okano 
et al, 1998a). These exons are suggested to be required for correct embryonic 
development. In addition to their function in cytosine methylation within the CpG 
context, both enzymes have recently been implicated in non CpG methylation 
(Gowher & Jeltsch, 2001; Ramsahoye et al, 2000). Consistent with their high 
expression in ES cells, non-CG methylation is most prevalent in these (Ramsahoye et 
al, 2000). 
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Non-canonical DNA methyltransferases 
Two structurally and functionally non-canonical members of the DNA 
methyltransferase family are DNMT2 and DNMT3L. DNMT2 is only comprised of 
the catalytic domains characteristic of DNMT family members (Figure 1.1B). It is 
the only mammalian DNA methyltransferase which does not have an N terminal 
domain involved in targeting and regulation of the enzyme. Transfer RNAs (tRNAs) 
have been identified as DNMT2 targets, but only weak methylation activity towards 
DNA has been shown (Hermann et al, 2003; Jurkowski et al, 2008; Tang et al, 2003)  
In contrast to DNMT2, DNMT3L has an N-terminal as well as a C-terminal 
domain (Figure 1.1B). It is catalytically inactive, functioning as a regulator of DNA 
methylation, predominantly in germ cells (Hata et al, 2002). DNMT3L has been 
shown to directly interact with DNMT3A and DNMT3B catalytic domains and 
stimulate their activity (Chedin et al, 2002; Gowher et al, 2005a). Consistently 
DNMT3L localization is dependent on DNMT3A and DNMT3B (Nimura et al, 
2006). DNMT3L functions specifically together with DNMT3A in ensuring correct 
DNA methylation at imprinted regions (Hata et al, 2002). Dnmt3l Knockout mice are 
viable but males are sterile due to defects in meiosis leading to loss of germ cells and 
females fail to produce viable offspring (Bourc'his & Bestor, 2004).  
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1.2.4 Effectors of DNA methylation 
DNA methylation can cause gene repression in two ways: Firstly by directly 
preventing transcription factor binding and secondly through recruitment of effector 
proteins. Effector binding can lead to recruitment of large co-repressor complexes to 
aid the establishment of a state repressive to gene transcription and other functions. 
Three families of methylated DNA binding proteins have been identified. These 
include MBD proteins (MBD1, MBD2, MBD3, MBD4 and MeCP2), Kaiso family 
proteins (Kaiso, ZBTB4, ZBTB38) and SRA family proteins (UHRF1 and UHRF2) 
(Figure 1.2). 
MBD family 
All MBD family proteins have a conserved methyl CpG binding domain 
(MBD). MBD3 has a mutation in this domain, rendering it unable to bind methylated 
DNA (Hendrich & Bird, 1998). MeCP2, MBD1 and MBD2 also have transcription 
repression domains (TRD). Apart from these conserved domains, each family 
member has distinguishing additional domains. MBD1 for example contains up to 3 
CxxC domains depending on the splice variant. CxxC domains have been previously 
characterised to bind unmethylated DNA but only the most C terminal domain in 
MBD1 shows this binding affinity (Jorgensen et al, 2004). MBD2 and MBD3 
contain coil-coil motifs involved in protein-protein interactions. MBD4 has a more 
distinctive glycosylase domain involved in nucleotide excision repair, especially 
directed at repairing spontaneous deamination products of 5meC (Hendrich et al, 
1999). Consistently, MBD4 deficient mice show increased levels of 5meC 
deamination products throughout the genome (Hendrich et al, 1999; Millar et al, 
2002; Wong et al, 2002). 











































Figure 1.2 Methylated DNA binding proteins
Domain annotation of murine methylated DNA binding proteins (drawn to scale 
within families). MBD, Kaiso and SRA family proteins are shown. Different 
domains are indicated. MBD: methylated DNA binding domain; TRD: transcription 
repression domain; CxxC-Zn: DNA binding domain (third CxxC domain in MBD1 
allows binding to unmethylated DNA); GR: Glycine-Lysine repeats; CC: coil-coil 
domain; E(12): Glutamic acid repeats; Glycosylase: Domain required for base 
excision DNA repair; BTB/POZ: binds methylated DNA; ZF: zinc finger domains 
required for methylated DNA and sequence specific DNA binding; PHD: Plant 
Homeo Domain involved in binding to unmodified and modified histone tails; SRA: 
Set and Ring associated domain required for binding to 5meC; RING: Really 
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MeCP2 is the most studied methyl binding protein due to mutation in its MBD and 
TRD domains leading to a neurological disorder called Rett syndrome (Amir et al, 
1999; Cheadle et al, 2000). Its most studied function is transcriptional repression 
consistent with binding to methylated DNA and recruitment of co-repressor 
complexes. Despite this, MeCP2 null mice with Rett syndrome only display small 
changes in gene expression (Tudor et al, 2002). This gave rise to a series of studies 
investigating potential other roles. MeCP2 to date has for example been found to 
associate with splicing factors and also localizes to many actively transcribed genes 
as well as interacts with transcriptional activator  CREB1 (Chahrour et al, 2008; 
Yasui et al, 2007; Young et al, 2005). Additionally, a chromatin architectural role of 
MeCP2 has also been proposed, independent of methylated DNA binding (Georgel et 
al, 2003). MBD1 and MBD4 on the other hand both bind to factors involved in DNA 
repair (Bellacosa et al, 1999; Watanabe et al, 2003). 
Kaiso family 
KAISO family proteins all share a conserved triple zinc finger domain 
involved in methylated DNA and sequence specific DNA binding (Sasai et al, 2010). 
ZBTB4 and ZBTB38 contain extra zinc finger motifs (Filion et al, 2006). The second 
characteristic domain present in KAISO family members is the POZ/BTB domain, 
implicated in protein-protein interaction and transcriptional repression (Perez-
Torrado et al, 2006).  
ZBTB4 and ZBTB38 are seen to localize to dense heterochromatin in a DNA 
methylation dependent manner, supporting their transcription repression role in 
reporter assays (Sasai & Defossez, 2009). Apart from binding co-repressors, KAISO 
                27
has also been found to localize to centromeres and spindle microtubules pointing 
towards a new role in mitosis (Soubry et al, 2010).  
SRA family 
SRA family members contain SRA domains implicated in hemi-methylated 
5meC binding, Tandem Tudor and PHD finger domains which bind modified 
histones and a RING ubiquitin ligase domain (Bostick et al, 2007; Johnson et al, 
2007; Karagianni et al, 2008; Nady et al, 2011; Wang et al, 2011; Xie et al, 2012).  
UHRF1 is the most characterized SRA protein family member. UHRF1 
accumulates at heterochromatic loci in a hemimethylated DNA dependent manner. 
Consistent with its binding to hemimethylated DNA, UHRF1 is found to interact 
with PCNA, DNMT1 and G9A (Bostick et al, 2007; Karagianni et al, 2008; Sharif et 
al, 2007; Uemura et al, 2000). The suggested mechanism of function is not 
recruitment of DNMT1, but facilitation of maintenance methylation by DNMT1. It 
has been proposed that UHRF1 may ‘flip’ out the unmethylated cytosine during 
replication making it more accessible to DNMT1 (Arita et al, 2008; Hashimoto et al, 
2008).  
1.2.5 Developmental dynamics of DNA methylation 
The embryonic lethal phenotypes of DNMT knockouts discussed above point 
to a developmentally important role of DNA methylation. DNA methylation has 
been found to be implicated in early cell lineage specifications, imprinting and X 
chromosome inactivation in early embryos. There are two stages during mammalian 
development at which DNA methylation reprogramming facilitates establishment of 
these processes (Figure 1.3) (Feng et al, 2010; Saitou et al, 2012).  
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The first DNA methylation reprogramming event occurs in the pre-
implantation embryo (Figure 1.3). Between the one cell and the blastocyst stage the 
genome undergoes major DNA demethylation. The paternal genome is more highly 
methylated. A recent study identified the oocyte genome to already be relatively 
hypomethylated and more similar to early embryonic stages than the sperm genome 
(Smith et al, 2012). It is thought that the paternal genome may undergo active DNA 
demethylation before the first S phase followed by passive demethylation of the 
maternal genome. Consistently, the transition between the sperm genome and the 
blastocyst shows most differences in DNA methylation whereas the oocyte genome 
shows fewer changes in methylation during reprogramming. 
Some regions have been shown to resist DNA demethylation. These include 
imprinted differentially methylated regions (DMRs) which have to be stably 
maintained throughout development after their establishment in the germ line. A 
recent study expanded on the idea that imprinted DMRs resist DNA demethylation 
and showed that boundary regions of DMRs do undergo demethylation by the 
blastocyst stage (Tomizawa et al, 2011).  
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Additional germ line specific methylated regions have recently been identified to 
partially resist DNA methylation (Kobayashi et al, 2012; Smith et al, 2012). 
Especially oocyte specific methylated CGIs have been identified, which partially 
resist DNA demethylation (Smallwood et al, 2011). Moreover repetitive elements 
have also for a long time been thought to remain methylated at this stage, to ensure 
genome stability, but recent studies point towards repeat elements such as long 
interspersed repeats (LINEs) and short interspersed repeats (SINEs) losing DNA 
methylation (Kobayashi et al, 2012; Smith et al, 2012). The above described recent 
finding give rise to additional complexity as to how DNA methylation and de 
methylation occur at certain regions. 
After genome wide DNA demethylation has reached its low point in the 
blastocyst, DNA re-methylation events occur to facilitate various processes (Figure 
1.3). Random X chromosome inactivation occurs upon differentiation of the inner 
cell mass (ICM). This is accompanied by loss of pluripotency, methylation and 
silencing of germ line specific and other tissue specific genes. An indication that this 
may in turn allow differentiation between different lineages comes from evidence 
that de novo methylation occurs in the ICM, but not cells destined to become part of 
the extraembryonic tissues (Figure 1.3). Additionally it has been found that the 
majority of genes methylated are germ line specific genes, leading to their 
transcriptional silencing (Borgel et al, 2010; Isagawa et al, 2011). This may point to 
divergence at this stage from a germ line methylation landscape. This is supported by 
a recent study looking at methylation patterns during differentiation of embryonic 
stem cells into the three early germ layers (Isagawa et al, 2011). All germ layers 
showed widespread methylation and silencing of germ line specific genes. 
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Differences in DNA methylation between germ layers on the other hand did not 
correspond to expression changes. This is an indication that further lineage 
differentiation may require other elements apart from DNA methylation.  
The second reprograming event occurs during germ line specification (Figure 
1.3). The blastocyst in the early embryo consists of the trophectoderm, primitive 
ectoderm and primitive endoderm (Rossant & Tam, 2009). The primitive ectoderm, 
gives rise to the epiblast whose cells differentiate into somatic cells as well as 
primordial germ cells (Rossant & Tam, 2009). Primordial germ cells are specified in 
the post implantation epiblast. At this stage methylation at imprinted regions and 
repetitive sequences is present and X inactivation has occurred (Saitou et al, 2012). 
During migration of germ cells to the genital ridge, reprogramming of germ cells 
occurs. This involves reactivation of the inactive X chromosome, imprinted region 
and repeat element DNA methylation erasure, re-establishment of pluripotency and 
subsequent specification of male and female germ cells (Saitou et al, 2012). DNA 
methylation after this stage ensures correct parental specific DNA methylation at 
imprinted regions. 
1.3 DNA packaging into chromatin 
Up to this point I have discussed DNA methylation in context of naked DNA, 
rather than regarding DNA as part of a more complex environment. In mammalian 
cells approximately 3 billion base pairs of DNA have to be packaged into the 5-10 
µm nuclear compartment. To achieve this, DNA undergoes several levels of 
condensation (Figure 1.4).  
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The first level involves wrapping of the DNA double helix 1.75 times around a core 
histone protein octamer to form a nucleosome (Kornberg, 1974; Woodcock et al, 
1976). The histone octamer consists of one H3/H4 tetramer and two H2A/H2B 
dimers (Luger et al, 1997). Core histones are positively charged and globular in 
structure apart from their protruding N-terminal tails, facilitating the wrapping 
around of DNA, resulting in up to 10 fold compaction. Like beads on a string 
nucleosomes are spaced by linker DNA which can be bound by linker histone H1. 
Unlike the globular core histones, histone H1 has a more extended structure which 
allows it to bind to both the linker DNA as well as the core histones. Binding of H1 
results in final wrapping of DNA twice around the histone octamer (Bednar et al, 
1998; Caterino & Hayes, 2011) (Figure 1.4). 
Histone H1 is also thought to promote the next level of compaction from a 
10nm nucleosomal array into more highly compacted fibres. The exact way DNA is 
compacted after the 10nm stage is still disputed. For a long time a few models of so 
called 30nm fibres were pursued. These included the solenoid model, as well as the 
twisted ribbon and crossed-linker models (Figure 1.4) (Finch & Klug, 1976; 
Horowitz et al, 1994; Woodcock et al, 1984). Crosslinking experiments between 
nucleosomes have now suggested the existence of all three above models in one 
30nm fibre (Grigoryev et al, 2009).  
Throughout recent years more precise studies have indicated the uncertainty 
of existence of the 30nm fibre, at least on its own. Different types of compaction are 
seen in the case of nucleosomal arrays with different linker lengths (Perisic et al, 
2010; Routh et al, 2008). Additionally chromosome conformation capture (3C) 
experiments have suggested the existence of a combination of 10nm and 30nm 
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chromatin segments (at variable proportions) as well as interactions between 
different chromatin fibres (Lu et al, 2006). Most recently a study demonstrated the 
irregular folding of nucleosome fibres, rather than a more rigid 30nm structure 
(Nishino et al, 2012). The varied models outlined above are discussed in a thorough 
recent review on chromatin structure and demonstrate the continued need for caution 
when proposing models for higher order structure (Bian & Belmont, 2012).  
Compaction of chromatin to the extent outlined above would make it highly 
inaccessible to regulatory factors and therefore functionally repressed. This gives rise 
to the question, how different regions of the genome are intricately regulated in 
different cells and at different stages during development. Analyses of the density of 
chromatin in the whole cell have shed light on this issue. Not all parts of the genome 
are condensed to the same extent (Elgin & Grewal, 2003; Trojer & Reinberg, 2007). 
This is readily visible by cytological staining as very densely compacted 
heterochromatin and less compacted euchromatin. Euchromatin is gene rich, 
transcriptionally active and to a large extent decompacted, showing irregular 
nucleosomal spacing (Elgin & Grewal, 2003). It is useful to consider two types of 
heterochromatin: constitutive  heterochromatin which is permanently condensed, 
gene poor and repeat rich (e.g. centromeric DNA) and facultative heterochromatin 
which is less tightly locked into the compact state (e.g. developmentally regulated 
genomic regions and the inactive X chromosome) (Elgin & Grewal, 2003; Trojer & 
Reinberg, 2007). Whereas centromeric and telomeric DNA is constitutively 
compacted, facultative heterochromatin and euchromatin undergo dynamic changes 
depending on cell type and developmental timing.  
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This variability and dynamics in chromatin structure demonstrates the need 
for mechanisms to allow transitions between different chromatin states. DNA 
methylation, is normally associated with the transition to a repressed chromatin state, 
though the ability of DNA methylation on its own to generate structural changes in 
chromatin is unclear. Additionally, there is the question of how DNA methylation is 
targeted to genomic regions. A recent study demonstrated the inhibitory effect of 
nucleosomes on methylation of DNA, revealing that linker DNA was readily 
methylated, whereas nucleosomal DNA remained largely unmethylated (Felle et al, 
2011). This suggests, that even relatively ‘open’ chromatin may still be inhibitory to 
DNA methyltransferases as well as other regulatory factors.  
Several epigenetic mechanisms of regulation of nucleosomal DNA have been 
identified. These include post-translational modification of histone proteins, as well 
as moving, removing and exchanging whole or parts of histone octamers by 
chromatin remodelling ATPases. 
1.4 Histone modifications 
Histones can be modified on their N-terminal tails, which protrude from the 
nucleosome. Although histone tail modifications comprise the majority, some 
modifications have also been found to occur within the globular domain (Williams et 
al, 2008). Histone N-terminal tails can be variously acetylated, methylated, 
phosphorylated, ubiquitinated, sumoylated, biotinylated and ADP-ribosylated. The 
best characterized modifications are lysine acetylation and methylation and serine 
and threonine phosphorylation. The result of these modifications can be a change in 
the charge of histone proteins and therefore their interaction with DNA. Lysine 
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acetylation for example reduces the positive charge of histones and therefore 
interaction with DNA, resulting in a more open conformation of chromatin (Shogren-
Knaak et al, 2006). A more common effect of histone modifications is the generation 
or inhibition of binding sites for effector proteins.  
Histone modifications are involved in many different functional pathways. A 
‘histone code’ has been proposed which links different combinations of histone 
modifications to specific functional outcomes such as gene activation or repression 
(Munshi et al, 2009) (Figure 1.5A). Histones can for example be mono-, di-, or tri-
methylated and each of these marks can give rise to different functional effects. This 
is epitomised by methylation of Histone 4 lysien 20 (H4K20). Different histone 
methyltransferases cause different levels of methylation on this histone residue 
(mono-, di- and tri methylation), leading to implication in different functions such as 
cell cycle progression, chromosome condensation, DNA damage and transcription 
regulation (Wang & Jia, 2009). 
1.4.1 Distribution of histone modifications and transcriptional activity 
Studies into the distribution of histone modifications across eukaryotic genes 
have in the past defined distinct profiles at active and inactive genes (Figure 1.5B). 
H3K4 methylation is usually found at active genes, with H3K4me2 across the gene 
body, whereas H3K4me3 has a more confined localization at the transcription start 
sites of genes (Bernstein et al, 2005). Additionally, H3K9 acetylation is also 
characteristic of active genes (Liang et al, 2004).  
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Figure 1.5 Histone modifications
A: Histone modifications and functions. Displayed is a nucleosome with protruding 
histone protein N-terminal tails. Positions of amino acid residues and their potential 
chemical modifications are indicated by the one letter amino acid abbreviation as 
well as a modification symbols. Modification symbols are explained underneath. The 
most well studied histone modifications are coloured. Functions of these are 
annotated next to the residues. B: Distribution of histone modifications along active 
and inactive genes. Coloured shading indicates which region of a gene is associated 
with histone modifications indicated within the shaded region.
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Inactive genes on the other hand show characteristic accumulation of H3K27me3, 
H3K9me2/3 and/or H4K20me3 marks throughout the gene body as well as at the 
promoter (Cao et al, 2002; Rice et al, 2003). This simple overview of distribution of 
histone modifications is consistent with functions allocated to different histone 
modifications in the histone ‘code’.  
An increasing number of studies demonstrate a more complex nature of 
interaction between histone modifications at active and inactive genes. One of the 
most striking discoveries was the presence of H3K9me2/3 (a repressive mark) 
throughout active genes, apart from transcription start sites (Vakoc et al, 2005; 
Vakoc et al, 2006). Additional studies identified the presence of repressive marks 
H3K36me3, H3K27me1 as well as H3K20me1 throughout active genes, excluding 
transcription start sites (Carrozza et al, 2005; Vakoc et al, 2006). Consistently, SET2 
histone methyltransferase responsible for H3K36 methylation has been found to 
interact with the elongating RNA PolII. Several studies have now pointed towards a 
function of H3K36 methylation in suppressing aberrant transcription initiation by 
RNA Pol II throughout transcribed genes (Carrozza et al, 2005; Joshi & Struhl, 2005; 
Keogh et al, 2005; Kizer et al, 2005). A very recent study demonstrates that H3K36 
methylation prevents histone exchange throughout gene bodies. Histone exchange is 
normally a co-transcriptional event to introduce acetylated histones. This is essential 
for repressing aberrant transcription initiation within transcribed gene bodies 
(Venkatesh et al, 2012).  
Another interesting discovery was the co-localization of H3K4me3 and H3K9 
acetylation at most gene promoters in human embryonic stem cells, independent of 
their transcription status (Mikkelsen et al, 2007). These so called bivalent chromatin 
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states have been found to occur widely in mouse ES cells, with enrichment of 
H3K4me3 and H3K27me3 marks at gene promoters poised for expression(Bernstein 
et al, 2006; Mikkelsen et al, 2007). Mikkelsen et al. identified that transcription of 
most of these promoters was initiated, but inactive genes contained paused RNA 
Polymerase which did not elongate. The above examples highlight a complex system 
of interactions between histone modification marks, to regulate the gene activity 
status. 
1.4.2 Effectors of histone modifications and crosstalk 
The most common mechanism for histone modifications to cause changes in 
downstream functions is to provide binding platforms for effector proteins (Figure 
1.6). This can cause the recruitment of other co-repressor/co-activator complexes 
(such as Polycomb Repressive Complex 2 by H3K27me3 and Chd1 by H3K4me3) 
(Torok & Grant, 2006). Proteins that recognize histone modifications are often 
enzymes themselves, which can catalyse additional histone modifications with 
similar functional outcome. Often a prerequisite for the functions of these enzymes is 
their binding to an already established modification. An example occurs during 
Polycomb mediated silencing of developmental genes discussed in more detail 
below. In this case Polycomb repressive complex 1 (PRC1) can be recruited to 
previously established H3K27me3 marks by Polycomb repressive complex 2 (PRC2) 
(Figure 1.6A). PRC1 in turn catalyses ubiquitination of H2AK119. Both H3K27me3 
and H2AK119ub are repressive marks.  
  























Figure 1.6 Effectors of histone modifications
A: Histone modifications catalysed by one enzyme can act as recruiting platforms for 
other enzymes, which put in place other histone modifications to support the 
formation of a specific chromatin state. B: Binding of effector proteins can be 
dependent on certain histone modifications. H3K4me3 can recruit coactivator 
complexes such as CHD1 and simultaneously inhibit binding of Suv39h1,NuRD and 
association of DNMT3A/3L complex with chromatin. C: Different histone 
modifications can be involved in crosstalk. H3S10 phosphorulation prevents binding 
of Heterochromatin protein 1 (HP1) to H3K9me3 marks. D: Histone modifications 
can initiate events to propagate a particular chromatin state. G9a histone 
methyltransferase catalyses H3K9me2 and also binds to this mark, ensuring 
continued modification of surrounding histone tails. Suv39h1 catalyses H3K9me3 
during formation of heterochromatin. HP1 binds the H3K9me3 mark and can 
self-dimerize. This may facilitate heterochromatin propagation through repeated 
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In Drosophila additional regulation involves stimulation of H2AK119 ubiquitination 
by PRC1 through H3K36 demethylation by the dRAF complex (Lagarou et al, 2008). 
Initial establishment of a specific chromatin state by binding of co-regulators 
is enhanced by frequent inhibition of recruitment of factors involved in creating 
opposite chromatin environments. H3K4 methylation is seen at active genomic 
regions and recruits CHD1, activator complex. It can simultaneously inhibit H3K9 
methylation by SUV39H1 and prevents binding of the NuRD repressive complex and 
Sir3 silencing factors to H3 tails (Figure 1.6B) (Nishioka et al, 2002; Zegerman et al, 
2002). 
Interesting, additional regulation by histone modifications occurs through 
regulation of recognition of relatively stable histone modifications with the aid of 
more flexible modifications.  This may allow stable modifications to be retained on 
chromatin whilst regulating their recognition at specific times during development or 
the cell cycle. An example is the phosphor switch which involves serine/threonine 
phosphorylation inhibiting binding of effector proteins to specific modified histone 
residues (Figure 1.6C). H3S10 phosphorylation for example is involved in 
chromosome condensation and segregation. During mitosis it inhibits binding of HP1 
to the H3K9me3 mark. This phenomenon can be seen to occur between adjacent 
modifications on the same N-terminal tail or modifications on different tails or 
nucleosomes (Fischle et al, 2005; Hirota et al, 2005)(Fischle et al. 2005; Hirota et al. 
2005). 
Change of a chromatin state is often also accompanied by spreading to 
neighbouring regions. Firstly, enzymes involved in catalysing a particular histone 
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modification often possess binding sites for these modifications. Therefore, once the 
modification is established, these enzymes are retained through binding this 
modification. An example of this is G9a euchromatin histone H3K9 
methyltransferase which contains a catalytic SET domain for H3K9 modification and 
also contains H3K9me3 binding domains (Figure 1.6D) (Collins et al, 2008).  
Effector protein self-dimerization can also facilitate the propagation of chromatin 
states as in the case of HP1. HP1 is recruited to H3K9me3 marks and can, through 
self-dimerization and recruitment of co-repressor complexes, promote propagation of 
heterochromatin. Finally, certain effector proteins have more than one 
chromatin/DNA binding site and can therefore cause bridging between different 
regions (Brasher et al, 2000; Cowieson et al, 2000; Eissenberg & Elgin, 2000). 
1.4.3 Histone modifications in developmental regulation of gene activity – 
PcG  
Histone modifications are proving to be multifaceted regulatory networks of 
different chromatin states. Drawing together all the function of histone 
modifications, the Polycomb repressive complexes (PRCs) are an example of how 
these mechanisms can be applied to developmental regulation of gene activity. 
Polycomb repression is important in silencing of genes in the Hox cluster as well as 
other lineage specific genes. EZH2 within PRC2 causes H3K27me3 at target genes 
(Figure 1.7A) (Kirmizis et al, 2004).  
  





























Figure 1.7 Polycomb complexes and regulation of lineage commitment
A: Outline of polycomb mediated repression. PRC2, consisting of SUZ12, EED and 
EZH2, catalyses the repressive H3K27me3 mark. This histone modification acts as a 
recruiting platform for PRC1 complex, which in turn catalyses H2AK119 
ubiquitination and also recruits accessory proteins such as JARID, to remove the 
H3K4me2/3 active mark from chromatin. B: Many polycomb target gene promoters 
have recently been found to be marked by a bivalent histone modification state 
(H3K4me3 as well as H3K27me3). These bivalent state are though to represent a 
poised chromatin state, allowing rapid activation or continued repression of lineage 
specific genes during differentiation of stem cells.
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PRC1 recognises the H3K27me3 mark through its chromodomain and catalyses the 
ubiquitination of H2A119 (Wang et al. 2004). In conjunction with this, JARID1D, a 
histone demethylase is thought to interact with PRC2 which may regulate its activity 
and causes removal of H3K4me2/3 marks, resulting in a repressive chromatin state 
(Lee et al, 2007; Morey & Helin, 2010; Pasini et al, 2008)(Figure 1.7A). 
Models have been proposed to explain how PRC2 complex is recruited to 
chromatin. Early models suggested PRC2 recruitment by transcription factors via 
Polycomb Repressive Elements (DNA sequence elements) (PREs). PREs have been 
identified in Drosophila melanogaster. They are several hundred base pairs long and 
can be located relatively far away from transcription start sites. They function in 
recruitment of Polycomb group proteins (PcG) through recruitment of transcription 
factors (Ringrose & Paro, 2007). A couple of studies have suggested the presence of 
PREs in vertebrate genomes (Sing et al, 2009; Woo et al, 2010). Still, targeting of 
PcG proteins to these in vertebrates remains uncertain from this study.  
A second model proposes the recruitment of PRC2 through cis- or trans- 
acting non-coding RNAs (ncRNAs). This method of recruitment has now been 
suggested in various recent studies. One example is the ncRNA HOTAIR which is 
involved in transcription repression of the HoxC locus. HOTAIR has been shown to 
recruit PRC2 in trans to the HoxD cluster (Rinn et al, 2007). Consistently, HOTAIR 
binds many PRC2 target genes (Chu et al, 2011). A similar effect is initiated by Xist 
RNA on the X chromosome, during X chromosome inactivation. A non-coding RNA 
(RepA) within Xist was shown to associate with PRC2 components (Zhao et al, 
2008). Additional evidence for a Polycomb recruitment mechanism using RNAs 
comes from studies demonstrating PRC2 association with many other long non-
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coding RNAs (lncRNAs) (Khalil et al, 2009; Zhao et al, 2010). Another interesting 
study revealed that short RNAs transcribed from Polycomb target genes associate 
with PRC2, suggesting RNA mediated recruitment mechanisms to be widespread 
(Kanhere et al, 2010).  
Polycomb complexes are involved in silencing of cell lineage-regulatory 
genes in pluripotent cells (e.g. Hox genes). Many Polycomb target genes have 
recently been found to be occupied by both active and repressive histone marks such 
as H3K27me3, H3K4me3 and H3K9ac (Figure 1.7B). This is now known as a 
bivalent chromatin state (Azuara et al, 2006). Interestingly many of these bivalent 
genes are resolved during differentiation of stem cells into neuronal progenitor cells 
to leave behind either active or inactive genes (Bernstein et al, 2006). Bivalency in 
this case is thought to provide a poised gene expression state, allowing quick 
decision between chromatin states to occur during lineage commitment. 
The outline of post-translational modifications to histones above provides a 
mechanism for initiating changes in chromatin. Since these modifications occur on 
N-terminal tails of histones, they provide mechanisms to recruit activator and 
repressor complexes to relatively compacted regions of the genome. These 
modifications are therefore more versatile than DNA methylation itself. Despite this, 
only a few histone modifications have been shown to alter chromatin structure 
directly, leaving us with the still unanswered question of how more large scale 
chromatin changes can occur. These are required to create nucleosome free regions, 
to allow access to regulatory proteins. As said above, this is necessary at both ‘open’ 
and compacted chromatin. 
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1.5 Chromatin remodelling 
1.5.1 Families of chromatin remodelling ATPases 
Chromatin remodelling is an ATP dependent process carried out by members 
of helicase families (Flaus et al, 2006). Three helicase superfamilies (SF1, SF2, SF3) 
exist, which all contain conserved helicase motifs. SF1 and SF2 are most similar to 
each other, possessing an ATPase domain comprised of two RecA like lobes with 
two alpha-helical protrusions in between, separated by a linker region (Figure 1.8A). 
This ATPase region contains the seven conserved helicase domains.  
The SF2 superfamily can be further subdivided into several families, 
including the Snf2 family (Figure 1.8B). The distinguishing feature of Snf2 family 
members is the lack of the common DNA strand separation ability. Instead family 
members show ATP dependent DNA translocation (Flaus et al, 2006). In support of 
this, the ATPase domain common to all Snf2 family members is very similar to those 
of known DNA translocation enzymes. An additional distinguishing feature is the 
longer helicase domain, which contains an insertion between helicase motifs III and 
IV (Flaus et al, 2006).  
Even further subdivision of the Snf2 family gives rise to distinct subfamilies 
of chromatin remodellers, depending on sequence homology of the helicase domains: 
SWI/SNF, ISWI, INO80/SWR1, NURD/Mi2/CHD (Cairns, 2007; Flaus et al, 2006) 
(Figure 1.8C). 
  

































Figure 1.8 SNF2 chromatin remodelling ATPases
A: Helicase superfamilies. SF1, SF2 and SF3 helicase superfamilies exist. SF1 and 
SF2 superfamilies are most similar to eachother, containing a conserved ATPase 
domain. B: Family of DNA translocases. SF2 superfamily can be subdivided into 
various families, including the SNF2 family of DNA translocases. C: Subfamilies. 
The SNF2 family can be subdivided further into subfamilies of chromatin 
remodelling ATPases: SWI/SNF, ISWI, CHD and INO80.
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All chromatin remodelling enzymes show affinity for nucleosomes, have domains 
that recognize histone modifications and associate with other proteins (e.g. 
transcription factors). Despite this, family members have evolved specialized roles 
which are in part conferred by various additional domains within and outwith the 
ATPase region (Clapier & Cairns, 2009)(Figure 1.8C). Many of these domains have 
been implicated in targeting to chromatin as well as in recruiting factors which 
stimulate ATPase activity. The HSA domain present in both SWI/SNF and INO80 
remodellers binds actin as well as actin related proteins (ARPs), which stimulate 
ATPase activity (Shen et al, 2003; Szerlong et al, 2008). In addition, INO80 family 
members have a distinctive extended linker region between the two RecA lobes (split 
ATPase domain). This allows binding of an additional ARP as well as helicase 
related protein RVB1/2, both of which are required for remodelling activity (Jonsson 
et al, 2004). The SANT-SLIDE domain within the ISWI complex contacts 
unmodified histone tails as well as the DNA itself (Boyer et al, 2004). CHD 
complexes have two tandem chromodomains, which can interact with H3K4me2/3 as 
well as DNA. Similarly, SWI/SNF remodellers have a bromo domain which 
recognizes acetylated histones (Clapier & Cairns, 2009). The above highlights the 
need for different domains to increase remodeller activity as well as to aid 
recruitment of remodellers to chromatin. 
1.5.2 Mechanism of action 
Chromatin remodellers can either reposition or eject nucleosomes or allow 
loading of histone variants. Studies have identified mechanistic differences between 
remodellers, which associate them with the above remodelling functions.   
 

















Figure 1.9 DNA translocation by monomeric chromatin remodeller
A: The chromatin remodeller has a hinge domain (HD), DNA binding domain (DB) 
and a DNA tracking domain (TD). The chromatin remodeller binds to DNA with its 
DNA binding domain (DB) and DNA tracking domain (TD). ATP hydrolysis 
induces a conformational change, allowing the TD to translocate in a 3’ to 5’ 
direction. B: Next, the DB binds further along the DNA to initiate another cycle of 
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SWI/SNF and ISWI remodellers have been most intensely studied with respect to 
their remodelling mechanisms, but all remodellers function using DNA translocation 
mechanisms (Saha et al, 2002; Saha et al, 2005; Whitehouse et al, 2003; Zofall et al, 
2006). A translocation mechanism for monomeric remodellers has been proposed 
which relies on two domains, the DNA tracking domain as well as a DNA binding 
domain (Figure 1.9). DNA translocation is initiated by ATP binding and hydrolysis, 
which induces conformational changes between the RecA motifs of the remodeller 
(Figure 1.9A). This results in the movement of the remodeller tracking domain in a 
3’ to 5’ direction. The DNA binding domain is located in front of the tracking 
domain.  
Once a cycle of ATP binding and hydrolysis has been completed, the DNA 
binding domain can bind further along the DNA and allow another cycle of 
translocation to occur (Figure 1.9B)(Cairns, 2007). This model has been in recent 
years adapted to translocation on the nucleosome surface, minimising steric clashes 
with histone octames, as well as the twist induced in the DNA (Cairns, 2007).  Three 
models of remodeller translocation and DNA movement around the nucleosome have 
been proposed. These are the bulge propagation, twist diffusion and histone core 
swivel models (Figure 1.10) (Bowman, 2010). 
1+10 ratchet model (bulge propagation) 
In this model, the remodeller binds with its hinge domain to the histone core 
(Figure 1.10A). The tracking domain and the DNA binding domain bind 
approximately 1 helical turn apart to the nucleosomal DNA.  
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Twist propagation1 bp DNA movement
A  1+10 ratchet (bulge propagation) model
B  Twist diffusion model










1 bp DNA movement DNA movement
initiates bulge
bulge propagation
Figure 1.10 Mechanisms of DNA movement around histone octamer
A: 1+10 ratchet/bulge propagation model. Remodeller binds with its hinge domain 
to the nucleosome core. The DNA tracking (TR) and DNA binding (DB)  domains 
bind two and three turns away from the axis going through the centre of the 
nucleosome respectively (dashed line). The DNA tracking domain moves 1bp of 
DNA towards the nucleosomal axis. Next, the DB domain binds 10bp further away 
from the TR domain and subsequently pulls DNA towards the tracking domain. The 
final step involves propagation of the DNA loop through the tracking domain. B: 
Twist diffusion model. Initiation of a twist in the DNA helix occurs through 
movement of 1bp of DNA (blue) from linker DNA to a region in between two 
histone-DNA contacts (red). The twist is propagated around the nucleosome. The 
difference to the 1+10 ratchet model is the lack of formation of a big bulge C: 
Histone core swivel model: Remodeller (green) binds two helical turns away from 
the DNA entry site. ATP hydrolysis induces conformational changes which disrupt 
histone-DNA contacts and allow the histone core to move one helical turn towards 
the remodeller. The final stage involves realignment of DNA relative to the histone 
core. 
DB
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The first step is thought to involve a 1 base pair movement of DNA by the 
tracking domain away from the DNA binding domain. In the second step, the DNA 
binding domain binds one helical turn (10bp) further away from the tracking domain 
and pulls DNA towards the DNA tracking domain, at the same time returning to its 
previous position. This produces a DNA loop which is subsequently propagated 
around the nucleosome through the tracking domain (Bowman, 2010; Cairns, 2007).  
Twist diffusion model 
The twist diffusion model involves the remodeller binding and pulling 1bp of 
DNA from the linker DNA into a region between two histone-DNA contacts (Figure 
1.10B)(Bowman, 2010). This induces increased twist into the double helix, which is 
subsequently propagated around the nucleosome. Unlike the bulge diffusion model, 
this method of DNA movement involves minimal disruption of histone-DNA contact 
sites. 
Histone core swivel model 
Unlike the other two models, this model involves rotation of the histone core, 
followed by a realignment of the DNA around it (Figure 1.10C)(Bowman, 2010). 
The remodeller binds two helical turns away from the DNA entry site of the 
nucleosome. ATP hydrolysis by the remodeller is accompanied by a DNA 
conformational change, which makes it favourable for the histone core to move one 
helical turn towards the remodeller. The final stage involves the DNA rewrapping 
with entry and exit sites to the nucleosome being equidistant from the dyad axis.  
The three above described mechanisms can cause differences in bulge size as 
well as amount of force produced. Structural differences in the complex between the 
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remodeller, DNA and histones may make certain remodellers more amenable to a 
specific mechanism. 
ISWI remodellers, for example, require H4 tails to stabilize the ATPase 
domain (Dang et al, 2006). In addition they form extensive contacts with the DNA 
around the nucleosome (Dang et al, 2006). SWI/SNF remodellers in contrast show 
fewer DNA contacts but on the other hand form more extensive contacts with the 
histone core (Dang & Bartholomew, 2007; Dechassa et al, 2008). More extensive 
contacts with histones may allow DNA to be more efficiently pulled from the histone 
surface, creating the characteristic bigger loops of DNA produced by these 
remodellers. Consistently, SWI/SNF remodellers are involved in more dramatic 
remodelling events such as nucleosome ejection or dimer displacement/exchange 
(Bruno et al, 2003; Kassabov et al, 2003).   
An additional contributing factor to the ways of action of remodellers is the 
requirement of linker DNA for efficient remodelling. Studies have shown that ISWI, 
Ino80 and CHD remodelling complexes require a certain length of linker DNA to 
efficiently perform nucleosome remodelling functions (Udugama et al, 2011) 
(Gangaraju & Bartholomew, 2007; Stockdale et al, 2006). Consistently, ISWI and 
Ino80 complexes are involved in nucleosome spacing (Udugama et al, 2011). They 
bind to regions with long linker DNA and dissociate once the nucleosomes have been 
more equally spaced. SWI/SNF complexes on the other hand have been identified 
not to be dependent on linker DNA length (Dechassa et al, 2010). This allows 
SWI/SNF complexes to bind more densely spaced nucleosomes.  
                54
Linker DNA requirement may arise from differences in binding of 
remodellers to the nucleosome. The DNA binding domain of ISWI for example may 
bind to linker DNA rather than within the nucleosomal DNA. Additionally, some 
remodellers have been found to bind as dimers, some as monomers (Hota & 
Bartholomew, 2011). This difference in binding can also be seen within families of 
remodellers (Racki et al, 2009). 
1.5.3 One remodeller, several functions 
Consistent with the diversity in chromatin remodelling mechanisms, 
remodellers are involved in processes such as chromatin assembly, correct spacing of 
nucleosomes after replication, regulation of accessibility to DNA binding factors, 
efficient DNA repair and progression of RNA and DNA polymerases (Clapier & 
Cairns, 2009). Functional diversity of different families of chromatin remodellers 
arises through differential assembly of subunits around a core chromatin remodeller. 
Complexes from each family of chromatin remodellers are outlined in Figure 1.11. 
The ISWI family of remodelling complexes is a good example of this. Seven ISWI 
complexes have been identified to date, all containing either Snf2H or Snf2L ATPase 
isoforms. Difference in functionality is conferred by additional subunits. WICH and 
RSF complexes for example only differ from each other by one subunit. WSTF 
catalyses the phosphorylation of H2AX and therefore implicates the WICH complex 
in DNA damage pathways (Xiao et al, 2009). The RSF complex on the other hand is 
seen to interact with Centromere protein A (CENP-A), regulating centromere 
structure (Perpelescu et al, 2009).  
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Combinatorial assembly of remodeller complex subunits has also been shown to be 
developmentally dependent (Ho & Crabtree, 2010). Extra dimension is added by 
families of proteins which can be exchanged during development. This allows 
assembly of the subunits required for interactions with developmental and cell type 
specific regulators. To date mammalian BAF chromatin remodelling complex within 
the SWI/SNF2 family shows the widest variety of combinatorial assemblies of 
subunits to produce complexes involved at most developmental stages (Ho & 
Crabtree, 2010). BAF complexes can be assembled around either BRG1 or BRM 
chromatin remodellers (Figure 1.11). In addition, many BAF subunits are expressed 
in gene families, whose members can be interchanged to form developmentally 
distinct complexes. BAF complexes are the complexes most involved in early 
development. They are required for maintaining the pluripotent state through 
regulation of the pluripotency transcriptome (Ho et al, 2009a; Ho et al, 2009b). 
Additionally they are also required for differentiation of stem cells into different cell 
lineages (Schaniel et al, 2009).  
1.6 Crosstalk 
1.6.1 Forming DNA methylation and histone modification landscapes 
Altered DNA methylation and histone modifications in cancer 
Establishment of correct DNA methylation landscapes has proven to be 
essential for development. Defects in DNA methylation processes have been linked 
to many human diseases. DNA hypomethylation was the first epigenetic 
modification defect linked to cancer (Feinberg & Vogelstein, 1983). 
Hypomethylation often occurs at repetitive elements, retrotransposons and in gene 
introns, resulting in genome instability through chromosomal rearrangements and 
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high probability of translocations of retrotransposons (Eden et al, 2003; Weber et al, 
2005). Hypomethylation can also affect genic regions, resulting in activation of 
tumour suppressor genes (Feinberg & Vogelstein, 1983). Consistently, DNA 
hypomethylation has been found to increase during tumour formation (Fraga et al, 
2004). Additionally, DNA hypermethylation has been detected at CpG island 
promoters as well as CpG island shores, potentially leading to silencing of tumour 
suppressor genes (Irizarry et al, 2009; Kron et al, 2009; Mori et al, 2006). A recent 
study carried out a DNA methylation fingerprint of 1628 human samples, revealing 
the extensive DNA methylation changes that occur in cancer tissues (Fernandez et al, 
2012). Apart from a direct effect of DNA methylation defects on gene expression in 
tumours, DNA hypermethylation has also been demonstrated to create mutational 
hotspots in somatic cells due to the high mutability of 5meC (Rideout et al, 1990).  
In addition to DNA methylation changes that occur during tumour formation, 
histone modifications also undergo changes. Interestingly, some specific changes in 
histone modifications have been demonstrated to be markers of high risk of 
recurrence of tumours and mortality (Barbisan et al, 2008; Barlesi et al, 2007; 
Seligson et al, 2005). Histone modification changes are often seen on global level, 
rather than being localized. These include global changes in H4K20me3 and H4K16 
acetylation, as well as changes in H3K9 methylation. Histone modification changes 
have been demonstrated to occur in conjunction with DNA methylation changes 
(Fraga et al, 2005; Muller-Tidow et al, 2010; Tryndyak et al, 2006). Additionally, 
tumour types have been found to be distinguishable by expression of histone 
modifying enzymes and co-factors (HDACs, Polycomb, G9a, LSD1) (Bracken & 
Helin, 2009; Chase & Cross, 2011; Kondo et al, 2008) 
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Loss of imprinting disorders 
Other diseases involving DNA methylation defects include a wide range of 
imprinting disorders. Imprinting disorders are accompanied by loss of imprinting 
(LOI). This can occur through gain or loss of DNA methylation or other changes 
resulting in defects in allele specific expression. In many cases LOI has been linked 
to development of cancers. An example is loss of imprinting at the Igf2/H19 gene 
cluster. Gain of expression of Igf2, encoding a growth promoting factor is a common 
cause of cancers, such as Wilms Tumour and Beckwith-Widemann syndrome (Riccio 
et al, 2009). Other imprinting disorders are accompanied by loss of imprinting of 
large clusters of imprinted genes (e.g. PWS and Angelman syndromes) (Robertson, 
2005). 
Repeat instability diseases 
DNA methylation defects have also been linked to repeat instability disorders 
such as Fragile X syndrome. This disorder involves the expansion of a CGG repeat at 
the 5’end of the Fmr1 gene and subsequent hypermethylation of this region, resulting 
in transcription repression of this region (Crawford et al, 2001; Oberle et al, 1991). 
Defects in DNA methylation machinery 
Finally, various well studied diseases arise from mutations in the DNA 
methylation machinery. Systemic Lupus Erythematosus is accompanied by losses of 
DNA methylation and reduced levels of DNMT1 in T cells (Richardson et al, 1990). 
In ICF syndrome individuals, hypomethylation of pericentric heterochromatin is 
visible on certain chromosomes in lymphoid cells. Most disease cases have been 
linked to mutations in Dnmt3b (Hansen et al, 1999; Tuck-Muller et al, 2000; Xu et 
al, 1999). 
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These varied diseases demonstrate the importance of correct establishment of 
DNA methylation landscapes. A question remaining open for study is, how intricate 
DNA methylation patterns are achieved during mammalian development as well as 
in adults. A multitude of studies have highlighted many different DNA sequence 
requirements in targeting DNA methylation. These include CpG density and 
transcription factor binding sites for example. This was especially well highlighted in 
a recent study by Lienert and colleagues, which showed correct establishment of ES 
cell and differentiated ES cell specific DNA methylation marks at ectopic sites, 
through introduction of short sequence elements termed methylation determining 
regions (MDRs) (Lienert et al, 2011) (Meissner, 2011). These regions were sufficient 
to recapitulate endogenous methylation patterns in ES cells as well as during 
differentiation. Despite these sequence determinants of DNA methylation, many 
studies have focused on the co-operation between histone modifications, DNA 
methylation and chromatin remodelling to generate correct epigenetic landscapes.  
One of the earliest examples of histone modification and DNA methylation 
cooperation came in the study of the mutually exclusive nature of DNA methylation 
and H3K4me3. Studies have consistently shown the presence of H3K4me3 at CpG 
island promoters which are devoid of DNA methylation. Recent studies even rely on 
this mark for identification of novel promoters (Illingworth et al, 2010). Consistently, 
certain H3K4 methyltransferases have been found to interact with RNA PolII which 
is mostly present at CpG island promoters in early embryos (Guenther et al, 2007; 
Terzi et al, 2011). DNMT3L has been shown to bind to unmodified H3K4 residues 
and recruit DNMT3A and 3B (Ooi et al, 2007). This interaction between DNMT3L 
and chromatin is disrupted by methylation of H3K4 residues (Meissner et al, 2008; 
                60
Mohn et al, 2008; Okitsu & Hsieh, 2007; Weber et al, 2007). This may provide a 
mechanism of preventing DNA methylation at CpG island promoters in early 
development.  
Additional examples of histone modifications or histone modification 
enzymes influencing DNA methylation have now been described. G9a H3K9 histone 
methyltransferase for example interacts with DNA methyltransferases in the process 
of pluripotency gene silencing as well as in X inactivation (Epsztejn-Litman et al, 
2008; Feldman et al, 2006). Suv39h1/2 histone methyltransferase on the other hand 
recruits DNMT3A/3B at satellite repeats. Consistently, knockout of Suv39h1 in ES 
cells results in reduced DNA methylation levels at centromeric satellite sequences 
(Lehnertz et al, 2003). This may be due to H3K9 methylation serving as a binding 
platform for HP1, which in turn recruits DNA methyltransferases (Fuks et al, 2003; 
Lehnertz et al, 2003). EZH2, a polycomb component has also been identified to 
interact with DNMT3A/B (Vire et al, 2006). Finally, genome DNA methylation 
patterns are also affected by histone acetylation. Inhibition of histone deacetylases by 
TSA results in reduced DNA methylation levels on an ectopically methylated 
sequence in HEK293 cells (Cervoni & Szyf, 2001).  
Conversely, DNA methylation has also been shown to affect histone 
modifications. Maintenance methyltransferase DNMT1 for example is found to 
interact with PCNA and recruit G9a histone methyltransferase to replication foci. 
This is an example of potential maintenance of histone modifications through DNA 
methylation during replication, although in many cases it is still unclear whether 
DNA methylation or histone modifications are the causative marks of a silent 
chromatin state. Many studies have considered DNA methylation to be a long-term 
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silencing mark, established towards the end of a silencing process. A good example 
of this is during X chromosome inactivation.  Repression of genes on the inactive X 
occurs independent of DNA methylation (Keohane et al, 1996; Lock et al, 1987; 
Sado et al, 2004; Wutz & Jaenisch, 2000). Similarly, DNA methylation is thought to 
be the secondary event during pluripotency gene silencing, occurring after the 
establishment of repressive histone marks as well as gene silencing (Feldman et al, 
2006). 
Additionally, crosstalk between DNA methylation, histone modifications 
and chromatin remodelling enzymes have also been shown to be essential for correct 
DNA methylation landscapes. To date, mutations in a few chromatin remodelling 
ATPases have been linked to diseases displaying DNA methylation defects. 
Mutations in the chromatin remodelling ATPase ATRX for example is linked to the 
disease α-thalassemia mental retardation (ATR-X) syndrome, which displays DNA 
hyper- and hypomethylation (Gibbons et al, 2000; Picketts et al, 1996). The crosstalk 
between chromatin remodelling, DNA methylation and histone modifications is 
supported by the interaction of various chromatin remodellers with histone 
modification enzymes as well as DNA methylation machinery or effector proteins. 
The mammalian NURD complexes for example contains histone deacetylase 
subunits, as well as methylated DNA binding proteins (Ho & Crabtree, 2010). 
Additionally, a novel putative chromatin remodelling ATPase (LSH) also forms a 
multisubunit complex together with DNMTs as well as HDACs (Myant & 
Stancheva, 2008). 
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1.6.2 Characterization of non-DNA methyltransferase proteins which 
affect DNA methylation 
Consistent with the above described ways of crosstalk between histone 
modifications, DNA methylation and chromatin remodelling, absence of various 
epigenetic modifiers leads to extensive DNA hypomethylation in murine cell lines as 
well as embryos, similar or even greater than DNA hypomethylation seen in DNMT 
knockouts themselves (Table 1.1). These include chromatin remodellers (ATRX and 
LSH), methylated and unmethylated DNA binding proteins (UHRF1, CGBP), 
histone modification enzymes (G9a and LSD1) as well non-epigenetic proteins 
(SMCHD1, PGC7/STELLA, ZFP576).  Apart from severe DNA methylation defects, 
absence of any of these proteins leads to early developmental defects, culminating in 
embryonic lethality (Table 1.1). Some of these proteins have been extensively 
studied, revealing their function in facilitating correct establishment and maintenance 
of DNA methylation. ZFP57 for example is required for correct maintenance of 
DNA methylation at imprinted regions established in the germ line (Li et al, 2008). 
UHRF1 has also been implicated in facilitating maintenance of DNA methylation, in 
association with G9a at replication forks (Zhang et al, 2011). CGBP and LSD1 are 
both implicated in regulating DNMT1 levels and stability respectively (Carlone et al, 
2005; Wang et al, 2009).  
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Table 1.1 Functions and knockout phenotypes of non-DNA methyltransferase 
proteins which affect DNA methylation 
 
Studies into some of the above proteins have indicated the possible 
requirement of different proteins to facilitate DNA methylation at different genomic 
regions (e.g. ZFP57 at imprinted regions). Regulation of these proteins may therefore 
highlight a way to provide DNA methyltransferases with increased specificity to 
different regions at different stages of development. Despite this, few of these 
proteins have been studied to determine in detail their genome wide DNA 
methylation targets, especially in protein coding regions. In the long term, genome 
wide studies such as these will be important in confirming whether different proteins 
indeed provide a mechanism to target DNA methyltransferases to distinct genomic 
regions. In the long term, full characterization of protein coding gene target regions 
of such proteins may allow us to further elucidate how different genomic regions are 
targeted for DNA methylation or protected from it during various methylation 
reprograming events during early development, as well as in adult life. 
My study therefore focused on further characterizing the role of three such 
proteins in DNA methylation. These included: Putative chromatin remodelling 
ATPase LSH whose mechanism of function in DNA methylation has not yet been 
fully characterized. Secondly, Smchd1, a structural maintenance of chromosomes 
domain containing protein which has recently been implicated in DNA methylation 









Hypomethylation of X 
linked CpG islands 
(Blewitt et 
al, 2008) 
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which has been more extensively studied, but whose genome wide protein coding 
targets have not yet been fully characterized either. During my study I aimed to 
answer three broad questions. More specific questions will be outlined in each 
chapter. 
1.7 Aims 
1. At which gene promoter regions do LSH, G9a and SmcHD1 facilitate DNA 
methylation. 
 
2. Do LSH, G9a and SmcHD1 facilitate DNA methylation at different or 
overlapping groups of promoters. 
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Chapter 2 - Materials and Methods 
2.1 Materials 
2.1.1 Protein analysis Buffers 
NE1: 20 mM Hepes pH 7.0, 10 mM KCl, 1 mM MgCl2, 0.1% (v/v) Triton X-100,  
20 % (v/v) glycerol. 0.5 mM DTT and complete protease inhibitors (Sigma) were 
added at time of use. 
NE2: 20 mM Hepes pH 7.0, 420 mM NaCl, 10 mM KCl, 1 mM MgCl2, 0.1 % (v/v) 
Triton X-100, 20 % (v/v) glycerol. 0.5 mM DTT and complete protease inhibitors 
(Sigma) were added at time of use. 
Ponceau S staining solution: 1 % (v/v) glacial acetic acid, 0.5 % (w/v) Ponceau S 
Coomassie Brilliant Blue R-250 staining solution: 30 % (v/v) methanol, 10 % 
(v/v) glacial acetic acid, 0.1 % (w/v) Coomassie Brilliant Blue R-250 
SDS PAGE loading buffer (5): 225 mM Tris-HCl pH 6.8, 50 % glycerol, 5 % 
SDS, 0.05 % bromophenol blue. 250 mM DTT was added at time of use  
SDS Separating gel: 0.1 % SDS, 0.05 % ammonium persulfate, desired 
concentration of acrylamide and 375 mM Tris pH 8.8 and made up to 10 ml with 
dH2O.  
SDS Stacking gel: 0.1 % SDS, 0.05 % ammonium persulfate, 4 % Acrylamide, 125 
mM Tris pH 6.8 and made up to 10 ml with dH2O. 
Transfer buffer: 25 mM Tris, 250 mM Glycine. 
IPTG stock: 1 M IPTG was prepared in dH2O, filtered through 0.2 um filter and 
stored at -20 degrees 
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Sodium Phosphate Buffer for MBD purification: 1 M sodium phosphate buffer 
(pH 8) was prepared by mixing 26.5 ml 2 M mono-sodium phosphate solution, 473.5 
ml di-sodium phosphate solution and 500 µl H2O. 
Lysis/Binding Buffer for MBD purification: 50 mM Sodium Phosphate Buffer 
(pH8), 300 mM NaCl2, 10 % Glycerol, 10 mM Imidazole, 0.5 mM PMSF 
Wash Buffer for MBD purification: 50 mM Sodium Phosphate Buffer (pH 8), 300 
mM NaCl2, 10 % Glycerol, 20 mM Imidazole, 0.5 mM PMSF 
Elution Buffer for MBD purification: 50 mM Sodium Phosphate Buffer (pH 8), 
300 mM NaCl2, 10% Glycerol, 250 mM Imidazole, 0.5 mM PMSF 
Wash buffer 1 for MBD column packing: 20 mM HEPES, 0.1 M NaCl2, 0.1 % 
Triton, 10 % Glycerol, 0.5 mM PMSF 
Wash buffer 2 for MBD column packing: 20 mM HEPES, 0.1M NaCl2, 0.1 % 
Triton, 10 % Glycerol, 0.5 mM PMSF, 10 mM Imidazole 
MBD column run buffer A: 20 mM HEPES pH 7.5; 0.1 % Triton; 10 % Glycerol; 
0.5 mM PMSF 
MBD column run buffer B: 20 mM HEPES pH 7.5; 0.1 % Triton; 10 % Glycerol; 
0.5 mM PMSF, 1 M NaCl2 
 
2.1.2 DNA analysis Buffers 
Tris-EDTA (TE): 10 mM Tris-HCl pH 7.5, 1 mM EDTA pH 8.0 
Church & Gilbert (modified) hybridisation solution: 44.5 g Na2HPO4.H2O and 2 
ml H3PO4 were dissolved in total volume of 500 ml. 10 g BSA were added slowly to 
pre-warmed solution on stirrer. Solution was completed with H2O to 1l. The pH was 
adjusted to 7.2-7.4. 
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Southern Blot Wash Buffer I: 80 mM Na2HPO4 pH 7.5, 5 % SDS 
Southern Blot Wash Buffer II: 80 mM Na2HPO4 pH 7.5, 1 % SDS 
SSC buffer: 175.3 g NaCl2, 88.2 g Na3C6H5O7 were dissolved in 800 ml water. pH 
was adjusted to pH 7 with HCl; Volume was added up to 1 l with water. 
Bisulfite conversion solution: 3.8 g sodium bisulfite dissolved in 5 ml H2O and 1.5 
ml fresh 2 M NaOH. This solution was resuspended in the dark. 110 mg 
hydrochinone was dissolved in 1 ml water at 55 degrees for 10 mins and 
subsequently added to the sodium bisulfite solution. 
 
2.1.3 Primers 
All primers were ordered from MWG Eurofins. Lyophilised primers were 
resuspended in dH2O to 100 uM stock concentration and stored at -20 degrees. 
Gene Primers 
Hoxa5 (RT PCR) AGC CAC AAA TCA AGC ACA CA 
 AGA TCC ATG CCA TTG TAG CC 
Hoxa6 (RT PCR) TAC GGG GCC TCA TGT TTC TA 
 CTG CAT CCA GGG GTA AAC AG 
Hoxa7 (RT PCR) CAC ATG GTT CCA GTT TGT GG 
 CTG AAC CCC AGA TCC ACT GT 
Hoxa10 (RT PCR) GGA AGC ATG GAC ATT CAG GT 
 CCA GGC AAG CAA GAC CTT AG 
Hoxa11 (RT PCR) CCC CTG GTG GTT CAC TCT TA 
 CTT GGG GCA CAC AGT TTC TT 
Rhox2 (RT PCR) CAA GCT TGA TGT GGG ACC TGA G 
 GAA TCA GGG ACT GGC TCC TCT G 
Rhox6 (RT PCR) AAA CCC ACA TGT TCT GAA TAG G 
 GCC ATC ATG GGT GGC TCA GAA G 
Rhox9 (RT PCR) CAG CCA TTC CTG AGG GCA TGA 
 GCC TGC TGT GTC TGC GGA AA 
Rhox11 (RT PCR) TGG AGG AGG ACG AGT GTC TGT G 
 TGG TGG CCC TCT TTC GGG ATG 
C21_Rik (RT PCR) AGC GAG GAC GAG AAT GAA CC 
 ATG CTC AGG AGC TCG GAT AG 
Cul4b (RT PCR) GTG CAG GCA ACA AAG AAG CTA C 
 GCA CAT ATG TTG GCC AGT AAC C 
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Gm9 (RT PCR) GGC AAA CAC AAG GGC TAT GG 
 ACC GGA GGT AAA GGT CGT TG 
Actin (RT PCR) GGC CCA GAG CAA GAG AGG TAT 
 ACG CAC GAT TTC CCT CTC AGC 

























Nnat GCTGGCATGGGTTTAAAATTCAC  
 ATTCTACATGCCGCGTAACCAG 









qPCRs (on cDNA) 
Oct4 CCC ACT TCA CCA CAC TCT AC 
 CCA AAG CTC CAG GTT CTC TT 
Dppa2 GCA TTC ATT CAG CGG CTG CCT TT 
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 TGC GTA GCG TAG TCT GTG TTT GG 
Dppa3 GAA CCG CAT TGC AGC CGT ACC T 
 GGC TCA CTG TCC CGT TCA AAC TCA  
Dppa4 CAA GGG CTT TCC CAG AAC AAA TGC 
 GCA GGT ATC TGC TCC TCT GGC AC 
GAPDH GGC TCA TGA CCA CAG TCC ATG CC 
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 ATATAGGAGATTAGGAAAT 
 CTATCCTACATCTCACAA T 
Peg12 GGTGGTAATGATTAGAATA 
 TGTTGTAGTAGGAGGAAGTTGT 
 CTT AAC CTC CAC CCA ACC TAA A 
















Cdkn1c AGGATTTAGTTGGTAGTAGT (F) 
 TTTTCAATTTCAACAACACC (R)  
 TATCCTATCCAACTTAAACC (R) 
 
2.1.4 Antibodies 
LSH (Mouse monoclonal Santa Cruz sc-46665/H0205): 1:1000 (1:500 for 
Immunohistochemistry) working concentration in 2 % milk + 0.1 % Tween 
HDAC (Rabbit polyclonal Santa Cruz sc-7872 / D171): 1:1000 working 
concentration in 2-4 % milk + 0.1 % Tween 
MRE11: 1:1000 working concentration in 2 % milk + 0.1 % Tween 
G9a (Mouse monoclonal Perseus Proteomics): 1:500-1:1000 working 
concentration in 2-4 % milk + 0.1 % Tween 
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FLAG M2 (Mouse monoclonal Sigma): 1:2000 working concentration in 2-4 % 
milk + 0.1 % Tween 
Licor secondary antibodies: 1:10,000 working concentration 
Alexa Dye secondary antibody for Immunohistochemistry: 1:1000 working 
concentration. 
2.1.5 Cell Lines 
Lsh-/- MEFs: Isolated from Lsh-/- embryos derived from crosses of heterozygous 
animals (Kathrin Muegge) 
G9a-/- ES: Gene conversion of heterozygous G9a+/- ES cells through stringent 
antibiotic selection. This can cause chromosome loss and duplication (Yoichi 
Shinkai) 
Smchd1 mutant MEFs: Cell lines homozygous for non-sense mutation in exon 23 of 
Smchd1, resulting in nonsense mediated RNA decay and a null allele (Emma 
Whitelaw). 
2.2 Methods 
2.2.1 DNA manipulations 
Plasmid Preps: 5 ml culture plasmid preps were carried out using the Quiagen 
Miniprep Kit. 400 ml culture plasmid preps were carried out using the Quiagen 
Maxiprep Kit. DNA was eluted in desired volume of Elution Buffer. 
Restriction digestion: Restriction digests were carried out in 20 or 50 ul volumes 
according to manufacturer’s recommendations (up to 500 ul volume was used for 
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gDNA digestions for use in Southern Blotting). Incubation times ranged from 1 h to 
o/n at 37 °C. Completion of digestion was assessed by agarose gel electrophoresis. 
Gel extraction: DNA fragments were excised from agarose gels and extracted using 
the Quiagen or Fermentas gel extraction kits. 
DNA sequencing: Big Dye Reactions were set up in a total volume of 10 ul, 
including 2 ul BigDye, 1 uM primer, and 500 ng of template DNA or 3.5 ul of PCR 
product. The following program was used for the sequencing reactions: 96 °C for 1 
minute and 25 cycles of cycling between 96 °C for 10 seconds, 50 °C for 5 seconds, 
and 60 °C for 4 min. The Gene Pool Sanger Sequencing Service at University of 
Edinburgh was used for Sanger Sequencing. 
gDNA extraction: Cell pellets from T175 flasks were resuspended in 4 ml TE 
buffer. Proteinase K was added to final concentration of 200 ug/ml and SDS added to 
a final concentration of 1 % o/n at 55 degrees. 100 ug/ml RNAse was added for 1h at 
37 °C. The salt concentration was subsequently adjusted to 200 mM with NaCl.  
Digested peptides were removed through one phenol:chloroform:isoamyl alcohol and 
one chloroform extraction. DNA was precipitated in 1 volume isopropanol and 1/10-
1/5 volume Sodium Acetate (3 M, pH 5.3). DNA was pelleted, washed in Ethanol 
and resuspended in a suitable volume of TE buffer or water. 
Bisulfite conversion of gDNA: 1 ug of gDNA was resuspended in a total volume of 
25 ul. To denature, DNA was boiled at 95 °C for 5 mins and chilled immediately on 
ice. 2.5 ul of fresh NaOH (3 M) was added and samples incubated at 37 °C for 20 
minutes. 270 ul sodium bisulfite solution (see buffers section) was added to each 
DNA sample. Samples were overlaid with mineral oil to prevent evaporation and 
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incubated o/n for sulfonation at 55 °C. DNA was precipitated in isopropanol and 
sodium acetate in presence of 2.5 ug glycogen. DNA pellets were resuspended in 25 
ul TE buffer. DNA was then denatured by addition of 2.5 ul 3 M NaOH and  
incubation at 37 °C for 15 mins. Samples were then desulfonated and precipitated by 
addition of 32.5 ul 5M ammonium acetated (pH 7) and 180ul ethanol. DNA pellet 
was then resuspended in 35 ul TE buffer. 
Methylated DNA affinity purification (MAP): 65 mg of purified His tagged MBD 
domain (see protein methods) of MeCP2 was bound to 1 ml of nickel coated 
Chelating Sepharose Fast Flow beads (GE Healthcare). MBD bound beads were 
packed into a 1 ml Tricorn column (GE healthcare) which was connected to the 
AKTA liquid chromatography machine. The column was washed using a 0.1 M to 1 
M NaCl2 gradient (mixture of column run buffers A and B) three times to eliminate 
any bacterial DNA carried over from MBD peptide expression and purification from 
E.coli. Genomic DNA was sonicated to an average size of ~300 bp and loaded onto 
the MBD column . Unmethylated and methylated DNA fragments were eluted at low 
(up to 0.715 M) and high (1 M) NaCl concentrations. The success of each run was 
tested by actin and Igf2R-DMR2 PCRs (see primer tables) as unmethylated and 
differentially methylated controls respectively. Conditions used were: 95 °C– 5 min; 
94 °C – 30 s; 60 °C – 1 min; 72 °C – 1min (25 cycles), 72 °C – 10 min). Methylated 
DNA fractions were pooled, concentrated and de-salted in 30 K filters (Amicon Ultra 
Centrifugal Filters, Millipore). Samples were then ethanol precipitated and 
resuspended in 20 ul TE buffer.  
Whole genome Amplification: Whole genome amplification of methylated DNA 
from Methylated DNA Affinity purification was carried out using the Sigma 
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GenomePlex Genome Amplification Kit. This kit is based on attachment of linker 
DNA to the ends of the sample DNA and subsequent amplification with linker 
specific primers. Samples were purified using Quiagen PCR purification kit. 
Whole genome methylation analysis: Whole genome methylation levels were 
determined in different cell lines using the Sigma Imprint Methylated DNA 
Quantification Kit. 
Southern Blotting: 15 ug Genomic DNA was digested with methylation sensitive 
(HpaII) and insensitive (MspI) restriction enzymes overnight in a total volume of 
300-500 ul. Digested DNA was precipitated in isopropanol and resuspended in 25 ul 
volume and run on a 1 % agarose gel for 8 h. DNA was transferred onto a Nylon 
membrane overnight in 0.4 M NaOH. The membrane was washed in 2 x SSC buffer. 
100 ng of probe was radioactively labelled using the Fermentas DecaLabel DNA 
Labelling Kit and then purified using GE Healthcare Illustra ProbeQuant G-50 Micro 
Columns. The membrane was incubated in pre-warmed (65 °C) Church & Gilbert 
(modified) hybridisation solution for 1h. The probe was added to the membrane in 
hybridisation solution and incubated at 65 °C o/n on rotor. After hybridisation the 
membrane was washed for an hour with Wash solution I and half an hour with Wash 
solution II. 
2.2.2 RNA methods 
RNA extraction: Cell pellets from confluent T175 flask were resuspended in 1 ml 
Trizol reagent and 200 ul chloroform added. Samples were centrifuged at 5500 rpm 
at 4 °C for 15 mins. Top aqueous phase was removed and precipitated with 500 ul 
isopropanol per ml Trizol used. Precipitated samples were spun at 13000 rpm for 15 
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min at 4 °C. RNA pellets were washed in cold 75 % ethanol and air dried for 5 mins. 
RNA was resuspended in RNAse free water and 1 ul RiboLock RNAse inhibitors 
added. 
50 ul RNA was DNAse treated for 1 h at 37 °C. DNAse was inactivated at 90 °C for 
5 mins. 
cDNA synthesis (for qPCR): 1-5 ug RNA were used in reverse transcription 
reaction. 1 ul oligo dT primers were added and reaction made up to 11 ul with water. 
Samples were heated at 65 °C for 5 mins and then cooled on ice. A mastermix was 
prepared with 1 ul dNTPs (10 mM), 4 ul 5x FS buffer; 2 ul DTT (0.1 M) and 1 ul 
RNAse OUT (40 U/ul) per sample and 8 ul added to each reaction. Samples were 
mixed and heated at 42 °C for 2 min and Superscript II added to RT + reactions. The 
reverse transcription was carried out at 42 °C for 2 h. 
Expression Array normalization: See (Myant & Stancheva, 2008) for details 
Quantitative PCR reaction mix: 10 ul SYBR qPCR mix, 0.25 uM primers were 
added to 2 ul diluted cDNA and added up to a total volume of 20 ul. 
2.2.3 Protein methods 
MBD protein purification: 1 ul of His tagged MBD plasmid was added to 100 ul 
Bl21 cells and left for 30 min on ice. Cells were heat shocked for 45 s at 42 °C and 
returned to ice for 2 min. 200 ul LB media was added and cells left to shake for 30 
min at 37 °C, before plating on 50 µg/ml Kanamycin plates. Next day, 200 ml 
kanamycin media was inoculated with a single colony o/n. The o/n culture was 
diluted 1:50 in kanamycin media and grown to OD 600 of 0.45-0.6 before inducing 
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MBD expression with 1 mM IPTG for 3-4 h. The induced culture was spun down for 
1 h at 4 °C at 4200 rpm. The supernatant was decanted and pellets frozen at – 80 °C 
o/n to facilitate cell lysis. Cell pellets were resuspended in 30 ml lysis buffer and 
lysed at 25 KPSI in Constant Systems TS cell Disruptor. Triton was added to 0.1 % 
and cell lysates spun 30 min at 4 °C at 13000 rpm. Fractogel beads were used for 
Nickel purification of MBD protein. Beads were washed with 20 ml water per 1 ml 
bead volume. 10 ml 0.1 M NiSO4 was added per ml of beads and left on rotor for 15-
20 min. Beads were washed with 40 ml water and subsequently 20 ml lysis buffer 
per 1 ml bed volume. The relevant volume of beads were resuspended in cell lysate 
and left on rotor for 1-2 h. The beads were washed with at least 1 l wash buffer. Then 
a bed volume of elution buffer was added to the beads and incubated for 10 min. The 
elution buffer was drained through the beads and collected. 5 more elutions were 
carried out. The elutions were stored at 4 °C while being assessed by SDS PAGE. 
Elutions containing most MBD protein and least contaminating proteins were pooled 
and dialysed for 2 h and then o/n in 2 l lysis buffer without imidazole. Dialysis 
product was centrifuged at 13000 rpm for 20 min to remove precipitate and Bradford 
assay was carried out to quantify protein. Dialysed product was stored at 4 °C short 
term or in 50 % Glycerol at -20 °C long term. 40-60 mg MBD protein was bound to 
1 ml of nickel coated beads for 1-2 h and then washed with 20 ml wash buffer 1 , 20 
ml wash buffer 2 and 20 ml wash buffer 1 again per ml of beads.  
Nuclear extracts: 1 ml of NE1 Buffer was added to cells and homogenized in 
Dounce Homogenizer. The cell suspension was transferred to 2 ml eppendorf tubes 
and centrifuged at 3000 rpm for 5 mins at 4 °C to collect nuclei. The nuclear pellet 
was resuspended in 100 ul NE1 and homogenized with a pipette tip. 250 U of 
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Benzonase (Merck) was added on ice for 1 h. NaCl2 was added to 420 mM. Tubes 
were placed on spinning wheel for 20 min at 4 °C. Samples were then centrifuged at 
13000 rpm for 15 min at 4 °C. The supernatant contained the nuclear extract.  
Protein quantification: Bicinchoninic Acid Protein Assay Kit (Sigma) was used for 
protein quantification. 0.04 absorbance units are approximately equivalent to 1ug 
protein. Quantified protein extracts were stored at -80 °C. 
SDS gel: Separating gel was prepared and poured first, followed by the stacking gel. 
5 ul of sample buffer was added to 44-50 ug of protein, boiled for 5 min and run at 
270 V on prepared SDS gel. 
Transfer onto Nitrocellulose membrane: Protein from the SDS gel was transferred 
onto Nitrocellulose membrane for 1 h in Tris/Glycine transfer buffer. 
Western Blotting: Membranes were blocked with milk in 1 x TBS with 0.1 % 
Tween for 1 h at RT. Membranes were incubated o/n at 4 °C in fresh blocking 
solution with desired concentration of primary antibody. Membranes were then 
washed three times 20 mins each with 1 x PBS + 0.1 % Tween and then blocked 
again for 1 h as before. Secondary antibody was added to desired concentration (see 
materials for concentrations) and left to incubate for 1-3 h depending on the 
antibody. Membranes were washed as before to remove secondary antibody and 
scanned on Licor scanner. 
Immunohistochemistry: Coverslips were washed in HCL for 15 mins, then dH2O 
and sterilized in ethanol. Cells were plated at a density of 1-2x10
5
 per well of a 6-
well plate containing one coverslip each. Cells were left to adhere overnight. Media 
was removed and cells washed with PBS. Washed cells were fixed with 0.04 % w/v 
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paraformaldehyde for 5 min at RT. Fixing solution was removed and cells washed 
twice in PBS. 1 ml PBS with 0.1 % Triton was added for 15 min at 37 degrees. Cells 
were blocked for 1 h in blocking reagent (4 % BSA in PBS) on rocking platform. 
Blocking solution was changed and correct concentration of primary antibody added 
and incubated for 1 h on rocking platform. Primary antibody was removed and cells 
washed three times 5 min with PBS. 1:1000 dilution of secondary antibody (Alexa 
Dye) in fresh blocking solution was added and incubated for 1h on rocking platform. 
Secondary antibody was removed and cells washed three times 10 min with PBS. 
Coverslips were then mounted on microscope slides using Prolong Gold (containing 
DAPI dye). 
2.2.4 Mammalian Cell Culture 
MEFs, NIH3T3 and Phoenix cells: Cultured in DMEM + 10 % FBS and PSG 
ES cells: Cultured on gelatinized culture flasks in MEM, 10 % FBS, 500 ul 2-
mercaptoethanol, 5 ml sodium pyruvate, 5 ml PSG, 5 ml non-essential amino acids 
and 1:1000 dilution of LIF. 
ES cell differentiation: ES cells were cultured for 4 days before starting 
differentiation. LIF was withdrawn from culture on day 0. Media was changed on 
Day 2. Retinoic Acid was added to medium on Day 4 of differentiation and media 
changed with RA on Day 6. Embryoid Bodies were collected on Day 8 and 
dissociated with trypsin and plated in N2 media at a density of 1-2 x 10
5
 cells/cm2 – 
1.57 x 10
7
 cells/plate. N2 media was changed 2 h after plating and the next day. N2 
media was changed to complete neuronal media after 2 days. (Bibel et al, 2004) 
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Transient transfection: Transient transfections of 10 ug plasmid DNA were carried 
out using the Polyplus Jetpei or Jetprime reagents on 1 x 10
6
 cells in 10 cm dishes. 
Cells were harvested after 48 h.  
Viral packaging and infection: 3.5 x 10
6
 PhoenixA cells were seeded for each 
packaging reaction on 10 cm mammalian culture dishes. 8 ug of DNA was 
transfected into Phoenix cells using the Polyplus JetPei transfection kit. Transfected 
cells were left over night with 8 ml media and then media changed to 5 ml. The 
media containing lentivirus was harvested 48 h and 72 h after transfection, filtered 
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Chapter 3 - Characterization of LSH-dependent DNA 
methylation at gene promoters 
3.1 Introduction 
3.1.1 A putative chromatin remodelling ATPase implicated in Arabidopsis 
thaliana DNA methylation 
Screening in Arabidopsis thaliana for DNA methylation mutants (specifically 
those showing genome hypomethylation) identified Decrease in DNA methylation 1 
(DDM1). DDM1-deficient plants show a 70% reduction in DNA methylation levels 
with hypomethylation seen at repetitive elements but also at some single copy genes 
(Navarro et al, 2008; Vongs et al, 1993). Methylation defects are accompanied by 
gene expression defects with silenced reporter genes for example undergoing 
reactivation in Ddm1 mutants. The possibilities of Ddm1 encoding a DNA 
methyltransferase or reducing adeno-methionine levels were eliminated early on 
(Kakutani et al, 1995). Instead, protein sequence similarities suggested DDM1 being 
a novel SNF2 chromatin remodelling ATPase (Vongs et al, 1993). This is 
demonstrated in the ClustalW protein alignment of Arabidopsis thaliana DDM1 and 
chromatin remodelling ATPase BRM, displaying highly conserved SNF2 as well as 
Helicase domains, characteristic of SNF2 chromatin remodelling ATPases (Figure 
3.1A).  
ATP-dependent nucleosome repositioning activity of DDM1 was later 
confirmed in an independent study (Brzeski & Jerzmanowski, 2003). DDM1 was 
therefore the first chromatin remodelling enzyme of the SNF2 family identified to 
participate in DNA methylation (Jeddeloh et al, 1999).  
                82
Furthermore, co-operation between DDM1 and histone methyltransferases leading to 
repressive H3K9 methylation has been observed (Gendrel et al, 2002).When DDM1 
is deleted, this histone mark is replaced by the activating H3K4 methyl mark 
(Gendrel et al, 2002). Mutant phenotypes of Ddm1 in Arabidopsis include 
morphological developmental abnormalities, meiotic defects as well as defects in 
DNA damage response (Melamed-Bessudo & Levy, 2012; Mittelsten Scheid & 
Paszkowski, 2000; Shaked et al, 2006). 
3.1.2 Mammalian homolog of DDM1 is also required for DNA 
methylation 
The mammalian homolog of DDM1, Lymphoid-specific helicase LSH, was 
identified in early T cells in an attempt to find a helicase involved in V(D)J 
recombination (Jarvis et al, 1996). Lsh was found to be expressed in thymus, early 
lymphocytes and activated lymphocytes, but is now known to be ubiquitously 
expressed (Jarvis et al, 1996). The sequence conservation between DDM1, murine 
and human LSH as well as murine SNF2H chromatin remodelling ATPase (Figure 
3.1B) shows high sequence conservation of Coiled-coil, SNF2 as well as Helicase 
domains. A schematic of LSH protein structure can be seen in Figure 3.1C. Even 
though sequence conservation with known chromatin remodelling ATPases is 
evident, significant ATPase and chromatin remodelling activities of LSH are yet to 
be identified.  























(Geiman et al, 2001)
hypomorphic knockout
(Sun et al, 2004)
Figure 3.1 Chromatin remodelling ATPases DDM1 (A.thaliana) and LSH 
(M.musculus) 
A: ClustalW alignment of Arabidopsis thaliana DDM1 with chromatin remodelling 
ATPase BRM1. Conservation patterns were visualized using JalView. Top pannel in 
blue indicates conserved amino acid residues between all proteins. Bottom pannel 
indicates conservation of chemical properties of amino acid residues with a white – 
brown – yellow colour gradient of increasing conservation. Despite amino acid 
differences between proteins, functional conservation may be achieved through the 
presence of chemically similar amino acids. The location of conserved domains is 
indicated above the alignment. B: ClustalW alignment of Arabidopsis thaliana DDM1 
with human and murine LSH as well as murine chromatin remodelling ATPase 
SNF2H. C: Domain structure of murine LSH, drawn to scale. Indicated are the 
Coiled-coil domain (CC), Nuclear Localization signal (NLS), ATPase site (ATPase), 
SNF2 N termain domain (SNF2-N) and the Helicase C terminal domain (Helicase C). 
Indicated on the diagram are the locations of insertions of knockout cassettes leading 
to full knockout (Geiman et al. 2001) as well as to a hypomorphic knockout (Sun et al. 
2004). D: Mapped protein interactions by Myant and Stancheva 2008. Note: Only the 
interaction between LSH and DNMT3B is direct. 
chemical
conservation
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Several studies have showed that LSH is required for mammalian cell 
proliferation and development (Fan et al, 2003; Raabe et al, 2001; Sun et al, 2004). 
Although Lsh-/- mice occur at a normal frequency at birth, they die within a few days 
(Geiman et al, 2001). These mice display normal breathing and exterior appearance 
but their body weight was reduced by 22% compared to heterozygous littermates. 
Newborns also suffer severe renal lesions, but other organs are similar to those of 
control animals (Geiman et al, 2001). Interestingly, hypomorphic knockout mice in 
which a truncated protein is detectable survive into adulthood but show signs of 
premature ageing. Importantly, Lsh alterations have been implicated in diseases such 
as Leukaemia, making the study of LSH an important step towards understanding its 
function in disease (Fan et al, 2008; Lee et al, 2000). 
3.1.3 LSH regulates gene expression through DNA methylation and 
histone modifications 
Similar to the plant homolog DDM1, LSH is involved in DNA methylation. 
Knockout of Lsh causes up to 50% loss of global DNA methylation in cell lines as 
well as embryos (Donohoe et al, 2009; Tao et al, 2011). More specifically, LSH is 
now thought to function in DNA de novo methylation rather than maintenance of 
DNA methylation (Zhu et al, 2006). Despite this, one study identified progressive 
loss of DNA methylation from some repetitive elements upon knockdown of LSH 
(Suzuki et al, 2008). This may suggest a role of LSH in maintenance of DNA 
methylation. Similarly to DDM1, LSH deficiency also causes changes in histone 
modification patterns. H3K4 methylation becomes more abundant at pericentromeric 
DNA but H3K9 methylation seems to remain unaltered (Tao et al, 2011; Yan et al, 
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2003b). LSH Immunochemistry after mild extraction with detergents has shown 
association of LSH with mouse centromeric regions. The same study, as well as co-
immunoprecipitation assays, demonstrate colocalization and association of LSH with 
Heterochromatin Protein 1 (HP1) (Yan et al, 2003a). The above studies suggest that 
LSH might be essentially for establishment of pericentromeric heterochromatin. 
Consistent with this inference, LSH has been implicated in meiotic chromosome 
synapsis, mitosis and silencing of retrotransposons as well as repetitive elements, 
which all require functional centromeres (De La Fuente et al, 2006; Huang et al, 
2004). 
There are four previous studies investigating the effects of LSH on DNA 
methylation and gene expression at single genes (Donohoe et al, 2009; Fan et al, 
2005; Huang et al, 2004; Xi et al, 2007). Huang et al investigated LSH targets within 
the genome and, as previously, identified repetitive elements. RT-PCR showed no 
difference in single gene expression of Igf2R, Aprt, β-actin, H19 or Pgk-1 between 
WT and Lsh-/- embryos (Huang et al, 2004). The same study also carried out an 
embryonic cDNA microarray experiment. Only ~ 0.5% cDNAs showed more than 2-
fold changes in gene expression in liver and brain of Lsh-/- mice (Huang et al, 2004). 
One of the authors’ explanations for the few single, non-repeat genes showing 
expression alterations, was close proximity to repeat elements targeted by LSH, 
leading to genes in close proximity being subjected to the same repressive or 
activating state (Huang et al, 2004). The study by Huang et al. also identified that 
Lsh knockout may cause changes in single gene expression, due to changes in cell 
composition of tissues. Lsh knockout leads to impaired lymphoid development, 
which may cause reduced levels of certain lymphoid cells in tissues analysed, which 
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may cause the single gene expression changes observed (Huang et al, 2004). The 
study by Dennis et al, on the other hand, identified various single genes showing 
hypomethylation. These included H19 and Pgk-1, suggesting that LSH may be 
required for DNA methylation. This study was closely followed by analysis of the 
effect of LSH on imprinted genes, identifying increased expression and reduced CpG 
methylation of the differentially methylated region of Cdkn1 in Lsh-/- cells (Fan et 
al, 2005). Other imprinted genes tested in this study were shown not to be affected 
(Fan et al, 2005). The fourth study showed the importance of LSH in developmental 
regulation of specific genes (Xi et al, 2007). Most homeobox genes (Hox5, Hox6 and 
Hox7) were found to show increases in expression as well as reduced DNA 
methylation at their promoters upon knockout of Lsh (Xi et al, 2007). Together, all 
these studies highlight the need for LSH in gene expression and DNA methylation of 
some single genes. Despite this, the extent of requirement for LSH outwith repeat 
sequences is not yet clear, as all studies focused on a select few genes. 
3.1.4 Potential mechanisms of LSH-dependent DNA methylation 
Previous work in our lab indicated that the native LSH exists mostly as a 
monomeric protein in nuclear extracts of mammalian cells, unlike other chromatin 
remodelling ATPases which are associated with large multisubunit complexes 
(Myant & Stancheva, 2008). Luciferase reporter gene assays combined with histone 
deacetylase inhibitors (TSA) on the other hand identified the need for histone 
deacetylases (HDACs) for efficient gene repression. Consistently, depletion of 
Hdac1 and Hdac2 alleviated the ability of LSH to silence the reporter gene. 
Subsequent co-immunoprecipitation experiments identified the requirement of the N-
terminal coiled-coil domain of LSH for interaction with HDAC1 and HDAC2 as well 
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as DNMT1 and DNMT3B. The interaction with HDACs and DNMT1 was dependent 
on DNMT3B, suggesting a direct interaction of DNMT3B with LSH (Myant & 
Stancheva, 2008) (Figure 3.1D). A standing hypothesis is that LSH induces localized 
accumulation of DNMT3B and other chromatin modifiers upon binding to 
DNA/chromatin. DNA methylation could result in initiation or further stabilization 
of a repressive chromatin state established at LSH bound regions (Myant & 
Stancheva, 2008). Consistent with this model, studies characterizing LSH-mediated 
formation of pericentromeric heterochromatin identified association of LSH with 
various repressive epigenetic regulators. LSH for example associates with HP1, the 
major heterochromatin regulator (Yan et al, 2003b). Another study showed reduced 
levels of H2A-K119 ubiquitynation at Hox genes as well as reduced association of 
PRC1 components at these genes in Lsh-/- MEFs. This suggests that LSH is required 
for correct assembly of PRC2 complex as well as recruitment of PRC1 complex to 
chromatin (Xi et al, 2007). 
In summary, studies to date have extensively investigated the role of LSH in 
DNA methylation and silencing of transcription at repetitive elements and have 
pinpointed that DNA methylation and gene expression of a few single genes are 
dependent on LSH. Additionally, several hypotheses have been suggested for the 
function of LSH at repetitive genomic regions as well as single genes. However, it is 
yet unknown what the extent of LSH function in single gene DNA methylation and 
gene expression genome wide is. As discussed in the introduction, several non-DNA 
methyltransferase proteins have been identified to be crucial for correct 
establishment and maintenance of DNA methylation. Still not well defined is, 
whether these proteins target different or overlapping regions genome wide. This will 
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be essential in determining whether these proteins can aid the recruitment of DNMTs 
to correct regions at different stages of development. I therefore set out to identify 
genome-wide the promoters of protein coding genes, which require LSH for correct 
DNA methylation. Secondly I set out to determine whether DNA methylation 
established by LSH is required for correct expression of associated genes. All results 
discussed in this chapter have been published in Genome Research (Myant et al, 
2011). 
3.2 Results 
3.2.1 Methylated DNA affinity purification and microarray analysis 
Previous work in the lab applied a methylated DNA affinity purification 
technique (Illingworth et al, 2008), followed by hybridization to mouse promoter 
microarrays to define genome wide differences in DNA methylation between WT 
and Lsh-/- MEFs (Figure 3.2) (Myant et al, 2011). WT and Lsh-/- MEFs were 
isolated from littermate embryos in Kathrin Muegge lab. Knockout mice were 
obtained though crossing heterozygous mice for the knockout allele, meaning that 
WT LSH would have been present during germ cell determination in the parents. 
Any DNA methylation defects observed in Lsh-/- MEFs can therefore only be 
attributed to defects in maintenance of DNA methylation patterns established in the 
germline or to de novo methylation defects at later stages of embryo development.  







































Figure 3.2 Methylated DNA affinity purification and promoter microarray 
A: Nickel affinity purification of His tagged MBD domain of rat MeCP2. Shown is 
the MBD protein within the cell lysate (left pannel) and in subsequent elutions from 
nickel beads by immidazole. The purified MBD protein is packed onto a nickel 
sepharose column. Sonicated genomic DNA from cells of interest is passed through 
the MBD column at low salt to allow binding of methylated DNA. Unmethylated 
DNA is eluted at low salt and methylated DNA at high salt. B: Validation of 
methylated DNA affinity purifications by PCR on unmethylated actinB control and 
differentially methylated Igf2r DMR2. Actin DNA elutes at low salt (0.715M) and 
Igf2R DMR2 DNA elutes at low (0.715M) and high (1M) salt. C: Hybridization of 
whole genome amplified methylated DNA and input DNA fractions to Nimblegen 
microarrays containing 22,036 mouse RefSeq promoters (spanning 1500bp upstream 
to 500bp downstream of transcription start site). 
bp
MBD
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Methylated DNA affinity purification was carried out on 2 biological 
replicate WT and KO cell lines. This technique involved the purification of 
methylated DNA by liquid chromatography on a nickel column containing rat 
MeCP2 methylated DNA binding domain (MBD) (Figure 3.2A). Genomic DNA 
isolated from cultured MEFs and sonicated, was passed through the column and 
fractionated into unmethylated and methylated fragments with the aid of an 
increasing salt gradient. The purification was assessed by PCR analysis on 
unmethylated Actin and differentially methylated Igf2r DMR  (Figure 3.2B).  
The methylated DNA fractions as well as the input DNA were whole genome 
amplified and subsequently sent to Roche NimbleGen for hybridization to tiling 
microarrays representing 24,000 mouse protein-coding gene promoters (MM8 
RefSeq) spanning 1500bp upstream to 500bp downstream of transcription start sites 
(TSSs) (Figure 3.2C). The tiling microarray contained probes mapping to the 
promoter regions of all protein coding genes. Each promoter region was covered by 
25 probes (50-70bp) which are spaced at ~100bp. Each probe was present in multiple 
copies to allow quantitative analysis.  
Microarray data was analysed with the help of Jose de las Heras and Arvind 
Sundaram (Myant et al, 2011). Raw fluorescence intensities were Loess normalized 
using the LIMMA package. Subsequently log2 values of MAP/Input were calculated 
for each probe (probe value). A log2(MAP/Input) value ≤ 0 indicates lack of 
enrichment in the methylated DNA fraction compared to Input DNA. To allow 
comparison between microarrays, probe values were adjusted to have the same 
median absolute deviation. For ease of analysis the region was divided into a 1000bp 
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upstream region (-500 to -1500bp relative to TSS) and a 1000bp promoter region (-
500bp to +500bp relative to TSS) (Figure 3.2C). Aggregate log2 (MAP/Input) values 
were then generated by determining the median of all probes in the promoter or 
upstream region (M value). Promoters and upstream regions with less than 5 probes 
were discarded. Additionally, a low stringency filter was used to eliminate low 
intensity probe binding. Finally average M values were calculated from replicate 
experiments.  
3.2.2 LSH regulates DNA methylation at protein coding gene promoters 
The first stage of my study involved calculation of total numbers of 
methylated promoters in WT and Lsh-/- MEFs (Figure 3.3A). This involved grouping 
of all promoters into three different classes, according to their CpG density: Low 
CpG density (LCP), Intermediate CpG density (ICP) and High CpG density (HCP). 
These categories were determined by using observed/expected CpG density cut-offs 
described previously (Mohn et al. 2008). Expected CpG densities are calculated by 
taking into account the base composition of a given promoter region. This allows the 
calculation of a probability value for a CpG dinucleotide to occur in a specific 
promoter region. Subsequent multiplication by the total number of base pairs in the 
given region results in a number of CpGs expected to occur. Different average M 
value cut-offs were then used to determine the number of methylated promoters in 
LCP (M value ≥0.8), ICP (M value ≥0.9) and HCP (M value ≥1) groups of promoters 
to allow for CpG density related differences in binding affinity to the MBD column 
(Figure 3.3A). The thresholds used were similar to those used in previous studies 
(Mohn et al, 2008; Weber et al, 2007).  
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Figure 3.3 Comparison of promoter DNA methylation in WT and Lsh-/- MEFs
A: Total number of methylated promoters in WT and Lsh-/- MEFs. Median 
log2(MAP/Input) values are plotted against number of CGs per 100bp. MAP = 
methylated DNA affinity purified. Low, intermediate and high CpG density promoters 
were definied according to the observed to expected ratio of CpG dinucleotides in a 
given promoter region. Different thresholds were used for quantifying total numbers 
of methylated promoters in low (0.8), intermediate (0.9) and high (1) CpG density 
classes to account for differences in binding to the MBD column. n indicates number 
of promoters methylated. Left pannel shows an avarage over all CpG density classes. 
B: Scatter plot of 2-fold changes in DNA methylation in promoter and upstream 
regions (see Fig 3.2c). All WT log2(MAP/Input) values are plotted agains Lsh-/- 
log2(MAP/Input) values. A threshold was applied to indicate promoters/ upstream 
regions undergoing 2-fold or more hypomethylation (red) or hypermethylation (blue) 
in Lsh-/- MEFs compared to WT. 
n = 92
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In summary, all classes of promoters display loss of DNA methylation in Lsh-/- 
MEFs compared to WT, although a lower percentage of high CpG promoters are 
hypomethylated.  Averages across all CpG density groups highlight that 1899 
promoters are methylated in WT MEFs and 1508 are methylated in Lsh-/- MEFs. 
This represents hypomethylation of ~20% of all methylated promoters.  
Subsequently, differentially methylated regions were identified by calculating 
the difference between M values between WT and Lsh-/- MEFs. It is unclear, how 
fold change in enrichment of microarray signal between different cell lines relates to 
absolute changes in DNA methylation. I therefore used a high threshold (2-fold) to 
identify significant differences in DNA methylation (Appendix 3). The scatter plot in 
Figure 3.3B (left) highlights 376 gene promoters (red) being 2-fold or more 
hypomethylated in Lsh-/- MEFs, comprising around 20% of all normally methylated 
promoters. Interestingly, a smaller group of 92 promoters which are normally 
unmethylated become methylated in the absence of LSH. A role of LSH in 
preventing DNA methylation has not been identified before.  Whether the 
hypermethylation we see in Lsh-/-  MEFs is a direct effect of LSH, or an indirect 
effect through DNA methylation defects at other gene promoters has yet to be 
identified.  A similar trend was seen in the case of upstream regions (Figure 3.3B 
right). The rest of the chapter focuses specifically on the 1000bp promoter region.  
At this stage, it is important to consider the correlation between replicate 
experiments carried out, to determine, how significant the determination of 
differentially methylated regions may be. For this purpose scatter plots comparing 
replicates with eachother were generated and Spearman’s correlation coefficients 
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calculated (Appendix 1). Both WT and Lsh-/- replicates display a high Spearman’s 
correlation coefficient (~0.89). We were therefore satisfied, that replicate 
experiments were sufficiently similar to carry out further analysis. False discovery 
rate (FDR) calculations (Benjamini Hochberg) are often used to analyse the 
significance of microarray data. Due to the nature of the promoter microarray set up, 
we did not think an FDR analysis would be especially conclusive: 25 probes span the 
regions represented on the microarray. For a lot of promoter regions, differences in 
fluorescence intensities are limited to a small part of the entire region. Calculating 
FDRs for summarised probe values may therefore lead to an overestimation of the 
number of false discoveries which may be encountered. To overcome this, future 
work would have to involve re-analysis of the raw data, to calculate FDRs for each 
probe separately. 
In summary, LSH is required for DNA methylation of a large number of 
intermediate- and low- CpG density class promoters of protein coding genes. 
  
                95
3.2.3 LSH is required for DNA methylation throughout the 
genome at single gene promoters as well as clusters of 
promoters 
The next objective was to determine the location of LSH dependent 
promoters across all chromosomes, with the intention to identify whether LSH is 
equally required for DNA methylation of promoters on all chromosomes. From 
Figure 3.4A, it can be seen that both hypo- and hypermethylated genes are spread 
over all chromosomes. Despite the spread across all chromosomes, DNA methylation 
at single promoters as well as groups of up to 18 adjacent promoters requires LSH. 
This indicates that lack of LSH affects DNA methylation of large chromosomal 
regions.  
The Rhox cluster on the X chromosome (Figure 3.4B) is most striking, as 11 
members, including the neighbouring Gm9 gene, show great reduction in DNA 
methylation in Lsh-/- MEFs. It is therefore the largest contiguous genomic region 
affected by LSH deficiency. The Rhox cluster encodes a group of reproductive 
homeobox genes on the X chromosome (Maclean et al, 2005). Initially 12 members 
of the Rhox gene family were identified but now several sub members have been 
shown to exist, suggesting an expansion of the cluster (Wang & Zhang, 2006). These 
genes are expressed in a cell type specific manner. Nine out of 12 Rhox genes are 
exclusively expressed in reproductive tissues (Maclean et al, 2005). Rhox4, 7 and 8 
also show expression in thymus, stomach and intestine respectively (Maclean et al, 
2005).  
  

























Figure 3.4 Chromosomal distribution of LSH target promoters
A: Chromosomal map of promoters undergoing 2-fold changes in DNA methylation 
in Lsh-/- MEFs (hypomethylated in red and hypermethylated in blue). B: Structure of 
the Rhox locus on the X chromosome. 
n = 376
n = 92
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Several of these genes are regulated by hormones and all are colinearly expressed 
(timing of expression is dependent on chromosomal position). Noticeable is the fact 
that they are highly expressed in extraembryonic tissues (Maclean et al, 2005).  
DNA methylation of Rhox genes was previously analysed in Dnmt3a and 
Dnmt3b null mouse embryos (Oda et al, 2006). In this study it was found that Rhox 
gene promoters undergo methylation reprogramming during early embryonic 
development. Rhox gene promoters are hypomethylated in the pre-implantation 
embryo and gain DNA methylation by the E9.5 stage in embryonic, but not 
extraembryonic tissues (Oda et al, 2006). Importantly, DNA methylation of Rhox 
gene promoters is independent of X inactivation.  
Rhox promoter de novo methylation in the embryo is dependent on DNMT3B 
and to a lesser extent on DNMT3A (Oda et al, 2006). Requirement of LSH for DNA 
methylation of Rhox genes highlights the potential need for LSH in early 
differentiation into the embryonic cell lineages. 
3.2.4 LSH may be involved in DNA methylation at different stages of 
early development 
To address the potential role of LSH in early cell lineage commitment I set 
out to determine the developmental time point at which LSH-dependent promoters 
are normally methylated. As described in the introduction, LSH is thought to be 
mainly required for de novo methylation. The aim was therefore to identify at which 
stage of mammalian development LSH may be required for correct DNA 
methylation establishment. For this purpose I carried out an additional MBD column 
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and microarray analysis experiment on WT embryonic stem cells (ES cells). This 
enabled comparison of DNA methylation levels of gene promoters in WT ES cells, 
WT MEFs and Lsh-/- MEFs. The WT ES cells used in this study were not isolated 
from the same mice as WT and Lsh-/- MEFs. Conclusions therefore have to be seen 
as preliminary and future repeats with cell lines isolated from the same mice will be 
important. This will be possible once Lsh-/- mice have been generated in our lab. 
Results of the DNA methylation comparison are presented as a heat map in 
Figure 3.5. I clustered gene promoters displaying 2-fold or greater differences in 
DNA methylation between cell lines, giving rise to three groups of LSH dependent 
gene promoters. Group I is the largest and encompasses 233 gene promoters which 
are normally methylated  in WT ES cells and WT MEFs but are hypomethylated in 
the absence of LSH. GOFFA gene ontology analysis demonstrates that genes in this 
cluster show involvement in processes such as signalling pathways, morphogenesis 
as well as sensory perception. Additionally, genes involved in trophectoderm 
development were identified. Group II gene promoters (143) are normally 
unmethylated in ES cells and methylated in MEFs. Ontology analysis reveals 
presence of genes involved in neural development, cell as well as anatomical 
morphogenesis. Additional genes involved in embryo development are found, which 
include pluripotency genes and imprinted genes. The smallest group of promoters 
(92) shows increases in DNA methylation in the absence of LSH. This cluster of 
promoters is normally unmethylated in both ES cells and MEFs, which prevents 
determination of normal timing of DNA methylation in the comparison of these cell 
lines. Members of this cluster include genes involved in metabolic processes, 
transport as well as cell differentiation and proliferation.  
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Figure 3.5 Developmental timing of LSH dependent DNA methylation
Comparison of DNA methylation between WT ES, WT MEFs and Lsh-/- MEFs. The 
heat map was generated to show all promoters with 2-fold changes between the three 
cell lines (total number of promoters = 1462). Each row is a promoter and a blue – 
white – red colour gradient of increasing methylation (log2(MAP/Input)) was used. -3 
is the lowest and 3 the highest M value in the dataset. Top: All promoters with 2-fold 
less DNA methylation in Lsh-/- MEFs compared to WT ES cells, ranked by 
decreasing methylation in WT MEFs. Middle: All promoters with 2-fold higher DNA 
methylation in WT MEFs compared to ES cells, ranked by increasing methylation in 
Lsh-/- MEFs. Bottom: All promoters with 2-fold more DNA methylation in Lsh-/- 
MEFs compared to WT ES cells, ranked by increasing methylation in WT MEFs. 
This enabled assignment of LSH dependent gene promoters into three groups 
depending on their normal methylation status in the two WT cell lines (indicated on 
the right of the heat map).
Gene ontology: p<0.0001
                100
Due to the 2-fold cut-offs (for significant methylation changes) used in this 
analysis, some genes are allocated to group II instead of group I, when comparing 
with WT ES cells. These include some members of the Rhox gene cluster, which are 
all known to be methylated in most embryonic tissues. Additionally some genes are 
omitted from the heat map. These include members of the Prader Willi Syndrome 
(PWS) imprinted gene cluster. Ndn is represented in GroupII, but Mkrn3 and Peg12 
from the same imprinted gene cluster are omitted due to DNA methylation 
differences compared to ES cells not being above the 2-fold threshold. This analysis 
therefore enables rough identification when LSH dependent promoters may normally 
be methylated during development. It can be used to predict that LSH may be 
required for DNA methylation during epiblast and extraembryonic tissue 
specification (group I) and during stem cell differentiation into somatic cells (group 
II). Group III gene promoters are not methylated in ES cells or MEFs. I could 
therefore not determine their usual timing of DNA methylation.  
Another aspect to consider in this study is that it involved comparison of cell 
lines not derived from each other. To determine more accurately developmental 
timing of LSH dependent DNA methylation, embryonic studies or stem cell 
differentiation experiments would have to be carried out. Our recent study for 
example investigated the role of LSH in silencing of pluripotency genes during 
retinoic acid differentiation of Lsh knockdown ES cells into neuronal progenitors. 
Pluripotency genes were silenced less efficiently in the absence of LSH (Myant et al, 
2011). This confirms that LSH is required during ES cell differentiation for silencing 
pluripotency genes. Additionally, inefficient silencing of pluripotency genes during 
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ES cell differentiation supports the hypothesis that LSH may be required for 
establishment rather than maintenance of DNA methylation and gene silencing. 
3.2.5 Validation of DNA methylation defects in Lsh-/- MEFs 
The observations described above were based on analyses of high throughput 
data. Validation of these data was required to exclude technical artefacts of MBD 
column purification of methylated DNA and analyses of microarray hybridizations. 
For this purpose, I used sodium bisulfite genomic DNA sequencing to investigate 
DNA methylation profiles of promoters from each of the three LSH dependent 
promoter groups outlined in Figure 3.5. These included Rhox2 (Group I), Ndn 
(Group II) and Dbt (Group III). In addition I also carried out bisulfite sequencing of 
some other gene promoters within the Rhox cluster and the imprinted PWS cluster 
(which contains Ndn). I used Oct4 as a negative control, which has previously been 
identified to remain largely methylated in absence of LSH (Athanasiadou et al, 
2010).  
Bisulfite analysis of several members of the Rhox cluster (Rhox2, 6 and 9) is 
shown in Figure 3.6A. It reveals almost complete loss of DNA methylation in Lsh-/- 
MEFs compared to WT MEFs. Additionally, I carried out bisulfite sequencing on 
genomic DNA from stable Lsh knockdown ES cells and non-silencing control ES 
cells. The bisulfite profile displays no loss of DNA methylation at the Rhox2 
promoter in Lsh knockdown ES cells (Figure 3.6A). This suggests, that LSH is 
required for de novo methylation of gene promoters within the Rhox locus. 
  



















Figure 3.6 A Validation of MBD column and microarray by bisulfite sequencing
Bisulfite genomic DNA sequencing on Oct4 and Rhox genes in WT and Lsh-/- MEFs 
as well a control shRNA and shLSH knockdown ES cells. Oct4 was used as a control, 
which had previously been identified to only undergo DNA hypomethylation in some 
CpG positions. Black circles indicate methylated CpG positions and white circles 
indicate unmethylated CpG positions. Each row represents a DNA sequence from a 
different cell in the population (potential clonal sequences were removed in BiQ 
Analyzer). Diagrams above each bisulfite profile indicate the position of the 
sequenced region in relation to the transcription start site of the gene associated with 
the promoter region. 
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Group II of gene promoters whose methylation was identified to be 
dependent on LSH in the above high throughput data, includes various imprinted 
gene promoters. Previous studies, as outlined in the introduction, showed that LSH is 
required for DNA methylation at the imprinted Cdkn1c gene promoter, but not other 
imprinted differentially methylated regions (DMR). This study argued that Cdkn1c 
was the only DMR analysed which gains differential DNA methylation in the 
embryo, rather than the germ line. This indicates that LSH may be required for 
establishing tissue specific imprinted DNA methylation in the embryo, rather than 
maintaining imprinted DNA methylation which is established in the germ line. I 
carried out bisulfite sequencing on several imprinted gene promoters which normally 
gain DNA methylation in the embryo (Figure 3.6B). These included Ndn, Peg12 and 
Mkrn3. These three genes are part of the Prader Willi Syndrome locus on 
chromosome 7 and are regulated by a differentially methylated region in the Snrpn 
promoter, which is methylated during germ cell specification. My methylated DNA 
affinity purification and microarray analysis did not indicate hypomethylation of the 
Snrpn promoter. Ndn, Peg12 and Mkrn3 promoters on the other hand show extensive 
DNA hypomethylation in bisulfite profiles of Lsh-/- MEFs (Figure 3.6B). This 
supports the idea that LSH is required primarily in establishing DNA methylation 
patterns at imprinted genes, rather than maintaining them. 
Finally, for the validation of Group III promoters, bisulfite sequencing on Dbt 
was carried out, confirming DNA hypermethylation in Lsh-/- MEFs. Although 
significant, the extent of hypermethylation was less than hypomethylation seen in 
Group I and Group II promoters (Figure 3.6B). 
  

















Figure 3.6 B Validation of MBD column and microarray by bisulfite sequencing
Bisulfite genomic DNA sequencing on genes in the PWS imprinted cluster as well as 
on Dbt, a gene displaying increased DNA methylation in Lsh-/- MEFs in promoter 
microarray analysis. Black circles indicate methylated CpG positions and white 
circles indicate unmethylated CpG positions. Each row represents a DNA sequence 
from a different cell in the population (potential clonal sequences were removed in 
BiQ Analyzer). Diagrams above each bisulfite profile indicate the position of the 
sequenced region in relation to the transcription start site of the gene associated with 
the promoter region.
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In summary, bisulfite sequencing confirms requirement of LSH for DNA 
methylation at promoters normally methylated during the establishment and 
differentiation of embryonic stem cells. LSH is especially required for de novo rather 
than maintenance of DNA methylation at the Rhox2 gene promoter. Additionally, 
results suggest that imprinted DNA methylation marks are established rather than 
maintained by LSH. This could be further confirmed by carrying out bisulfite DNA 
sequencing on imprinted gene promoters in Lsh knockdown MEFs.  
3.2.6 Gene expression patterns are altered in absence of LSH 
From the above analysis the question arises, whether LSH dependent 
promoter DNA methylation is required for correct gene expression at associated 
genes or whether other factors are sufficient to maintain gene expression patterns in 
absence of LSH. For this purpose I isolated cDNA from WT and Lsh-/- MEFs for 
subsequent expression microarray analysis of 25,658 protein coding genes 
(Nimblegen MM8-60mer-expr-X4) (See materials and methods for normalization 
methods). 755 genes are overexpressed in Lsh-/- MEFs, whereas 516 transcripts 
show 4-fold or greater decrease in expression in absence of LSH (Figure 3.7A). In 
summary, 5% of all protein coding genes are miss expressed in Lsh-/- MEFs. 
Strikingly, Lsh-/- MEFs display many more gene expression defects than 
DNA methylation defects. This could be an indication of either indirect effects of 
LSH on gene expression or that LSH is required for regulating gene expression 
independent of DNA methylation. To further investigate this, I sought to determine 
whether expression and DNA methylation changes are inversely proportional with 
each other as would normally be predicted (Figure 3.7B).  
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Figure 3.7 Gene expression analysis in WT and Lsh-/- MEFs
A: Expression microarray analysis. Plotted are all log2 median fluorescence intensity 
values for WT and Lsh-/- MEFs for each gene analysed on the Nimblegen expression 
array. In red are genes which show 4-fold or more increase in expression in Lsh-/- 
MEFs and in blue are genes which show 4-fold or more decrease in expression in 
Lsh-/- MEFs. B: Validation of expression array by reverse transcription PCR of Rhox 
and Hox genes. PCRs were carried out with three different concentrations of cDNA as 
well as on a negative cDNA synthesis reaction (RT-). C: Comparison of expression 
changes with DNA methylation changes in Lsh-/- MEFs. Shown is a histogram of the 
4-fold or more up- or down regulated genes which also display 2-fold or higher DNA 
methylation changes. Highlighted are the genes whose expression changes and 
methylation changes are inversely proportional. 4% of upregulated genes loose DNA 
methylation at their gene promoters. 5% of downregulated genes gain DNA 
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Plotted are the numbers of genes showing 4-fold or greater up or down regulation. 
Highlighted are those expression changes, which can be directly attributed to 2-fold 
or higher inversely proportional DNA methylation changes. In summary, ~5% of 4-
fold or greater expression changes can be directly attributed to 2-fold or greater 
promoter or upstream region DNA methylation changes.  
To validate expression microarray conclusions that LSH is required for 
correct expression of specific genes, I carried out reverse transcription PCR analysis 
of WT and Lsh-/- MEF cDNA on Rhox and Hox genes (Figure 3.7C). Several Rhox 
genes analysed, are activated, consistent with hypomethylation of their promoters in 
Lsh-/- MEF. Rhox4b is an exception and remains silent, despite being 
hypomethylated in Lsh-/- MEFs. Hox genes are weakly expressed in WT MEFs and 
are upregulated in absence of LSH, despite not undergoing any changes in promoter 
DNA methylation. Other work from our lab confirmed the miss expression of other 
group I and group II genes that show LSH-dependent DNA methylation (Myant et al, 
2011). 
In summary, absence of LSH causes more extensive expression changes than 
DNA methylation changes. This could be due to indirect effects of promoter DNA 
methylation changes on gene expression. If for example the promoter of a repressor 
of gene expression is hypomethylated in absence of LSH, this could lead to 
expression changes at genes regulated by this repressors. In some cases DNA 
methylation defects are not accompanied by expression defects, indicating that DNA 
methylation is not required for the maintenance of a correct gene expression status. 
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3.3 Discussion 
In summary, the above study allowed more detailed characterization of LSH 
dependent DNA methylation at gene promoters than ever published before. Before 
my study, LSH requirement for repetitive element DNA methylation was extensively 
characterized. Previously identified effects of LSH absence on single gene DNA 
methylation and gene expression were suggested to be exceptions arising from close 
proximity to repetitive elements, rather than direct regulation by LSH. Contradicting 
this notion, I identified extensive DNA methylation and expression defects at protein 
coding gene promoters genome wide. I identified extensive changes in DNA 
methylation at single genes as well as gene clusters in Lsh-/- MEFs. Both hypo- and 
hypermethylation was observed, suggesting either a dual role of LSH in ensuring 
correct DNA methylation patterns or indirect effects of DNA hypomethylation of 
some promoters on the methylation status of others. This suggests that LSH may 
indeed be directly involved in regulating DNA methylation and gene expression at 
non-repeat regions of the genome. 
Additionally, I identified LSH to be required for DNA methylation at some 
gene promoters whose DNA methylation status distinguishes early embryonic 
lineages (e.g. Rhox genes and pluripotency genes).  This, suggests, that LSH may be 
implicated in de novo DNA methylation and gene expression patterns during early 
development. Interestingly Lsh-/- embryos survive until after birth, without any 
major developmental defects, suggesting that de novo methylation events which fail 
to take place in absence of LSH do not result in gross developmental abnormalities 
during embryonic development. Direct facilitation of DNA methylation by LSH 
could be tested by Chromatin Immunoprecipitation of LSH at specific gene 
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promoters. Since my data suggests that LSH is required for DNA methylation of 
pluripotency gene promoters, ChIP could be carried out on these promoters during 
differentiation of stem cells into neuronal progenitors. This would enable to 
determine whether LSH interacts with these promoters to facilitate de novo DNA 
methylation during differentiation. 
Since this study focused on Lsh-/- or knockdown cell lines, the next step 
towards confirming a potential involvement of LSH in DNA methylation and gene 
expression during early development would require studies in embryos as well as 
more stem cell differentiation experiments (Myant et al, 2011). Use of conditional 
knockout embryos with the potential to reactivate and inactivate LSH at different 
developmental stages would allow more precise characterization of the 
developmental timing of LSH-dependent de novo DNA methylation events. 
However, embryo studies can be difficult and have to be carried out according to 
guidelines. Therefore gaining as much insight into LSH function in DNA 
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Chapter 4 - Investigating a cell-autonomous function of 
LSH in DNA methylation 
4.1 Introduction 
4.1.1 Potential requirements for LSH dependent DNA methylation 
Following the conclusion from chapter 3, that LSH may function in DNA 
methylation and gene expression regulation as early as in the pre-implantation 
embryo, some other evidence for an early role of LSH exists. When comparing WT 
MEFs and WT ES cells, LSH expression is 10-fold reduced in WT MEFs (Figure 
4.1B). Accordingly, an ES cell differentiation experiment I carried out demonstrates 
a 5-fold drop in LSH protein levels at the onset of differentiation. LSH levels peak 
slightly during differentiation but remain low compared to WT ES cells (Figure 4.1A 
and B). This substantiates the notion that LSH may function early in development 
and only carry out limited function in differentiated cells. Additionally, this poses the 
question, whether LSH can only exert its DNA methylation function during a 
specific early developmental window. In this chapter I therefore outline my attempt 
to answer the following questions:  
Can LSH function in an autonomous manner in somatic cells, to facilitate 
DNA methylation establishment at any of the identified LSH dependent loci? Or is 
LSH function in establishing DNA methylation restricted to a particular 
developmental window, due to the requirement of other specific co-factors or signals 
not present in somatic cells? In addition I wanted to determine, whether LSH 
requires its catalytic activity (ATP hydrolysis) for its function in DNA methylation.  
  

















































































































































Figure 4.1 LSH protein levels during embryonic stem cell differentiation into 
neurons
A: ES cell differentiation timeline. Steps of neuronal differentiation are displayed, 
including removal of Leukemia inhibitory factor, addition of retinoic acid and 
addition of neuronal media. Time points at which cells were harvested are indicated in 
red. B: Western blot on LSH and HDAC1 as loading control (top pannel). 
Quantification of Western blot is shown below. LSH protein levels were normalized 
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I sought to answer the above questions through re-expression of WT and 
catalytically mutant LSH in Lsh-/- MEFs. The catalytic mutation used in this study is 
a conversion of a conserved lysine into glutamine in the catalytic domain of LSH. 
The inability of this mutant to hydrolyse ATP was confirmed by Kevin Myant, a 
previous PhD student in our lab. 
The primary pre-requisite for establishing correct DNA methylation patterns 
is the presence of de novo methyltransferases. As mentioned in the introduction of 
chapter 3, LSH has been shown to interact with DNMT3B directly as well as 
indirectly with DNMT1 and HDACs (Myant & Stancheva, 2008). One immediate 
restriction to the ability of LSH to rescue DNA methylation in mouse embryonic 
fibroblasts may therefore be the reduced level of the full length isoform of DNMT3B 
(DNMT3B1) in somatic cell lines (Okano et al, 1998a). Additionally this DNMT3B 
isoform is active on its own but is enhanced by presence of DNMT3L. DNMT3L is 
also expressed at low levels in somatic cells (Ooi et al, 2010). 
Apart from this, DNA methylation has for a long time been thought to be a 
secondary event to gene silencing, perhaps ensuring long term stability of a silent 
state. This notion is supported by various studies. On the X chromosome for 
example, DNA methylation is not required for initiation of X chromosome 
inactivation. Prolonged culture of male ES cells in absence of DNA methylation, on 
the other hand leads to activation of Xist on the active X chromosome. Additionally 
DNA methylation also occurs at promoters of genes silenced during X inactivation. 
This is also thought to be a secondary event after silencing has taken place (Cohen et 
al, 2012; Jonkers et al, 2008; Sado et al, 2000). During stem cell differentiation DNA 
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methylation has also been demonstrated to occur at pluripotency gene promoters 
(especially Oct4) after silencing has occurred. Measurements of levels of Oct3/4 
protein, H3K4me3, H3K9ac, H3K9me3 and DNA methylation have been previously 
profiled at different time points during differentiation of stem cells (Feldman et al, 
2006). H3K9 methylation is the first repressive mark, appearing within the first day 
of differentiation. This initiates silencing of Oct3/4 and is followed by rapid decrease 
in H3K9ac, H3K4me. However, DNA methylation is only detectable after 2 days of 
differentiation, by which time Oct3/4 is already silent (Feldman et al, 2006). DNA 
methylation has been demonstrated to gradually increase throughout differentiation 
(Feldman et al, 2006). This suggests that DNA methylation may require prior 
formation of a repressive chromatin state upon initiation of differentiation. Can the 
establishment of a repressive chromatin state be initiated at early developmental 
genes in somatic cells, to facilitate subsequent DNA methylation establishment with 
the help of LSH? 
Finally, correct initiation of gene silencing has been demonstrated to require 
initiation of signalling pathways at specific time points during early development. A 
recent study for example demonstrated the activation of G9a histone 
methyltransferase by a signalling cascade resulting in inhibition of APC/C ubiquitin 
ligase (Yamamizu et al, 2012). This signalling pathway is thought to ensure correct 
timing of pluripotency gene inactivation during differentiation of stem cells. These 
type of signals may be absent in somatic cells, potentially preventing re-
establishment of pluripotency gene silencing and DNA methylation.  Similarly 
silencing and DNA methylation of genes during divergence between embryonic and 
extraembryonic lineage cells also requires specific signals generated through 
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signalling pathways. An example of this is the Hippo signalling pathway which is 
imitated in ICM cells in the early embryo to allow continued repression of 
extraembryonic lineage markers (Avner & Heard, 2001; Heard et al, 2001). Re-
introduction of LSH into somatic cells may not allow re-establishment of DNA 
methylation and gene silencing at early developmental loci due to the absence of 
such initiating signals of gene repression in somatic cells. 
The above analysis suggests, there may be a developmental window during 
which gene silencing and DNA methylation of early developmental gene silencing 
can be established. Somatic cells may have mechanisms in place to maintain already 
established silent state, but may not be able to initiate the formation of these. An 
example of this is in X chromosome inactivation. Studies have demonstrated, that 
late expression of Xist RNA does not allow initiation of X chromosome inactivation. 
This suggests, that X inactivation occurs during a specific developmental window 
and cannot be established at later stages (Sado et al, 2004). 
4.2 Results 
4.2.1 Expression of WT and catalytic mutant LSH in Lsh-/- MEFs 
Various attempts have been made in the lab to re-express LSH in Lsh-/- 
MEFs. These used expression vectors containing different promoters, different 
integration methods as well as different tagged LSH sequences. Expression of LSH 
under a CMV promoter failed completely and expression using a vector containing 
an MMLV promoter resulted in low transient expression of LSH protein.  
Previous studies have identified the efficient silencing of retroviral promoters 
such as CMV and MMLV in different murine cell lines (Haas et al, 2003; He et al, 
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2005; Kawasaki et al, 2011; Lorincz et al, 2001; Swindle & Klug, 2002).Therefore I 
used a lentiviral Murine Stem Cell Virus vector to clone the WT and catalytically 
mutant Lsh (K237Q) open reading frame with a 3’ 3 x FLAG tag followed by the 3’ 
untranslated region into the Murine Stem Cell Virus vector (MSCV). The MSCV 
vector contains long terminal repeats from the murine stem cell PCMV virus which 
act as a promoter (Figure 4.2). The differences to the MMLV LTR are several point 
mutations and a deletion which enhance activation and have been shown to prevent 
endogenous silencing in stem cells. The idea was to try and use this vector to obtain 
more constitutive expression of LSH in Lsh-/- MEFs. The MSCV virus was 
packaged into lentiviruses using the Phoenix cell method (Figure 4.2). Harvested 
viruses containing the WT and catalytic mutant LSH constructs were used to infect 
Lsh-/- MEFs. Empty MSCV vector was used in a control infection. Positive pool cell 
lines were selected with puromycin and individual clonal lines isolated for further 
analysis.  
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Figure 4.2 Retroviral expression system
A: Retroviral vector containing viral 5’ long terminal repeat (LTR) which acts as a 
promoter for expression of a gene of interest. Vector also contains bacterial and 
mammalian selection markers. B: Transfection of the retroviral vector into PhoenixA 
cells. Viral LTRs within expression vector induce the expression of viral genes Env 
(envelope protein), Gag (retroviral core protein) and Pol (reverse transcriptase and 
integrase) present in Phoenix cells. This results in packaging of the gene of interest 
into viral particles. C: Viruses containing the gene of interest cause Phoenix cell lysis 
(dashed appearance of phoenix cell) and can be used to introduce the gene of interest 
into target cells by viral infection.
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4.2.2 Characterization of rescue cell lines 
I carried out Western blot analysis and quantification of LSH protein levels in 
the different WT and catalytic mutant clonal cell lines isolated (Figure 4.3A). All 
clonal lines apart from WT LSH rescue clonal line number 8 express LSH at lower 
levels compared to WT MEFs.  The three mutant LSH rescue cell lines express LSH 
at higher levels than the WT1 and WT4 rescue cell lines. Any lack of DNA 
methylation or gene expression changes in mutant compared to WT rescue lines in 
following experiments can therefore not be attributed to insufficient expression of 
mutant LSH. I selected three cell lines displaying similar LSH expression levels for 
further analysis (WT1, WT4 and Mut4). Immunocytochemistry analysis confirms 
nuclear LSH expression in WT1, WT4 and mut4 cell lines (Figure 4.3B). 
Additionally, I used the other clonal cell lines (especially WT8) in some experiments 
to identify, whether different expression levels of LSH had variable effects on DNA 
methylation and gene expression. Apart from this, using different clonal lines 
enabled me to exclude the possibility that any DNA methylation or gene expression 
changes are due to derivation of certain clonal lines, rather than LSH expression 
itself. 
To further characterize LSH rescue cell lines, I carried out growth measurements to 
determine the population doubling time of each cell line (Figure 4.3C). All rescue 
cell lines display increased population doubling times compared to WT and Lsh-/- 
MEFs.  This indicates that re-expression of wild-type and mutant LSH by retroviral 
infection causes some growth disadvantage. Re-expression of WT and mutant LSH 
in these cells may cause aberrant DNA methylation or gene expression, which could 
lead to growth defects.  
































































Figure 4.3 A LSH expression levels in rescue cell lines
A: Anti-LSH Western blot. Top pannel: LSH protein detection in three clonal cell 
lines each from  infections of Lsh-/- MEFs with WT LSH open reading frame (ORF) 
or ATPase mutant LSH ORF. An anti-MRE11 antibody was used as a loading control. 
Bottom pannel: Western Blot quantification using Licor. LSH protein levels are 
normalized to MRE11 loading control and displayed relative to WT. 
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WT MEF
Lsh-/- + MSCV
Lsh-/- + WT LSH4
Lsh-/- + mut LSH4
DAPI anti FLAG(LSH) merge
Lsh-/- + WT LSH1
B
Figure 4.3 B & C LSH rescue cell line characterization
B: Cell morphology and Immunocytochemistry analysis: The left pannel shows 
control and rescue cell, cell morphology (40x magnification). The right pannel shows 
anti-FLAG immunofluorescence staining of LSH in MSCV empty vector and rescue 
cell lines. Merge with the DAPI nuclear signal  confirms nuclear LSH expression. C: 
Population doubling time measurements of rescue cell lines. Error bars shown 
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The catalytic mutant cell line displays the slowest growth rate, indicating that 
a mutation in the catalytic domain causes LSH to exert an additional negative effect 
compared to wild-type LSH. This is the first indication that there is a difference in 
function of wild-type and catalytically inactive LSH. To expand on this, I compared 
cell morphology of the clonal lines (Figure 4.3B left column). WT rescue cell lines 
look morphologically more similar to WT MEFs, whereas the mutant rescue cell 
lines resemble more the MSCV vector only control cell line. This suggests, that wild-
type LSH, but not mutant LSH can cause some reversal of knockout phenotypes in 
these cells. 
4.2.3 Wild-type but not catalytically inactive mutant LSH restores DNA 
methylation at repetitive sequences in Lsh-/- MEFs 
After a general characterization of rescue cell lines, the immediate question 
was, whether LSH re-expression leads to rescue of DNA methylation defects in Lsh-
/-MEFs. To obtain an indication whether DNA methylation levels had changed in 
these cell lines I carried out Southern blot analysis on minor satellite repeats, 
characteristic of centromeric DNA. This involved digestion of genomic DNA with 
MspI (methylation insensitive) and HpaII (methylation sensitive) restriction enzymes 
and probing with a 120bp minor satellite repeat fragment. For this analysis, three 
different clonal lines expressing either wild-type or catalytically inactive LSH were 
used (Figure 4.4A). All genomic DNAs are equally digested by methylation 
insensitive enzyme MspI. This was used as a loading control indicating equal DNA 
amounts as well as equal ability to digest the DNA fully. WT MEF gDNA is only 
digested to a small extent by methylation sensitive enzyme HpaII, indicating high 
levels of DNA methylation.  



















































































































Figure 4.4 Repetitive element and whole genome DNA methylation analysis
A: Minor satellite DNA methylation by southern blotting of MspI (methylation 
insensitive) and HpaII (methylation sensitive) digested rescue cell line genomice 
DNA. The southern blot was probed with a minor satellite repeat probe. B: IAP 
element bisulfite sequencing on rescue cell line gDNA. C: Left: Whole genome DNA 
methylation levels in rescue cell lines were determined by HPLC analysis of genomic 
DNA. Values displayed are ratios of methyl cytosine to cytosine. Error bars show 
standard deviation of triplicates. Significance of DNA methylation differences 
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Lsh-/- MSCV control cell gDNA display higher levels of digestion, confirming a loss 
of DNA methylation in these cells. This confirmed previous studies which showed 
minor satellite hypomethylation in Lsh-/- cell lines (Dennis et al, 2001). Southern 
blot analysis on wild-type LSH rescue cell lines displays intermediate levels of 
digestion by HpaII. This indicates increased levels of methylation at minor satellite 
repeats upon re-expression of wild-type LSH. Mutant cell lines on the other hand 
display similar HpaII digestion patterns to MSCV control cell lines. This suggests 
that catalytically mutated LSH is unable to cause increases in DNA methylation at 
minor satellite repeats.  
Additionally, I determined DNA methylation patterns at Intracisternal A 
particle (IAP) repeat elements by sodium bisulfite DNA sequencing in three different 
rescue cell lines (Figure 4.4B). IAP elements are similar to retroviral repeats and are 
present only in rodent genomes (Qin et al, 2010).  Consistent with minor satellite 
repeats, IAP elements display increased DNA methylation upon re-expression of WT 
Lsh (especially WT4), but not in cells expressing the mutant form of LSH (Figure 
4.4B). Interestingly WT1 rescue cells display completely methylated IAP repeats as 
well as some completely unmethylated IAP repeats. Unlike bisulfite sequencing at 
single genes, repetitive element bisulfite sequencing amplifies repeats located in 
different genomic regions. Differences in DNA methylation of non-clonal sequences 
from the same rescue cell line could therefore be representative of DNA methylation 
at different IAP repeats within the genome being rescued to different extents.  
 
  
                123
To extend this study and determine global levels of 5meC, I prepared 
genomic DNA samples for HPLC analysis by Bernard Ramsahoye’s group in the 
University of Edinburgh Cancer Research UK centre. HPLC analysis involves 
hydrolysis of DNA into single nucleotides and subsequent separation by High-
performance reverse phase liquid chromatography (Ramsahoye, 2002). Presence of 
different bases can then be identified by detecting UV absorbances. Consistently 
with southern blot analysis of repeat elements, both WT rescue cell lines display 
genome methylation levels higher than those in the control Lsh-/- MSCV cells 
(Figure 4.4C). However, the cell lines expressing wild-type LSH showed only partial 
(~50%) rescue of DNA methylation, when comparing with WT MEFs. The mutant 
cell line showed no significant difference in genome-wide 5meC levels compared to 
Lsh-/- MEFs. Two-tailed t-tests between all samples confirmed these differences in 
DNA methylation (Figure 4.4C).  
In summary, whole genome and repetitive sequence analysis reveals a partial 
rescue of DNA methylation in WT but not catalytic mutant rescue cell lines. The 
question arising is, why full DNA methylation could not be restored in these cell 
lines. I investigated several possible reasons for this partial rescue. Firstly, most 
rescue cell lines used showed LSH expression levels lower than those in WT MEFs. 
Because of this I included WT rescue cell line number 8 in my analysis of minor 
satellite DNA methylation as this cell line showed overexpression of LSH compared 
to WT. Despite LSH being overexpressed in this cell line, minor satellite DNA 
methylation levels were similar to other WT rescue cell lines investigated by 
Southern blot analysis. This suggests, that partial rescue of DNA methylation 
observed in the cell lines analysed is not due to low expression of LSH. Secondly, all 
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analysis was carried out on clonal cell lines, which were derived by seeding cells at 
low density and subsequently isolating colonies. Despite this, immunofluorescence 
analysis revealed non-homogeneous populations of cells, with some expressing LSH 
whereas others not to detectable levels by eye (Figure 4.5A). We therefore counted 
the number of cells (Rebekah Tillotson, honours project student) expressing LSH in 
the two WT rescue and one mutant rescue cell population (Figure 4.5B). All rescue 
cell populations express LSH in over 50% of cells. This suggests that 50% rescue of 
repetitive element and whole genome DNA methylation is not directly proportional 
to the number of cells expressing detectable levels of LSH. Additionally, a similar 
number of cells in the LSH mutant rescue population express LSH as within the 
wild-type LSH4 rescue cell population. Despite this, mutant rescue cells do not show 
increase in DNA methylation at repetitive elements and in the genome as a whole. 
This substantiates the conclusion that the ability of LSH to hydrolyse ATP is 
required for DNA methylation at repeat elements. 
In summary, my analysis shows, that wild-type but not catalytic mutant LSH 
can partially restore DNA methylation at repetitive elements when introduced into 
Lsh-/- MEFs. This partial rescue of DNA methylation is not directly proportional to 
the number of cells expressing LSH in the population. Additionally, rescue of DNA 
methylation is not enhanced by increased levels of LSH expression. This suggests, 
that partial rescue of DNA methylation could have occurred due to the absence of 
other developmental factors or signals required. 
  












Lsh-/- MEF + WT LSH 1
DAPI LSH 3 x FLAGA
B
Lsh-/- MEF + WT LSH 4
Lsh-/- MEF + Mut LSH 4
Figure 4.5 Homogeneity of LSH rescue populations.
A: Immunofluorescence images taken at 1s exposure of Lsh-/- MEFs expressing WT 
or mutant LSH. DAPI staining of the nuclei is shown on the left and anti-FLAG 
stained cells showing LSH expression on the right. White arrows indicate cells with 
nuclear FLAG staining indistinguishable from background. Green arrows indicate 
cells expressing LSH at very low levels, highlighting non-homogenous cell 
population. B: Histogram showing percentage of cells in each rescue cell line 
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4.2.4 Wild-type, but not mutant LSH, restores DNA methylation at 
promoters of protein-coding genes in Lsh-/- MEFs 
The next question was, whether LSH re-expression can also restore correct 
DNA methylation patterns at protein-coding gene promoters. In chapter 3 I described 
and discussed protein coding gene promoter DNA methylation defects in Lsh-/- 
MEFs. The objective was to investigate promoters classified as group I (early 
methylation events) and group II (late methylation events), which underwent 
hypomethylation in Lsh-/- MEFs.  Together with honours student, Rebekah Tillotson, 
I carried out bisulfite genomic DNA sequencing on Rhox2, Rhox6, and Rhox9 
(Figure 4.6). These results show that Lsh-/- MEFs expressing wild-type LSH display 
elevated DNA methylation at Rhox2, Rhox6 and Rhox9 gene promoters.  Mutant 
LSH had no effect on DNA methylation, confirming the data obtained for repetitive 
elements and whole genome DNA methylation. Bisulfite sequencing on single genes 
was also a way to determine whether different cells in the population undergo 
different levels of de novo DNA methylation at gene promoters. Each row in a 
bisulfite diagram reflects a non-clonal sequence from a single cell. This generates an 
overview of DNA methylation in a cell population. As can be seen from bisulfite 
sequencing of Rhox2 and Rhox6, both WT rescue cell lines show even DNA 
methylation in all unique sequences (apart from Rhox2 in WT1 cell line). This 
suggests that even though the population of cells might not be uniform in LSH 
expression levels, most cells have sufficient levels of LSH to allow DNA 
methylation at these genes.  
  







-159 +44 -138 +207
Figure 4.6 Bisulfite DNA sequencing of Rhox2 and Rhox6 in rescue cell lines
Black circles indicate methylated CpGs and unmethylated CpGs are indicated by 
white circles. Location of bisulfite sequencing product relative to transcription start 
site of gene is indicated above the diagram.
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4.2.5 Restoration of DNA methylation at protein coding gene promoters is 
accompanied by rescue of gene expression defects at some genes 
To investigate whether LSH dependent de novo DNA methylation at selected 
promoters is accompanied by reversal of gene expression defects, we carried out 
qPCR analysis of cDNA from WT4 and Mut4 cell lines (Rebekah Tillotson, honours 
student). This was also an easier way to assay more different genes in the rescue cell 
lines, than by bisulfite sequencing. Quantitative PCR was carried out on transcripts 
in the Rhox and Hox clusters, pluripotency genes (Dppa4) and imprinted genes (Ndn, 
Peg12, Peg3). These represent genes from group I as well as group II of LSH 
dependent methylated loci.  
Expression of wild-type LSH in Lsh-/- MEFs leads to most genes analysed 
(apart from Peg3) being expressed to more similar levels to WT MEFs (Figure 4.7). 
The Rhox cluster is hypomethylated as well as overexpressed in absence of LSH. 
Gm9 is the neighbouring gene of the Rhox cluster shown to be hypomethylated and 
overexpressed as well (Myant et al. 2011). Gm9, Rhox2a and Rhox6 show up to 10-
fold repression in rescue cell lines containing WT LSH. Other transcripts analysed 
only display up to 2-fold repression. Re-expression of WT LSH causes reduced 
expression of Hoxa4 as well as Hoxc6. Dppa4 is a pluripotency gene and also shows 
reduction of expression in presence of WT LSH. Out of the three imprinted genes 
investigated, both Ndn and Peg show reduced expression in presence of WT LSH.  
 
 














































































































































































Figure 4.7 Gene expression in LSH rescue cell lines
Gene expression levels in rescue cell lines by quantitative qPCR, normalized to 
GAPDH. All expression values are displayed relative to MSCV control cell levels. 
Different groups of genes are indicated in different colours. Light blue: Rhox cluster. 
Dark blue: Differentiation associated genes. Purple: imprinted genes. Error bars 
represent 2 x standard deviation of triplicate experiments.
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Cells expressing catalytically inactive LSH seem to be more varied in expression of 
the analysed transcripts (Figure 4.7). Only Rhox2a and Ndn show mildly reduced 
expression in the presence of mutant LSH. Other transcripts analysed show increase 
in expression compared to MSCV control cells. This is interesting, as it suggests that 
the mutant LSH has a negative effect, enhancing the defects seen in absence of LSH. 
4.3 Discussion 
In summary, I found that expression of WT LSH, but not catalytically 
inactive LSH in Lsh-/- MEFs results in 50% rescue of DNA methylation at repetitive 
sequences such as minor satellites and IAP elements. Additionally, re-expression of 
WT, but not mutant LSH, caused gain of DNA methylation at promoters which are 
hypomethylated in the absence of LSH. This was accompanied by reduced 
expression of associated genes. Strikingly, the Rhox cluster is a specific example 
where genes with increased methylation showed up to 10-fold reduced transcription 
upon re-expression of LSH. This resembled more their expression patterns in WT 
MEFs. However, re-expression of WT LSH only caused up to 2-fold reduction in 
Hox gene, pluripotency gene and imprinted gene expression. The methylation and 
expression patterns of pluripotency and Hox genes undergo changes during ES cell 
differentiation. Hox genes become expressed in a lineage specific manner, whereas 
Pluripotency genes become silenced. Imprinted gene methylation and silencing is 
also regulated during ES cell differentiation into different cell types.  All these genes 
therefore have a common developmental time when they are regulated, with the help 
of LSH. An explanation why expression of imprinted genes may not be restored 
efficiently in rescue cell lines is the presence of DNMT3L at very low levels. 
DNMT3L has been shown to function in DNA methylation at imprinted genes and 
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may be required for DNA methylation of these by LSH. Pluripotency genes are 
silenced upon differentiation of stem cells. Since LSH is expressed at high levels in 
ES cells, before silencing of pluripotency genes, initiation of their inactivation must 
require other factors or chromatin states in addition to LSH which may not be present 
in MEFs. Hox genes are silent in stem cells and usually marked by bivalent 
chromatin signatures (H3K4 methylation and H3K27 methylation) which are then 
resolved during differentiation. In LSH knockout cells this bivalent chromatin state 
may not exist, which may be a pre-requisite for efficient gene silencing and 
subsequent DNA methylation by LSH. This suggests, that expression of LSH on its 
own may not be sufficient to allow their silencing. Additionally, in the presence of 
all required factors for DNA methylation to occur, there may only be a particular 
time frame (directed by signals in vivo) during which silencing and DNA 
methylation of early developmental genes can occur.  
Immediate future work should focus on characterizing promoters of protein 
coding genes genome wide, to determine at which promoters LSH can facilitate 
DNA methylation in a cell autonomous manner. Additionally, expression array 
analysis would be useful to correlate re-establishment of DNA methylation with gene 
expression in the rescue cell lines. From the experiments in this study, I attempted to 
provide explanations, why gene silencing was re-established at some loci, but not 
others in Lsh-/- cells re-expressing WT LSH. High throughput studies may help us to 
more closely define these loci and therefore infer more accurately, which 
developmental factors/signals may be missing, preventing re-establishment of DNA 
methylation and gene expression at some loci. 
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4.3.1 Functional significance of LSH catalytic mutation – towards a 
functional mechanism 
This study demonstrates that ATPase hydrolysis is required for LSH 
dependent DNA methylation at repetitive sequences, gene promoters as well as on 
the whole genome level. The only exception to this was Rhox2, which displayed 
reduced expression levels in presence of WT as well as mutant LSH. Intriguingly, 
mutant LSH did have an additional effect on the expression of genes analysed.  Most 
genes analysed (Rhox, Hox, Dppa and some imprinted genes) showed increases in 
expression in presence of mutant LSH. This enhancement of gene expression defects 
in cell lines expressing mutant LSH compared to cells with completely absent LSH, 
suggests that the mutant LSH has a dominant effect on gene expression. 
Previous studies have documented negative effects of chromatin remodeller 
ATPase site mutations. Drosophila melanogaster chromatin remodeller Brahma 
carrying a mutation in its ATPase site renders the protein inactive but does not 
prevent assembly of the BRM complex (Elfrig et al. 1998). This poses the possibility 
that the ATPase mutant LSH may have similar effects. Experiments in our lab have 
shown that catalytically inactive LSH still binds DNA as efficiently as wild-type 
LSH. It is on the other hand yet unknown, whether mutant LSH still binds DNMTs 
as well as HDACs. It is most likely that mutant LSH can still bind these factors, as 
the catalytic mutation only affect one amino acid. Despite this, a previous study from 
our lab identified the N terminal portion of LSH sufficient for silencing a reporter 
gene (Myant & Stancheva, 2008). This suggests that the N-terminal (amino acids 1-
226) region may be required for interactions with DNMTs and HDACs. The catalytic 
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mutation is located between amino acids 202 and 394. Therefore interactions 
between mutant LSH and HDACs and DNMTs would still have to be tested. 
To come to a potential model for the mechanism of how mutant LSH may 
cause a dominant effect on gene expression it is helpful to consider the effect of the 
mutant LSH on DNA methylation and gene expression again. DNA methylation is 
almost completely lost in Lsh-/- MEFs from loci requiring LSH for DNA 
methylation. Consistently, catalytically inactive LSH is unable to cause even more 
reduced levels of DNA methylation. Despite this, mutant LSH causes a dominant 
effect on gene expression, with LSH target genes being even more upregulated in 
presence of mutant LSH than in complete absence of LSH. This suggests, that mutant 
LSH may negatively affect silencing mechanisms such as histone deacetylation, 
instead of DNA methylation. One idea is that in absence of LSH, gene expression 
increases at analysed loci, but is still to some extent repressed by other remodellers 
or co-repressor complexes being able to recruit HDACs to the promoter regions of 
genes. Catalytic mutant LSH can bind DNA (unpublished work, Irina Stancheva) and 
may still be able to bind HDACs and DNMTs but the mutation in the ATPase 
domain would prevent LSH from translocating along chromatin. HDACs and 
DNMTs may therefore be permanently sequestered to a localized region, unable to 
be targeted throughout the locus by other repressor complexes. This may result in 
increased gene expression. Additionally, ‘static’ LSH (due to lack of ATPase 
hydrolysis activity) may inhibit binding of other repressive complexes to target 
regions. This may lead to inhibition of turnover between LSH and other repressive 
complexes.  
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These effects of the mutant LSH may result in elevated levels of acetylation 
throughout promoter regions compared to those in Lsh-/- MEFs. Chromatin 
immunoprecipitation of acetylated histones throughout regions spanning the 
promoters of LSH target regions in Lsh-/- MEFs  and Lsh-/- MEFs re-expressing 
mutant LSH could be carried out. In Lsh-/- MEFs, histone deacetylation may still 
occur, facilitated by co-repressors other than LSH. This may preserve some extent of 
gene repression despite DNA hypomethylation in absence of WT LSH. The catalytic 
mutant LSH on the other hand may bind to chromatin together with HDACs and 
DNMTs. HDACs may therefore be sequestered, unable to be recruited by other co-
repressors. Additionally, the catalytic mutation would prevent LSH to translocate 
along the promoter region of genes, to facilitate histone deacetylation. The 
hypothesis therefore is, that acetylation in Lsh-/- MEFs expressing the catalytic 
mutant LSH may be more widespread (with only localized deacetylation) than in 
Lsh-/- MEFs.  
4.3.2 Applications of the LSH expression rescue system 
I have identified that LSH can act in a cell autonomous manner at some 
genomic regions but not others. The regions identified to be rescued by WT LSH re-
expression could therefore be used in further studies of LSH function. Different 
truncated or mutated forms of LSH could be re-expressed in Lsh-/- MEFs, using the 
retroviral system described above. I have proposed different models for a dominant 
effect of catalytically inactive LSH on gene expression. One of these argues, that 
mutant LSH could sequester HDACs, which may then be unavailable to be recruited 
to LSH target loci by other repressor complexes. This could lead to even more 
increased gene expression compared to Lsh-/- MEFs. A way to test this hypothesis 
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would be to make an N-terminal truncation of catalytically inactive LSH. The N-
terminal domain has been proposed to be required for the interactions between LSH, 
DNMTs and HDACs. If LSH exerts a dominant effect by sequestering HDACs, 
truncation of the domain required for these interactions should lead to release of 
HDACs and ability for them to be recruited to LSH target genes by other repressor 
complexes. If on the other hand static binding of LSH prevents binding of other 
repressor complexes, an N-terminal mutation would release HDACs but still prevent 
recruitment of these by other repressors. In this case no change in gene expression 
would be observed. 
Additionally, an N-terminal truncation on its own would also enable us to 
determine, whether interaction between LSH, HDACs and DNMTs is required for 
correct DNA methylation and gene silencing. This mutant may have a lesser effect 
on DNA methylation and gene expression than the Lsh knockout, as it may still be 
able to remodel chromatin, facilitating access to other repressor complexes. 
Finally this system could also be used to re-introduce several factors into 
Lsh-/- MEFs at the same time. DNMT3B1 and DNMT3L would be candidates for 
this. Since these DNMTs are expressed at low levels in somatic cells, the ability for 
LSH to rescue DNA methylation and gene expression may be reduced. 
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Chapter 5 - G9a function in maintenance of imprinted DNA 
methylation and gene expression 
5.1 Introduction 
5.1.1 G9a, a histone lysine methyltransferase, with a role in DNA 
methylation 
Increasingly more non-DNA methyltransferase proteins are found to play a 
role in facilitating DNA methylation. Knockout of major euchromatic histone lysine 
methyltransferase G9a in ES cells leads to 50% loss of DNA methylation (Dong et 
al, 2008). A role for G9a in de novo DNA methylation has been demonstrated in 
silencing of pluripotency genes, to prevent their reactivation after silencing 
(Athanasiadou et al, 2010; Epsztejn-Litman et al, 2008; Feldman et al, 2006). 
Additionally, a study has described G9a function in DNA methylation at the 
imprinted Snrpn gene (Xin et al, 2003). Both of these studies support a 
developmental role for G9a. Apart from genic regions, G9a is required for correct 
DNA methylation at retrotransposons and major satellite repeats as well as in 
proviral gene silencing (Dong et al, 2008; Leung et al, 2011). A role for G9a in 
maintenance of DNA methylation has been proposed based on interactions with 
DNMT1 as well as PCNA at replication forks (Esteve et al, 2006). This suggests a 
mechanism for maintaining correct DNA methylation as well as histone 
modifications during replication. A recent study on the other hand dismissed a role 
for G9a in maintenance of DNA methylation in somatic cells, suggesting that G9a 
may function more during early development (Sharma et al, 2012).Consistent with 
these roles in de novo and maintenance DNA methylation, G9a interacts with DNA 
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methyltransferases DNMT1 (at replication forks), 3A and 3B (through its ankyrin 
domain) (Epsztejn-Litman et al, 2008; Esteve et al, 2006).  
Interestingly DNA methylation and gene repression of G9a target genes and 
repeat elements can be re-established inG9a-/- ES cells through reintroduction of a 
catalytically inactive G9a transgene, whilst H3K9me2 levels remain low (Figure 
5.1B) (Dong et al, 2008; Zhao et al, 2008). This points towards the function of G9a 
in DNA methylation being independent of its histone methyltransferase activity. The 
role of G9a in DNA methylation in comparison with the role of LSH was interesting 
to me, as it may elucidate whether G9a has non-overlapping or overlapping DNA 
methylation targets to LSH. This may provide insight into different mechanisms to 
ensure correct establishment and maintenance of DNA methylation at various 
genomic regions.  
5.1.2 Structure of G9a histone methyltransferase complex 
H3K9 methylation is one of the most well studied repressive histone 
modification. Several different enzymes have been identified to catalyse this 
modification. Distinguishing features of enzymes include the type and position of 
histone residues they target, as well as whether they function in euchromatic or 
heterochromatic regions of the genome. The first identified H3K9 methyltransferase 
was SUV39H1/2, now widely recognised as the major heterochromatin histone 
methyltransferase (Peters et al, 2003; Rea et al, 2000; Rice et al, 2003). It catalyses 
mainly H3K9me3 with the help of a SET domain and consistent with its 
heterochromatin function it has been shown to interact with HP1 (Peters et al, 2003; 
Rice et al, 2003; Schotta et al, 2004). Several other SET domain containing histone 
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H3K9 methyltransferases have now been studied. These include G9a, GLP and 
SETDB1.  
G9a is the second most well studied histone methyltransferase. Similarly to 
SUV39H1, it contains a catalytic SET domain and has been implicated in H3K9 
methylation (Tachibana et al, 2001). The protein structure of G9a can be seen in 
Figure 5.1A. In contrast to Suv39H, G9a catalyses H3K9me1/2 and displays 10-20 
fold higher H3K9 methylation activity (Tachibana et al, 2002).  
Additionally, weak H3K27 methylation by G9a has also been demonstrated 
in vitro, recently argued to occur in vivo as well (Tachibana et al, 2001; Trojer et al, 
2009; Weiss et al, 2010; Wu et al, 2011). The most striking difference between 
SUV39H1/2 and G9a came from studies of nuclear localization of these enzymes. 
Whereas SUV39H1/2 colocalizes with heterochromatin, G9a associates with 
euchromatin, making it to date the major euchromatin histone methyltransferase 
(Tachibana et al, 2002) 
Consistently, G9a-/- embryos undergo dramatic reduction in H3K9 mono and 
di methylation. They develop severe growth impairments, leading to early lethality 
by E8.5 (Tachibana et al, 2002). G9a-/- ES cells have also been analysed and 
similarly display 80% loss of H3K9 di methylation compared to WT levels 
(Tachibana et al, 2002). Additionally H3K9 acetylation and H3K4 methylation 
levels, both signs of actively transcribed regions, increase in knockout cells. In 
contrast to embryos, G9a-/- ES cells remain viable but display growth defects upon 
differentiation. These effects can be reversed by expression of exogenous G9a 
(Tachibana et al, 2002). 























































Figure 5.1 Domain structures and function of G9a and interacting partners GLP 
and WIZ
A: Protein domain structure (drawn to scale) of murine G9a-L, GLP and WIZ. Both 
G9a and GLP have N-terminal Cysteine rich regions  (Cys). GLP also has a 
glutamate/aspartate rich region (E/D) and G9a has an aspartate rich region (E).  In 
addition both G9a and GLP contain Ankyrine repeats (ANK) for interaction with 
DNMT3A/B and with H3K9me1/2 and Pre-SET and SET domains for interactions 
between G9a, GLP and WIZ. WIZ contains six Zinc finger motifs (Zn), the sixth of 
which interacts with G9a and GLP pre-SET and SET domains. All domain 
interactions are highlighted (Adapted from Shinkai and Tachibana 2011). B (left): 
DNA methylation (black ‘lollipops’) and H3K9me1/2 (purple diamonds) at target 
genomic regions. B (right): A point mutation in  the G9a catalytic SET domain 
prevents H3K9me1/2 by the complex but does not affect facilitation of correct DNA 
methylation by the complex.
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Another SET domain containing histone methyltransferase, GLP, has been 
identified, with very similar target specificities and functions to G9a (Tachibana et 
al, 2005). G9a and GLP are structurally almost identical (Figure 5.1A). Glp knockout 
also leads to early embryonic lethality and mimics the phenotype of G9a-/- embryos 
(Tachibana et al, 2005). Studies have now identified the preferential formation of a 
heteromeric complex between G9a and GLP, dependent on their pre-SET and SET 
domains (Figure 5.1B). This complex results in increased stability of G9a in ES cells. 
Accordingly, absence of GLP is accompanied by reduced levels of G9a protein 
(Tachibana et al, 2005).  
Another interacting partner of G9a and GLP has also been implicated in 
stability of the methyltransferase complex (Ueda et al, 2006). This is the zinc finger 
protein WIZ (Figure 5.1A). WIZ can interact with G9a or GLP on their own but is 
more stable in the trimolecular complex containing all three proteins (Figure 5.1B). 
Similar to GLP, WIZ increases the stability of G9a. Consistently knockdown of WIZ 
also results in reduced levels of G9a (Ueda et al, 2006). 
5.1.3 G9a is required for gene repression 
G9a/GLP histone methyltransferase complex has been extensively studied 
with regards to its effect on gene activity. HDAC independent repression of a 
reporter gene by G9a was demonstrated. Accordingly, several co-repressors interact 
with or recruit G9a to chromatin and several studies have characterized its repressive 
functions (Table 5.1) (Shinkai & Tachibana, 2011). Repressive functions include 
silencing of the pluripotency genes during stem cell differentiation and imprinted 
gene regulation in the placenta and ES cells, which may explain early embryo and 
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germ line defects in G9a knockout mice (Chang et al, 2006; Feldman et al, 2006; 
Redrup et al, 2009; Xin et al, 2003). Non-embryonic functions of G9a have also been 
identified. These include establishment of proviral gene silencing, silencing of 
neuronal genes in non-neural cells and expression of lineage specific cytokines in the 
immune system (Lehnertz et al, 2010; Leung et al, 2011; Roopra et al, 2004). 
Table 5.1 G9a interacting partners and repressive functions 
 
Despite this well-known repressive function of G9a, several studies have 
identified a role of G9a in gene activation. Functions of G9a dependent gene 
activation include activation of beta globin gene transcription in adult erythroid cells, 
co-activator functions on nuclear receptors and gene activation during T helper cell 
differentiation and function (Chaturvedi et al, 2009; Lee et al, 2006; Lehnertz et al, 
2010). A recent study demonstrated that gene activation is a direct function of G9a, 
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identifying different G9a protein domains being required for gene repression (SET 
domain) and activation (N terminal domain) (Figure 5.1A) (Purcell et al, 2011). This 
may indicate that G9a functions in gene silencing and activation at different loci as 
well as at different stages of development. 
5.2 Aims 
Only two larger scale studies have characterized genomic regions whose DNA 
methylation and gene expression are dependent on G9a. One study used restriction 
landmark genomic scanning (RLGS) analysis in G9a-/- ES cells. This method uses 
two-dimensional gel electrophoresis with genomic DNA digested with a methylation 
sensitive enzyme (Ikegami et al, 2007; Smiraglia et al, 2007). The other study carried 
out microarray analysis on G9a conditional knockout ES cells to detect aberrant gene 
expression (Ikegami et al, 2007; Yokochi et al, 2009). Despite this, both of these 
studies only focused on a subset of genomic regions (late replicating regions at 
nuclear periphery and CpG rich loci). I aimed to generate a genome wide overview 
of G9a dependent DNA methylation at promoters of protein coding genes. The 
second aim was to compare identified promoters whose DNA methylation is 
dependent on G9a with those whose DNA methylation is dependent on LSH. 
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5.3 Results 
5.3.1 DNA methylation defects at promoters of protein coding genes in 
G9a-/- ES cells 
I used the methylated DNA affinity purification technique, as described in 
Chapter 3, and promoter microarray hybridization analysis, to compare the genome 
wide promoter DNA methylation between WT and G9a-/- ES cells. Cell lines for this 
experiment were obtained from Yoichi Shinkai’s lab by gene conversion. This 
involved treatment of heterozygous cells for the knockout with increased selection 
drug concentrations, leading to forced loss of heterozygosity through chromosomal 
loss. Three technical replicates were carried out in this study. Biological replicates 
could not be carried out at this time, due to the unavailability of G9a-/- mice in our 
lab.  
Using the microarray data for purified methylated DNA, I first calculated the 
total numbers of methylated promoters in WT and G9a-/- ES cells across promoters 
with different CpG density, to allow for CpG density related differences in binding 
affinity to the MBD column (Figure 5.2A). All classes of promoters display DNA 
hypomethylation in G9a-/- compared to WT ES cells, although a slightly lower 
percentage of high density CpG promoters are hypomethylated in G9a-/- ES cells. 
Averages across all CpG density groups indicate that 620 promoters are methylated 
in WT ES cells and 436 are methylated in G9a-/- ES cells. This represents DNA 
hypomethylation of ~29% of all normally methylated promoters.  
It is unclear, how fold change in enrichment of microarray signal between 
different cell lines relates to absolute changes in DNA methylation. Therefore I used 
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a high threshold to identify significant differences in DNA methylation. I highlighted 
all 2-fold differences in DNA methylation between WT and G9a-/- ES cells (Figure 
5.2B). Consistent with other studies there are promoters which lose DNA 
methylation in absence of G9a (9 promoters) as well as promoters which gain DNA 
methylation (6 promoters). To determine, whether variation occurred between 
replicate experiments, scatter plots were plotted and Spearman correlation 
coefficients calcluated (Appendix 2). Average Spearman correlation coefficient for 
WT replicates is 0.8 and for G9a-/- ES cells is 0.85. These corraltion coefficients 
demonstrate significant correlation between replicates.  
For initial validation of the MBD column and microarray experiment, I 
searched for previously identified promoters whose DNA methylation is dependent 
on G9a. These include some Mage genes such as Magea-2 and Magea-8, which did 
not undergo 2-fold or greater changes in DNA methylation in G9a-/- compared to 
WT ES cells, according to my experiment. The question arose whether a 2-fold 
threshold was too high to detect significant differences in DNA methylation between 
WT and G9a-/- ES cells. I therefore reduced the threshold to highlight all 1.4 fold 
changes in DNA methylation, which also included previously identified G9a target 
genes (Figure 5.2C). 163 gene promoters display hypomethylation in G9a-/- ES cells 
compared to WT ES cells (Appendix 3). These promoters represent 26% of all 
normally methylated promoters in WT ES cells. Additionally 76 gene promoters 
display hypermethylation in G9a-/- compared to WT ES cells (Appendix 3). 
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Figure 5.2 DNA methylation analysis in WT and G9a-/- ES cells
A: Total number of methylated promoters in WT and G9a-/- ES cells. Median 
log2(MAP/Input) values are plotted against number of CGs per 100bp. Different 
thresholds were used for quantifying total numbers of methylated promoters in low 
(0.9), intermediate (1) and high (1.1) CpG denstiy classes to account for differences in 
binding to the MBD column. n indicates number of promoters methylated. Left pannel 
shows an average over all CpG density classes. B: Scatter plot comparing DNA 
methylation levels in WT and G9a-/- ES cells. All WT log2(MAP/Input) values are 
plotted agains G9a-/- log2(MAP/Input) values. A threshold was applied to indicate 
promoters undergoing 2-fold hypomethylation (red) or hypermethylation (blue) in 
G9a-/- compared to WT ES cells. C: Scatter plot highlighting all 1.4 fold changes in 
DNA methylation.  D: Venn Diagram of overlapping G9a and LSH target promoters. 
D
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5.3.2 There is some overlap between G9a and LSH target promoters 
Comparing the number of promoters whose DNA methylation depends on 
G9a with those whose DNA methylation depends on LSH, there are fewer G9a target 
promoters than LSH target promoters. This may suggest the requirement for G9a in 
maintenance of DNA methylation at a smaller and more defined group of promoters. 
Following this, I decided to define the overlap between promoters requiring G9a or 
LSH for their DNA methylation. The Venn diagram in Figure 5.2D outlines the 
extent of overlap between G9a and LSH dependent promoters. 34 promoters require 
both LSH and G9a to ensure correct DNA methylation. In summary, 21% of 
promoters which require G9a for their correct DNA methylation also require LSH.  
This suggests that G9a and LSH facilitate DNA methylation at different promoters, 
but that some promoters require both proteins for full methylation. 
 Bisulfite sequencing analysis carried out by others in the lab showed that 
reproductive homeobox genes (Rhox) are hypomethylated in absence of G9a. Rhox2 
and Rhox9 are 70-80% hypomethylated in G9a-/- ES cells. In Lsh-/- MEFs, these 
genes are hypomethylated almost completely. Further analysis suggested that LSH is 
required for correct targeting of G9a to the Rhox promoters. In Lsh-/- MEFs G9a was 
no longer bound to these loci. This demonstrates that LSH facilitates the recruitment 
of G9a to Rhox gene promoters (Myant et al, 2011). Both LSH and G9a allow correct 
establishment of DNA methylation at these promoters. In absence of G9a, LSH can 
still facilitate DNA methylation, although only partially. In absence of LSH, G9a 
fails to be recruited and neither factor is present to allow DNA methylation to be 
established. This would explain the more severe effect of the LSH knockout on DNA 
methylation at these loci. 
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My microarray data on DNA methylation in WT and G9a-/- ES cells did not 
highlight the need for G9a for DNA methylation at Rhox promoters above the 
threshold of significance (1.4 fold differences in log2MAP/input).  This suggests that 
DNA methylation differences between WT and G9a-/- ES cells may have been 
underestimated during methylated DNA affinity purification and microarray 
hybridization. However, my data provide a more comprehensive list than before, of 
gene promoters whose DNA methylation depends on G9a. Further experiments may 
be needed to generate a more complete list of promoters whose DNA methylation is 
dependent on G9a.  
5.3.3 Imprinted gene promoters are hypomethylated in absence of G9a 
Strikingly, within the 163 hypomethylated gene promoters in the absence of 
G9a, I found several promoters of imprinted genes (Figure 5.3A).  
Imprinting is an epigenetic phenomenon, which leads to parent-of-origin 
allele specific expression of a gene. Imprinting was first identified when embryos 
containing only paternal or maternal chromosomes failed to develop to term (Barton 
et al, 1984; McGrath & Solter, 1984). An imprinted status is achieved through 
differential epigenetic modifications (DNA methylation and histone modifications) 
on the two parental alleles. As described in the introduction, differentially methylated 
imprinting marks are established during DNA methylation reprogramming in 
developing germ cells. These regions are the so called Imprinting Control Centres 
(ICRs) whose DNA methylation is stable in the second round of DNA methylation 
reprogramming in the pre-implantation embryo (Arnaud, 2010). Imprinted genes are 
located in clusters, each controlled by one, or in some cases two ICRs (Bartolomei & 
Ferguson-Smith, 2011).  
























































Figure 5.3 Imprinting control region (ICR) DNA methylation analysis in WT 
and G9a-/- ES cells
A: Heatmap displaying DNA methylation differences between WT and G9a-/- ES 
cells at imprinted gene promoters. Differences are diplayed with a blue-white-red 
colour gradient of increasing DNA methylation. Ankrd50 is used as positive control, 
methylated in both cell lines. Ndufa and GAPDH are negative controls, unmethylated 
in both cell lines. These controls were identified from the MBD microarray 
experiment B: Quantitative PCR of Imprinting Control Region (ICR) enrichment in 
the methylated DNA fraction compared to input from MBD purification of WT (blue) 
and G9a-/- ES (red) cell gDNA. Error bars highlight 2 x standard deviation of 
technical replicates. All values represent methylated DNA fraction enrichment 
compared to Input, normalized to Ankrd50. ICRs indicated in red were subsequently 
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Many imprinted genes have secondary differentially methylated regions 
(DMRs) associated with them (Bartolomei & Ferguson-Smith, 2011). DNA 
methylation at secondary DMRs is often established in a cell and developmental 
timing specific manner.  
22 germ line DMRs have been found to date (Table 5.2) (Arnaud, 2010). 12 
germ line DMRs are maternally imprinted and are located within protein coding gene 
promoters and are therefore represented on the promoter methylation microarray 
(Table 5.2). Paternally imprinted ICRs are not represented on the microarray, as they 
are intergenic (Table 5.2). Additionally, ICRs located in promoters of non-coding 
RNAs (such as Kcnq1ot1) are also absent from the microarray. 
Eight germ line DMRs represented on the microarray are hypomethylated in 
absence of G9a (Figure 5.3A). This is intriguing, as imprinted DNA methylation in 
the germ line is thought to be established and stably maintained throughout 
development. Hypomethylation of germ line imprints in absence of G9a is an 
important discovery, as recent studies identified other factors (such as 
ZFP57/STELLA) which may explain how imprinted regions escape various 
epigenetic reprograming events during development (Messerschmidt, 2012; 
Nakamura et al, 2007). 
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Table 5.2 All known Imprinting Control Regions (and whether they are maternal or 
paternally imprinted are shown). Indicated are the ones represented on the 
microarray and those which display 1.4-fold hypomethylation. 
 
 





Dlk1 between Dlk1 and Gtl2 paternal     
Rasgrf1 upstream of Rasgrf1 paternal     
Igf2 upstream of H19 paternal     
Zdbf2 upstream of Zdbf2 paternal     
Mcts2 promoter maternal     
Gnas GnasXL/Nespas promoter maternal x x 
  Gnas 1A promoter maternal x   
Peg10 promoter maternal x x 
Mest promoter maternal x x 
Nap1L5 promoter maternal x   
Peg3 promoter maternal x x 
Snrpn promoter maternal x 
 Inpp5f promoter maternal x  
Kcnq1 Kcnq1ot1 promoter maternal     
Plagl1 promoter maternal x x 
Grb10 promoter maternal x   
U2af1-
rs1 promoter maternal x x 
KcnK9 promoter maternal x   
Slc38aA promoter maternal     
Igf2r Airn promoter maternal     
Impact promoter maternal x x 
Nnat promoter maternal x x 
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5.3.4 Most Imprinting Control Regions are hypomethylated in G9a-/- ES 
cells 
To expand these observations, I decided to carry out quantitative PCR on the 
enrichment of imprinted regions in the input DNA and purified methylated DNA 
fraction used for the microarray analysis. I included most of the maternal germ line 
DMRs appearing in the microarray analysis (Table 5.2). Additionally I quantified the 
enrichment of some other maternal germ line DMRs located at non-coding RNA 
promoters, such as Kcnq1ot1, as well as the four paternal germ line DMRs (Dlk1, 
Rasgrf1,Igf2/H19 and Zdbf2). Ankrd50 and Ndufa were used as positive and negative 
controls respectively as they did not show changes in DNA methylation between WT 
and G9a-/- ES cells in the microarray data (Figure 5.3A). 
Quantitative PCR allowed me to determine the enrichment of germ line 
imprinted regions in the methylated DNA fraction compared to input DNA in WT 
and G9a-/- ES cells (Figure 5.3B). All germ line imprinted regions analysed, apart 
from Zdbf2, were hypomethylated in G9a-/- ES cells compared to WT ES cells. The 
reason why I did not identify some of these ICRs to be significantly hypomethylated 
in promoter microarray analysis, may come from imprinted regions only being 50% 
methylated in WT ES cells. Only one allele of these regions will bind to the MBD 
column, reducing the enrichment in the methylated fraction (compare imprinted gene 
MAP enrichment to Ankrd50 in WT ES). Any loss of DNA methylation may 
therefore be less detectable than loss at non imprinted regions. Quantitative PCR may 
be a more sensitive method of quantifying differences in enrichment in the 
methylated DNA fraction. 
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Validation of Imprinting Control Region hypomethylation 
To validate the observation that DNA methylation at imprinting control 
regions is dependent on G9a, I carried out bisulfite genomic DNA sequencing on 
ICRs located in the Igf2-H19, Dlk1 and Kcnq1 imprinted clusters. Additionally I 
included the Uty gene promoter (a non-imprinted region control affected by G9a 
absence), as well as Ankrd50 (a highly methylated region showing no change in 
DNA methylation in G9a-/- ES cells) in the analysis (Figure 5.4). Although MBD 
column and microarray analysis did not indicate a significant change in DNA 
methylation at Ankrd50 gene promoter in G9a-/- ES cells compared to WT ES cells, 
bisulfite DNA sequencing displays a mild reduction in DNA methylation (74% in 
WT ES cells and 63% in G9a-/- ES cells). As Ankrd50 was used for normalization in 
the above qPCRs, the changes in DNA methylation at imprinted regions may have 
been underestimated.  
Bisulfite sequencing of IG DMR, KvDMR and Igf2/H19 DMR indicate almost 
complete lack of DNA methylation at these genomic regions in G9a-/- ES cells 
(Figure 5.4). Bisulfite sequencing and MeDIP analysis on other imprinting control 
regions have also confirmed my observations (Tuo Zhang, unpublished). Not all 
ICRs are 50% methylated (indicating DNA methylation on one parental allele only) 
in WT ES cells, especially IG DMR (Figure 5.4). A recent study identified dynamic 
changes in the size of germ line DMRs during early development (variable outer 
boundaries of DMRs) (Tomizawa et al, 2011). The IG-DMR region I sequenced falls 
slightly out with the blastocyst DMR, but within the embryonic DMR. As ES cells 
originate from the blastocyst, the region I investigated by bisulfite sequencing may 
be on the boundary of the differentially methylated region.  


















Figure 5.4 Validation of DNA hypomethylation
Bisulfite DNA sequencing validation of germline 
imprinted region DNA hypomethylation in G9a-/- 
ES cells compared to WT ES cells. Ankrd50 was 
used as a positive control which displayed high 
levels of DNA methylation in both cell lines in the 
MBD column microarray experiment. Uty is a 
non-imprinted region whose DNA methylation is 
dependent of G9a. KvDMR, Igf2/H19 and IG DMR 
are germline  imprinted regions. Regions to which 
the bisulfite sequenced data maps to (green) in 
relation to adjacent genes (grey) are shown above 
bisulfite profiles. Transcription start sites are 
indicated by directional arrows.
WT ES
Igf2/H19 DMR
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The region I sequenced may therefore not display a characteristic differential 
methylation pattern between the two parental alleles. Additionally, WT ES cells 
often display unstable DNA methylation, especially at imprinted regions. Other 
divergence from 50% methylation in WT ES cells in my data may therefore be due to 
this instability. Finally, bisulfite sequencing of Uty (a non-imprinted control 
identified to be hypomethylated in G9a-/- ES cells on the promoter microarray) also 
displays extensive hypomethylation in absence of G9a. 
From the above analysis, absence of G9a in murine ES cells results in loss of 
DNA methylation at the majority of Imprinting Control Regions. The question was, 
whether these DNA methylation defects are accompanied by changes in gene 
expression of imprinted genes regulated by these ICRs. As discussed in the 
introduction, in many cases DNA methylation is considered to be the secondary 
epigenetic mark, lack of which does not necessarily lead to expression changes at 
genes. Two clusters previously shown to encompass imprinted genes expressed in ES 
cells are the Dlk1 and the Kcnq1 clusters. The Dlk1 cluster is controlled by a 
paternally imprinted ICR, whereas the Kcnq ICR is maternally imprinted. My 
attempts at qPCR analysis of imprinted gene expression within the Dlk1 and Kcnq1 
clusters in WT and G9a-/- ES cells were unsuccessful. Many imprinted genes, 
although imprinted, are lowly expressed in ES cells, making qPCR analysis of these 
difficult (Li et al, 2010). Therefore I decided to determine their expression levels in 
embryoid bodies (EBs), derived from WT and G9a-/- ES cells after differentiation 
induced by withdrawal of leukaemia inhibitory factor (LIF) and addition of retinoic 
acid (Bibel et al, 2004).  
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5.3.5 Expression defects of genes at the Dlk1/Gtl2 imprinted locus in G9a-
/- EBs 
The Dlk1 locus is located on chromosome 12 and consists of three paternally 
expressed protein coding genes Dlk1, Rtl1 and Dio3 as well as an array of maternally 
expressed non-coding RNAs (Figure 5.5A) (da Rocha et al, 2008). A germ line 
imprinting control regions is located between the Dlk1 and Rtl1 genes (da Rocha et 
al, 2008). This region is unmethylated on the maternal allele and methylated on the 
paternal allele. Deletion studies of the imprinting control region from both parental 
chromosomes point towards a role of the maternal unmethylated ICR in imprinting 
control of all genes within the locus (Lin et al, 2003). Deletion of the maternal 
unmethylated ICR leads to ‘epigeneotype’ switching of the maternal allele to 
resemble the paternal allele gene expression patterns. One hypothesis is that the 
unmethylated ICR promotes the expression of non-coding RNAs within this cluster, 
which in turn regulate the silencing of protein coding genes. A second hypothesis is, 
that the ICR directly regulates protein coding gene expression and repression on the 
maternal chromosome (Lin et al, 2003). Deletion of the ICR from the paternal 
chromosome on the other hand had no effect on expression of genes within the 
imprinted cluster. This suggests that there may be another mechanism to activate 
protein coding gene promoters on the paternal chromosome, which is independent of 
the ICR (Lin et al, 2003).  
DNA methylation is important in regulation of protein coding gene 
expression on the paternal chromosome as seen by silencing of Dlk1 in Dnmt1-/- 
embryos (Hirasawa et al, 2008). Therefore the question I posed is, whether DNA 
hypomethylation of IG-DMR, in absence of G9a, is required for correct expression 
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of imprinted genes within the Dlk1 locus. I hypothesized, that loss of DNA 
methylation at the paternal ICR may cause the paternal allele to resemble the 
maternal allele in terms of gene expression status. Quantitative PCR analysis showed 
that in the absence of G9a and DNA methylation at the ICR, Dlk1 was repressed, 
consistent with the idea that DNA methylation is required for expression of Dlk1 
(Figure 5.5C). Rtl1 and Dio3 on the other hand were not repressed (Figure 5.5C). 
Rtl1 was upregulated and Dio3 is only marginally repressed. The qPCR detection of 
Rtl1 may have been biased due to the expression of microRNAs which overlap with 
the Rtl1 transcript (Figure 5.5A) and may therefore have been detected in the qPCR 
analysis. In the absence of DNA methylation at the paternal ICR, non-coding RNAs 
would be expected to become biallelically expressed. This may dilute down the 
effect of repression of Rtl1 seen in this analysis. Dio3, on the other hand, has been 
found to be partially imprinted, with the paternal allele accounting for only 84% of 
the expression and leaky transcription from the maternal allele in embryos and the 
placenta (Tsai et al, 2002). The absence of ICR DNA methylation on the paternal 
chromosome in G9a-/- ES cells may generate two chromosomes with leaky 
transcription, reducing the extent of loss of gene expression seen. The reduction in 
expression of Dio3as cannot be explained by the hypothesis, that loss of DNA 
methylation at the ICR results in epigenotype reversion.  
Snrpn was used as a positive control in this experiment, as it has previously 
been identified to be biallelically expressed in the absence of G9a (Xin et al, 2003). 
Consistently Snrpn expression doubles in G9a-/- embryoid bodies (Figure 5.5C). 
  




























































Figure 5.5 Gene expression at the Kcnq1 and Dlk1/Gtl2 imprinted loci
A and B: Structure and transcription status of maternal and paternal chromosomes at 
two imprinted loci (Kcnq1 and Dlk1-Gtl2 loci). Transcription start sites are depicted 
by directional arrows. Light grey arrows indicate leaky transcriptional activity. 
Differentially methylated ICRs are depicted by black (methylated) and white 
(unmethylated)  ‘lollipops’. Some genes are completely silent on one parental 
chromosome (no arrow). C: Quantitative PCR on imprinted genes within the Kcnq1 
and Dlk1-Gtl2 loci in WT (blue) and G9a-/- differentiated ES cells (red) (embryoid 
bodies day 8). qPCR results were normalized to Gapdh. Error bars represent 2 x 
standard deviations of technical triplicates.
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5.3.6 Expression defects of genes at the Kcnq imprinted locus in G9a-/- 
EBs 
The Kcnq1 cluster is located on chromosome 7 and consists of 12 
differentially expressed genes (Figure 5.5B) (Ideraabdullah et al, 2008). Amongst 
these is the antisense non-coding RNA (ncRNA) Kcnq1ot1 whose promoter is 
located within intron 10 of the Kcnq1 gene (Ideraabdullah et al, 2008). This cluster is 
regulated by one imprinting control element (KvDMR1) which overlaps with the 
Kcnq1ot1 promoter (Ideraabdullah et al, 2008). This ICR is methylated on the 
maternal chromosome and unmethylated on the paternal chromosome (Engemann et 
al, 2000; Ideraabdullah et al, 2008). The unmethylated ICR on the paternal 
chromosome allows transcription of the Kcnq1ot1 ncRNA (Ideraabdullah et al, 
2008)(Smilinich et al. 1999). All other imprinted genes are expressed primarily from 
the maternal chromosome, although some leaky expression is seen on the paternal 
chromosome.  
Deletion studies have also been undertaken in this locus. Paternal deletion of 
KvDMR1 resulted in disruption of silencing of six genes on both sides of the 
deletion (Fitzpatrick et al, 2002; Mancini-Dinardo et al, 2006). Maternal deletion of 
the ICR, on the other hand did not lead to imprinted expression defects. Further 
insight into the regulation of imprinting at this cluster came from deletion studies of 
the Kcnq1ot1 promoter. On the paternal chromosome this resulted in activation of 
normally silent genes. Equally, premature termination of Kcnq1ot1 transcript on the 
paternal chromosome led to imprinted expression defects (Fitzpatrick et al, 2002). 
These observations confirmed that the Kcnq1ot1 transcript or the complete 
transcription process of Kcnq1ot1 is required for correct imprinting in this cluster 
              159
(Mancini-Dinardo et al, 2006). Deletion on the maternal chromosome again had no 
effect. 
I carried out qPCR analysis of expression of several genes within the 
Kcnq1ot1 cluster in WT and G9a-/- EBs (Figure 5.5C). I detected an increase in 
Kcnq1ot1 gene expression and reduction in expression of Kcnq1, Cdkn1c and 
Phlda2. Unlike the Dlk1 cluster, all genes follow my hypothesis that loss of DNA 
methylation at the ICR would lead to reversal of the previously methylated maternal 
allele to a state similar to the paternal allele. This hypothesis would have to be 
confirmed by either Fluorescence In Situ Hybridization (FISH) to detect expression 
from both parental chromosomes. Alternatively analysis of gene expression could be 
carried out in cells derived from strains containing parental allele specific 
polymorphisms, which can be used to distinguish expression from both alleles on 
mRNA level.  
The question arising from my work is, whether it is the lack of DNA 
methylation or histone modification function of G9a, which causes the defects in 
imprinted gene expression in G9a-/- ES cells. Other work in our lab demonstrated 
that DNA methylation at ICRs could not be re-established in G9a-/- ES cells through 
introduction of a G9a transgene (Tuo Zhang, unpublished). This demonstrates, that 
G9a is unable to establish imprinting marks in ES cells, without earlier 
developmental signals. Additionally, this observation means, that a catalytically 
inactive G9a cannot be used to test whether DNA methylation at ICRs is able, on its 
own, to ensure correct expression of imprinted genes. Alternatively, an inhibitor of 
G9a catalytic activity could be used to address this question. This would help to 
identify, whether the absence of the histone methyltransferase function of G9a is 
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responsible for the gene expression defects at imprinted genes rather than absence of 
the DNA methylation function in G9a-/- ES cells.  
5.4 Discussion 
In summary, I set out to characterize dependence of DNA methylation at 
promoters of protein coding genes on G9a, in mouse ES cells. Methylated DNA 
affinity purification and subsequent hybridization to mouse promoter microarrays 
allowed genome-wide characterization of DNA methylation patterns at promoters of 
protein-coding genes in G9a-/- compared to WT ES cells. Strikingly, amongst these 
were several maternally imprinted regions, which displayed decrease in DNA 
methylation. Further, analysis showed that most maternal and paternal germ line 
Imprinting Control Regions (ICRs) were hypomethylated in absence of G9a. 
Additionally, this was accompanied by expression defects of several genes regulated 
by these ICRs. These observations are intriguing, since stable imprinting is essential 
in the developing embryo and adult mammals and imprinted regions normally escape 
epigenetic reprogramming during development. Such dramatic defects in imprinted 
DNA methylation or gene expression have only been seen upon deletion of maternal 
and zygotic Dnmt1, zinc finger protein Zfp57(Quenneville et al, 2011), Kap1/Trim28 
and PGC7/STELLA (Hirasawa et al, 2008; Messerschmidt, 2012; Nakamura et al, 
2007). ZFP57 and PGC7/STELLA have recently been characterized in detail for 
their role in establishing and maintaining imprinting marks. Hypomethylation of 
ICRs in G9a-/- ES cells may therefore point towards a role of G9a in maintenance of 
DNA methylation at maternal and paternal ICRs in conjunction with these other 
proteins. 
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5.4.1 Mechanism of G9a dependent maintenance of DNA methylation at 
ICRs 
G9a function in de novo or maintenance DNA methylation? 
The G9a-/- ES cells used in this study were obtained through gene conversion 
of heterozygous cells by exposure to high concentrations of selection antibiotics 
(Tachibana et al, 2002). The ES cells used for this were initially derived from wild-
type blastocysts. As discussed in the introduction, ICR DNA methylation is set up in 
the parental male and female germ line at regions called Imprinting Control Regions. 
ES cells derived from WT blastocysts would therefore have correctly established 
ICR DNA methylation. Any defects in ICR DNA methylation and imprinted gene 
expression seen in this study can therefore be attributed to a defect in the 
maintenance, rather than establishment of imprinting. This is consistent with the 
knowledge that G9a interacts with maintenance DNA methyltransferase DNMT1 at 
replication forks. Whether G9a is also implicated in de novo DNA methylation at 
imprinted regions is yet unknown. Previous studies have identified interactions of 
G9a with DNMT3A and DNMT3B as well as roles in de novo DNA methylation at 
non-imprinted genes (discussed in the introduction). Suggesting an additional 
function of G9a in de novo methylation at imprinted regions is the dramatic increase 
in G9a expression in postnatal day15 mouse oocytes (Kageyama et al, 2007). This is 
the stage at which maternal ICR de novo methylation occurs.  
At which developmental stage does G9a maintain DNA methylation? 
After establishment of imprinting marks in the germ line, they are stably 
maintained throughout mammalian development, even during genome-wide DNA 
methylation reprogramming in the pre-implantation embryo. At this stage, several 
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questions arise, regarding the mechanisms which ensure stability of DNA 
methylation at imprinting control regions. The first wave of DNA demethylation in 
the pre-implantation embryo occurs in the paternal pronucleus through an active 
pathway prior to the first cell division (Saitou et al, 2012; Santos et al, 2002). How 
are paternal imprinted DNA methylation marks maintained at this stage? At the onset 
of the first cell divisions, both maternal and paternal genomes undergo passive DNA 
demethylation (Saitou et al, 2012; Santos et al, 2002). Again, at this stage 
methylation at imprinted regions has to be stably maintained in both parental 
genomes. The differences in dynamics of DNA methylation of the parental genomes 
were suggested to potentially point to the need for different mechanisms to maintain 
maternal and paternal imprints. The loss of DNA methylation at most maternal and 
paternal ICRs in G9a-/- ES cells is therefore surprising.  
Upon completion of DNA demethylation of the genome, a wave of DNA de 
novo methylation leads to re-establishment of DNA methylation specific to cells 
destined to become embryonic as well as extraembryonic tissues (Saitou et al, 2012; 
Santos et al, 2002). This poses the opposite question, of how monoallelic DNA 
methylation at imprinted regions is maintained, whilst other regions undergo de novo 
DNA methylation. Finally, long term stability of imprinted regions in somatic cells 
also has to be ensured. 
Defects in DNA methylation of imprinting control regions in G9a-/- ES cells 
in my study suggest the requirement of G9a in long term maintenance of DNA 
methylation. This function of G9a was confirmed through knockdown of G9a in ES 
cells, which also resulted in hypomethylation of ICRs (Tuo Zhang, unpublished). A 
yet unanswered question is, whether G9a is also required for maintenance of DNA 
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methylation during genome reprograming. An answer to this question could be 
obtained from analysis of ICR DNA methylation at the stages of active and passive 
genome DNA demethylation during early development. If ICRs lose DNA 
methylation, G9a may be required for protecting ICRs from demethylation during 
genome reprograming. Previous studies have argued that G9a is not required for 
DNA methylation at imprinted loci in embryos, since imprinting defects were only 
demonstrated in G9a-/- ES cells, but not embryos (Xin et al, 2003). This gives rise to 
difficulties in studying G9a function in embryonic development. Potential 
explanations for these observations will be discussed later.  
How does G9a prevent demethylation? 
An additional question is, whether G9a prevents passive DNA demethylation 
through co-operation with DNMT1, or does G9a inhibit active DNA demethylation 
pathways. To test whether G9a protects ICRs from active DNA demethylation, 
components of active DNA demethylation pathways (such as TET proteins) could be 
inhibited at the same time as knocking down G9a in ES cells. If inhibition of active 
DNA demethylation pathways prevents ICR hypomethylation in absence of G9a, 
G9a may function to prevent active demethylation.  
How does G9a fit into current models of DNA methylation at imprinted 
regions? 
The combination of several other studies into proteins required for correct 
establishment and maintenance of DNA methylation at ICRs have led to a proposed 
model (Figure 5.6) (Strogantsev & Ferguson-Smith, 2012). Establishment of DNA 
methylation at imprinted regions requires mainly DNMT3A and DNMT3L (Figure 
5.6A)(Kaneda et al, 2010; Kaneda et al, 2004). DNMT3B has been implicated in de 
              164
novo methylation of some regions such as Rasgrf1, a paternal ICR (Watanabe et al, 
2011). Another protein, ZFP57, has a minor role in de novo DNA methylation at 
ICRs (at the Snrpn locus) (Li et al, 2008).  ZFP57 recruits a co-repressor KAP1, 
which in turn recruits SETDB1 histone lysine methyltransferase and NuRD co-
repressor complex (Lechner et al, 2005; Schultz et al, 2002; Underhill et al, 2000). 
Interestingly ZFP57 binds specifically to a motif containing methylated CG 
dinucleotides (Quenneville et al, 2011). This is more consistent with a role in 
maintenance of DNA methylation. 
Maintenance of DNA methylation at ICRs requires ZFP57, complexed with co-
repressor molecules (Figure 5.6B). Additionally, ZFP57 interacts with maintenance 
methyltransferase DNMT1 as well as de novo methyltransferases DNMT3A and 3B 
(Quenneville et al, 2011; Zuo et al, 2012). DNMT1 has been shown to prevent 
passive DNA demethylation of ICRs in male and female pronuclei in the pre-
implantation embryo. Unlike the oocyte form of DNMT1 (DNMT1-o) (which 
becomes excluded from the nucleus to facilitate passive DNA demethylation), the 
somatic DNMT1-s is still present in the nucleus during this period (Kurihara et al, 
2008). SETDB1 which interacts with ZFP57 causes H3K9 trimethylation for 
stabilization of the repressive state (Schultz et al, 2002). Additionally, 
PGC7/STELLA inhibits Tet-protein mediated active DNA demethylation at 
imprinted loci in the maternal genome during genome reprograming upon 
fertilization (Jonkers et al, 2009).  
  





















Figure 5.6 Current model of de novo and maintenance DNA methylation at ICRs 
(adapted from Strogantsev and Ferguson-Smith, 2012)
A: De novo DNA methylation of ICRs. DNMT3A/3L complex is recruited to 
nucleosomes depleted of H3K4me3. DNMT3B and ZFP57 complex are only required 
at a few ICRs. Interactions between proteins are highlighted by dashed arrows. DNA 
methylation is indicated by black ‘lollipops’ and unmethylated CpGs by white 
lollipops.  The potential interaction of G9a with DNMT3A and DNMT3B in this 
pathway is indicated. B: ZFP57 is the main factor to date, required for maintaining 
DNA methylation at ICRs. It interacts with corepressor KAP1, Histone lysine 
methyltransferase SETDB1 as well as DNMT1. The potential interaction of G9a with 
DNMT1, PGC7/STELLA and DNMT3A/3L or other components of the maintenance 
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The above model highlights the requirement for different factors in de novo 
DNA methylation at ICRs, as well as in preventing demethylation at different stages 
of development. This may shed light on ways G9a may function. From my study as 
well as others, evidence points towards a role in maintenance of DNA methylation. 
The question is, why knockout of G9a leads to complete loss of DNA methylation at 
ICRs, despite the continued presence of factors such as ZFP57 and PGC7/STELLA 
in G9a-/- ES cells (at known ZFP57 target ICRs). This either demonstrates non-
redundant functions of these three proteins, or suggests regulation of ZFP57 and 
PGC7/STELLA by G9a. Absence of G9a may prevent ZFP57 and PGC/STELLA 
from exerting their function in maintaining DNA methylation.  
First of all, a co-operative function of G9a, PGC7/STELLA and ZFP57 could 
be investigated by determining any potential interactions between these proteins. 
Mass spectrometry analysis in our lab of interacting partners of G9a only identified 
GLP, WIZ and DNMT3A (Tuo Zhang, unpublished). An interaction with ZFP57 and 
PGC7/STELLA was not detected. Interestingly, interactions between G9a and 
DNMT1 could not be identified in mass spectrometry analysis either. This suggests, 
that this interaction may be more transient, especially compared to interactions of 
G9a with GLP and WIZ. Any interaction between G9a and ZFP57 may also be 
transient and therefore more difficult to detect. 
A recent study into the function of PGC7/STELLA in maintaining DNA 
methylation identified the interaction of PGC7/STELLA with H3K9me2 (Figure 
5.6B)(Nakamura et al, 2012). The interaction of PGC7/STELLA with chromatin was 
reduced in absence of G9a. The same study also identified the need for 
PGC7/STELLA in maintaining DNA methylation at maternal and paternal imprinted 
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regions which have H3K9me2 (Nakamura et al, 2012). Finally the study 
demonstrates that Tet3 binding is inhibited by PGC7/STELLA binding to H3K9me2 
(Nakamura et al, 2012). This suggests, that G9a mediated H3K9me2 may be 
necessary for maintenance of imprinted DNA methylation by PGC7/STELLA. 
However, experiments in our lab demonstrate that G9a catalytic activity is not 
required for maintenance of DNA methylation at ICRs. Additionally, rescue of G9a 
expression in G9a-/- ES cells through reintroduction of a transgene does not allow 
re-establishment of DNA methylation at ICRs (Tuo Zhang, unpublished). However, 
PGC7/STELLA interaction with chromatin is re-established. These observations 
suggest, that G9a may facilitate DNA methylation at ICRs in co-operation with 
PGC7/STELLA, but that G9a also functions in maintaining DNA methylation 
independent of H3K9 methylation and PGC7/STELLA, perhaps at a different time 
point.  
5.4.2 G9a dependent maintenance of DNA methylation in embryos 
A difficulty in studying G9a dependent maintenance of DNA methylation at 
ICRs in vivo becomes apparent from previous studies. Several studies reported that 
G9a is required for imprinted gene regulation in the placenta (Redrup et al, 2009; 
Wagschal et al, 2008). These studies did not detect imprinting defects in the embryo 
proper. One study to date has identified the requirement of G9a in DNA methylation 
and correct monoallelic expression of Snrpn ICR in ES cells (Xin et al, 2003). The 
same study showed absence of any defects at this locus in G9a-/- embryos. One of 
the reasons argued are, that DNA methylation in ES cells is often unstable. Female 
ES cells in particular frequently undergo DNA hypomethylation at imprinted genes 
during their in vitro culture (Dean et al, 1998; Zvetkova et al, 2005). The WT and 
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G9a-/- ES cells used in this study are male ES cells which do not normally undergo 
large scale DNA hypomethylation events during culture, but sometimes display 
localized DNA methylation defects at imprinted genes. Variations in how prone 
imprinted regions are to these defects are seen.  
My bisulfite sequencing of the KvDMR in WT ES cells indicated that DNA 
methylation is not quite limited to 50% of sequences, as would normally be expected 
(Figure 4). Still, only marginal DNA hypermethylation is seen. The Igf2/H19 region 
has been previously described to have very unstable DNA methylation in ES cells. In 
my data 50% DNA methylation exists at Igf2/H19 ICR, but is not evenly distributed 
over 50% of the sequences.  
Despite this, I detect DNA hypomethylation in G9a-/- ES cells. Additionally 
knockdown of G9a in ES cells lead to hypomethylation of most ICRs compared to 
control cells (Tuo Zhang, unpublished). This confirms that DNA hypomethylation 
seen is due to absence of G9a, rather than due to non-related effects of in vitro ES 
cell culture. Hypomethylation may be enhanced by the reduced stability of 
imprinting in ES cells as well as differences in mechanism of silencing in embryos 
compared to ES cells.  This could occur through presence of another factor in 
embryos, which ensures correct imprinted DNA methylation, independent of G9a.  
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Chapter 6 - DNA methylation, facilitated by a chromosome 
structural protein 
6.1 Introduction 
6.1.1 A Structural Maintenance of Chromosome Protein is required for 
correct X chromosome inactivation 
SmcHD1 was initially identified as a modifier of position effect variegation 
in screens for modifiers of transgene variegation (Rius & Lyko, 2012). It is a well 
conserved protein which contains a structural maintenance of  chromosomes (SMC) 
hinge domain normally found in proteins involved in chromosome condensation, 
cohesion, segregation as well as DNA repair (Figure 6.1A). Interestingly, 
homozygous mutant female embryos die before E13.5 whilst male mutants remain 
healthy (Sorge et al, 2013). This was the first indication that SmcHD1 may have an 
X chromosome linked role.  
X chromosome inactivation is a means to achieve dosage compensation of gene 
expression on the X chromosomes between males (which only have one X 
chromosome) and females (which have two X chromosomes). A role of an SMC 
protein in dosage compensation has only been described once before, in C.elegans. 
The process of X chromosome dosage compensation in these organisms is achieved 
through transcription repression on both X chromosomes in female nematodes by 
half. SMC proteins DPY-27 and MIX-1 form a complex with non-SMC proteins to 
function in this gene repression (Gendrel, 2012; Prinapori et al, 2012).  SmcHD1 is 
therefore the first mammalian SMC protein to be implicated in X chromosome 
inactivation.  
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Figure 6.1 X inactivation mechanism and dynamics
A: SmcHD1 protein domain structure (to scale) showing the ATP binding and SMC 
hinge domains. B: Left: X inactivation dynamics during early mammalian 
development. Different stages of development are indicated as a circular timeline. 
Changes in X inactivation are indicated in boxes. Right: ES cells are derived from the 
ICM/epiblast and their differentiation into embryoid bodies is used as a model system 
for random X inactivation. ES cells have two active X chromosomes (XaXa) and 
inactivate one X chromosome during differentiation (XiXa). C: Genomic structure of 
the X inactivation centre on the X chromosome. Genes are indicated by directional 
arrows and enhancers by rectangles. Green and red indicate elements which enhance 
or inhibit Xist expression respectively. Binding of transcription factors is indicated 




              171
 
6.1.2 Mammalian X inactivation  
X inactivation is a dynamic process in early mammalian development (Figure 
6.1B) (Gendrel & Cohen, 2012). At fertilization the two X chromosomes are active. 
The first wave of X inactivation occurs between the 4-cell and blastocyst stage at 
which imprinted X inactivation of the paternal X chromosome occurs. Upon 
expansion of the blastocyst, the paternal X chromosome is reactivated in embryonic 
lineage cells (epiblast) but remains inactive in extraembryonic lineage cells 
(trophectoderm and primitive endoderm) (Gendrel & Cohen, 2012). This is closely 
followed by the onset of random X inactivation in differentiating embryonic cells. 
From this stage onwards, random X inactivation is stably transmitted through cell 
divisions. The only exception occurs during the establishment of the germ line. At 
this stage random X chromosome inactivation ceases during formation of primordial 
germ cells (Gendrel & Cohen, 2012). When considering the dynamics of X 
inactivation during early development it becomes apparent that X inactivation is 
linked to loss of pluripotency (Gendrel & Cohen, 2012). This has led to the use of 
embryonic stem cell differentiation as a model for X inactivation (Figure 6.1B right). 
Undifferentiated ES cells, derived from the ICM/epiblast have two active X 
chromosomes whereas one X is inactivated during differentiation. 
X inactivation has been widely studied in mammals since the discovery by 
Mary Lyon. It has now been established that X inactivation is orchestrated by various 
non-coding RNAs as well as protein-coding genes on the X chromosome (Figure 
6.1C) (Gendrel et al, 2012; Lee, 2011). These regulators of X inactivation are located 
in a ~1MB region termed the X inactivation centre (XIC). This region encodes Xist, a 
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non-coding RNA which is seen to coat the inactive X chromosome in females 
(Brockdorff et al, 1991; Brockdorff et al, 1992; Hong et al, 1999; Jonkers et al, 
2008). Regulation of Xist is of great importance in ensuring correct X inactivation. 
Xist has to be expressed on the X chromosome to be inactivated in females and 
repressed on the other female and the male X chromosome. Several elements of the 
XIC are implicated in positive or negative regulation of Xist (Figure 6.1C). Tsix, an 
antisense non-coding RNA overlapping with Xist is a negative regulator of Xist (Lee 
et al, 1999). Consistently in ES cells, where both X chromosomes are active, the Tsix 
promoter is bound by pluripotency transcription factors, promoting its expression 
(Navarro et al, 2010). Xist promoter on the other hand is bound by other pluripotency 
transcription factors, causing its repression (Donohoe et al, 2009; Navarro et al, 
2008). Several other genes encoded by the XCI have now been found to regulate Xist 
and Tsix expression. FTX, Jpx and RNF12 for example are positive regulators of Xist 
(Barakat et al, 2011; Jonkers et al, 2009; Tian et al, 2010). Additionally enhancer 
regions Xite and Dxpas34 regulate correct Tsix expression (Navarro et al, 2010; 
Ogawa & Lee, 2003).  
The XIC region is thought to be involved in various stages of X inactivation. 
The first of these is chromosome pairing and counting (Bacher et al, 2006; Jeon et al, 
2012). As the differentiation process of ICM stem cells initiates, pluripotency genes 
are downregulated, leading to biallelic expression of Xist and loss of Tsix expression. 
It is thought, that at this stage, the two active X chromosomes associate with 
eachother through several regions (Figure 6.1C) (Xu et al, 2007). This is thought to 
occur via CTCF interactions with pluripotency factors at the Tsix promoter at the 
onset of differentiation, before pluripotency genes are downregulated (Xu et al, 
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2007). This initiates subsequent activation of Tsix on one allele only, followed 
rapidly by coating of the Xist expressing X chromosome with Xist (Jeon et al, 2012). 
At this stage Xist expression on one allele is promoted by RNF12 and Jpx in cis and 
trans. Xist coating of the X chromosome is followed by heterochromatinization. 
Recent studies have identified possible mechanisms of spreading of a repressive state 
along the inactive X chromosome (Jeon et al, 2012). Binding of PRC2 components to 
a region called the A-repeats which are part of Xist but can also be separately 
transcribed is one example (Zhao et al, 2008). This promotes the establishment and 
spreading of repressive H3K27me3 marks along the inactive X chromosome. 
Additional silencing mechanisms include CpG methylation as well as incorporation 
of histone variants (macro H2A) (Chang et al, 2006).  
6.1.3 Function of DNA methylation in mammalian X inactivation 
DNA methylation plays an important role in X inactivation. Firstly, DNA 
methylation is seen at the Xist promoter on the active X chromosome. DNA 
methylation at the Xist promoter has been shown to be dispensable for the initiation 
of X inactivation (Cohen et al, 2012; Sado et al, 2004). Prolonged culture of male ES 
cells in the absence of DNA methylation on the other hand leads to activation of Xist 
on the active X chromosome. This suggests that DNA methylation is required for 
stable long term repression of Xist on the active X chromosome (Sado et al, 2004). 
Secondly, DNA methylation is put in place at CpG island promoters on the inactive 
X, to allow long-term silencing of X linked genes. Accordingly, studies have 
revealed DNA methylation to be a late step in the X inactivation process (Jonkers et 
al, 2008). 
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A recent study from the Brockdorff lab we collaborated with has addressed 
the dynamics of DNA methylation on the X chromosome (Gendrel et al. 2012). In 
summary, sequencing of purified methylated DNA from day7 and day10 embryoid 
bodies demonstrated three different classes of CGIs on the X chromosome, which 
gain DNA methylation at different stages during X chromosome inactivation (DNA 
methylation gained by day 7, by day 10 and outwith this timeframe) (Figure 6.2). 
Fast methylating CGIs displayed high CpG content, which is surprising, as elsewhere 
in the genome sequences with lower CpG content are more readily methylated. The 
relationship between expression levels in ES cells and DNA methylation kinetics 
during X inactivation was more conclusive. Fast methylating CGIs tend to fall into 
the class of repressed Polycomb target genes in ES cells. The reason for the ease of 
methylation of these CGIs may come from the absence of H3K4 methylation, since 
previous studies have described inhibition of DNMT3A, 3B and 3L recruitment by 
H3K4 methylation. The class of slow methylating CGIs on the other hand was 
enriched in genes highly expressed in ES cells. This may be the reason for their slow 
methylation, as active chromatin marks inhibit DNA methyltransferases. 
6.1.4 Smchd1 is required for correct DNA methylation and gene silencing 
on the inactive X 
Studies so far on SmcHD1 have focused on characterizing the role of 
SmcHD1 on the X chromosome, due to the limited phenotypes observed in Smchd1-
/-  male embryos. Forced X inactivation by mutating Xist on one X chromosome and 
insertion of a GFP transgene on the other X chromosome was used to show that 
SmcHD1 is required for silencing of one of the X chromosomes. GFP expression 
was only visible in SmcHD1 mutant female embryos as well as extraembryonic 
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tissues, but not in WT tissues (Sorge et al, 2013). Further investigation showed that 
X inactivation initiates normally, indicating that SmcHD1 may be involved in 
maintenance of correct X chromosome inactivation in females (Sorge et al, 2013). A 
further observation supporting SmcHD1 role in X inactivation was the colocalization 
of SmcHD1 with Xist on the inactive X chromosome (Sorge et al, 2013).  
A link between DNA methylation on the inactive X and Smchd1 was 
identified in the same study (Sorge et al, 2013). The study investigated 16 CpG 
islands subject to X inactivation as well as CpG islands which are methylated 
independently of X inactivation (Sorge et al, 2013). This showed dependence of CpG 
island methylation on SmcHD1 in response to X inactivation. X inactivation 
independent CpG islands such as those present within reproductive homeobox loci 
remained unaltered in female Smchd1 mutant cell lines (Sorge et al, 2013). 
Consistently, many but not all X linked genes are upregulated in female Smchd1 
mutant embryos.   
The above observations have therefore defined SmcHD1 as a novel epigenetic 
regulator of X inactivation. This was an interesting observation as, unlike LSH and 
G9a, this factor is not a known histone, DNA or chromatin modifying enzyme, 
demonstrating that not only epigenetic modifiers can play a role in facilitating correct 
DNA methylation establishment and maintenance. Previous chapters defined a wide 
role of LSH in facilitating DNA methylation genome wide. The most striking targets 
of G9a dependent DNA methylation on the other hand are ICR. This suggests, that 
different proteins may be required for targeting DNA methylation to different 
regions. Studying SmcHD1 was of interest to me, as it represents a protein which 
may have a more confined role in facilitating DNA methylation on the X 
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chromosome, since male embryos mutated in Smchd1 display limited phenotypes. 
The combined study of all three factors may provide an overview of how DNA 
methylation is correctly targeted to a variety of genomic regions.   
Although, it has been demonstrated that SmcHD1 is required for correct DNA 
methylation on the inactive X chromosome, several questions still remain 
unanswered: 
 Is SmcHD1 required for DNA methylation of all X inactivation dependent 
CGIs? 
 Is SmcHD1 dispensable for autosomal CGI methylation? 
 
6.2 Characterization of SmcHD1 dependent DNA methylation 
genome wide 
To answer the above questions I collaborated with the Brockdorff lab to 
determine genome wide the SmcHD1 dependent CGIs. For this purpose I carried out 
methylated DNA affinity purification on female WT and Smchd1-/- MEFs. Smchd1 
knockout arise from a non-sense mutation in exon 23, leading to non-sense mediated 
RNA decay. Smchd1-/- MEFs were isolated from knockout embryos. Smchd1-/- 
Male WT MEFs were used as controls for genes which become methylated 
independent of X chromosome inactivation. Male Smchd-/- MEFs were used as a 
control to confirm previous data demonstrating that Smchd1 is not required for DNA 
methylation on the active X chromosome. I validated the methylated DNA 
purifications by PCR amplification of different elution fractions with actin and Igf2r 
DMR2 primers (Figure 6.2). Actin is an unmethylated control gene and Igf2r DMR2 
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is a differentially methylated region. PCR analysis confirms efficient enrichment of 
methylated DNA in the high salt elution fractions. These samples could therefore be 
used for DNA methylation analysis.  
All affinity purified methylated DNA samples were processed for Solexa sequencing 
by the Brockdorff lab (Gendrel et al, 2012). Purified methylated DNA was end-
repaired, A-tailed and adaptors were ligated using an Illumina DNA sample prep Kit. 
The DNA with attached adapters was amplified by 18 cycles of PCR and size 
selected for 200-500bp fragments. The resultant library was sequenced with an 
Illumina Genome Analyser II using 51bp reads. 25 million reads were obtained, 
which were subsequently mapped to the mouse mm9 genome (Gendrel et al, 2012). 
Numbers of mapped reads for different experiments were:  13903829 (XX WT MEF), 
1937780 (7 day differentiated XX ES cell), 2663037 (10 day differentiated XX ES 
cells), 29104137 (XX Smchd1 null MEF), 8903268 (XY WT MEF) and 7150486 (XY 
Smchd1 mutant MEF). Data visualization was carried out in Gbrowse (Stein et al., 
2002). CGI were annotated, using those detected in cerebellum DNA using CAP-seq 
(Illingworth et al., 2010). Only those CGIs were annotated which displayed MBD-seq 
peaks in XX but not XY MEFs. For analysis of DNA methylation between samples, 
reads were counted logged to base 2, then normalized to the largest (XX Smchd1 null 
MEF) dataset using Seqmonk 
(http://www.bioinformatics.bbsrc.ac.uk/projects/seqmonk/) probes designed around 
Ensembl gene features (Gendrel et al, 2012).  
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Actin
Igf2r DMR2
WT MEFs Smchd1-/- MEFs WT MEFs Smchd1-/- MEFs
WT EB D7 WT EB D10
Actin
Igf2r H19
0.715M 1MNaCl2 0.715M 1M 0.715M 1M 0.715M 1M
Figure 6.2 X chromosome DNA methylation dynamics
MBD column validation using Actin (unmethylated control) or Igf2r (differentially 
methylated) PCRs. PCRs are shown for the low salt and high salt elutions of MBD 
column runs.
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Firstly sequencing demonstrated that SmcHD1 is required for DNA 
methylation at 1299 CGIs genome wide (>2-fold hypomethylation in absence of 
SmcHD1) (Appendix). Of these, 177 CGIs are X linked, which confirms previous 
results that SmcHD1 is required for DNA methylation on the X chromosome. 
Analysis of this data by the Brockdorff lab identified a significant overlap between 
SmcHD1 dependent CGIs and the class of CGIs methylated slowly during X 
chromosome inactivation, as described in the introduction (Gendrel et al, 2012). This 
suggests that SmcHD1 may be required for facilitating DNA methylation at CGIs, 
which have less favourable characteristics for DNA methylation (high expression 
levels, H3K4me3). Additionally SmcHD1 is recruited to the X chromosome when 
DNMT3B levels are low. This suggests requirement for SmcHD1 in facilitating 
DNA methylation in presence of low levels of DNMT3B (Gendrel et al, 2012). This 
is supported by the observation that fast methylating CGIs do not require Smchd1 for 
their methylation, but are not methylated to the same levels in mutant cells as WT 
cell (Gendrel et al, 2012). The above observations are summarised in Figure 6.3. 
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During my PhD studies I was interested in the requirement of different non-DNA 
methyltransferase proteins in DNA methylation genome wide, not just on the X 
chromosome. In the case of SmcHD1, studies up to now have focused on the 
involvement of SmcHD1 in DNA methylation on the X chromosome. The minimal 
effect of Smchd1 mutation in males suggests function primarily in female X 
chromosome inactivation. It is unclear whether SmcHD1 is dispensable for DNA 
methylation elsewhere in the genome. Indications of a role wider than its function in 
X inactivation potential come from studies of SmcHD1 homologs in Arabidopsis 
thaliana, which have been implicated in RNA dependent DNA methylation, as well 
as in humans, in DNA repair (Lee & Lu, 1999; Lorkovic et al, 2012). Therefore I 
was interested to look at the autosomal sequencing data for methylated DNA I 
purified from WT and Smchd1-/- MEFs.  
1122 autosomal CGIs were identified to be hypomethylated in Smchd1 
mutant MEFs (Appendix 3). This is a greater number than expected from the lack of 
phenotype in male mutant embryos, suggesting, that SmcHD1 may have a more 
widespread role than previously outlined.  Figure 6.4 shows some examples of 
autosomal CGIs, which are hypomethylated in Smchd1-/- MEFs compared to WT. 
Interestingly, Peg12 in the PWS imprinted gene cluster is more than 2-fold 
hypomethylated in absence of SmcHD1. Visualization of methylation peaks in the 
entire PWS gene cluster demonstrates loss of DNA methylation at Peg12 as well as 
at the Ndn promoter CGIs. When examining the imprinting control region (Snrpn 
ICR) for this imprinted gene cluster, no change in DNA methylation can be 
observed. Strikingly the Snrpn ICR does not appear as a methylated peak in WT 
MEFs.  
























Figure 6.4 SmcHD1 requirement for autosomal DNA methylation and gene 
expression
A: Sequencing results of affinity purified methylated DNA from WT and Smchd1 
mutant MEFs. Peak hights indicate amount of methylation. CpG islands (CGIs) and 
genes analysed are indicated below. B: Venn Diagram outlining the overlap between 
LSH, G9a and SMCHD1 target genes (Gendrel et al. 2012)
B
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This suggests that the sequencing depth may not have been sufficient to 
identify all differences in DNA methylation between cell lines, especially at 
imprinted regions, which have one methylated and one unmethylated allele. Future 
work may therefore require resequecing with an increased number of reads per 
sample. Additionally validation of the sequencing results by bisulfite sequencing 
would be necessary to confirm the differences.  
Despite the drawbacks of the sequencing data, I decided to compare the identified 
SmcHD1 target genes with those of G9a and LSH determined in previous chapters. 
The Venn diagram in Figure 6.3 B displays minimal overlap between all autosomal 
SmcHD1 target genes and those of LSH and G9a (Appendix 4). This suggests, that 
SmcHD1 may be involved in regulating DNA methylation at mostly distinct genomic 
regions to those regulated by LSH and G9a.  
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Chapter 7 Discussion 
7.1.1 Achieving diverse DNA methylation patterns during 
mammalian development 
The initial question posed, when DNA methylation was identified to be 
widespread in vertebrates and plants, was what its functions are. As mentioned in the 
introduction, DNA methylation is thought to have originated from a genomic 
immune system to silence transposable elements, which has evolved to function in 
gene regulation, imprinting, X chromosome inactivation and regulation of genome 
stability through silencing of transposable elements in mammals (Lee et al, 1999). 
Throughout the years it has also become apparent, that DNA methylation forms 
distinct landscapes in different cell types as well as at different stages of mammalian 
development. As discussed in the introduction, correct generation of DNA 
methylation landscapes is important to prevent diseases such as cancer. In somatic 
cells, DNA methylation is relatively stable, but during early development many 
dynamic changes occur to DNA methylation landscapes. Somatic methylation 
patterns have to be erased in germ cells, to be substituted with gender-specific DNA 
methylation at imprinted regions as well as novel differentially methylated regions.  
Differential DNA methylation at imprinted regions is thereafter maintained 
throughout early development and adult life. Erasure of DNA methylation and re-
establishment is also important in the divergence between extraembryonic and 
embryonic tissues as well as during differentiation of embryonic stem cells.  
The above outlines the importance of correct targeting and maintenance of 
DNA methylation. It is known, that DNA methyltransferases establish and maintain 
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DNA methylation, but how can DNA methyltransferases be directed to only the 
regions requiring methylation at different stages of development? This is the focus of 
many recent studies. One possibility, as to how DNA methylation landscapes are 
formed, is that the default state of the genome may be a methylated state. Factors 
may exist to prevent DNA methylation at some regions but not at others. One 
example is the inhibitory effect of histone modifications, for example H3K4me3, on 
DNA methylation (Meissner et al, 2008; Mohn et al, 2008; Okitsu & Hsieh, 2007; 
Weber et al, 2007). More recent studies are in support of the existence of an opposite 
model whereby DNA methylation is targeted to some regions, but not others. 
Sequence elements have been identified, which preferentially recruit DNA 
methylation (Lienert et al, 2011; Meissner, 2011). Additionally, different isoforms of 
DNMTs seem to target common as well as different genomic regions (Navarro et al, 
2010). These mechanisms could explain some of the complexity of ensuring correct 
DNA methylation landscapes.  
Additional, several non-DNMT proteins have been shown to facilitate DNA 
methylation. Absence of these can lead to severe loss of DNA methylation, 
sometimes similar to the hypomethylation seen in Dnmt  knockouts themselves 
(Donohoe et al, 2009; Jonkers et al, 2009; Navarro et al, 2008; Tian et al, 2010; Xin 
et al, 2003). 
7.1.2 Accessory proteins target DNA methylation to distinct 
genomic regions 
In this study I sought to characterize three such ‘accessory’ proteins. LSH 
(putative chromatin remodelling ATPase), G9a (histone methyltransferase) and 
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SmcHD1 (protein related to structural maintenance of chromosomes proteins) have 
all been implicated in DNA methylation, due to DNA methylation defects seen in 
knockout cells and embryos.  
Both LSH and G9a have previously been reported to be required for DNA 
methylation at repetitive sequences and few single genes. In my study, I successfully 
expanded these findings, characterizing promoters of protein-coding genes genome-
wide which require either LSH or G9a for DNA methylation. This enabled me to 
define the role of LSH in de novo methylation of genes that normally undergo 
methylation in the pre- and post- implantation embryo. Additionally, it was striking 
to find G9a to be necessary for maintenance of DNA methylation at imprinting 
control regions. DNA methylation at ICRs is normally established in the germ line 
and maintained throughout development. 
SmcHD1 is a novel factor required for correct DNA methylation on the 
inactive X chromosome. In this study we found SmcHD1 to be essential for DNA 
methylation of a subset of CGIs normally methylated slowly during X chromosome 
inactivation. Analysis of targets of SmcHD1 identified extensive hypomethylation of 
autosomal CGIs in absence of SmcHD1. This finding suggests a wider role for 
SmcHD1 apart from on the X chromosome. Most striking is the need for SmcHD1 in 
DNA methylation at the autosomal PWS imprinted locus. Differentially methylated 
regions in the Peg12 as well as Ndn promoters were found to be hypomethylated in 
absence of SmcHD1. Other imprinted regions did not display hypomethylation in 
absence of SmcHD1 in this experiment. Due to low sequencing depth, these are only 
preliminary findings, which would have to be confirmed through bisulfite sequencing 
as well as through additional sequencing at higher depth. 
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In summary, the methylated DNA affinity purification method enabled me to 
characterize the requiremenet for different proteins in DNA methylation genome 
wide. This method can be adapted to analyse the requirement of any protein of 
interest in DNA methylation at different stages of mammalian development. My 
findings suggest LSH, SmcHD1 and G9a facilitate DNA methylation at partially 
overlapping time points during development, but at large groups of unique target 
genes (Figure 7.1). This supports the hypothesis, that different accessory proteins 
may facilitate DNA methylation at different genomic regions.  
There are several considerations which have to be made in drawing the above 
conclusions about the different ‘accessory proteins’. First of all, different cell types 
were used in this study to investigate LSH, G9a and SmcHD1 roles in DNA 
methylation. Lsh-/- and SmcHD1-/- MEFs were used, whereas the G9a-/- was in ES 
cells. Especially in the case of G9a, some later developmental target regions may 
have been missed, due to the use of ES cells, rather than MEFs. Additionally, there 
are also a few drawbacks to the methylated DNA affinity purification method used. 
This method has been previously used to identify highly methylated CpG rich 
regions genome wide. In my study we have demonstrated that we could enrich for 
methylated low, intermediate and high CpG density promoters. Despite this there 
may still be a skew towards detection of more CpG rich promoters. Additionally, 
differences in methylation at differentially methylation regions as well as at regions 
with smaller changes (e.g. ICRs) are harder to detect using the MBD-microarray 
method. This was demonstrated during the analysis of MBD-microarray data on WT 
and G9a-/- ES cells.  
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Hypomethylation of some imprinted regions could be detected, but the extent of 
DNA hypomethylation at ICRs only became apparent during qPCR analysis of 
purified methylated DNA. This suggests, that microarray analysis of purified 
methylated DNA may not always be sensitive enough to detect smaller changes in 
DNA methylation.  
7.1.3 Suitability of different accessory proteins for targeting 
DNA methylation to specific genomic regions 
The first question arising from my study is why different accessory proteins 
may be suited to facilitate DNA methylation at specific regions. Comparing target 
regions between the three proteins I studied, identified some overlap, but the 
majority were unique regions. Can other functions of these proteins aid our 
understanding of how they facilitate DNA methylation? 
LSH being a putative chromatin remodeller gives rise to the hypothesis, that 
it may facilitate targeting of DNMTs and other factors to difficult to access regions, 
through chromatin remodelling. Similarly, previous studies have found other 
chromatin remodelling ATPases to facilitate DNA methylation. These include the 
LSH homolog DDM1 as well as another SNF2 family ATPase, ATRX (Navarro et 
al, 2008; Tian et al, 2010). Attempts to demonstrate LSH chromatin remodelling 
activity in vitro have been unsuccessful, with only a weak ATPase activity 
detectable. The question arising was, whether chromatin remodelling is required for 
LSH to exert its function in promoting DNA methylation. Instead, LSH may cause 
accumulation of DNA methyltransferases and histone deacetylases at target regions 
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without the need for remodelling. Therefore, the question I posed was, whether 
ATPase activity is required for LSH dependent DNA methylation.  
I carried out rescue experiments with WT and catalytically inactive LSH in 
Lsh-/- MEFs. The catalytically inactive LSH was unable to re-establish DNA 
methylation at repetitive elements as well as single genes, compared to wild-type 
LSH. This suggests that LSH may use its ATPase activity to remodel nucleosomes, 
making chromatin more accessible to DNA methyltransferases and other chromatin 
modifiers. In vivo, since DNA methylation is often seen as the secondary effect of 
gene silencing, which promotes a long term silent state, DNA methyltransferases 
may have to access an already compacted chromatin environment. This could explain 
the need for a chromatin remodeller. However, reintroduction of catalytically 
inactive LSH prevented establishment of DNA methylation and gene silencing at the 
expressed Rhox loci in Lsh-/- MEFs. This suggests, that even in relatively ‘open’ 
chromatin, remodelling activity of LSH is required. In support, a recent study 
demonstrated that nucleosomes inhibit DNA methylation (Felle et al, 2011). 
Therefore, even in active regions, nucleosomes may have to be remodelled. 
Additionally, this poses the question whether regions, whose DNA methylation is 
dependent on LSH are different from others in terms of nucleosome density or 
stability, which may necessitate the presence of a chromatin remodeller.  
SmcHD1 on the other hand is similar to many structural maintenance of 
chromosomes proteins. SMC proteins have been found to link strands of nucleotides 
together (Losada & Hirano, 2005). Well known roles include chromosome cohesion, 
condensation, segregation and DNA repair (Losada & Hirano, 2005). A couple of 
recent studies identified a plant SMC homolog to be involved in RNA-dependent 
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DNA methylation (Barakat et al, 2011; Ogawa & Lee, 2003). RNA-dependent DNA 
methylation usually utilises short siRNAs, made by the enzyme, DICER. These 
siRNAs can in turn direct DNA methylation to particular sequences (Xu et al, 2007). 
Based on their known function, SMC proteins have therefore been proposed to 
‘clamp’ short RNA molecules to DNA regions to facilitate DNA methylation (Xu et 
al, 2007).  
The function of SmcHD1 in X inactivation could potentially utilise a similar 
mechanism, the difference being, that X inactivation is achieved through a long non-
coding RNA, rather than small RNAs. SmcHD1 may interact with Xist and facilitate 
the spreading of DNA methylation. Consistently previous studies have indicated that 
DNA methylation on the inactive X chromosome may commence close to the Xist 
gene. In our study, the class of CGIs methylated at intermediate kinetics were located 
closer to the Xist locus than other classes, which partially supports this notion 
(Gendrel et al, 2012). Requirement of SmcHD1 in DNA methylation at the PWS 
locus is more unclear, as this locus does not utilise RNAs in the silencing 
mechanism. Additionally, other imprinted regions did not seem to require SmcHD1, 
despite being regulated by non-coding RNAs. 
Why G9a is required for DNA methylation at imprinting control regions is 
yet unclear. My study, combined with others highlights that G9a is required for DNA 
methylation in ES cells. On the other hand, in embryos, DNA methylation was 
unaffected at G9a target genes and especially at several imprinted regions (Chang et 
al, 2006; Xin et al, 2003; Zhao et al, 2008). This suggests a mechanism of 
maintaining DNA methylation in embryos, independent of G9a.  
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7.1.4 Regulation of DNA methylation through regulation of accessory 
proteins 
In summary the above discussion, combined with previous studies highlights 
the requirement of specialised proteins to facilitate DNA methylation at different 
genomic loci. This provides a mechanism of controlling tissue- and developmental 
stage-specific DNA methylation through regulation of accessory proteins. 
Consistently, LSH for example is highly expressed in stem cells but is downregulated 
during differentiation. This highlights its function in DNA methylation during early 
development. A recent study into G9a requirement for pluripotency gene silencing 
demonstrated stimulation of G9a expression in presence of Protein Kinase A 
(Yamamizu et al, 2012). This was required for correct regulation of timing of 
differentiation of stem cells. Additionally, G9a is upregulated in oocytes, at the time 
of establishment of DNA methylation marks at Imprinting Control Regions 
(Kageyama et al, 2007). This suggests that G9a could also be involved in the 
establishment of imprinted methylation patterns in the germ line. Expression patterns 
of DNA methylation accessory proteins can therefore also be used to infer possible 
developmental and cell type specific function. SmcHD1 for example is highly 
expressed in cells of the immune system, which may point to additional functions of 
SmcHD1 apart form in CpG island methylation establishment during X inactivation. 
7.1.5 Therapeutic uses 
Understanding the mechanisms of how proteins function in the mammalian 
cell is crucial for studies into diseases. As discussed in detail in the introduction, 
DNA methylation is increasingly found to be defective in diseases, especially 
cancers. Absence of all three proteins I have studied (LSH, G9a and SmcHD1) 
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results in extensive DNA hypomethylation. DNA hypomethylation can be linked to 
genome instability and loss of imprinting, which are frequently characteristic of 
cancers. LSH for example has been demonstrated to play a role in ensuring stability 
of repetitive elements, regulating cell proliferation and cell divisions (Fan et al, 
2003). Additionally, LSH expression is characteristic of highly proliferating tissues 
such as thymus, testis and bone marrow (Raabe et al, 2001). These are all important 
functions, defects of which are frequent hallmarks of cancers (Hanahan & Weinberg, 
2011). Consistently, LSH deficiency has been demonstrated to play a role in 
development of leukaemia. One study identified DNA hypomethylation in absence of 
LSH to cause activation of oncogenes, which may promote development of 
erythroleukemia (Fan et al, 2008). Additionally another study identified frequent 
occurrence of a deletion in LSH protein in various leukaemias (Lee et al, 2000). The 
above are observations made in the case of murine LSH. The human homolog of 
LSH, HELLS, has also been widely characterized regarding its function in the 
development of cancers. Several studies have highlighted overexpression of HELLS 
in many cancers (Ryu et al, 2007). 
Histone methyltransferase G9a has similarly been found to be implicated in 
cancers. G9a is overexpressed in many human cancers. Consistently, knockdown of 
G9a inhibits growth of cancer cells. G9a has also been found to methylate p53, 
resulting in inactivation of p53. This may be of importance as over 50% of cancers 
display inactive p53.  
The importance of continued development of more specific DNA 
demethylation therapeutics has been highlighted in various studies and reviews 
(Esteller, 2005; Rius & Lyko, 2012). Inhibiting specific DNA methylation accessory 
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proteins rather than using DNA demethylation drugs may provide a treatment with 
less widespread effects on gene regulation.  
Apart from their function in DNA methylation, LSH, G9a and SmcHD1 are 
also implicated in other functions. In addition to its function in DNA methylation 
several studies have for example implicated LSH and its plant homolog DDM1 in 
DNA damage repair pathways (Geiman et al, 1998; Shaked et al, 2006; Yao et al, 
2012). A recent study in our lab, run in parallel to my study focused on 
characterizing the role of LSH in DNA damage repair (Burrage et al., accepted for 
publication). This study demonstrated increased sensitivity of Lsh-/- mouse and 
human fibroblasts to ionizing radiation. More detailed analysis identified defects in 
the events downstream of a double strand DNA damage events. Use of LSH rescue 
cell lines (same as the ones used in my study) in the study demonstrated the 
requirement of catalytic activity of LSH in its role in DNA damage repair. 
Additionally, the DNA damage repair function of LSH was suggested to be 
independent of its DNA methylation function.  
One of the most common hallmarks of cancer is genomic instability, which 
occur through for example random mutations and defects in repetitive element 
silencing which can lead to chromosomal rearrangements (Hanahan & Weinberg, 
2011). The discovery of proteins such as LSH which are implicated in various 
distinct functions related to genomic instability makes it a sought after target for 
cancer therapy. My study and the study of Burrage et al. (accepted) highlight the 
independence of DNA methylation and DNA damage repair functions of LSH, which 
may make LSH even more amenable to new cancer therapeutics, as different 
              195
inhibitors may be able to target the different functions of LSH, so as not to disrupt 


































































Appendix 1: Correlation between LSH MBD microarray replicate samples
Axes represent M values of two different biological replicates. Indicated on
the bottom right are the Spearman’s correlation coefficients.
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Loss of DNA methylation in Lsh-/- MEFs (2-fold) 
              
Chr Start Stop Gene av_LSH KO av_WT DM(WT-KO) 
1 4485994 4486994 Sox17 -1.0 0.6 1.6 
1 9283578 9284578 Sntg1 0.1 1.1 1.0 
1 9283952 9284952 Sntg1 0.1 1.3 1.2 
1 9284223 9285223 Sntg1 0.2 1.3 1.1 
1 19193627 19194627 Tcfap2b -0.2 1.1 1.2 
1 34504966 34505966 Tesp2 -0.1 1.3 1.4 
1 36217462 36218462 Lincr 0.3 1.5 1.1 
1 53005707 53006707 Gdf8 -0.5 0.9 1.4 
1 58154442 58155442 Aox4 0.2 1.5 1.3 
1 64997185 64998185 Crygd -0.3 1.0 1.3 
1 72755889 72756889 Igfbp2 -0.5 1.0 1.5 
1 74868299 74869299 B230363K08Rik -0.2 0.8 1.0 
1 79318514 79319514 Scg2 0.0 1.0 1.0 
1 79318614 79319614 Scg2 0.0 1.0 1.0 
1 82916955 82917955 Slc19a3 0.0 1.3 1.2 
1 87852616 87853616 Spata3 -0.2 0.9 1.1 
1 97497471 97498471 N/A St8sia4 0.2 1.3 1.0 
1 98702144 98703144 9530060I07 0.3 1.5 1.2 
1 111810783 111811783 Cdh7 -0.2 1.3 1.5 
1 123355409 123356409 Htr5b 0.5 1.7 1.2 
1 123355511 123356511 Htr5b 0.3 1.4 1.1 
1 130419255 130420255 Cxcr4 0.4 1.9 1.4 
1 156488074 156489074 Cacna1e 0.2 1.7 1.5 
1 169525732 169526732 Lmx1a 0.2 1.9 1.7 
1 177815289 177816289 B020018G12Rik -0.3 0.8 1.1 
1 189963321 189964321 Ush2a -0.3 1.4 1.7 
2 55252041 55253041 Kcnj3 0.3 1.5 1.2 
2 57974948 57975948 Pscdbp -0.3 1.3 1.6 
2 62212421 62213421 Dpp4 0.2 1.4 1.1 
2 62212570 62213570 Dpp4 0.0 1.1 1.1 
2 62374253 62375253 Fap -0.3 1.1 1.4 
2 62374360 62375360 Fap -0.3 0.9 1.2 
2 67918066 67919066 B3galt1 -0.7 0.3 1.0 
2 74475413 74476413 Hoxd12 0.9 1.9 1.0 
2 79929278 79930278 Pde1a -0.4 0.7 1.1 
2 80092813 80093813 Prdx6-rs1 0.0 1.4 1.4 
2 103224415 103225415 Elf5 0.3 1.5 1.2 
2 105024682 105025682 0610012H03Rik 0.4 2.2 1.8 
2 119936023 119937023 Pla2g4e 0.1 1.4 1.4 
2 119936276 119937276 Pla2g4e 0.0 1.3 1.3 
2 124844670 124845670 Slc12a1 -0.1 1.3 1.4 
2 130850961 130851961 1700037H04Rik 0.2 1.3 1.1 
2 135748867 135749867 6330527O06Rik -0.2 0.8 1.0 
2 135749170 135750170 6330527O06Rik -0.2 1.2 1.4 
2 152067507 152068507 Gm123 0.0 1.3 1.2 
2 152271253 152272253 Defb19 -0.3 1.2 1.5 
2 163912549 163913549 Wfdc15 -0.6 1.4 2.1 
2 170292722 170293722 4930470P17Rik -0.5 0.8 1.3 
2 171939196 171940196 Mc3r -0.2 0.8 1.0 
2 172795511 172796511 Pck1 -0.1 0.9 1.1 
2 181142078 181143078 Srms 0.2 1.2 1.0 
3 10179254 10180254 Fabp9 0.2 1.2 1.0 
3 10283215 10284215 1700008G05Rik -0.2 1.6 1.8 
3 26828203 26829203 Spata16 0.0 1.4 1.4 
3 45474123 45475123 Pcdh10 0.0 1.7 1.7 
3 45474305 45475305 Pcdh10 0.2 1.6 1.4 
3 48704780 48705780 1700018B24Rik 0.1 1.6 1.5 
3 58972641 58973641 Ush3a 0.0 1.2 1.2 
3 82633513 82634513 Npy2r 0.0 1.1 1.0 
3 82989401 82990401 Lrat 0.4 2.0 1.7 
3 95219288 95220288 Lysmd1 -0.1 1.3 1.5 
3 97010835 97011835 Gja8 -0.1 1.1 1.1 
3 98307057 98308057 Reg4 0.2 1.3 1.1 
3 101416471 101417471 Cd2 0.0 1.1 1.1 
3 102025431 102026431 N/A -0.2 1.1 1.3 
3 105586371 105587371 Kcnd3 0.1 1.1 1.0 
3 109701562 109702562 Vav3 -0.5 0.6 1.1 
3 110270994 110271994 Ntng1 0.5 1.5 1.0 
3 129191464 129192464 Pitx2 0.1 1.6 1.5 
3 129746409 129747409 Egf -0.1 1.1 1.1 
3 135284923 135285923 4933425K02Rik -0.5 1.2 1.7 
3 141919138 141920138 Bmpr1b -0.3 1.5 1.7 
4 3946229 3947229 Rdhe2 -0.7 0.5 1.2 
4 33323944 33324944 Rragd 0.3 1.7 1.4 
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4 42894795 42895795 BC049635 -0.7 0.5 1.2 
4 43727166 43728166 Olfr71 0.3 1.5 1.3 
4 46595743 46596743 LOC634450 -0.3 0.7 1.0 
4 62657907 62658907 Kif12 -0.6 0.8 1.4 
4 73484172 73485172 Frmd3 0.2 1.3 1.1 
4 118066879 118067879 1110020C03Rik 0.1 1.6 1.6 
4 128120293 128121293 Tlr12 0.0 1.0 1.0 
4 128620562 128621562 Hpca -0.1 1.7 1.8 
4 134898393 134899393 1700029M20Rik -0.3 2.0 2.3 
4 134958099 134959099 Il28ra 0.3 1.4 1.0 
4 141194002 141195002 Fhad1 -0.2 1.2 1.4 
4 151540839 151541839 Gm833 -0.1 1.2 1.3 
4 153511033 153512033 Actrt2 -0.2 1.2 1.4 
4 153742327 153743327 2810405K02Rik 0.2 1.4 1.1 
5 28172233 28173233 Htr5a -0.1 1.0 1.1 
5 34842202 34843202 Sh3bp2 0.0 2.0 2.0 
5 44388189 44389189 LOC624120 0.1 1.6 1.5 
5 66282920 66283920 9130230L23Rik 0.1 1.4 1.3 
5 71978650 71979650 Gabrb1 -0.1 1.7 1.7 
5 78189398 78190398 Hod 0.2 1.7 1.5 
5 78285709 78286709 Spink2 -0.1 1.3 1.4 
5 82095653 82096653 Lphn3 0.1 1.4 1.3 
5 110855286 110856286 Galnt9 -0.6 0.4 1.0 
5 114426016 114427016 Acacb 0.0 1.3 1.3 
5 116549462 116550462 Ccdc60 -0.2 1.2 1.3 
5 116852306 116853306 1500001A10Rik 0.6 1.8 1.1 
5 118127648 118128648 Nos1 -0.1 2.2 2.3 
5 121269635 121270635 Rph3a -0.1 1.0 1.1 
5 129050453 129051453 Piwil1 0.3 1.7 1.4 
5 132826607 132827607 N/A 1.0 2.0 1.0 
5 146894253 146895253 Gpr12 0.0 1.6 1.6 
5 150286553 150287553 Lgr8 -0.3 1.8 2.1 
6 3917854 3918854 Tfpi2 -0.4 1.6 2.0 
6 7504570 7505570 Tac1 0.4 1.8 1.4 
6 8899314 8900314 Nxph1 0.2 1.3 1.1 
6 13174465 13175465 Gm467 0.0 1.3 1.3 
6 18058555 18059555 Asz1 -0.2 1.7 1.9 
6 21165609 21166609 Kcnd2 0.4 1.6 1.2 
6 25640239 25641239 Gpr37 -0.3 1.1 1.5 
6 29009730 29010730 Lep -0.2 0.9 1.1 
6 36317503 36318503 9330158H04Rik -0.5 1.9 2.4 
6 40372056 40373056 BC052883 -0.5 0.6 1.1 
6 52242575 52243575 Evx1 0.3 1.5 1.1 
6 55946592 55947592 Gsbs -0.4 0.6 1.1 
6 65073808 65074808 Ptgds2 -0.2 1.6 1.9 
6 65881686 65882686 4930544G11Rik -0.2 0.9 1.1 
6 67305215 67306215 Il12rb2 0.0 1.6 1.6 
6 67464874 67465874 Tacstd2 0.2 2.0 1.9 
6 73398628 73399628 4931417E11Rik -0.3 1.7 2.0 
6 82367632 82368632 Tacr1 0.1 1.2 1.1 
6 82367944 82368944 Tacr1 0.0 1.9 1.9 
6 87338498 87339498 1810036H07Rik -0.5 0.6 1.1 
6 87394173 87395173 Bmp10 -0.2 1.2 1.4 
6 87498131 87499131 Arhgap25 0.0 1.5 1.5 
6 87498376 87499376 Arhgap25 -0.1 1.0 1.1 
6 97025334 97026334 C130034I18Rik -0.2 0.8 1.0 
6 103476148 103477148 Chl1 0.0 1.1 1.0 
6 103476275 103477275 Chl1 0.0 1.5 1.5 
6 105643048 105644048 Cntn4 0.1 1.3 1.1 
6 116471634 116472634 Olfr212 -0.1 1.5 1.6 
6 116521545 116522545 Olfr214 -0.6 0.6 1.3 
6 122247951 122248951 Klrg1 -0.4 1.0 1.4 
6 122591542 122592542 Dppa3 -0.1 1.2 1.4 
6 122707622 122708622 Slc2a3 0.0 1.7 1.7 
6 129296946 129297946 4922502D21Rik -0.4 0.8 1.2 
6 136745438 136746438 Gucy2c 0.1 1.4 1.4 
7 6119012 6120012 Olfr1349 -0.1 1.1 1.3 
7 6813475 6814475 BC023179 -0.8 1.4 2.2 
7 25085082 25086082 4732471J01Rik 0.0 1.7 1.7 
7 28249144 28250144 Sycn 0.2 1.6 1.4 
7 30131563 30132563 AY078069 0.0 1.4 1.4 
7 30223381 30224381 Gm1082 0.2 1.9 1.7 
7 30379844 30380844 4930479M11Rik -0.3 0.8 1.1 
7 30532035 30533035 Ffar2 -0.5 1.3 1.8 
7 49777668 49778668 Slc6a5 0.5 1.8 1.3 
7 51378547 51379547 Tmem16e 0.1 1.4 1.3 
7 62298589 62299589 Mkrn3 0.1 1.2 1.1 
7 72179608 72180608 Gm489 0.2 1.6 1.4 
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7 84481412 84482412 Fah 0.8 1.9 1.1 
7 100456665 100457665 Mrpl48 0.1 1.5 1.4 
7 104092136 104093136 Trim6 0.2 1.2 1.0 
7 105211035 105212035 Olfr691 -0.8 0.4 1.1 
7 108873999 108874999 Ric3 0.1 1.2 1.1 
7 120119318 120120318 Abca15 -0.4 1.6 2.1 
7 126842625 126843625 1810010M01Rik -0.5 0.9 1.4 
7 136789110 136790110 Mgmt -0.3 1.0 1.3 
7 140959494 140960494 Trp53i5 -0.5 0.8 1.3 
8 3352936 3353936 A430078G23Rik 0.0 1.2 1.2 
8 15045546 15046546 LOC434285 -0.2 1.6 1.9 
8 26139798 26140798 Adam18 0.1 1.6 1.5 
8 26190833 26191833 Adam3 -0.1 1.2 1.3 
8 46806783 46807783 Klkb1 -0.5 1.6 2.0 
8 48850665 48851665 Stox2 -0.4 1.1 1.5 
8 50173007 50174007 Odz3 -0.3 2.3 2.6 
8 58832528 58833528 Glra3 -0.5 0.8 1.4 
8 59186234 59187234 Hpgd 0.0 1.4 1.4 
8 61803396 61804396 BC030500 -0.6 1.4 1.9 
8 69632269 69633269 Npy1r -0.3 0.7 1.0 
8 86430750 86431750 Olfr370 -1.0 1.7 2.6 
8 89456195 89457195 Abcc12 -0.1 1.2 1.2 
8 107181803 107182803 Cmtm2a -0.4 1.0 1.4 
8 107210865 107211865 Cmtm2b 0.0 1.4 1.4 
8 112503145 112504145 Pkd1l3 0.0 1.3 1.3 
9 6168083 6169083 Pdgfd 0.2 1.3 1.1 
9 8861760 8862760 Pgr 0.1 1.4 1.3 
9 15624353 15625353 Mtnr1b 0.1 1.2 1.1 
9 29712075 29713075 Hnt -0.3 0.9 1.2 
9 44805682 44806682 A530065I17Rik 0.2 1.2 1.0 
9 53772938 53773938 Elmod1 0.4 1.4 1.0 
9 76108955 76109955 Hcrtr2 0.0 1.0 1.1 
9 105667248 105668248 E330026B02Rik -0.2 1.2 1.4 
9 110795860 110796860 Lrrc2 -0.2 1.0 1.3 
9 112032115 112033115 Arpp21 -1.0 1.3 2.2 
9 112032306 112033306 Arpp21 -0.8 1.2 2.0 
9 119672058 119673058 Scn11a -0.3 1.1 1.4 
10 6473374 6474374 Plekhg1 -0.2 1.4 1.6 
10 19045452 19046452 Olig3 -0.2 1.4 1.6 
10 22509044 22510044 Tcf21 -0.5 1.3 1.8 
10 23638473 23639473 Taar3 -0.6 1.3 2.0 
10 23649409 23650409 Taar4 -0.6 0.4 1.0 
10 23798450 23799450 Taar9 -0.9 0.5 1.4 
10 28832754 28833754 6330407J23Rik -0.3 1.7 2.0 
10 28833110 28834110 N/A -0.4 1.8 2.2 
10 39675559 39676559 BC021785 -0.2 1.3 1.6 
10 49471324 49472324 Grik2 -0.3 1.9 2.3 
10 61817314 61818314 Hkdc1 0.3 1.4 1.1 
10 62456473 62457473 0610038K03Rik 0.5 1.6 1.1 
10 71375490 71376490 1700049L16Rik -0.6 0.7 1.3 
10 77296048 77297048 1700009J07Rik -0.7 0.9 1.7 
10 88935926 88936926 Nr1h4 -0.5 0.8 1.4 
10 105873948 105874948 Ppfia2 0.0 1.2 1.2 
10 106889744 106890744 Myf5 -0.2 1.7 1.9 
10 106898339 106899339 Myf6 -0.3 0.8 1.1 
10 108103702 108104702 C6.1AL -0.2 1.2 1.3 
10 117607434 117608434 Il22 Iltifb -0.2 1.1 1.3 
10 117697509 117698509 Iltifb -0.6 1.2 1.8 
10 117843539 117844539 Ifng -0.6 0.6 1.1 
10 119221948 119222948 Grip1 -0.7 1.0 1.7 
10 119222071 119223071 Grip1 -0.8 0.8 1.6 
11 11014246 11015246 A930041G11Rik 0.0 1.6 1.6 
11 11780157 11781157 Ddc -0.5 0.9 1.4 
11 42262679 42263679 Gabrb2 -0.1 1.1 1.2 
11 46078479 46079479 C030019I05Rik -0.1 1.1 1.2 
11 46247652 46248652 RP23-273O7.4 -0.4 1.2 1.7 
11 50730366 50731366 Zfp454 0.2 1.6 1.4 
11 58593823 58594823 Olfr315 -0.4 1.1 1.6 
11 59428660 59429660 Olfr225 0.0 1.0 1.0 
11 67586848 67587848 Glp2r 0.0 1.0 1.1 
11 68409749 68410749 Ccdc42 0.2 1.4 1.2 
11 69211041 69212041 Gm740 -0.4 1.0 1.4 
11 81389234 81390234 1700071K01Rik 0.5 1.6 1.1 
11 99059570 99060570 6330509G02Rik -0.4 0.8 1.2 
11 99138531 99139531 4631426H08Rik -0.1 1.4 1.6 
11 99153557 99154557 4732407F15Rik 0.0 1.4 1.4 
11 99166684 99167684 Krt1-c29 0.0 1.5 1.5 
11 99253726 99254726 9030623C06Rik -0.2 0.9 1.2 
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11 99308694 99309694 Krt1-23 -0.5 1.9 2.4 
11 99336848 99337848 4732494G06Rik -0.3 1.6 1.9 
11 99911814 99912814 Krt1-24 0.3 1.9 1.6 
11 100023100 100024100 Krt1-14 -0.9 0.4 1.3 
11 113881541 113882541 Sdk2 0.5 1.5 1.0 
11 115150368 115151368 Otop3 0.6 1.6 1.0 
12 3954466 3955466 Pomc1 0.0 1.2 1.1 
12 11462397 11463397 Vsnl1 -0.1 1.0 1.0 
12 29168251 29169251 Allc -0.7 0.4 1.1 
12 32792957 32793957 Pik3cg -0.5 1.1 1.5 
12 32793217 32794217 Pik3cg -0.4 1.1 1.5 
12 36502683 36503683 Agr2 -0.5 0.5 1.0 
12 37618311 37619311 Meox2 -0.2 2.1 2.3 
12 37618412 37619412 Meox2 -0.2 2.2 2.4 
12 62442144 62443144 Lrfn5 -0.2 1.3 1.5 
12 62442314 62443314 Lrfn5 0.0 1.2 1.2 
12 66143621 66144621 Wdr20 -0.2 1.6 1.8 
12 66143834 66144834 Wdr20 0.0 1.8 1.8 
12 82403389 82404389 1810020G14Rik -0.4 1.1 1.4 
12 85306447 85307447 Rnf113a2 0.2 1.3 1.1 
12 86575322 86576322 Batf -0.3 0.8 1.1 
12 93289101 93290101 LOC625794 -0.6 0.7 1.3 
12 103299855 103300855 Cox8c 0.1 1.4 1.2 
12 104096079 104097079 Serpina1f -0.7 0.9 1.5 
12 105623256 105624256 Tcl1 -0.4 1.5 1.9 
13 56904710 56905710 Trpc7 -0.1 1.1 1.2 
14 9954786 9955786 Fhit 0.1 1.7 1.6 
14 25729626 25730626 Asb14 -0.5 1.0 1.5 
14 47586557 47587557 Otx2 0.5 1.7 1.2 
14 49791993 49792993 Tep1 -0.3 1.4 1.6 
14 56078831 56079831 Gjb6 -0.2 0.8 1.0 
14 62462702 62463702 Tdh -0.1 1.2 1.3 
14 68124782 68125782 Nkx2-6 0.1 1.1 1.0 
14 68343647 68344647 Loxl2 0.4 1.4 1.0 
14 68344055 68345055 Loxl2 0.2 1.5 1.3 
14 73870079 73871079 Lcp1 -0.2 0.8 1.0 
14 83253089 83254089 Pcdh17 0.2 1.7 1.6 
14 83253197 83254197 Pcdh17 0.3 1.6 1.3 
14 95401668 95402668 Klhl1 -0.2 1.1 1.3 
14 102728875 102729875 Ednrb 0.2 2.2 1.9 
14 102729581 102730581 Ednrb -0.2 1.6 1.8 
14 107795590 107796590 Slitrk1 -0.8 1.1 1.9 
14 119177117 119178117 Oxgr1 -0.3 1.5 1.9 
14 123859749 123860749 Fgf14 -0.6 0.7 1.3 
14 123859855 123860855 Fgf14 -0.6 0.6 1.3 
15 4325144 4326144 Plcxd3 -0.2 0.9 1.2 
15 10121870 10122870 Prlr -0.1 1.0 1.1 
15 10121988 10122988 Prlr 0.0 1.0 1.0 
15 28147854 28148854 Dnahc5 -0.2 0.9 1.0 
15 37177124 37178124 Grhl2 0.7 1.9 1.3 
15 37177335 37178335 Grhl2 0.8 2.0 1.2 
15 74645830 74646830 Hemt1 0.0 1.4 1.4 
15 98168473 98169473 Olfr284 -0.5 1.4 1.9 
15 98206642 98207642 Olfr283 -0.2 1.8 2.0 
15 98283845 98284845 Olfr281 -0.2 1.6 1.9 
15 100192118 100193118 Yghl1-4 -0.3 0.9 1.2 
15 100763858 100764858 Scn8a -0.4 1.8 2.2 
15 101301011 101302011 Krt2-10 -0.8 0.4 1.1 
15 101378193 101379193 Krt2-20 0.2 1.4 1.2 
15 101389933 101390933 Krt2-18 -0.2 0.8 1.0 
15 101401438 101402438 Krtcap1 -0.3 1.0 1.3 
15 101645669 101646669 Krt2-17 -0.1 0.9 1.1 
15 101752245 101753245 Krt2-4 0.2 1.8 1.6 
16 9905611 9906611 Grin2a 0.6 1.8 1.1 
16 10083305 10084305 4930517K11Rik 0.0 2.4 2.4 
16 22537048 22538048 Dgkg -0.2 1.3 1.5 
16 32084723 32085723 Lrrc33 0.5 1.7 1.1 
16 48350362 48351362 Morc1 0.0 1.0 1.0 
16 64420836 64421836 Ckt2 -0.3 2.0 2.3 
16 74293400 74294400 Robo2 -0.1 1.2 1.3 
16 88178587 88179587 Grik1 0.2 1.8 1.6 
16 88395337 88396337 Cldn17 -0.3 0.8 1.1 
16 88784808 88785808 Krtap8-2 -0.4 0.7 1.2 
16 93896877 93897877 Cldn14 -0.1 1.0 1.1 
16 96305113 96306113 Sh3bgr 0.2 1.5 1.3 
16 97765450 97766450 Tmprss2 0.4 1.5 1.0 
17 21087942 21088942 A830058L05Rik -0.1 1.0 1.1 
17 30924258 30925258 Tmprss3 -0.3 0.9 1.2 
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17 30925487 30926487 Tmprss3 -0.1 0.9 1.0 
17 31005554 31006554 Tsga2 0.0 1.2 1.2 
17 31023692 31024692 Slc37a1 0.3 1.4 1.1 
17 32876175 32877175 Morc2b -0.5 1.3 1.7 
17 33808082 33809082 Psmb8 0.5 1.6 1.2 
17 35113603 35114603 Pou5f1 -0.1 0.9 1.0 
17 36588790 36589790 2410137M14Rik -0.3 0.7 1.1 
17 40257060 40258060 Crisp2 -0.7 1.3 1.9 
17 47916568 47917568 Bzrpl1 0.2 1.4 1.1 
17 55923716 55924716 M6prbp1 -0.4 1.0 1.4 
17 56790228 56791228 Tnfsf9 0.2 2.2 2.0 
17 56963934 56964934 Vav1 0.2 1.7 1.5 
17 70420423 70421423 Dlgap1 0.0 1.1 1.1 
17 71657242 71658242 BC027072 -0.1 1.3 1.4 
17 73854537 73855537 Xdh -0.2 1.0 1.1 
17 81646195 81647195 Slc8a1 -0.5 1.4 1.9 
17 90362539 90363539 LOC623954 0.0 1.1 1.0 
17 93503212 93504212 Adcyap1 -0.3 1.0 1.3 
18 31459638 31460638 Rit2 -0.1 1.2 1.3 
18 37078148 37079148 Pcdha4 0.2 1.4 1.2 
18 37117940 37118940 Pcdha8 0.2 1.5 1.3 
18 37390471 37391471 Pcdhb1 -0.1 1.1 1.2 
18 37568044 37569044 Pcdhb13 -0.3 1.8 2.1 
18 42520115 42521115 Pou4f3 0.4 1.5 1.1 
18 52456404 52457404 Ftmt 0.1 1.5 1.5 
18 52818558 52819558 Gykl1 -0.5 1.0 1.5 
18 66094970 66095970 Cplx4 -0.2 0.8 1.0 
18 72475447 72476447 Dcc 0.1 1.4 1.3 
18 86846740 86847740 Cbln2 0.2 1.2 1.0 
19 12103285 12104285 Olfr1423 -0.3 0.8 1.1 
19 22514804 22515804 Trpm3 -0.3 0.8 1.1 
19 25739007 25740007 Dmrt2 0.2 1.9 1.7 
19 32168637 32169637 Asah2 0.8 1.9 1.0 
19 44039299 44040299 Cpn1 0.3 1.8 1.5 
19 58723114 58724114 Pnlip -0.3 1.3 1.5 
X 6198063 6199063 Ccnb3 0.2 1.2 1.0 
X 8189943 8190943 Fthl17 0.2 1.4 1.2 
X 17302328 17303328 1700094E07Rik -0.1 1.5 1.6 
X 20517323 20518323 LOC331392 0.1 1.8 1.7 
X 33641986 33642986 Gm9 0.8 1.8 1.1 
X 33675936 33676936 Rhox2 0.3 1.8 1.5 
X 33696261 33697261 LOC665169 Rhox4a -0.2 1.9 2.0 
X 33696404 33697404 Rhox4a -0.1 2.0 2.2 
X 33737970 33738970 Rhox4b -0.2 2.1 2.3 
X 33785722 33786722 Rhox4c -0.4 1.8 2.1 
X 33819884 33820884 Rhox4b -0.1 1.9 2.1 
X 33819991 33820991 Rhox4d -0.1 1.9 2.0 
X 33862906 33863906 Rhox4e -0.3 2.3 2.6 
X 33913143 33914143 Rhox4h -0.2 1.8 2.0 
X 33956784 33957784 Rhox4g -0.1 1.7 1.8 
X 33967141 33968141 LOC621852 -0.2 1.3 1.5 
X 34071181 34072181 Rhox6 0.1 1.4 1.3 
X 34145836 34146836 Rhox9 0.1 1.5 1.5 
X 34310601 34311601 Rhox10 0.2 1.6 1.4 
X 34329266 34330266 Rhox11 0.0 1.6 1.6 
X 53849985 53850985 Gpr101 0.2 1.3 1.0 
X 70429503 70430503 Tktl1 0.3 1.8 1.5 
X 79740143 79741143 Tsga8 0.1 1.4 1.3 
X 82508438 82509438 CN716893 0.3 1.7 1.3 
X 85661908 85662908 Pet2 0.4 1.8 1.4 
X 101059375 101060375 Magee2 0.1 1.3 1.1 
X 114597090 114598090 Tgifx1 0.0 1.3 1.3 
X 118513726 118514726 Nap1l3 0.2 1.2 1.1 
X 118513829 118514829 Nap1l3 0.1 1.1 1.0 
X 130648179 130649179 Pramel3 N/A 0.0 1.9 1.9 
X 130719147 130720147 4930481M05 N/A -0.1 1.9 2.1 
X 136159297 136160297 Tex13 0.2 1.8 1.6 
X 159104934 159105934 1700045I19Rik 0.2 1.5 1.3 
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Gain of DNA methylation in Lsh-/- MEFs (2-fold)  
            
Chr Start Stop Gene av_LSH KO av_WT DM(WT-KO) 
1 40734703 40735703 4931419K03Rik 1.0 -0.1 -1.1 
1 154716818 154717818 Nmnat2 1.0 -0.5 -1.5 
1 196639109 196640109 Cd34 1.9 0.0 -1.9 
2 24783930 24784930 2810443J12Rik 1.7 -0.6 -2.2 
2 44934525 44935525 Zfhx1b 1.6 0.4 -1.3 
2 51756396 51757396 0610033I05Rik 1.7 0.3 -1.4 
2 51756672 51757672 0610033I05Rik 1.6 0.1 -1.5 
2 60183603 60184603 Ly75 1.2 0.1 -1.2 
2 91244961 91245961 1110051M20Rik 1.7 -0.3 -2.0 
2 112085026 112086026 Slc12a6 1.2 -0.2 -1.4 
2 119353739 119354739 Ndufaf1 1.1 0.0 -1.1 
2 135432770 135433770 Plcb4 1.3 0.2 -1.0 
2 152653446 152654446 Ttll9 1.7 -0.6 -2.3 
2 181528054 181529054 Samd10 2.2 1.0 -1.2 
3 10333333 10334333 Zfand1 1.1 0.0 -1.0 
3 55869953 55870953 Mab21l1 2.0 -0.1 -2.1 
3 86633642 86634642 Lrba Mab21l2 2.6 -0.3 -2.9 
3 114022094 114023094 Col11a1 1.1 0.1 -1.1 
3 114022228 114023228 Col11a1 1.1 0.1 -1.1 
3 116504626 116505626 Dbt 2.4 -0.4 -2.8 
4 21970007 21971007 Coq3 1.5 0.0 -1.5 
4 48684113 48685113 2310039E09Rik 1.4 -0.5 -1.9 
4 129125682 129126682 Ccdc28b 1.4 -0.7 -2.1 
4 134766020 134767020 Npal3 1.0 0.0 -1.0 
5 13404814 13405814 Sema3a 1.3 0.2 -1.1 
5 31197975 31198975 Khk 1.1 0.0 -1.0 
5 125629553 125630553 Scarb1 1.6 0.2 -1.5 
6 52093914 52094914 Hoxa2 2.6 1.4 -1.2 
6 52147656 52148656 Hoxa7 1.7 0.4 -1.3 
6 72309401 72310401 Vamp5 1.5 0.4 -1.1 
6 83121511 83122511 Wdr54 1700003E16Rik 1.9 0.4 -1.5 
6 83121622 83122622 1700003E16Rik 2.0 0.3 -1.7 
6 100670331 100671331 BC049816 1.0 0.0 -1.0 
6 125180699 125181699 Vamp1 1.0 0.0 -1.0 
6 131258410 131259410 2010012C16Rik 1.6 0.2 -1.4 
6 135030878 135031878 Gprc5a 1.3 0.0 -1.4 
6 149098185 149099185 4833442J19Rik 2.5 1.1 -1.4 
6 149098290 149099290 4833442J19Rik 2.6 1.1 -1.4 
7 24928107 24929107 Dedd2 0.5 -0.5 -1.0 
7 44842316 44843316 Cpt1c 1.4 0.0 -1.5 
7 78450796 78451796 Ntrk3 2.1 0.9 -1.1 
7 78450988 78451988 Ntrk3 2.1 1.1 -1.0 
7 81662444 81663444 3110040N11Rik 1.1 -0.7 -1.8 
7 139829543 139830543 6430531B16Rik 2.3 1.1 -1.1 
7 141117221 141118221 Irf7 1.7 0.0 -1.6 
8 23631447 23632447 Nek3 1.1 -0.5 -1.6 
8 73695138 73696138 Ifi30 1.1 -0.3 -1.3 
8 108143732 108144732 C76566 1.4 0.2 -1.2 
8 110291812 110292812 Nqo1 1.1 -0.3 -1.4 
9 57634121 57635121 Arid3b 1.6 -0.4 -2.0 
9 78400960 78401960 Cd109 1.3 0.2 -1.1 
10 33986387 33987387 Tspyl4 1.8 -0.1 -1.9 
10 68928921 68929921 Ank3 0.4 -0.7 -1.1 
10 68929022 68930022 Ank3 0.5 -0.5 -1.0 
10 128336266 128337266 Itga7 2.5 1.1 -1.4 
11 29414528 29415528 2010316F05Rik 1.5 0.0 -1.4 
11 54941039 54942039 Gm2a 1.7 0.5 -1.1 
11 69619363 69620363 Tmem102 1.8 0.0 -1.8 
11 84644659 84645659 BC022224 1.6 0.3 -1.4 
11 96643305 96644305 Nfe2l1 2.3 0.8 -1.5 
11 96643545 96644545 Nfe2l1 2.2 0.8 -1.5 
11 101709944 101710944 Meox1 1.2 0.1 -1.1 
11 110153265 110154265 Abca5 1.2 0.2 -1.0 
12 8999399 9000399 Wdr35 1.2 0.0 -1.3 
12 8999518 9000518 Wdr35 1.2 0.0 -1.3 
12 96087584 96088584 Flrt2 2.7 0.2 -2.5 
13 21447866 21448866 4921509E05Rik 2.8 1.7 -1.1 
13 21448009 21449009 4921509E05Rik 2.7 1.4 -1.3 
13 64138030 64139030 Slc35d2 2.5 0.1 -2.4 
13 101115331 101116331 Mccc2 1.0 0.0 -1.0 
14 30994300 30995300 Ncoa4 1.0 -0.1 -1.0 
14 45308565 45309565 Bmp4 1.1 0.0 -1.1 
14 60314033 60315033 Ebpl 1.4 -0.1 -1.5 
15 8657125 8658125 Slc1a3 1.9 -0.4 -2.3 
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15 8657445 8658445 Slc1a3 1.8 -0.3 -2.1 
15 51707069 51708069 D530033C11Rik 1.3 0.0 -1.3 
15 51707318 51708318 D530033C11Rik 1.1 0.1 -1.0 
15 55137333 55138333 Col14a1 2.1 1.1 -1.0 
15 76134000 76135000 Oplah 2.5 1.5 -1.0 
15 98555664 98556664 Fkbp11 1.9 0.3 -1.5 
16 3787102 3788102 Zfp597 2.5 1.5 -1.0 
16 56810614 56811614 Tmem45a 0.8 -0.4 -1.3 
17 24949681 24950681 Unkl 2.0 0.7 -1.3 
17 45616590 45617590 Mad2l1bp 1.6 -0.2 -1.8 
17 79622867 79623867 Cyp1b1 1.4 0.1 -1.3 
18 34533723 34534723 Pkd2l2 1.3 0.1 -1.2 
18 34703401 34704401 Nme5 2.4 1.3 -1.1 
18 60626360 60627360 2010002N04Rik 1.7 0.1 -1.5 
18 77251237 77252237 3110023G01Rik 1.4 -0.5 -1.9 
19 4854628 4855628 Ctsf 1.3 0.3 -1.0 
19 44346898 44347898 Scd2 1.4 0.0 -1.3 
19 47589831 47590831 Obfc1 2.1 -0.1 -2.2 
       
Loss of DNA methylation in G9a-/- ES (1.4-fold)   
          
Chr Start Stop Gene av_G9a KO av_WT M(WT-KO) 
1 98702144 98703144 9530060I07 0.22 1.04 0.82 
1 95655179 95656179 D2hgdh -0.04 0.57 0.61 
1 87431373 87432373 LOC434484 -0.87 -0.27 0.6 
1 1.36E+08 1.36E+08 LOC667414 1.24 1.74 0.5 
1 98702041 98703041 Slco4c1 0.29 1.06 0.77 
1 90042629 90043629 Ugt1a1 -0.21 0.35 0.56 
2 1.52E+08 1.52E+08 2400002F11Rik -0.15 1.61 1.76 
2 1.79E+08 1.79E+08 4930591A17Rik -0.01 0.63 0.64 
2 1.30E+08 1.30E+08 AU015228 0.59 1.25 0.66 
2 1.74E+08 1.74E+08 Gnas 0.42 1.43 1.01 
2 55252041 55253041 Kcnj3 0.32 0.84 0.52 
2 1.57E+08 1.57E+08 Nnat 0.87 1.74 0.87 
2 24916640 24917640 Noxa1 1.11 1.85 0.74 
2 85521745 85522745 Olfr1009 0.24 0.87 0.63 
2 61604791 61605791 Tbr1 0.42 0.93 0.51 
3 1.03E+08 1.03E+08 5730470L24Rik 0.19 0.72 0.53 
3 96014182 96015182 Anp32e -0.93 -0.35 0.58 
3 36244596 36245596 BC050811 0.38 0.91 0.53 
3 1.01E+08 1.01E+08 Cd2 0.82 1.35 0.53 
3 1.30E+08 1.30E+08 Egf -0.01 0.51 0.52 
3 90084072 90085072 Hax1 -1.02 -0.42 0.6 
3 49852976 49853976 Pcdh18 0.04 0.63 0.59 
3 26828203 26829203 Spata16 0.48 1.22 0.74 
3 96266131 96267131 Sv2a -0.53 0 0.53 
3 57382320 57383320 Tm4sf1 1.02 1.55 0.53 
3 1.46E+08 1.46E+08 Wdr63 0.03 0.99 0.96 
4 33323944 33324944 Rragd 0.28 0.79 0.51 
5 1.46E+08 1.46E+08 1700001J03Rik 0.2 0.76 0.56 
5 93423554 93424554 Cxcl10 0.03 0.59 0.56 
5 71978650 71979650 Gabrb1 -0.3 0.35 0.65 
5 1.15E+08 1.15E+08 Oasl2 -0.12 0.82 0.94 
5 98420779 98421779 Prdm8 0.11 0.64 0.53 
5 3241895 3242895 Rpl26 0.89 1.54 0.65 
5 1.38E+08 1.38E+08 Trfr2 0.01 0.71 0.7 
6 1.31E+08 1.31E+08 2010012C16Rik -1.3 0.39 1.69 
6 72291390 72292390 2500002L14Rik -0.94 -0.29 0.65 
6 1.29E+08 1.29E+08 4922502D21Rik -0.16 0.78 0.94 
6 89061255 89062255 4933427D06Rik 0.64 1.25 0.61 
6 1.37E+08 1.37E+08 Art4 0.84 1.36 0.52 
6 18058555 18059555 Asz1 0.74 1.52 0.78 
6 1.29E+08 1.29E+08 BC048546 -0.03 0.6 0.63 
6 86403921 86404921 C87436 -0.72 -0.13 0.59 
6 1.29E+08 1.29E+08 Cd69 -0.62 -0.12 0.5 
6 1.25E+08 1.25E+08 Emg1 -0.53 0.12 0.65 
6 25640239 25641239 Gpr37 -0.78 -0.19 0.59 
6 1.35E+08 1.35E+08 Gprc5d 0.06 0.65 0.59 
6 1.37E+08 1.37E+08 Gucy2c 1.29 1.83 0.54 
6 82739531 82740531 Hk2 -0.36 0.14 0.5 
6 48484037 48485037 Lrrc61 -0.96 -0.27 0.69 
6 30687572 30688572 Mest 0.19 1.07 0.88 
6 17440740 17441740 Met 0.6 1.1 0.5 
6 1.35E+08 1.35E+08 Pbp2 0.65 1.21 0.56 
6 4696805 4697805 Peg10 0.46 1 0.54 
6 57464504 57465504 Ppm1k -0.27 0.33 0.6 
7 30379844 30380844 4930479M11Rik -0.22 0.77 0.99 
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7 4135029 4136029 6030429G01Rik 0.05 0.78 0.73 
7 12177159 12178159 6330408A02Rik 0.38 0.91 0.53 
7 1.20E+08 1.20E+08 Abca15 1.32 2.05 0.73 
7 1.25E+08 1.25E+08 Jmjd5 0.42 1.09 0.67 
7 12176961 12177961 Lig1 0.48 0.99 0.51 
7 97274777 97275777 Ndufc2 0.06 0.66 0.6 
7 6119012 6120012 Olfr1349 0.66 1.29 0.63 
7 6333993 6334993 Peg3 0.06 0.99 0.93 
7 6334168 6335168 Usp29 -0.07 0.98 1.05 
7 5824864 5825864 Zfp371 0.59 1.24 0.65 
8 38461598 38462598 AI429214 -0.34 0.97 1.31 
8 70423363 70424363 Nat2 -0.16 0.52 0.68 
8 50173007 50174007 Odz3 1.42 1.98 0.56 
8 86430750 86431750 Olfr370 1.14 1.8 0.66 
9 78153316 78154316 Dppa5 0.86 1.4 0.54 
9 43863546 43864546 Rnf26 no.1 0.86 1.45 0.59 
9 96540527 96541527 Zbtb38 0.33 1.17 0.84 
10 1.08E+08 1.08E+08 C6.1AL 0.71 1.62 0.91 
10 99188644 99189644 Csl no.1 1.1 1.69 0.59 
10 99188846 99189846 Csl 1.06 1.58 0.52 
10 57631517 57632517 LOC245263 1.21 1.82 0.61 
10 21379760 21380760 LOC432436 0.82 1.35 0.53 
10 1.20E+08 1.20E+08 Msrb3 1.22 1.73 0.51 
10 1.07E+08 1.07E+08 Myf5 0.63 1.19 0.56 
10 12780485 12781485 Plagl1 no.1 0.28 1 0.72 
10 12780606 12781606 Plagl1 0.26 1 0.74 
10 50583565 50584565 Sim1 no.1 -0.46 0.08 0.54 
10 50583772 50584772 Sim1 -0.51 0.01 0.52 
10 22509044 22510044 Tcf21 -0.01 0.58 0.59 
11 16951436 16952436 1500041B16Rik 0.03 0.61 0.58 
11 81389234 81390234 1700071K01Rik 1.42 1.98 0.56 
11 84773534 84774534 Car4 0.27 0.78 0.51 
11 68409749 68410749 Ccdc42 0.81 1.55 0.74 
11 41843242 41844242 Gabrg2 no.1 -0.45 0.24 0.69 
11 41843455 41844455 Gabrg2 -0.46 0.05 0.51 
11 69211041 69212041 Gm740 0.49 1.09 0.6 
11 36787166 36788166 Odz2 0.21 0.71 0.5 
11 58441739 58442739 Olfr323 0.95 1.51 0.56 
11 16951884 16952884 Plek 0.12 0.65 0.53 
11 80626109 80627109 Tmem98 -0.64 -0.1 0.54 
11 22871536 22872536 U2af1-rs1 0.22 0.79 0.57 
11 11361911 11362911 Zpbp -0.22 0.29 0.51 
12 1.03E+08 1.03E+08 Cox8c 0.82 1.57 0.75 
12 34513171 34514171 Ferd3l -0.03 0.95 0.98 
12 40709238 40710238 Gm889 0.55 1.05 0.5 
12 37618311 37619311 Meox2 no.1 -0.12 0.48 0.6 
12 37618412 37619412 Meox2 -0.06 0.54 0.6 
12 66143621 66144621 Wdr20 no.1 0.74 1.46 0.72 
12 66143834 66144834 Wdr20 0.76 1.68 0.92 
13 99736990 99737990 0610009B10Rik 1.69 2.29 0.6 
13 67999105 68000105 A530094I17Rik -0.46 0.09 0.55 
13 1.01E+08 1.01E+08 Birc1f 0.21 0.76 0.55 
13 84211581 84212581 C130071C03Rik -0.26 0.29 0.55 
13 3803048 3804048 Calml3 0.78 1.45 0.67 
13 70276753 70277753 D13Wsu50e -0.06 0.44 0.5 
13 40870605 40871605 Gcnt2 0.77 1.34 0.57 
13 45517940 45518940 Gmpr 0.08 0.59 0.51 
13 26777080 26778080 Hdgfl1 0.7 1.2 0.5 
13 21723376 21724376 Hist1h2ac Hist1h2ai 0.14 0.81 0.67 
13 21840440 21841440 Hist1h2ao N/A -0.08 0.49 0.57 
13 23941121 23942121 Hist1h2ba 0.99 1.65 0.66 
13 21729062 21730062 Hist1h2bm 0.17 0.68 0.51 
14 64220310 64221310 Fbxo16 -0.27 0.37 0.64 
14 9954786 9955786 Fhit -0.31 0.45 0.76 
14 73870079 73871079 Lcp1 0.65 1.16 0.51 
14 27844920 27845920 Lrtm1 -0.34 0.21 0.55 
14 1.08E+08 1.08E+08 Slitrk1 -0.09 1.3 1.39 
15 77945715 77946715 Cacng2 0.33 0.87 0.54 
15 54749582 54750582 Enpp2 no.1 0.1 0.77 0.67 
15 54749692 54750692 Enpp2 0.21 0.78 0.57 
15 74645830 74646830 Hemt1 1.34 1.88 0.54 
15 98283845 98284845 Olfr281 1.28 1.84 0.56 
15 78000863 78001863 Rabl4 -0.78 -0.17 0.61 
16 4633787 4634787 1110025F24Rik 0.54 1.08 0.54 
16 52372922 52373922 Alcam 0.11 0.81 0.7 
16 22537048 22538048 Dgkg 0.62 1.13 0.51 
17 93503212 93504212 Adcyap1 0.57 1.08 0.51 
17 40257060 40258060 Crisp2 0.38 1.01 0.63 
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17 6417939 6418939 Dynlt1 -0.41 0.1 0.51 
17 89108501 89109501 Fshr 0.63 1.15 0.52 
17 58698095 58699095 Nudt12 0.04 0.82 0.78 
17 35140753 35141753 Psors1c2 0.07 0.62 0.55 
17 6522768 6523768 Sytl3 1.17 1.85 0.68 
17 30925487 30926487 Tmprss3 0.57 1.14 0.57 
18 9618966 9619966 Cetn1 1.33 1.85 0.52 
18 52818558 52819558 Gykl1 -0.05 1.07 1.12 
18 13114920 13115920 Impact -0.36 0.2 0.56 
18 84220255 84221255 Tshz1 -0.76 -0.26 0.5 
18 13987078 13988078 Zfp521 1.55 2.1 0.55 
19 8955447 8956447 1810009A15Rik 0.12 0.67 0.55 
19 46760283 46761283 As3mt 0.06 0.89 0.83 
19 34592912 34593912 N/A Lip1 -0.04 0.78 0.82 
X 5258382 5259382 AU022751 0.73 1.24 0.51 
X 1.60E+08 1.60E+08 Bmx 0.66 1.17 0.51 
X 49864486 49865486 Cxx1a Cxx1b 0.12 0.77 0.65 
X 1.02E+08 1.02E+08 Cypt2 0.51 1.08 0.57 
X 33967141 33968141 LOC621852 1.11 1.7 0.59 
X 1.50E+08 1.50E+08 Magea2 0.32 0.91 0.59 
X 1.50E+08 1.50E+08 Magea8 0.29 1.02 0.73 
X 1.31E+08 1.31E+08 Nxf3 0.03 0.58 0.55 
X 1.30E+08 1.30E+08 Rpl36a -0.65 0.31 0.96 
X 38615 39615 Sybl1 -0.34 0.49 0.83 
X 1.40E+08 1.40E+08 Trpc5 no.1 -0.67 0.01 0.68 
X 1.40E+08 1.40E+08 Trpc5 -0.67 0.01 0.68 
X 27106937 27107937 Xmr -0.83 -0.3 0.53 
X 95139999 95140999 Yipf6 -0.47 0.04 0.51 
Y 581563 582563 Uty no.1 -0.32 1.66 1.98 
Y 581667 582667 Uty -0.33 1.62 1.95 
          
Gain of DNA methylation in G9a-/- ES   
  
Chr Start Stop GeneName av_G9a KO av_WT M(WT-KO) 
1 58657339 58658339 Cflar 1.28 0.12 -1.16 
1 58739477 58740477 Casp8 0.81 -0.2 -1.01 
1 58739585 58740585 Casp8 0.81 -0.2 -1.01 
1 74594460 74595460 Ttll4 1.09 0.42 -0.67 
1 1.30E+08 1.30E+08 Rab3gap1 0.49 -0.31 -0.8 
1 1.64E+08 1.64E+08 Myoc 0.56 -0.01 -0.57 
1 1.72E+08 1.72E+08 1700084C01Rik 0.51 -0.12 -0.63 
2 37180741 37181741 Pdcl 1.08 -0.25 -1.33 
2 1.51E+08 1.51E+08 Nsfl1c 0.85 0.17 -0.68 
2 1.53E+08 1.53E+08 Ttll9 1.34 0.51 -0.83 
2 1.55E+08 1.55E+08 Acss2 1.44 0.67 -0.77 
2 1.69E+08 1.69E+08 1700101G07Rik 0.46 -0.07 -0.53 
2 1.74E+08 1.74E+08 Gnas 1.07 0.39 -0.68 
2 1.81E+08 1.81E+08 BC050777 0.27 -0.31 -0.58 
3 27373576 27374576 Aadacl1 -0.31 -0.86 -0.55 
3 51748665 51749665 Mgst2 0.76 0.22 -0.54 
3 97973612 97974612 Pde4dip 0.44 -0.09 -0.53 
4 1.36E+08 1.36E+08 6030445D17Rik 0.43 -0.08 -0.51 
4 1.47E+08 1.47E+08 Fv1 2.02 0.64 -1.38 
5 78090297 78091297 1700023E05Rik 1.77 0.86 -0.91 
5 1.15E+08 1.15E+08 N/A 0.71 -0.01 -0.72 
5 1.24E+08 1.24E+08 Ogfod2 1.26 0.36 -0.9 
6 83740914 83741914 Tex261 0.4 -0.14 -0.54 
7 28888661 28889661 Psmd8 0.47 -0.07 -0.54 
7 28888774 28889774 Psmd8 0.47 -0.07 -0.54 
7 29940862 29941862 Polr2i 0.13 -0.46 -0.59 
7 1.28E+08 1.28E+08 Inpp5f 0.88 0.3 -0.58 
8 4779034 4780034 Shcbp1 0.82 0.21 -0.61 
8 11839992 11840992 1700018L24Rik 0.59 0.09 -0.5 
8 20438598 20439598 A430108E01Rik 2610005L07Rik 1.27 0.02 -1.25 
8 95743977 95744977 Aytl1 0.27 -0.27 -0.54 
9 13269840 13270840 LOC434635 0.17 -0.37 -0.54 
9 19372003 19373003 Zfp75 0.37 -0.29 -0.66 
9 20135060 20136060 Zfp560 1.15 0.36 -0.79 
9 21688175 21689175 BC018242 0.85 0.11 -0.74 
9 21938067 21939067 9530015I07Rik 1.11 0.47 -0.64 
9 44276916 44277916 Blr1 0.35 -0.2 -0.55 
9 1.07E+08 1.07E+08 Cish 0.35 -0.22 -0.57 
10 81359779 81360779 BC024063 0.35 -0.44 -0.79 
11 29030243 29031243 N/A Pnpt1 0.45 -0.26 -0.71 
11 69478266 69479266 Mpdu1 0.03 -0.59 -0.62 
11 97591467 97592467 1700001P01Rik 0.77 0.25 -0.52 
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12 18157029 18158029 LOC245297 0.57 0.05 -0.52 
12 85532143 85533143 7420416P09Rik 0.01 -0.55 -0.56 
12 1.09E+08 1.09E+08 Wdr25 0.82 0.19 -0.63 
13 1.21E+08 1.21E+08 LOC633640 0.76 0.2 -0.56 
13 1.21E+08 1.21E+08 3110070M22Rik 1.15 0.62 -0.53 
14 19462394 19463394 Sec24c 0.88 0.02 -0.86 
14 19840208 19841208 Ap3m1 0.44 -0.07 -0.51 
14 51941865 51942865 C920008G01Rik 1.33 0.77 -0.56 
14 53385316 53386316 Mmp14 -0.11 -0.69 -0.58 
14 53559613 53560613 4931414P19Rik 0.64 -0.04 -0.68 
14 62941390 62942390 4930578I06Rik 0.45 -0.05 -0.5 
14 66660255 66661255 Cdca2 0.57 0.02 -0.55 
14 1.23E+08 1.23E+08 Vgcnl1 0.19 -0.41 -0.6 
15 99981929 99982929 AI317237 0.9 0.4 -0.5 
16 4656340 4657340 Hmox2 0 -0.53 -0.53 
16 13022813 13023813 Ercc4 0.05 -0.48 -0.53 
16 92189677 92190677 1190017O12Rik 1.26 0.44 -0.82 
17 20439296 20440296 V1re6 0.58 -0.1 -0.68 
17 25093432 25094432 Mcpt6 0.67 0.08 -0.59 
17 25093649 25094649 Mcpt6 0.96 0.14 -0.82 
17 28417076 28418076 Slc26a8 0.69 -0.24 -0.93 
17 30353446 30354446 Dnahc8 0.39 -0.13 -0.52 
17 42351655 42352655 Cd2ap 0.73 0.12 -0.61 
17 56559071 56560071 Acsbg2 0.81 0.3 -0.51 
18 37055657 37056657 Pcdha1 1.24 0.52 -0.72 
18 37055758 37056758 Pcdha1 1.08 0.52 -0.56 
18 37071680 37072680 Pcdha3 1.39 0.75 -0.64 
18 37123353 37124353 Pcdha9 1.55 0.68 -0.87 
18 37145703 37146703 Pcdha12 1.02 0.45 -0.57 
18 37146153 37147153 Pcdha11 1.11 0.55 -0.56 
18 37862409 37863409 Pcdhga9 0.43 -0.24 -0.67 
18 37881246 37882246 Pcdhga11 0.31 -0.29 -0.6 
18 74393140 74394140 Mbd1 1.24 0.59 -0.65 
19 42308593 42309593 4933417O08Rik 0.35 -0.15 -0.5 
       
       
Loss of DNA methylation in Smchd1-/-       
              
Chr Start Stop Gene Name av_Smchd1 
KO 
av_WT M(WT-KO) 
1 137250294 137250399 U6.608 -2.5 0.4 2.8 
1 169153958 169154050 Uck2 -2.5 0.1 2.6 
1 188949017 188949862 1700007P06Rik -1.3 0.9 2.2 
1 139863216 139863295 Mir181b-1 -2.3 -0.3 2.0 
1 134710805 134710925 SNORA17.507 -2.5 -0.5 2.0 
1 171899540 171902526 3110045C21Rik -2.3 -0.5 1.8 
1 172207507 172216900 Sh2d1b1 0.0 1.8 1.8 
1 185505657 185506073 AC107787.1 -2.5 -0.8 1.7 
1 59538991 59543791 Fzd7 1.6 3.3 1.7 
1 188944748 188948244 Gm15509 -0.7 0.8 1.6 
1 9999895 9999998 U6.223 -2.3 -0.8 1.6 
1 55294021 55296902 Mars2 -2.3 -0.8 1.6 
1 174886899 174887948 Olfr16 -2.3 -0.8 1.6 
1 175151402 175157360 Fcer1a -2.3 -0.8 1.6 
1 132697479 132711317 Fcamr 2.3 3.9 1.5 
1 65126804 65128862 Crygb -0.7 0.7 1.5 
1 175942129 175961886 Ifi205 -1.3 0.1 1.4 
1 177907908 177909245 B020018G12Rik -0.3 1.1 1.4 
1 87407708 87423736 Gm16092 -2.5 -1.1 1.4 
1 139863032 139863118 Mir181a-1 -2.5 -1.1 1.4 
1 136538831 136543097 AC122771.1 1.3 2.6 1.3 
1 193916253 193923511 Gm16621 1.4 2.6 1.2 
1 152006173 152012078 AC114655.1 -0.7 0.5 1.2 
1 173155185 173156510 Apoa2 0.3 1.5 1.2 
1 136401915 136402040 SNORA61.5 -1.3 -0.1 1.2 
1 136705852 136705945 AC131591.1 -1.3 -0.1 1.2 
1 148267564 148268004 AL592462.1 -1.3 -0.1 1.2 
1 176066877 176067824 Olfr424 -1.3 -0.1 1.2 
1 180251239 180254302 Gm16586 -1.3 -0.1 1.2 
1 23298540 23298623 Mir30c-2 -2.3 -1.1 1.2 
1 133997216 133997331 U6.779 -2.3 -1.1 1.2 
1 175145738 175146771 Olfr1404 -2.3 -1.1 1.2 
1 175999431 176000384 Olfr430 -2.3 -1.1 1.2 
1 94407625 94415092 Olfr1414 1.4 2.6 1.2 
1 73061657 73062473 Tnp1 1.8 2.9 1.2 
1 155251957 155255726 E330020D12Rik 2.0 3.1 1.1 
1 68051660 68072470 Gm15671 -0.3 0.8 1.1 
              211
1 132916422 132921551 Il10 1.0 2.1 1.1 
1 74928083 74931993 Fev 0.3 1.4 1.1 
1 195333432 195335997 AL365334.1 -0.7 0.4 1.1 
1 174405489 174408706 Slamf9 1.1 2.2 1.1 
1 44260915 44275806 4832428D23Rik 1.3 2.3 1.0 
1 15258880 15259878 Gm10566 -1.3 -0.3 1.0 
1 94376258 94377196 Olfr1416 -1.3 -0.3 1.0 
1 171862829 171864379 Gm15852 0.7 1.7 1.0 
1 176019169 176020111 Olfr429 -1.3 -0.3 1.0 
1 180567036 180567202 U1.47 -1.3 -0.3 1.0 
1 132829235 132836650 Il19 2.0 3.0 1.0 
1 135971747 135975697 Btg2 1.3 2.3 1.0 
2 89814866 89818869 Olfr1260 -2.3 0.7 3.0 
2 89136508 89137425 Olfr1230 -2.5 0.4 2.8 
2 24146716 24149340 Il1f10 -2.3 0.5 2.8 
2 71381466 71384749 Dlx2 1.4 4.2 2.8 
2 125108424 125109714 Gm14003 -1.3 1.4 2.8 
2 168886620 168886740 AL772258.1 -2.5 0.2 2.7 
2 129390783 129391804 Gm14041 -2.3 0.4 2.7 
2 166015197 166015301 5S_rRNA.83 -2.3 0.2 2.6 
2 171131668 171131931 SCARNA13.2 -2.3 0.2 2.6 
2 60249582 60250636 Gm13580 -1.3 1.2 2.5 
2 71366740 71372038 Dlx1 1.8 4.3 2.4 
2 24070938 24081222 Il1f6 -2.3 0.1 2.4 
2 160751277 160752384 Gm14228 -2.3 0.1 2.4 
2 152395074 152395274 AL845162.1 -2.5 -0.1 2.4 
2 89861295 89862221 Olfr1264 -0.7 1.6 2.3 
2 130230995 130231810 1700020A23Rik -2.3 -0.1 2.2 
2 147149298 147150823 Gm14110 -2.3 -0.1 2.2 
2 10433594 10433689 Mir466d -2.5 -0.3 2.2 
2 89122296 89128111 Olfr1229 -2.5 -0.3 2.2 
2 117074007 117074170 U1.99 -2.5 -0.3 2.2 
2 19579689 19582217 Otud1 0.5 2.7 2.2 
2 86989877 86990816 Olfr1111 -2.3 -0.3 2.0 
2 9804668 9811167 9230102O04Rik 2.2 4.2 2.0 
2 151296278 151301889 4921509C19Rik -2.5 -0.5 2.0 
2 127343028 127343545 AL731831.1 -1.3 0.6 1.9 
2 158182160 158182290 SNORA71.8 -1.3 0.6 1.9 
2 58759370 58760029 Gm11099 -0.7 1.2 1.9 
2 151691051 151692696 Gm14157 0.7 2.5 1.8 
2 86037960 86038907 Olfr1045 -2.3 -0.5 1.8 
2 87622693 87623643 Olfr152 -2.3 -0.5 1.8 
2 88326891 88327826 Olfr1184 -2.3 -0.5 1.8 
2 130101973 130102105 SNORA51.4 -2.3 -0.5 1.8 
2 151654803 151657844 Gm14155 -0.7 1.1 1.8 
2 32077490 32077574 SNORD62.2 -2.5 -0.8 1.7 
2 85744226 85745209 Olfr1024 -2.5 -0.8 1.7 
2 129190306 129196875 Il1b 0.8 2.6 1.7 
2 169407581 169408733 1700101G07Rik -2.5 -0.8 1.7 
2 179710698 179713718 4921531C22Rik -2.5 -0.8 1.7 
2 130389478 130394431 Mrps26 1.4 3.1 1.7 
2 25562399 25563237 Bmyc 0.3 2.0 1.7 
2 51219092 51221019 Gm13499 -1.3 0.4 1.7 
2 103683575 103683670 AL928544.1 -1.3 0.4 1.7 
2 144068977 144070585 4930444E06Rik -0.3 1.4 1.7 
2 167363695 167368314 Snai1 2.6 4.3 1.7 
2 29617048 29621994 Gm13547 1.8 3.4 1.7 
2 174661465 174666675 Gm14617 0.0 1.6 1.6 
2 173220067 173221221 Gm14642 0.8 2.4 1.6 
2 167684085 167688042 Gm14319 2.6 4.2 1.6 
2 71585564 71588257 Gm13663 -0.3 1.2 1.6 
2 87802109 87808414 Olfr1157 -1.3 0.2 1.6 
2 128249390 128250301 Gm14010 -0.3 1.2 1.6 
2 131124281 131125571 Gm14233 -1.3 0.2 1.6 
2 147187277 147188145 AI646519 -1.3 0.2 1.6 
2 11306630 11308691 Gm13291 -2.3 -0.8 1.6 
2 36667669 36668610 Olfr3 -2.3 -0.8 1.6 
2 49762291 49762400 Y_RNA.20 -2.3 -0.8 1.6 
2 51483031 51483927 Tas2r134 -2.3 -0.8 1.6 
2 130103752 130103823 Snord57 -2.3 -0.8 1.6 
2 135495189 135496161 Gm14209 -2.3 -0.8 1.6 
2 158185534 158185665 SNORA71.1 -2.3 -0.8 1.6 
2 177282920 177297014 Gm14403 -2.3 -0.8 1.6 
2 71586132 71588219 AL928963.1 -0.3 1.2 1.5 
2 172113633 172116020 Gm14275 -0.3 1.2 1.5 
2 3670258 3672449 Gm13185 0.8 2.3 1.4 
2 75567649 75568229 Gm13656 -1.3 0.1 1.4 
2 103905983 103907643 Gm10912 -1.3 0.1 1.4 
              212
2 118571494 118574546 5430417L22Rik -1.3 0.1 1.4 
2 158205270 158205402 SNORA71.3 -1.3 0.1 1.4 
2 163983140 163983257 n-R5s207 -1.3 0.1 1.4 
2 27395946 27398882 Gm13421 2.1 3.5 1.4 
2 25508640 25511737 Lcn8 1.1 2.5 1.4 
2 36334707 36335648 Olfr341 -2.5 -1.1 1.4 
2 86932614 86933552 Olfr1109 -2.5 -1.1 1.4 
2 103880826 103880964 SCARNA21.1 -2.5 -1.1 1.4 
2 106649492 106649615 SCARNA4.3 -2.5 -1.1 1.4 
2 164080099 164082376 Svs3b -2.5 -1.1 1.4 
2 131679414 131685483 Erv3 1.1 2.5 1.4 
2 158201374 158211881 Snhg11 3.0 4.4 1.4 
2 75615245 75620363 Gm13657 0.8 2.2 1.4 
2 111086288 111096320 Gm13962 -0.7 0.6 1.4 
2 79292678 79296908 Neurod1 1.0 2.3 1.3 
2 106896297 106899813 Fshb 0.5 1.8 1.3 
2 33571881 33574419 9430024E24Rik 1.0 2.3 1.3 
2 156203661 156204704 Gm14170 0.0 1.3 1.3 
2 167027076 167028299 Gm14291 1.1 2.4 1.3 
2 74529948 74533160 Hoxd10 0.3 1.6 1.3 
2 152418927 152425135 Defb45 1.9 3.2 1.3 
2 154923525 154925817 2310005A03Rik 1.4 2.7 1.3 
2 94092036 94104915 E530001K10Rik 2.0 3.3 1.3 
2 31872164 31872864 Gm13609 0.5 1.8 1.3 
2 179628614 179629398 Gm10711 0.5 1.8 1.3 
2 153606615 153620918 Efcab8 3.2 4.5 1.3 
2 164481440 164482868 Wfdc10 1.8 3.0 1.3 
2 10636794 10639296 Gm10852 -0.7 0.5 1.2 
2 144649402 144650151 1700010M22Rik -0.7 0.5 1.2 
2 167073817 167074078 AL591854.1 -0.7 0.5 1.2 
2 18594011 18597858 Commd3 -0.3 0.9 1.2 
2 89684223 89685128 Olfr48 0.0 1.2 1.2 
2 150396151 150404680 Cst7 1.5 2.7 1.2 
2 163340252 163340354 U6.703 -1.3 -0.1 1.2 
2 171813695 171814695 Gm14272 0.8 2.1 1.2 
2 10429257 10429341 Mir467d -2.3 -1.1 1.2 
2 23678573 23678747 7SK.177 -2.3 -1.1 1.2 
2 25126559 25127958 Ssna1 -2.3 -1.1 1.2 
2 26312664 26313836 Gm13568 -2.3 -1.1 1.2 
2 37075011 37075940 Olfr366 -2.3 -1.1 1.2 
2 83540814 83541273 Gm13686 -2.3 -1.1 1.2 
2 111219124 111220187 Olfr1284 -2.3 -1.1 1.2 
2 150574017 150576498 Gm16962 0.5 1.7 1.2 
2 156211843 156212058 7SK.215 -2.3 -1.1 1.2 
2 162505191 162506265 Gm14246 -2.3 -1.1 1.2 
2 174093005 174093086 Mir298 -2.3 -1.1 1.2 
2 180133084 180133187 Mir133a-2 -2.3 -1.1 1.2 
2 169408912 169413245 Gm11011 1.8 3.0 1.2 
2 43914758 43920844 A430092G05Rik 0.7 1.9 1.2 
2 25532306 25537128 Lcn6 1.6 2.8 1.2 
2 4208641 4222213 Gm13187 2.7 3.9 1.2 
2 93820191 93823732 4921507L20Rik 1.6 2.7 1.2 
2 84581272 84581335 Mir130a 0.0 1.2 1.2 
2 156688864 156699299 1110008F13Rik 3.1 4.3 1.2 
2 112319229 112320974 Chrm5 2.7 3.9 1.1 
2 152398480 152400680 Defb21 1.3 2.4 1.1 
2 164014967 164016344 Wfdc12 1.7 2.8 1.1 
2 164101688 164104195 Svs4 0.5 1.6 1.1 
2 26301216 26314910 0610009E02Rik 1.8 2.9 1.1 
2 31064990 31066867 Gm13405 1.3 2.4 1.1 
2 163961439 163966155 Gm11455 2.2 3.3 1.1 
2 25480186 25483550 Fcna 2.3 3.4 1.1 
2 25632537 25635799 Lcn11 0.7 1.8 1.1 
2 157421319 157423056 2410019O14Rik 0.5 1.6 1.1 
2 129024500 129037352 Slc20a1 3.6 4.7 1.1 
2 31001977 31007811 D330023K18Rik 1.1 2.2 1.1 
2 32429704 32431204 9430097D07Rik 1.6 2.6 1.1 
2 31817210 31818067 Gm13442 0.3 1.3 1.0 
2 36762431 36763514 Olfr354 -1.3 -0.3 1.0 
2 89142806 89143747 Olfr1231 -1.3 -0.3 1.0 
2 94569171 94570895 Gm13793 -1.3 -0.3 1.0 
2 104932175 104933917 Gm11060 -1.3 -0.3 1.0 
2 164115004 164117236 Svs3a -1.3 -0.3 1.0 
2 164439022 164443712 Wfdc6b 2.6 3.7 1.0 
2 166099408 166120331 Gm11468 5.1 6.1 1.0 
2 164395195 164398959 Spint3 1.4 2.4 1.0 
2 25182970 25188091 AL732557.1 1.1 2.2 1.0 
2 25475587 25477525 Tmem141 1.1 2.2 1.0 
              213
2 132520168 132524259 Gm14097 2.6 3.7 1.0 
2 152284791 152290356 Defb23 2.6 3.6 1.0 
2 180940267 180947890 Srms 3.0 4.0 1.0 
3 86349503 86352205 Mab21l2 0.0 4.4 4.4 
3 5212838 5215209 Gm10748 -2.3 1.1 3.4 
3 55586432 55589207 Mab21l1 1.3 4.5 3.3 
3 108301036 108301158 U6atac.18 -2.3 0.2 2.6 
3 68112747 68113103 Gm5848 -2.5 -0.3 2.2 
3 90407692 90409967 S100a4 -1.3 0.7 2.0 
3 24231969 24232474 Gm7536 -2.3 -0.3 2.0 
3 88187423 88188386 Bglap -2.5 -0.5 2.0 
3 4338998 4339116 n-R5s194 -2.3 -0.5 1.8 
3 92592972 92593391 Lce1j -2.3 -0.5 1.8 
3 139080721 139080827 U6.346 -2.3 -0.5 1.8 
3 153452269 153455051 5730460C07Rik -0.3 1.4 1.8 
3 108164469 108165174 Gm12525 0.3 2.0 1.7 
3 90330778 90332755 S100a14 0.0 1.4 1.4 
3 100542375 100542636 7SK.81 -1.3 0.1 1.4 
3 89031038 89031120 Mir92b -2.5 -1.1 1.4 
3 89771921 89772085 U1.55 -2.5 -1.1 1.4 
3 102755872 102756036 U1.86 -2.5 -1.1 1.4 
3 116169537 116169633 SNORA17.486 -2.5 -1.1 1.4 
3 89049888 89053644 Krtcap2 1.7 3.1 1.4 
3 93246252 93252999 Tchh 0.7 2.0 1.4 
3 14766217 14778459 Car1 -0.3 1.0 1.3 
3 38773492 38787181 C230034O21Rik 3.1 4.4 1.3 
3 90412445 90415702 S100a5 -0.7 0.5 1.2 
3 9402175 9402485 7SK.156 -1.3 -0.1 1.2 
3 27052948 27055941 1700125G22Rik -1.3 -0.1 1.2 
3 126135801 126142187 RP23-60D3.2 1.5 2.7 1.2 
3 30166747 30168869 Gm10258 -2.3 -1.1 1.2 
3 148691896 148692002 U6.284 -2.3 -1.1 1.2 
3 13471906 13474596 Gm10958 0.0 1.2 1.2 
3 107356616 107357991 Ubl4b 0.0 1.1 1.1 
3 36058444 36065142 Gm9760 1.3 2.3 1.1 
3 89799378 89802608 Hax1 -1.3 -0.3 1.0 
3 121040610 121040877 7SK.62 -1.3 -0.3 1.0 
3 94762956 94765970 B230398E01Rik 0.0 1.0 1.0 
4 43833207 43834305 Olfr156 -2.3 1.0 3.3 
4 129985406 129985918 Gm10570 -2.3 0.9 3.2 
4 62917885 62917966 Mir455 -1.3 1.7 3.0 
4 120778256 120781831 Tmco2 -2.3 0.5 2.8 
4 152592285 152592704 Gm13174 -2.3 0.4 2.7 
4 34631128 34631434 7SK.169 -2.5 0.1 2.6 
4 149940978 149942653 Gm13091 -1.3 1.1 2.4 
4 155135301 155137669 2610204G22Rik -1.3 1.0 2.3 
4 45652808 45655176 Gm12408 0.0 2.3 2.3 
4 94755774 94758110 4930551L18Rik -1.3 0.9 2.2 
4 9194470 9197062 AL844180.1 -2.3 -0.1 2.2 
4 41586411 41588449 Gm12406 -2.3 -0.1 2.2 
4 41763904 41812834 Gm13307 -2.3 -0.1 2.2 
4 115452439 115453623 4930544O15Rik -2.3 -0.1 2.2 
4 123536922 123540408 4933427I04Rik -2.3 -0.1 2.2 
4 118626878 118627524 Gm12863 -2.5 -0.3 2.2 
4 43864437 43868335 Olfr155 0.3 2.4 2.1 
4 63017196 63020545 Orm3 -0.7 1.3 2.0 
4 155573533 155574927 Isg15 -1.3 0.7 2.0 
4 56908101 56908170 Mir32 -2.5 -0.5 2.0 
4 83151051 83151458 Gm10154 -2.5 -0.5 2.0 
4 133520653 133524565 Hmgn2 -2.5 -0.5 2.0 
4 86204350 86205708 4930457A20Rik -1.3 0.5 1.8 
4 88400772 88401320 Gm13271 -2.3 -0.5 1.8 
4 120445211 120445302 Mir30e -2.3 -0.5 1.8 
4 120756591 120756754 U1.157 -2.5 -0.8 1.7 
4 114353409 114360200 Gm12829 1.6 3.3 1.7 
4 118105506 118109957 Cdc20 1.0 2.6 1.6 
4 20270853 20274965 Gm11872 -1.3 0.2 1.6 
4 43782922 43783881 Olfr159 -1.3 0.2 1.6 
4 101562625 101566394 C130073F10Rik -0.3 1.2 1.6 
4 71829802 71830483 Gm11250 -2.3 -0.8 1.6 
4 34853373 34858730 2410114N07Rik 1.5 3.0 1.5 
4 116309115 116324285 Akr1a4 1.4 2.8 1.4 
4 149154133 149154823 Gm13073 0.5 1.9 1.4 
4 116796582 116797771 Gm13014 -1.3 0.1 1.4 
4 108690260 108690335 Mir761 -2.5 -1.1 1.4 
4 130305549 130305621 Snord85 -2.5 -1.1 1.4 
4 137771629 137772104 2310026L22Rik -2.5 -1.1 1.4 
4 44956625 44961202 Gm12678 0.5 1.9 1.4 
              214
4 120807262 120807580 7SK.2 0.0 1.4 1.4 
4 116791824 116798271 Btbd19 0.3 1.6 1.4 
4 141538907 141542712 Gm13037 2.5 3.9 1.3 
4 153281495 153282775 Gm13115 0.0 1.3 1.3 
4 155177645 155183885 Mrpl20 0.0 1.3 1.3 
4 63257936 63266295 Gm11213 1.1 2.4 1.3 
4 118656663 118669803 Gm12865 1.5 2.8 1.3 
4 63023483 63026912 Orm2 0.7 2.0 1.3 
4 141736517 141740054 Gm13062 1.9 3.2 1.3 
4 122638552 122640718 4933421A08Rik -0.7 0.5 1.2 
4 147359897 147361314 Nppb 0.7 1.9 1.2 
4 86500564 86503316 Rps6 -1.3 -0.1 1.2 
4 151784909 151785371 Gm16333 -1.3 -0.1 1.2 
4 88451435 88454284 Gm13288 -2.3 -1.1 1.2 
4 136714997 136715786 Gm13003 0.5 1.7 1.2 
4 141573813 141584911 4930455G09Rik 2.7 3.8 1.2 
4 57184943 57189426 Gm12530 1.5 2.6 1.2 
4 82527655 82531052 Cer1 1.4 2.5 1.2 
4 123970936 123977091 Gm12916 0.7 1.8 1.1 
4 25726376 25727293 Fut9 -0.7 0.4 1.1 
4 33114117 33118298 4933421O10Rik 0.3 1.4 1.1 
4 124760101 124762191 Gm12932 -0.7 0.4 1.1 
4 88401099 88401494 Gm16686 0.7 1.8 1.1 
4 98590501 98602234 Usp1 0.0 1.1 1.1 
4 133683321 133684704 Sh3bgrl3 1.3 2.3 1.1 
4 43672494 43682017 4930412F15Rik 2.2 3.3 1.1 
4 39397328 39398809 1700009N14Rik 1.3 2.3 1.0 
4 47021188 47023653 Gm568 1.3 2.3 1.0 
4 114806437 114810469 Gm12835 -1.3 -0.3 1.0 
4 135904465 135906249 9130020K20Rik -1.3 -0.3 1.0 
4 53575855 53577569 1700060J05Rik 1.8 2.8 1.0 
4 133559245 133574756 Lin28a 2.1 3.1 1.0 
4 32683935 32689735 Gja10 0.0 1.0 1.0 
5 99938963 99939701 Gm16227 1.0 5.2 4.2 
5 99646445 99681946 Rasgef1b 6.1 9.4 3.2 
5 99726263 100158084 A930011G23Rik 8.6 11.4 2.8 
5 115266797 115267341 Gm13820 -1.3 1.2 2.6 
5 138644837 138648536 Gm454 -0.7 1.8 2.6 
5 96290662 96291912 Gm5559 -2.3 0.1 2.4 
5 31208258 31210161 Ost4 -1.3 0.9 2.2 
5 139003068 139005922 1700123K08Rik -1.3 0.7 2.0 
5 27879091 27880415 Gm16058 -2.3 -0.3 2.0 
5 125197448 125197545 U6.752 -2.3 -0.3 2.0 
5 143916709 143916806 AC123686.1 -2.3 -0.3 2.0 
5 113473164 113473272 U6.319 -2.5 -0.5 2.0 
5 116265841 116265919 AC162461.1 -2.5 -0.5 2.0 
5 139919553 139919659 U6.290 -2.5 -0.5 2.0 
5 119747254 119747370 n-R5s175 -1.3 0.6 1.9 
5 77085537 77087380 Gm10430 -0.3 1.4 1.8 
5 115547698 115548304 Gm10401 0.0 1.7 1.7 
5 123930162 123932594 Il31 1.0 2.7 1.7 
5 92775664 92777915 Cxcl10 1.7 3.4 1.7 
5 25004885 25007359 AC134910.1 -2.5 -0.8 1.7 
5 138293375 138299277 Pilrb1 -2.5 -0.8 1.7 
5 134680339 134680626 7SK.71 -0.3 1.4 1.7 
5 115795651 115798990 Cox6a1 0.0 1.7 1.7 
5 112171869 112177196 Gm16019 -0.3 1.3 1.6 
5 92416501 92419330 Gm1045 -1.3 0.2 1.6 
5 24694179 24694461 7SK.236 -2.3 -0.8 1.6 
5 60892072 60892179 U6.637 -2.3 -0.8 1.6 
5 120514344 120514452 n-R5s176 -2.3 -0.8 1.6 
5 135390119 135391396 Cldn13 1.3 2.7 1.4 
5 52765892 52766785 Gm447 -1.3 0.1 1.4 
5 67376330 67376880 Gm15949 -1.3 0.1 1.4 
5 122167675 122177412 Gm16552 1.0 2.4 1.4 
5 86508791 86508960 U1.39 -2.5 -1.1 1.4 
5 91322406 91322522 5S_rRNA.26 -2.5 -1.1 1.4 
5 117082917 117083471 AC156984.1 -2.5 -1.1 1.4 
5 138307057 138312986 Pilrb2 -2.5 -1.1 1.4 
5 31252439 31257464 Abhd1 1.7 3.1 1.4 
5 116762369 116768290 B230112J18Rik 1.7 3.0 1.4 
5 73548253 73549119 1700071G01Rik -0.7 0.6 1.4 
5 116755691 116759369 Gm13838 1.7 3.0 1.3 
5 31594628 31598250 Fndc4 1.8 3.2 1.3 
5 23839741 23843034 Gm15589 0.7 1.9 1.2 
5 110424530 110425417 AC123679.1 -1.3 -0.1 1.2 
5 10236829 10237461 Gm10482 -2.3 -1.1 1.2 
5 92731200 92731318 U6atac.21 -2.3 -1.1 1.2 
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5 139461462 139461950 AC117698.1 -2.3 -1.1 1.2 
5 145803859 145806547 1700018F24Rik -2.3 -1.1 1.2 
5 106243792 106248007 Gm15817 2.3 3.5 1.2 
5 31788232 31790849 4930548H24Rik 0.0 1.2 1.2 
5 144780673 144787539 Ocm 2.1 3.2 1.1 
5 73601348 73603873 RP23-318I19.1 2.7 3.8 1.1 
5 130384410 130387150 4930579G22Rik 0.7 1.8 1.1 
5 143664794 143668433 Actb 0.3 1.3 1.0 
5 33773665 33773844 Nkx1-1 -1.3 -0.3 1.0 
5 65527541 65527659 5S_rRNA.6 -1.3 -0.3 1.0 
5 149818538 149824352 Gm15408 2.4 3.5 1.0 
5 149632343 149640984 Gm15407 3.5 4.5 1.0 
6 144618947 144621240 Gm10396 -1.3 1.7 3.0 
6 27886655 27886750 Mir592 -2.5 0.2 2.7 
6 42861524 42862456 Olfr447 -2.3 0.4 2.7 
6 36371742 36371825 Mir490 -2.3 -0.1 2.2 
6 42694038 42694991 Olfr453 -1.3 0.8 2.1 
6 127268359 127270593 Gm10414 -1.3 0.7 2.0 
6 116490473 116491456 Olfr213 -2.3 -0.3 2.0 
6 42877232 42878158 Olfr446 -2.5 -0.5 2.0 
6 125208067 125208195 SNORA70.40 -2.5 -0.5 2.0 
6 89090999 89097347 Gm1965 0.3 2.2 1.9 
6 89090999 89097379 Gm1965 0.3 2.2 1.9 
6 136391504 136391634 AC124779.1 -1.3 0.6 1.9 
6 85815416 85819152 Cml2 -2.3 -0.5 1.8 
6 125071742 125071877 SCARNA11.2 -2.3 -0.5 1.8 
6 125141819 125145601 Mrpl51 -2.3 -0.5 1.8 
6 52127497 52130850 5730596B20Rik 1.0 2.7 1.7 
6 99525885 99526131 7SK.32 -2.5 -0.8 1.7 
6 121275598 121275694 AC153982.1 -2.5 -0.8 1.7 
6 43117009 43118026 Olfr437 -1.3 0.4 1.7 
6 89199462 89199596 5S_rRNA.9 -1.3 0.4 1.7 
6 116531956 116533049 Olfr215 0.8 2.5 1.7 
6 144672085 144673427 Gm7518 0.5 2.1 1.6 
6 42846452 42847384 Olfr448 -0.7 0.8 1.6 
6 70676429 70676751 Igk-C -0.7 0.8 1.6 
6 116506423 116507430 Olfr214 0.8 2.3 1.5 
6 91962388 91966111 4930466I24Rik 1.3 2.7 1.5 
6 119429686 119433904 Fbxl14 1.8 3.2 1.5 
6 117163674 117164066 AC155646.1 1.0 2.4 1.4 
6 30093801 30094127 7SK.7 0.8 2.3 1.4 
6 116715547 116715670 SNORA17.412 -1.3 0.1 1.4 
6 42436162 42437213 Olfr456 -2.5 -1.1 1.4 
6 69942459 69942971 Gm16689 -2.5 -1.1 1.4 
6 85710643 85715738 Cml3 -2.5 -1.1 1.4 
6 98508733 98508825 AC158665.1 -2.5 -1.1 1.4 
6 83028380 83030841 Pcgf1 1.0 2.4 1.4 
6 86315677 86320051 Fam136a 0.8 2.2 1.4 
6 51233531 51237854 Gm9953 1.4 2.7 1.3 
6 52212769 52217597 Gm15053 0.8 2.2 1.3 
6 40494035 40494976 Olfr461 -2.3 -1.1 1.2 
6 68784840 68785301 Gm16905 -2.3 -1.1 1.2 
6 71832551 71832687 SNORD94.1 -2.3 -1.1 1.2 
6 86474493 86476165 Pcbp1 -2.3 -1.1 1.2 
6 129588711 129593355 Klrc3 -2.3 -1.1 1.2 
6 112646771 112654662 Gm16598 1.6 2.7 1.2 
6 89161159 89166231 Gm839 0.8 2.0 1.2 
6 42767472 42768404 Olfr450 -0.7 0.4 1.1 
6 83621201 83627851 Cd207 2.0 3.1 1.1 
6 48879895 48883685 1600015I10Rik 2.5 3.6 1.1 
6 42350237 42351118 Tas2r143 0.0 1.1 1.1 
6 83391749 83398316 B230319C09Rik 1.0 2.1 1.1 
6 122576428 122580290 Dppa3 2.1 3.2 1.1 
6 24509557 24512070 AC153635.1 -0.3 0.7 1.0 
6 32461073 32465576 B230378P21Rik 0.7 1.7 1.0 
6 124665250 124665520 snoU89.1 -0.3 0.7 1.0 
7 111063576 111078425 Olfr631 -2.3 1.1 3.4 
7 69606757 69609396 Peg12 -0.7 2.6 3.4 
7 109818415 109819437 Olfr556 -2.5 0.2 2.7 
7 111232557 111233689 Olfr645 -1.3 1.4 2.7 
7 106883655 106884605 Olfr520 -2.3 0.2 2.6 
7 110640429 110641393 Olfr609 -2.3 0.2 2.6 
7 31484802 31485399 2200002J24Rik -2.3 0.1 2.4 
7 106628073 106628217 Snord15b -2.3 0.1 2.4 
7 111254795 111255733 Olfr646 -1.3 1.1 2.4 
7 112204762 112205700 Olfr677 -2.5 -0.1 2.4 
7 3218920 3219001 Mir291a -2.3 -0.1 2.2 
7 6432927 6433883 Olfr5 -2.3 -0.1 2.2 
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7 6296993 6300606 CAAA01104267.1.18771.1 -2.5 -0.3 2.2 
7 25507751 25511082 Gm4763 -2.5 -0.3 2.2 
7 15974297 16142195 Obox1 -2.3 -0.3 2.0 
7 51480807 51484987 Klk1 -2.3 -0.3 2.0 
7 112328827 112329914 Olfr685 -2.3 -0.3 2.0 
7 112351873 112352890 Olfr686 -2.3 -0.3 2.0 
7 110698882 110704018 Olfr613 -2.5 -0.5 2.0 
7 130153626 130154138 AC125221.1 -2.5 -0.5 2.0 
7 53967368 53971046 Saa3 -0.3 1.6 1.9 
7 110654511 110655458 Olfr610 -0.7 1.2 1.9 
7 109752870 109753823 Olfr552 -0.3 1.6 1.9 
7 16418595 16425028 Obox6 -0.3 1.5 1.8 
7 109788762 109789715 Olfr554 -0.3 1.5 1.8 
7 52436552 52437208 Pth2 -0.7 1.1 1.8 
7 111530579 111539100 Trim30c -2.3 -0.5 1.8 
7 111881956 111882876 Olfr664 -2.3 -0.5 1.8 
7 147347838 147348913 Olfr522 -1.3 0.5 1.8 
7 117771175 117773331 Adm 0.7 2.5 1.8 
7 4985720 4986848 4632433K11Rik -2.5 -0.8 1.7 
7 29868655 29868713 Mir1963 -2.5 -0.8 1.7 
7 51495118 51495405 7SK.186 -2.5 -0.8 1.7 
7 80790871 80790975 U6.362 -2.5 -0.8 1.7 
7 128850703 128851525 1700069B07Rik -2.5 -0.8 1.7 
7 51307660 51312075 Klk1b27 -1.3 0.4 1.7 
7 52308983 52318047 Prrg2 1.1 2.8 1.7 
7 110333317 110336055 Olfr592 -0.7 0.9 1.7 
7 110599853 110600812 Olfr606 -0.3 1.3 1.6 
7 147142904 147143938 Gm2044 -0.3 1.3 1.6 
7 103106725 103110123 Gm9966 -0.7 0.8 1.6 
7 112064828 112065808 Olfr667 -1.3 0.2 1.6 
7 19996973 19997621 AC118017.2 -2.3 -0.8 1.6 
7 35036057 35036512 Gm6096 -2.3 -0.8 1.6 
7 137178608 137178717 U6.369 -2.3 -0.8 1.6 
7 13533941 13547117 AC107704.2 2.6 4.2 1.5 
7 7154833 7162506 Zfp772 0.0 1.5 1.5 
7 20355960 20360752 Gm16733 1.6 3.0 1.5 
7 112885106 112891439 Ilk 0.3 1.7 1.5 
7 4916862 4922770 Gm1078 1.1 2.6 1.4 
7 31455741 31456610 4930479M11Rik -1.3 0.1 1.4 
7 54007203 54009684 Saa2 -1.3 0.1 1.4 
7 112955172 112959613 Mrpl17 -0.3 1.1 1.4 
7 80953108 80961389 Gm10619 1.0 2.4 1.4 
7 112516744 112517869 Olfr692 0.0 1.4 1.4 
7 109690452 109691384 Olfr548-ps1 -0.7 0.6 1.4 
7 147604741 147605670 Olfr532 -0.7 0.6 1.4 
7 49700832 49703450 4933421I07Rik -0.3 1.0 1.3 
7 133551964 133558384 Cd19 1.4 2.6 1.2 
7 148031464 148032667 Scgb1c1 1.4 2.6 1.2 
7 106700779 106700873 Mir326 -1.3 -0.1 1.2 
7 106915674 106916640 Olfr521 -0.3 0.9 1.2 
7 109846730 109847786 Olfr557 -1.3 -0.1 1.2 
7 5929764 5929844 AC026949.1 -2.3 -1.1 1.2 
7 53995871 53998350 Saa1 -2.3 -1.1 1.2 
7 93511886 93512845 Olfr305 -2.3 -1.1 1.2 
7 111160159 111161214 Olfr639 -2.3 -1.1 1.2 
7 112087042 112087995 Olfr669 -2.3 -1.1 1.2 
7 112217983 112218924 Olfr678 -2.3 -1.1 1.2 
7 114767485 114768675 5330417H12Rik -2.3 -1.1 1.2 
7 115209282 115210310 Olfr480 -2.3 -1.1 1.2 
7 125628628 125629997 Itpripl2 -2.3 -1.1 1.2 
7 19399286 19406956 Psg17 0.7 1.9 1.2 
7 50906440 50915531 Siglece 3.1 4.3 1.2 
7 110486526 110487575 Olfr599 0.0 1.2 1.2 
7 130605808 130611517 Aqp8 1.4 2.5 1.2 
7 30345534 30360497 4930432E11Rik 2.1 3.2 1.1 
7 103960943 103965995 Gm15416 -0.3 0.8 1.1 
7 119670486 119679197 A230071N21Rik 1.3 2.4 1.1 
7 109736255 109737333 Olfr551 0.5 1.6 1.1 
7 27716650 27724405 AC167659.1 -0.7 0.4 1.1 
7 111095082 111096020 Olfr633 0.3 1.4 1.1 
7 123834893 123834999 U6.670 -0.7 0.4 1.1 
7 148153120 148155724 Ifitm1 0.3 1.4 1.1 
7 134115234 134119612 D830044I16Rik 0.0 1.1 1.1 
7 148657759 148661031 Polr2l 0.8 1.9 1.1 
7 106626406 106632248 Rps3 1.6 2.6 1.1 
7 3218627 3218709 Mir290 -1.3 -0.3 1.0 
7 87065641 87067407 AC109221.2 -1.3 -0.3 1.0 
7 111791394 111795819 Olfr658 -0.3 0.7 1.0 
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7 112108306 112109244 Olfr670 -1.3 -0.3 1.0 
7 117201501 117204839 AA474408 -0.3 0.7 1.0 
7 3583716 3596489 Gm15927 2.9 4.0 1.0 
7 3581587 3594088 Prpf31 2.8 3.9 1.0 
7 31853191 31861723 Fxyd3 2.9 3.9 1.0 
7 134355122 134357812 Mylpf 1.6 2.6 1.0 
8 110075144 110075213 Mir140 -2.5 0.8 3.3 
8 123640071 123642792 Foxc2 0.3 3.0 2.8 
8 106875211 106876739 Gm9853 -0.3 2.1 2.4 
8 48804600 48804723 n-R5s96 -2.5 -0.1 2.4 
8 74198856 74200573 Gm9933 -0.7 1.3 2.0 
8 12356153 12356469 7SK.277 -2.3 -0.3 2.0 
8 26789422 26789743 7SK.147 0.0 2.0 2.0 
8 96702989 96704225 Mt1 0.0 2.0 2.0 
8 99036240 99037431 1700047G07Rik -2.5 -0.5 2.0 
8 124354336 124354442 U6.507 -2.5 -0.5 2.0 
8 47292151 47296638 Slc25a4 1.7 3.6 1.9 
8 37088807 37089190 Gm10063 -1.3 0.5 1.8 
8 3621575 3624227 2900053A13Rik 0.0 1.8 1.8 
8 97523005 97523118 SNORA7.1 -2.5 -0.8 1.7 
8 41908363 41912215 Adam39 -1.3 0.4 1.7 
8 47377404 47380025 Helt -1.3 0.2 1.6 
8 106845467 106845687 Gm11020 -1.3 0.2 1.6 
8 108139366 108139473 Mir1966 -1.3 0.2 1.6 
8 44285176 44285744 AC142104.1 -2.3 -0.8 1.6 
8 4253102 4256219 Snapc2 0.5 1.9 1.4 
8 74411163 74414811 Zfp709 -1.3 0.1 1.4 
8 4115513 4115765 7SK.54 -2.5 -1.1 1.4 
8 33587355 33587801 Gm5908 -2.5 -1.1 1.4 
8 74623661 74624605 Olfr373 -2.5 -1.1 1.4 
8 96903137 96910872 Gm15890 2.8 4.1 1.3 
8 109553575 109555088 Gm16208 0.0 1.3 1.3 
8 111772617 111774008 4922502B01Rik 0.0 1.3 1.3 
8 96661104 96662931 Mt4 1.6 2.9 1.3 
8 11477929 11480241 AC124475.1 1.7 3.0 1.3 
8 12672186 12679229 4931415C17Rik 1.6 2.8 1.2 
8 26742422 26742551 SNORA70.12 -0.7 0.5 1.2 
8 73988825 73989651 Mrpl34 -0.7 0.5 1.2 
8 13896311 13896631 Gm7676 -1.3 -0.1 1.2 
8 87574106 87574175 SNORD41.1 -1.3 -0.1 1.2 
8 22812991 22814117 AY761184 -2.3 -1.1 1.2 
8 90698459 90698927 9430002A10Rik -2.3 -1.1 1.2 
8 109963051 109963463 Rps26-ps1 -2.3 -1.1 1.2 
8 13405081 13421945 Grk1 4.8 6.0 1.2 
8 35112316 35120100 Gm9951 2.8 4.0 1.2 
8 48794698 48799285 Cdkn2aip 1.8 2.9 1.2 
8 63462234 63464705 B230317F23Rik -0.3 0.8 1.1 
8 12706944 12719127 Gm15348 3.6 4.7 1.1 
8 67505550 67511545 Trim75 2.5 3.6 1.1 
8 35178084 35188239 Mboat4 3.6 4.7 1.1 
8 97846914 97849163 Zfp319 0.5 1.6 1.1 
8 42125110 42127407 Gm16192 1.5 2.6 1.1 
8 86064992 86066087 Olfr370 2.2 3.3 1.1 
8 112514337 112523703 Tat 4.0 5.1 1.1 
8 10924427 10928457 3930402G23Rik 2.0 3.0 1.0 
8 11838978 11840400 Gm15875 0.3 1.3 1.0 
8 3655770 3660110 Retn 1.5 2.5 1.0 
8 22083372 22084427 AY761185 -1.3 -0.3 1.0 
8 25548088 25549418 1810011O10Rik -1.3 -0.3 1.0 
8 3665762 3668905 1810033B17Rik 2.0 3.0 1.0 
8 12278819 12280657 A230072I06Rik 0.0 1.0 1.0 
9 118833991 118834895 Gm16295 -2.3 0.8 3.1 
9 39757422 39758354 Olfr975 -1.3 1.1 2.4 
9 57965622 57966796 Gm16131 -2.3 0.1 2.4 
9 88979462 88987673 Gm11058 -2.3 0.1 2.4 
9 58993481 58994017 Gm7589 -2.3 -0.1 2.2 
9 120038469 120038671 SNORA73.1 -2.5 -0.3 2.2 
9 44981080 44983244 RP23-284E19.7 -0.3 1.8 2.1 
9 110907315 110909334 Gm10030 -0.7 1.2 2.0 
9 20611478 20611798 7SK.80 -2.5 -0.5 2.0 
9 39972215 39972544 Gm4893 -2.5 -0.5 2.0 
9 107576808 107581923 Gnat1 2.7 4.6 1.9 
9 28005472 28007106 Gm15606 -1.3 0.5 1.8 
9 48855737 48856390 AC160137.1 -0.7 1.1 1.8 
9 86597857 86597984 SNORA17.577 -2.3 -0.5 1.8 
9 108888208 108889209 Ucn2 -2.3 -0.5 1.8 
9 109173350 109190190 Fbxw14 -2.3 -0.5 1.8 
9 111516402 111516519 n-R5s90 -2.3 -0.5 1.8 
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9 19122980 19123909 Olfr844 -2.5 -0.8 1.7 
9 38635200 38636267 Olfr923 -2.5 -0.8 1.7 
9 39526814 39527752 Olfr965 -2.5 -0.8 1.7 
9 78169106 78170164 AC138587.2 -2.5 -0.8 1.7 
9 81524950 81526222 Htr1b 1.9 3.6 1.7 
9 69324836 69327405 Gm16144 1.3 2.9 1.7 
9 123891782 123893241 Ccr1l1 -0.7 0.9 1.7 
9 106783260 106784620 Rbm15b -2.3 -0.8 1.6 
9 30888202 30890060 CT025653.1 0.5 2.0 1.6 
9 107886557 107888247 6230427J02Rik 1.7 3.2 1.5 
9 107465586 107468439 Tusc2 1.7 3.1 1.5 
9 39908129 39909073 Olfr984 0.0 1.4 1.4 
9 119068279 119070787 Gm10608 0.0 1.4 1.4 
9 78159779 78162604 Omt2a -1.3 0.1 1.4 
9 89989016 89990740 AC140392.1 -1.3 0.1 1.4 
9 53683583 53683959 Gm11147 -2.5 -1.1 1.4 
9 110887449 110892217 Rtp3 0.7 2.0 1.4 
9 81525158 81538763 D430036J16Rik 2.4 3.7 1.3 
9 109730457 109735220 3000002C10Rik -0.7 0.5 1.2 
9 111147096 111147371 7SK.260 -0.7 0.5 1.2 
9 21760197 21762714 2310047B19Rik -1.3 -0.1 1.2 
9 106056455 106056544 Mir135a-1 -1.3 -0.1 1.2 
9 39807791 39808835 Olfr979 -2.3 -1.1 1.2 
9 53448082 53448210 SNORA61.1 -2.3 -1.1 1.2 
9 60267670 60267792 SNORA17.443 -2.3 -1.1 1.2 
9 64023230 64023328 Snord16a -2.3 -1.1 1.2 
9 116134326 116134401 AC131777.1 -2.3 -1.1 1.2 
9 123544506 123546443 RP24-298N7.5 -2.3 -1.1 1.2 
9 124016689 124028296 Ccr2 -2.3 -1.1 1.2 
9 56454500 56462278 Gm16960 3.3 4.5 1.2 
9 69879303 69885895 Gcnt3 1.9 3.1 1.2 
9 24429629 24430271 Cypt4 -0.3 0.8 1.1 
9 20695201 20695280 snoU105B.1 -0.7 0.4 1.1 
9 112085316 112088238 AC100550.1 -0.7 0.4 1.1 
9 110842114 110848662 Tdgf1 2.4 3.5 1.1 
9 109334833 109351654 Fbxw16 1.5 2.6 1.1 
9 44777655 44788514 Cd3g 1.8 2.8 1.1 
9 58336770 58337735 CT030640.1 -1.3 -0.3 1.0 
9 71908720 71909406 Rpl15-ps2 -1.3 -0.3 1.0 
9 36339988 36349548 Gm5615 0.0 1.0 1.0 
9 56995987 56999744 Gm16493 0.0 1.0 1.0 
9 32122368 32151822 Kcnj5 4.1 5.1 1.0 
10 117099338 117099444 U6.213 -2.3 0.9 3.2 
10 117641998 117647098 Il22 0.5 3.7 3.2 
10 116724852 116729924 Lyz1 1.4 4.4 3.0 
10 117170735 117183414 Slc35e3 5.2 8.2 3.0 
10 117726685 117732094 AC158600.1 0.3 3.2 3.0 
10 117578843 117606053 Mdm1 6.3 9.2 2.9 
10 117066556 117124408 Cpm 7.2 10.1 2.9 
10 117878103 117882948 Ifng 2.6 5.4 2.8 
10 117187680 117229761 Nup107 7.4 10.0 2.6 
10 116669293 116675759 9530003J23Rik 4.1 6.6 2.6 
10 22057446 22057528 AC159330.1 -2.3 0.2 2.6 
10 127100895 127102540 Gm16229 0.0 2.5 2.5 
10 116683788 116685202 Gm10936 -0.3 2.1 2.4 
10 117251527 117282991 Rap1b 5.7 8.1 2.4 
10 93378914 93379081 SNORA73.10 -2.5 -0.1 2.4 
10 117125944 117147814 Mdm2 5.3 7.7 2.4 
10 116652198 116661563 Yeats4 5.9 8.2 2.4 
10 116714390 116719377 Lyz2 1.6 3.9 2.3 
10 116781724 116814029 Cpsf6 5.1 7.0 1.9 
10 77832758 77833065 7SK.19 -2.5 -0.8 1.7 
10 85270560 85271990 AC122408.1 -1.3 0.2 1.6 
10 30662185 30662291 U6.221 -2.3 -0.8 1.6 
10 95135625 95136085 Gm6843 -2.3 -0.8 1.6 
10 77888415 77890364 Cstb -0.7 0.5 1.2 
10 116407374 116409665 Gm10271 0.0 1.2 1.2 
10 69746983 69747701 Gm7097 1.7 2.7 1.1 
11 102977639 102981039 Hexim1 -1.3 1.8 3.1 
11 87702461 87703396 Olfr462 -2.3 0.6 2.9 
11 94638531 94644017 Tmem92-ps -2.3 0.6 2.9 
11 97022304 97022989 Gm11583 -2.5 0.4 2.8 
11 20731484 20731922 Gm12037 -2.3 0.5 2.8 
11 72153872 72154142 7SK.224 -2.3 0.5 2.8 
11 12548080 12548279 AL645934.1 -2.5 0.2 2.7 
11 83476086 83478185 Ccl4 -2.3 0.4 2.7 
11 107855336 107855945 Gm11657 -2.3 0.4 2.7 
11 87911560 87913610 2210416O15Rik -2.3 0.2 2.6 
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11 75275041 75280178 2210403K04Rik 0.0 2.3 2.3 
11 98485665 98486975 Gm12355 -2.3 -0.1 2.2 
11 58141223 58143841 Gm9900 -2.3 -0.3 2.0 
11 73201583 73205716 Olfr377-ps1 -2.3 -0.3 2.0 
11 120326180 120328921 Arl16 -0.7 1.2 2.0 
11 101139282 101140428 Ccdc56 -1.3 0.6 1.9 
11 115277003 115281276 Atp5h -0.3 1.5 1.8 
11 53514681 53514990 7SK.11 -2.3 -0.5 1.8 
11 69208989 69210182 Lsmd1 -2.3 -0.5 1.8 
11 82577847 82581124 Zfp830 -2.3 -0.5 1.8 
11 96038865 96040114 Gm11535 -1.3 0.5 1.8 
11 109298486 109299459 Gm15642 -2.3 -0.5 1.8 
11 35163571 35164287 Gm12122 -2.5 -0.8 1.7 
11 49106799 49107816 Olfr1392 -2.5 -0.8 1.7 
11 99475331 99476160 Krtap2-4 -2.5 -0.8 1.7 
11 97702094 97705413 B230217C12Rik 0.0 1.6 1.6 
11 4185463 4186942 Gm11958 -1.3 0.2 1.6 
11 69476545 69476627 Mir1934 -1.3 0.2 1.6 
11 97141442 97144211 Gm11592 -1.3 0.2 1.6 
11 106047758 106047901 U1.180 -2.3 -0.8 1.6 
11 116535107 116535178 snoR38.2 -2.3 -0.8 1.6 
11 70327018 70328118 Vmo1 1.8 3.3 1.5 
11 58259651 58266425 4930504O13Rik 1.7 3.2 1.5 
11 48973518 48974456 Olfr1394 0.3 1.8 1.5 
11 97702607 97705413 B230217C12Rik -0.3 1.2 1.5 
11 49154036 49154971 Olfr1390 -0.7 0.7 1.5 
11 70465352 70468146 Pfn1 -0.7 0.7 1.5 
11 119081474 119083787 Gm11752 1.3 2.7 1.5 
11 16851378 16854775 Fbxo48 -1.3 0.1 1.4 
11 53235683 53236672 Leap2 -1.3 0.1 1.4 
11 73934793 73935740 Olfr401 -1.3 0.1 1.4 
11 113064629 113070983 4732490B19Rik 2.2 3.6 1.4 
11 83658167 83658474 7SK.60 -2.5 -1.1 1.4 
11 87507984 87508083 U6.596 -2.5 -1.1 1.4 
11 96711707 96711779 Mir152 -2.5 -1.1 1.4 
11 120207004 120209856 Actg1 -2.5 -1.1 1.4 
11 54060773 54063169 Csf2 0.5 1.8 1.3 
11 101471928 101477270 Gm11635 1.9 3.3 1.3 
11 58234613 58239526 1810065E05Rik 1.6 2.9 1.3 
11 44399819 44404731 4930597A21Rik 0.7 1.9 1.2 
11 49257355 49258290 Olfr1388 0.3 1.5 1.2 
11 96064768 96066699 Gm11538 -0.7 0.5 1.2 
11 99248654 99249211 Gm11940 -0.7 0.5 1.2 
11 115114592 115114699 AL603828.1 -0.7 0.5 1.2 
11 67594445 67598816 Gm12302 -1.3 -0.1 1.2 
11 3434241 3434910 Gm11947 -2.3 -1.1 1.2 
11 33595894 33597908 Gm12119 -2.3 -1.1 1.2 
11 50324404 50324679 7SK.300 -2.3 -1.1 1.2 
11 51938032 51941281 AL935177.1 0.5 1.7 1.2 
11 65439896 65440005 U6.227 -2.3 -1.1 1.2 
11 71836257 71836359 U6atac.16 -2.3 -1.1 1.2 
11 75236233 75236842 Gm12336 -2.3 -1.1 1.2 
11 98807758 98807864 U6.37 -2.3 -1.1 1.2 
11 117275703 117276682 Gm11729 -2.3 -1.1 1.2 
11 120957955 120958521 Gm11791 1.0 2.2 1.2 
11 58246061 58255124 Gm12253 0.8 2.0 1.2 
11 110927478 110938135 Kcnj2 2.2 3.4 1.2 
11 97945771 97946738 Gm11632 0.5 1.7 1.2 
11 69413238 69419444 Atp1b2 2.8 4.0 1.2 
11 84642680 84644370 4930502E09Rik 0.0 1.2 1.2 
11 58303221 58304255 Olfr332 1.0 2.2 1.2 
11 73797164 73803561 Olfr398 1.8 2.9 1.2 
11 100107405 100110276 Krt16 -0.3 0.8 1.1 
11 120459735 120469512 Anapc11 2.5 3.7 1.1 
11 69943831 69951052 Mgl2 1.8 2.9 1.1 
11 84331479 84338923 Lhx1 3.7 4.8 1.1 
11 121282715 121292602 Fn3krp 1.9 3.0 1.1 
11 58599641 58600771 Olfr314 2.1 3.2 1.1 
11 96055630 96058761 Hoxb13 1.6 2.7 1.1 
11 85660292 85663835 Gm11444 2.5 3.6 1.1 
11 6531490 6538652 Wap 2.4 3.5 1.1 
11 101902823 101916934 Cd300lg 4.3 5.3 1.1 
11 67611689 67629507 Dhrs7c 3.3 4.4 1.1 
11 51498888 51502376 0610009B22Rik 1.6 2.6 1.1 
11 87514898 87518833 1110028F11Rik 1.6 2.6 1.1 
11 107271704 107274863 Gm11713 1.6 2.6 1.1 
11 101848370 101853570 1700006E09Rik 1.3 2.3 1.0 
11 23458058 23458842 Gm12060 -1.3 -0.3 1.0 
              220
11 49243929 49245001 Olfr1389 -0.3 0.7 1.0 
11 49477112 49478620 Scgb3a1 -0.3 0.7 1.0 
11 81915347 81916902 Ccl12 -1.3 -0.3 1.0 
11 83560442 83566144 1100001G20Rik -0.3 0.7 1.0 
11 87570366 87570429 Mir142 -0.3 0.7 1.0 
11 69496348 69499286 Tnfsf13 1.4 2.4 1.0 
11 68735337 68740583 Odf4 1.1 2.2 1.0 
11 83251188 83254734 1700020L24Rik 1.1 2.2 1.0 
11 33863013 33873641 Kcnmb1 2.4 3.5 1.0 
11 5815318 5816734 Gm11967 0.5 1.5 1.0 
11 35894166 35897356 Gm12126 1.0 2.0 1.0 
11 69435526 69437372 Sat2 1.0 2.0 1.0 
11 97884269 97888059 Gm11629 0.0 1.0 1.0 
12 110948385 110948480 Mir411 -2.3 1.1 3.4 
12 34613290 34614175 Ferd3l -1.3 1.7 3.0 
12 87059427 87059545 n-R5s64 -2.5 -0.1 2.4 
12 110950527 110950646 Mir1197 -1.3 0.9 2.2 
12 110965032 110965106 Mir381 -2.3 -0.1 2.2 
12 28025562 28027574 Sox11 0.8 2.7 1.9 
12 70258709 70260173 Rps29 -2.3 -0.5 1.8 
12 104966366 104976368 Serpina1b -1.3 0.5 1.8 
12 110956957 110957036 Mir495 -2.3 -0.5 1.8 
12 9581248 9588305 Osr1 2.9 4.7 1.8 
12 110844667 110844743 SNORD112.1 -2.5 -0.8 1.7 
12 33039750 33040067 7SK.8 -0.3 1.4 1.7 
12 89591799 89592682 CT485612.1 -0.7 0.9 1.7 
12 77893322 77896541 Gpx2 -0.3 1.3 1.6 
12 33063569 33067808 RP24-143P3.1 -2.3 -0.8 1.6 
12 110977329 110977407 Mir496 -2.3 -0.8 1.6 
12 110978720 110978787 Mir377 -2.3 -0.8 1.6 
12 114131774 114133577 AC160929.2 1.0 2.5 1.5 
12 102383824 102387492 AC122507.1 0.3 1.8 1.5 
12 110981925 110982005 Mir410 -0.7 0.7 1.5 
12 75416096 75417381 Gm11042 -1.3 0.1 1.4 
12 87818328 87818415 AC132189.1 -2.5 -1.1 1.4 
12 114812453 114812892 AC090887.2 -2.5 -1.1 1.4 
12 11228267 11229016 1700034J04Rik 0.5 1.8 1.3 
12 70285145 70287759 Mgat2 -0.3 0.9 1.2 
12 105366206 105377755 Serpina3b 0.0 1.2 1.2 
12 105501332 105507582 Serpina3i -1.3 -0.1 1.2 
12 110832716 110832809 Mir434 -1.3 -0.1 1.2 
12 58733565 58734002 Rpl26-ps2 -2.3 -1.1 1.2 
12 105091799 105104137 Serpina1a -2.3 -1.1 1.2 
12 106414568 106419353 Tcl1b5 -2.3 -1.1 1.2 
12 114184574 114188723 AC160929.1 2.3 3.4 1.1 
12 82046491 82051494 Srsf5 1.9 3.0 1.1 
12 108192022 108194138 Gm16087 1.3 2.3 1.0 
12 88221653 88225764 6430527G18Rik -1.3 -0.3 1.0 
12 106269285 106269559 Scarna13 -0.3 0.7 1.0 
12 110947270 110947335 Mir379 -1.3 -0.3 1.0 
12 81787357 81793453 0610009B14Rik 2.3 3.4 1.0 
12 104645032 104646030 9330161L09Rik 1.1 2.2 1.0 
12 114509391 114511457 Gm900 1.0 2.0 1.0 
12 114509484 114511358 Gm900 1.0 2.0 1.0 
13 63478069 63482353 Gm16132 -2.5 0.1 2.6 
13 99754045 99754520 1700024P04Rik -2.3 -0.3 2.0 
13 96100555 96100692 Snora47 -1.3 0.6 1.9 
13 78328234 78339237 Nr2f1 3.0 4.9 1.9 
13 34218877 34222223 Tubb2b -0.7 1.1 1.8 
13 60630657 60630770 AC123619.1 -2.3 -0.5 1.8 
13 112383634 112383833 Gm10736 -2.3 -0.5 1.8 
13 93344586 93346187 Spz1 1.5 3.3 1.8 
13 14179706 14179812 U6.86 -2.5 -0.8 1.7 
13 49809488 49809609 SNORA24.6 -2.5 -0.8 1.7 
13 25029270 25033286 9330162012Rik 1.3 2.9 1.7 
13 23519844 23522891 C230035I16Rik -0.7 0.8 1.6 
13 74145600 74146802 Gm15912 -1.3 0.2 1.6 
13 84544444 84545077 AC155294.1 -1.3 0.2 1.6 
13 4613426 4613908 Rpl29-ps2 -2.3 -0.8 1.6 
13 24578531 24578633 U6.899 -2.3 -0.8 1.6 
13 53621072 53621428 Gm5449 -2.3 -0.8 1.6 
13 9622626 9622873 7SK.175 -1.3 0.1 1.4 
13 27404496 27411121 Prl6a1 -1.3 0.1 1.4 
13 49588687 49591945 Tes3-ps -1.3 0.1 1.4 
13 22106337 22107239 Gm11290 0.3 1.6 1.3 
13 41896152 41897164 1700061E18Rik -1.3 -0.1 1.2 
13 54500453 54500695 Gm16248 0.0 1.2 1.2 
13 67001557 67006286 Uqcrb -1.3 -0.1 1.2 
              221
13 67461607 67462325 RP24-242F4.3 -1.3 -0.1 1.2 
13 12681832 12682058 SNORA73.5 -2.3 -1.1 1.2 
13 24428139 24429212 Gm11342 -2.3 -1.1 1.2 
13 31066073 31067845 Gm5447 -2.3 -1.1 1.2 
13 62441548 62441628 CT573034.2 -2.3 -1.1 1.2 
13 30032152 30034130 Gm11365 2.1 3.3 1.2 
13 23898862 23917049 Slc17a2 2.6 3.8 1.2 
13 23370219 23374136 4933404K08Rik 0.5 1.7 1.2 
13 55028124 55031566 4930526F13Rik 0.5 1.7 1.2 
13 112045221 112047957 Actbl2 2.3 3.5 1.2 
13 94395337 94398588 Gm15622 0.3 1.4 1.2 
13 48367785 48369253 A330048O09Rik -0.3 0.8 1.1 
13 33341481 33352715 Serpinb9e -0.7 0.4 1.1 
13 62318904 62319329 Gm10260 -0.7 0.4 1.1 
13 67005850 67010102 Gm10767 -1.3 -0.3 1.0 
13 22118568 22124065 Gm11292 1.4 2.4 1.0 
13 101185514 101185929 Gm9858 0.5 1.5 1.0 
13 29034917 29043540 AL606528.1 1.6 2.6 1.0 
14 54464909 54465501 Gm13893 -2.5 0.7 3.2 
14 96280485 96281994 4921530L21Rik -1.3 1.8 3.1 
14 56636801 56639228 Mcpt1 -2.5 0.5 3.0 
14 55567897 55567979 Mir208a -2.3 0.4 2.7 
14 23377304 23377675 Gm5670 -2.3 0.2 2.6 
14 62226319 62230753 Kcnrg -2.3 0.2 2.6 
14 78710956 78711107 Mir2145-2 -2.5 0.1 2.6 
14 121148574 121149193 AC125405.1 -2.5 -0.1 2.4 
14 32350143 32350444 7SK.278 -2.3 -0.1 2.2 
14 42660348 42904201 Gm7995 -1.3 0.8 2.1 
14 27813548 27815492 Hesx1 -0.7 1.3 2.0 
14 44534734 44540745 Ang5 -2.5 -0.5 2.0 
14 53029564 53030602 Olfr1510 -2.5 -0.5 2.0 
14 54450780 54451501 Gm13894 -2.5 -0.5 2.0 
14 54837511 54837576 Tcra-J -2.5 -0.5 2.0 
14 54741901 54741916 Gm16622 -2.3 -0.5 1.8 
14 54781665 54781718 CT030634.5 -2.3 -0.5 1.8 
14 56775419 56778416 Gzmg -0.3 1.4 1.8 
14 54768337 54768876 Gm6683 0.3 2.0 1.7 
14 67556202 67557573 4930578I07Rik 0.3 2.0 1.7 
14 49272174 49272277 U6.587 -2.5 -0.8 1.7 
14 51669126 51669838 Rnase11 -2.5 -0.8 1.7 
14 51734240 51737466 Eddm3b -2.5 -0.8 1.7 
14 54799637 54799699 Gm16669 -2.5 -0.8 1.7 
14 54811336 54811400 Gm16820 -2.5 -0.8 1.7 
14 70828303 70828404 U11.5 -2.5 -0.8 1.7 
14 105676096 105676203 U6.111 -2.5 -0.8 1.7 
14 56269019 56271376 Tssk4 1.6 3.2 1.6 
14 52991785 52992726 Olfr1512 0.3 1.9 1.6 
14 54495659 54496426 Gm13892 -0.7 0.8 1.6 
14 53009490 53010446 Olfr1511 -2.3 -0.8 1.6 
14 54794417 54794473 Gm16925 -2.3 -0.8 1.6 
14 51874941 51875787 Ear11 1.0 2.5 1.5 
14 12060066 12060506 Rpl21-ps4 -1.3 0.1 1.4 
14 51815161 51815598 Ang2 -1.3 0.1 1.4 
14 63616939 63619903 Defb47 1.0 2.4 1.4 
14 44579329 44584083 Ang6 -2.5 -1.1 1.4 
14 54781114 54781176 CT030634.4 -2.5 -1.1 1.4 
14 27208685 27215007 Gm16241 1.5 2.8 1.4 
14 55840844 55860272 Dhrs2 3.1 4.5 1.4 
14 41945071 41949741 Sftpa1 1.0 2.3 1.3 
14 29321260 29324578 CT025649.1 2.8 4.1 1.3 
14 53070068 53071077 Olfr1509 0.0 1.3 1.3 
14 56206278 56209950 Psme2 0.7 2.0 1.3 
14 47380216 47391200 Cdkn3 2.1 3.3 1.3 
14 21522249 21523639 Chchd1 -0.3 0.9 1.2 
14 52968778 52969719 Olfr1513 -0.3 0.9 1.2 
14 56039106 56039561 Gm8894 -1.3 -0.1 1.2 
14 56678581 56681147 Mcpt4 -1.3 -0.1 1.2 
14 109091411 109091860 Rpl27a-ps2 -1.3 -0.1 1.2 
14 54832363 54832424 Gm16920 -2.3 -1.1 1.2 
14 115443527 115443613 Mir19b-1 -2.3 -1.1 1.2 
14 35183460 35187975 Sncg 2.9 4.1 1.2 
14 9498904 9505892 4930455B14Rik 1.5 2.7 1.2 
14 60705908 60714930 4930563I02Rik 2.1 3.3 1.2 
14 45607870 45623495 Ptger2 2.8 4.0 1.2 
14 20894868 20902394 1810063B07Rik 2.3 3.4 1.1 
14 49277354 49287319 Otx2 2.3 3.4 1.1 
14 37891036 37911497 Cdhr1 3.3 4.4 1.1 
14 25728900 25732926 Gm10398 -0.3 0.7 1.0 
              222
14 33106110 33108160 RP24-84D8.2 -1.3 -0.3 1.0 
14 115442893 115442976 Mir17 -0.3 0.7 1.0 
14 75536077 75536719 Gm15628 1.0 2.0 1.0 
14 9046662 9056081 Kctd6 3.3 4.3 1.0 
14 49922981 49933884 Slc35f4 1.5 2.5 1.0 
14 56295455 56300654 Tinf2 2.5 3.5 1.0 
14 18717322 18717647 7SK.70 1.0 2.0 1.0 
14 51764677 51766442 Rnase1 0.0 1.0 1.0 
14 55657299 55661816 Gm10364 0.0 1.0 1.0 
14 109309208 109313456 Slitrk1 2.0 3.0 1.0 
14 115443073 115443168 Mir18 0.0 1.0 1.0 
15 98143020 98143979 Olfr285 -2.3 1.4 3.7 
15 79501291 79503292 Tomm22 -2.3 0.5 2.8 
15 58678133 58678876 Gm5959 -0.3 2.2 2.5 
15 84947259 84947720 Gm10923 -2.5 -0.1 2.4 
15 97900183 97900311 SNORA17.406 -2.3 -0.1 2.2 
15 38172915 38174731 AC122459.2 0.5 2.6 2.1 
15 74643884 74649245 Gml -1.3 0.7 2.0 
15 100446069 100451184 Dazap2 -0.3 1.7 2.0 
15 60650551 60656635 Fam84b 1.8 3.8 2.0 
15 60654520 60663348 9930014A18Rik 1.7 3.6 1.9 
15 98057106 98058074 Olfr286 -0.7 1.1 1.8 
15 75866889 75867046 U1.201 -2.5 -0.8 1.7 
15 98267901 98268828 Olfr282 2.1 3.8 1.7 
15 33334727 33335731 1700084J12Rik 0.0 1.7 1.7 
15 31123960 31124093 SNORA17.166 -2.3 -0.8 1.6 
15 74875447 74879260 Ly6c1 -2.3 -0.8 1.6 
15 77452631 77456620 AL592187.1 -2.3 -0.8 1.6 
15 97765716 97766026 7SK.276 -2.3 -0.8 1.6 
15 37172158 37172917 Gm16137 1.4 2.9 1.5 
15 99556049 99558567 2310016M24Rik 1.0 2.5 1.5 
15 98708209 98711835 Rhebl1 2.4 3.8 1.5 
15 78742396 78744090 1700027A07Rik 1.4 2.8 1.4 
15 79908211 79913836 Rpl3 0.3 1.7 1.4 
15 74987123 74989169 Ly6g -2.5 -1.1 1.4 
15 79522932 79523055 n-R5s40 -2.5 -1.1 1.4 
15 74573269 74577117 2300005B03Rik 0.7 2.0 1.4 
15 54143516 54143920 Gm5215 -0.7 0.6 1.4 
15 58765365 58771044 Ndufb9 2.5 3.8 1.3 
15 95654890 95660503 Gm10970 2.8 4.0 1.2 
15 85980014 85980281 7SK.172 -0.7 0.5 1.2 
15 59042458 59043338 Gm5045 -1.3 -0.1 1.2 
15 74825308 74828064 Ly6a -1.3 -0.1 1.2 
15 76551896 76554275 C030006K11Rik 0.8 2.1 1.2 
15 36135015 36135077 U6.662 -2.3 -1.1 1.2 
15 73559594 73559720 U4.20 -2.3 -1.1 1.2 
15 76778969 76781159 1110038F14Rik 1.0 2.2 1.2 
15 86016158 86017582 Gm15569 -2.3 -1.1 1.2 
15 94817438 94817569 SNORA17.154 -2.3 -1.1 1.2 
15 98761856 98764996 Tuba1b -2.3 -1.1 1.2 
15 99198460 99198566 U6.114 -2.3 -1.1 1.2 
15 85645106 85652163 Pkdrej 4.2 5.5 1.2 
15 100504856 100518351 Cela1 4.6 5.7 1.2 
15 89350527 89354108 Gm15609 2.4 3.6 1.2 
15 63689826 63700852 Gsdmc3 -0.3 0.8 1.1 
15 80091044 80094736 Rps19bp1 1.7 2.8 1.1 
15 82385538 82389843 Cyp2d12 -0.3 0.8 1.1 
15 98816396 98819712 4930578M01Rik 1.3 2.4 1.1 
15 75447109 75455730 Zfp41 3.5 4.6 1.1 
15 31520555 31531602 Cct5 3.4 4.5 1.1 
15 102493299 102501478 Atp5g2 1.8 2.8 1.1 
15 31370965 31383444 Ropn1l 3.7 4.7 1.1 
15 95882047 95909984 D030018L15Rik 5.3 6.3 1.1 
15 98310831 98313114 Lalba 1.1 2.2 1.1 
15 102953501 102977259 D930007P13Rik 3.3 4.4 1.0 
15 76168038 76168835 Rps6-ps1 -1.3 -0.3 1.0 
15 82620537 82624675 Cyp2d26 3.1 4.2 1.0 
15 82219584 82224452 Cyp2d11 0.5 1.5 1.0 
15 99005281 99005368 7SK.118 0.0 1.0 1.0 
16 96367083 96369191 Gm15317 -2.5 0.4 2.8 
16 10783901 10785629 Socs1 -0.7 2.0 2.7 
16 31427962 31428377 Gm15743 -2.3 0.4 2.7 
16 17139768 17140576 Gm15646 -1.3 1.1 2.4 
16 17711761 17712198 Rpl26-ps4 -2.5 -0.1 2.4 
16 17980514 17981366 Vpreb2 -2.3 -0.1 2.2 
16 38442943 38443349 CT571259.2 -2.3 -0.1 2.2 
16 77599181 77599245 Mir99a -2.3 -0.1 2.2 
16 88877758 88878283 Krtap16-5 -2.3 -0.1 2.2 
              223
16 23423495 23423808 7SK.13 -2.5 -0.3 2.2 
16 59035606 59039575 Olfr187 -2.5 -0.3 2.2 
16 4229230 4231206 Gm5766 -1.3 0.8 2.1 
16 13453933 13454019 Mir365-1 -2.3 -0.3 2.0 
16 8449591 8449879 7SK.16 -2.5 -0.5 2.0 
16 81261948 81262260 7SK.61 -1.3 0.6 1.9 
16 35234882 35235009 U4.25 -2.3 -0.5 1.8 
16 5324129 5324250 n-R5s30 -2.5 -0.8 1.7 
16 8996178 8996459 AC165274.1 -1.3 0.4 1.7 
16 3838975 3839913 Olfr15 1.1 2.7 1.6 
16 18355709 18355856 U1.190 -1.3 0.2 1.6 
16 30064470 30067882 Hes1 -1.3 0.2 1.6 
16 13531521 13531644 SNORA17.179 -2.3 -0.8 1.6 
16 14316167 14317378 Gm15869 -2.3 -0.8 1.6 
16 32108951 32113829 Gm15729 1.1 2.7 1.6 
16 32186278 32186976 Bex6 -2.3 -0.8 1.6 
16 16868495 16870936 Vpreb1 -0.7 0.7 1.5 
16 36359468 36367834 BC100530 -1.3 0.1 1.4 
16 36367156 36387492 Gm15845 -1.3 0.1 1.4 
16 90554409 90555129 1110008E08Rik -1.3 0.1 1.4 
16 18240810 18240935 SNORA77.1 -2.5 -1.1 1.4 
16 33001989 33002107 n-R5s33 -2.5 -1.1 1.4 
16 88924295 88924462 Gm9829 -2.5 -1.1 1.4 
16 11313905 11320167 Tnfrsf17 2.4 3.8 1.4 
16 33056539 33060275 Rpl35a 0.7 2.0 1.3 
16 50589972 50591267 Ccdc54 -0.7 0.5 1.2 
16 16048958 16049433 Gm10121 -1.3 -0.1 1.2 
16 20604525 20604609 Mir1224 -1.3 -0.1 1.2 
16 58404991 58408389 4930461C15Rik 0.0 1.2 1.2 
16 48872721 48874611 Retnlg -2.3 -1.1 1.2 
16 48283848 48294405 Dppa4 1.8 3.1 1.2 
16 5211921 5222392 AU021092 2.7 3.9 1.2 
16 3707215 3718124 Mefv 1.6 2.8 1.2 
16 96122005 96123335 Gm15340 0.5 1.7 1.2 
16 48816969 48819004 Retnlb 0.0 1.2 1.2 
16 8766262 8766369 U6.574 -0.3 0.8 1.1 
16 91677513 91689010 Donson 2.7 3.8 1.1 
16 23889667 23890930 Sst -0.7 0.4 1.1 
16 88896213 88896695 Krtap8-2 -0.7 0.4 1.1 
16 96027636 96029924 2810404F17Rik 1.1 2.2 1.1 
16 89570421 89571428 AC140433.1 1.7 2.7 1.1 
16 92319008 92321686 4930563D23Rik 2.8 3.8 1.1 
16 89403272 89404019 Krtap16-7 -0.3 0.7 1.0 
16 24391698 24393674 AC116484.1 1.0 2.0 1.0 
16 4941420 4964330 Anks3 4.3 5.3 1.0 
16 22918455 22939839 Fetub 3.7 4.7 1.0 
16 32400592 32408313 Tm4sf19 3.1 4.1 1.0 
16 88506052 88507223 Cldn17 1.5 2.5 1.0 
16 91320697 91329240 Gm15966 3.2 4.2 1.0 
16 14311934 14314107 Gm15868 0.0 1.0 1.0 
16 89507949 89508568 Krtap7-1 0.0 1.0 1.0 
17 35302064 35304124 CR974444.1 -2.5 1.2 3.6 
17 15080189 15082944 1600012H06Rik -1.3 1.2 2.6 
17 7047683 7047764 AC125143.1 -2.3 0.2 2.6 
17 76683755 76684201 Gm16391 -2.3 -0.1 2.2 
17 23658600 23658678 AC154753.1 -2.3 -0.5 1.8 
17 35836148 35836254 U6.372 -2.3 -0.5 1.8 
17 13714322 13721299 Smok4a -0.7 1.0 1.7 
17 37862944 37863936 Olfr120 -2.5 -0.8 1.7 
17 36097675 36097759 Mir877 -0.7 0.8 1.6 
17 14846073 14847062 Gm3222 -2.3 -0.8 1.6 
17 57977850 57978656 Rpl7a-ps5 -2.3 -0.8 1.6 
17 87815325 87815381 AC084383.1 -0.7 0.7 1.5 
17 29158238 29159347 Gm16195 -1.3 0.1 1.4 
17 35250889 35252345 Ly6g5b 1.3 2.6 1.4 
17 27700520 27702694 AI413582 0.3 1.6 1.4 
17 21622141 21625839 Gm10150 -1.3 -0.1 1.2 
17 35118805 35122834 Lsm2 -0.3 0.9 1.2 
17 50378729 50380849 AY702103 -1.3 -0.1 1.2 
17 33352340 33353287 Gm4461 -2.3 -1.1 1.2 
17 36245531 36248633 Gm8815 -2.3 -1.1 1.2 
17 36979171 36979297 SNORA51.5 -2.3 -1.1 1.2 
17 37287952 37288996 Olfr93 -2.3 -1.1 1.2 
17 47427905 47427977 5S_rRNA.105 -2.3 -1.1 1.2 
17 56382411 56382521 Mir7b -2.3 -1.1 1.2 
17 24830136 24833101 Gfer 1.8 3.0 1.2 
17 33896937 33898807 CT030732.1 -1.3 -0.3 1.0 
17 46141895 46141949 AC127690.1 -1.3 -0.3 1.0 
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17 24300833 24306647 Atp6v0c 1.0 2.0 1.0 
18 37815561 37818391 3222401L13Rik -0.7 1.4 2.1 
18 84888396 84890167 D030046N08Rik -0.7 1.2 2.0 
18 35929972 35930325 AC132837.1 -2.3 -0.5 1.8 
18 78546493 78547440 AC151578.1 -2.3 -0.5 1.8 
18 48204989 48208032 Gm5506 -1.3 0.2 1.6 
18 12657194 12657637 AC102131.1 -2.3 -0.8 1.6 
18 54143975 54144982 Gm5507 -2.3 -0.8 1.6 
18 61807470 61807557 Mir145 -1.3 0.1 1.4 
18 31979516 31980067 AC161511.1 -2.5 -1.1 1.4 
18 61557489 61557554 Mir378 -2.5 -1.1 1.4 
18 61298163 61298267 U6.855 -1.3 -0.1 1.2 
18 24919664 24919940 7SK.245 -2.3 -1.1 1.2 
18 39153289 39153846 Gm15334 -2.3 -1.1 1.2 
18 42412040 42412489 Gm6636 -2.3 -1.1 1.2 
18 74224756 74225238 Gm9925 -2.3 -1.1 1.2 
18 75069806 75069887 AC155261.1 -2.3 -1.1 1.2 
18 50727310 50728353 Hdhd1a -0.3 0.8 1.1 
18 35696237 35696605 Gm5239 0.0 1.0 1.0 
19 8847012 8848957 Tmem179b -2.3 0.9 3.2 
19 29209769 29209865 Mir101b -2.3 0.6 2.9 
19 5848508 5851372 Gm9783 -2.3 0.2 2.6 
19 45823998 45826800 Gm15491 -1.3 0.8 2.1 
19 11944636 11945795 Olfr1419 -0.7 1.4 2.1 
19 11122103 11125056 AW112010 -1.3 0.5 1.8 
19 12183090 12184034 Olfr1428 -2.3 -0.5 1.8 
19 29156223 29156303 AC157914.1 -2.3 -0.5 1.8 
19 51217118 51217225 AC101812.1 -2.3 -0.5 1.8 
19 11769531 11769669 SCARNA17.2 -2.5 -0.8 1.7 
19 34895177 34895263 Mir107 -2.5 -0.8 1.7 
19 41986361 41993154 Pgam1 0.5 2.2 1.7 
19 41667853 41670648 AI606181 1.5 3.1 1.6 
19 5728087 5729653 Mtvr2 -1.3 0.2 1.6 
19 4078299 4078512 U3.1 -2.3 -0.8 1.6 
19 29077895 29078332 Gm10136 -2.3 -0.8 1.6 
19 12921263 12921763 AC135633.1 -0.3 1.2 1.5 
19 41920468 41922622 Frat2 0.7 2.2 1.5 
19 6094419 6098233 Gm550 1.6 3.0 1.5 
19 11844881 11849434 Mrpl16 1.1 2.6 1.4 
19 12838150 12840122 Cntf -1.3 0.1 1.4 
19 28837651 28837920 AC163993.1 -0.3 1.1 1.4 
19 18807231 18807394 U1.45 -2.5 -1.1 1.4 
19 47132652 47132758 U6.16 -2.5 -1.1 1.4 
19 12110298 12111230 Olfr1423 0.8 2.2 1.4 
19 36806227 36811143 Ppp1r3c 2.2 3.5 1.3 
19 47806246 47810078 6330577E15Rik 1.5 2.7 1.3 
19 29038410 29041288 Ppapdc2 0.3 1.5 1.2 
19 33897398 33899561 Gm5519 -1.3 -0.1 1.2 
19 23717899 23718000 SNORA17.363 -2.3 -1.1 1.2 
19 25746907 25753500 Dmrt2 2.9 4.1 1.2 
19 30620353 30624155 Dkk1 2.4 3.6 1.2 
19 30078280 30080510 Trpd52l3 2.1 3.3 1.2 
19 4839366 4842528 Ccdc87 1.1 2.3 1.2 
19 50104614 50105225 Rpl13a-ps1 0.0 1.2 1.2 
19 56438752 56440731 RP23-116D4.2 1.9 3.1 1.2 
19 53893844 53899618 Gm16299 3.3 4.4 1.1 
19 47244959 47245624 AC132288.1 0.5 1.6 1.1 
19 10743447 10752561 Pga5 3.9 5.1 1.1 
19 31157331 31161080 Cstf2t 2.0 3.1 1.1 
19 44213756 44220936 Bloc1s2 2.2 3.3 1.1 
19 41136964 41151603 Opalin 3.3 4.4 1.1 
19 5366813 5371511 Eif1ad 1.6 2.6 1.1 
19 11970489 11971540 Olfr1420 -0.3 0.7 1.0 
19 38126374 38129018 I830134H01Rik -1.3 -0.3 1.0 
19 41819294 41819543 7SK.153 -1.3 -0.3 1.0 
19 52338813 52339946 Ins1 -0.3 0.7 1.0 
19 53446056 53446256 Gm10197 -0.3 0.7 1.0 
19 6268795 6276605 Gm14963 3.4 4.4 1.0 
19 60831890 60835816 Nanos1 0.5 1.5 1.0 
19 29772411 29782938 Mlana 3.8 4.8 1.0 
X 50408223 50410367 C430049B03Rik -2.3 2.8 5.1 
X 20192452 20194745 Ndufb11 -2.5 2.0 4.4 
X 163645025 163647247 Tmsb4x -2.5 2.0 4.4 
X 132703523 132706881 Tceal8 -2.5 1.5 4.0 
X 71611057 71614012 Ubl4 -1.3 2.3 3.6 
X 131291134 131295994 Armcx3 -1.3 2.3 3.6 
X 71032367 71036169 Ssr4 0.3 3.8 3.5 
X 58146828 58151242 Gm14662 -0.3 3.2 3.5 
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X 130222319 130241801 Gm16795 0.0 3.5 3.5 
X 50911099 50912309 Cxx1c -1.3 2.0 3.3 
X 131135718 131141599 Hnrnph2 -0.7 2.5 3.2 
X 132779618 132781678 Wbp5 -2.3 0.8 3.1 
X 119508174 119510994 Nap1l3 -1.3 1.8 3.1 
X 70473645 70476134 F8a 0.0 3.1 3.1 
X 10904948 10905277 Gm4906 -2.3 0.7 3.0 
X 132277272 132281861 Armcx5 -1.3 1.6 2.9 
X 137176499 137176800 7SK.64 -2.3 0.6 2.9 
X 71516151 71518474 Rpl10 -0.7 2.0 2.8 
X 131120193 131122601 Rpl36a 0.0 2.6 2.6 
X 78316033 78318441 Gm11014 0.3 2.9 2.6 
X 151647675 151650992 Sat1 -0.7 1.8 2.6 
X 34335646 34338802 Slc25a5 0.7 3.2 2.5 
X 92217846 92222021 Spin4 0.7 3.1 2.4 
X 70528235 70538315 Xlr5c -2.3 0.1 2.4 
X 97944760 97945087 7SK.252 -2.3 0.1 2.4 
X 131280034 131281452 Gm10344 -2.3 0.1 2.4 
X 149470709 149472106 Mageh1 -0.3 2.1 2.4 
X 133276397 133277682 BC065397 0.0 2.3 2.3 
X 96131655 96144356 Yipf6 2.5 4.9 2.3 
X 70158871 70163750 Cetn2 0.0 2.3 2.3 
X 71542436 71550060 Atp6ap1 1.0 3.3 2.3 
X 49321872 49325949 1700080O16Rik 0.7 3.0 2.3 
X 71527251 71535490 Taz 1.3 3.5 2.3 
X 149441012 149443959 Usp51 0.7 2.9 2.3 
X 55275877 55294913 Zic3 3.2 5.4 2.2 
X 70459672 70467795 Xlr4b -2.3 -0.1 2.2 
X 159186488 159186606 SNORA76.2 -2.5 -0.3 2.2 
X 35239616 35250409 Gm14543 -1.3 0.8 2.1 
X 133461864 133462912 1700014N06Rik 1.0 3.1 2.1 
X 117040805 117043774 Pabpc5 -0.7 1.4 2.1 
X 97818222 97821907 Pdzd11 1.3 3.3 2.1 
X 34873092 34888471 Rhox3c -1.3 0.7 2.0 
X 7904550 7913363 Ssxb10 -2.3 -0.3 2.0 
X 34894844 34899631 Rhox4c -2.3 -0.3 2.0 
X 152057332 152057904 Gm15156 0.3 2.3 2.0 
X 34450829 34451980 Gm15008 0.0 2.0 2.0 
X 131338684 131343760 Armcx2 0.8 2.8 2.0 
X 13788274 13788782 Gm5382 -2.5 -0.5 2.0 
X 134742704 134744119 Tex13a -2.5 -0.5 2.0 
X 131282994 131285956 Armcx6 0.0 2.0 2.0 
X 14687712 14688588 4930403L05Rik -0.3 1.6 1.9 
X 35180224 35183034 Rhox6 0.3 2.2 1.9 
X 131071795 131076404 Timm8a1 0.3 2.2 1.9 
X 7990431 7999284 Ssxb1 -2.3 -0.5 1.8 
X 9424073 9424626 1700054O13Rik -0.7 1.1 1.8 
X 33735899 33739153 Zcchc12 0.3 2.1 1.8 
X 34805370 34810131 Rhox4a -1.3 0.5 1.8 
X 35987726 35988259 AL590633.1 -2.3 -0.5 1.8 
X 90531846 90543696 Arx 3.2 5.0 1.8 
X 6953051 6955168 Gm14379 0.3 2.0 1.8 
X 34731240 34732457 Rnf113a1 1.7 3.5 1.8 
X 166412975 166416849 G530011O06Rik 0.5 2.2 1.8 
X 7291459 7299226 Gm14720 0.7 2.4 1.7 
X 149932775 149936080 Ubqln2 2.3 4.0 1.7 
X 102315735 102319248 Magee1 3.1 4.8 1.7 
X 5745814 5750133 Nudt10 -1.3 0.4 1.7 
X 71162212 71167283 Naa10 1.8 3.4 1.7 
X 99442720 99447520 Cited1 3.0 4.7 1.7 
X 46048181 46063900 Rbmx2 1.9 3.6 1.6 
X 108009729 108010910 Pou3f4 2.1 3.7 1.6 
X 139534137 139538878 Rgag1 1.0 2.6 1.6 
X 133267481 133278229 Morf4l2 2.1 3.7 1.6 
X 123346994 123350616 4932411N23Rik -0.7 0.8 1.6 
X 131219101 131221001 B230119M05Rik -1.3 0.2 1.6 
X 25903110 25972691 Slx -2.3 -0.8 1.6 
X 35083504 35087784 Rhox2h -2.3 -0.8 1.6 
X 35457254 35463964 Rhox12 1.1 2.7 1.6 
X 99903204 99910548 Dmrtc1b -2.3 -0.8 1.6 
X 124909930 124911507 Gm4916 -2.3 -0.8 1.6 
X 71500026 71506887 Emd 2.0 3.5 1.5 
X 148436388 148438985 Hsd17b10 1.0 2.5 1.5 
X 51272614 51278177 Gm15482 0.8 2.4 1.5 
X 101678157 101702829 Uprt 1.1 2.6 1.5 
X 133649936 133656622 Esx1 2.5 4.0 1.5 
X 100379515 100381979 Nap1l2 0.5 2.0 1.5 
X 8380817 8386512 Ssxb5 1.0 2.5 1.5 
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X 138159381 138160706 Gm15295 1.6 3.0 1.5 
X 72650185 72661923 Mtcp1 1.1 2.6 1.5 
X 72650185 72661927 Mtcp1 1.1 2.6 1.5 
X 151758461 151775297 Prdx4 1.8 3.3 1.4 
X 8469479 8472103 B630019K06Rik 1.5 2.9 1.4 
X 71654822 71674533 G6pdx 2.6 4.0 1.4 
X 20281032 20297665 Usp11 2.8 4.2 1.4 
X 20518848 20539143 Uxt 1.8 3.2 1.4 
X 40944337 40946151 Gm362 -1.3 0.1 1.4 
X 150266768 150268786 Spin2 -0.3 1.1 1.4 
X 23585725 23585819 AL773580.1 -2.5 -1.1 1.4 
X 35017402 35022193 Rhox4f -2.5 -1.1 1.4 
X 50945665 50946940 Cxx1a -2.5 -1.1 1.4 
X 70319684 70327817 Xlr4a -2.5 -1.1 1.4 
X 71024302 71032236 Idh3g 2.2 3.6 1.4 
X 17722996 17723816 Dusp21 1.1 2.5 1.4 
X 46817122 46853421 Arhgap36 3.6 4.9 1.4 
X 149993136 149993972 Cypt3 -0.7 0.6 1.4 
X 71550337 71557201 Gdi1 2.2 3.5 1.3 
X 7245067 7248516 Plp2 1.5 2.8 1.3 
X 50880264 50912156 Gm14597 1.1 2.5 1.3 
X 78316037 78343211 Tmem47 1.8 3.1 1.3 
X 71518556 71527676 Dnase1l1 1.3 2.6 1.3 
X 67639052 67642592 1110012L19Rik 0.7 2.0 1.3 
X 49929020 49972224 A630012P03Rik 3.3 4.6 1.3 
X 7501402 7505733 Eras 2.0 3.3 1.3 
X 162895185 162917799 Rab9 2.8 4.1 1.3 
X 120217104 120302404 3110007F17Rik 1.8 3.0 1.3 
X 160346949 160371598 Ap1s2 2.4 3.6 1.3 
X 5624571 5632228 Nudt11 -0.7 0.5 1.2 
X 72818791 72820607 Gm15063 0.3 1.5 1.2 
X 99380280 99384733 Rps4x 0.7 1.9 1.2 
X 70310126 70313529 Pnma3 0.8 2.1 1.2 
X 131252502 131256456 Armcx1 -0.3 0.9 1.2 
X 8325558 8331713 Ssx9 -2.3 -1.1 1.2 
X 25627804 25658481 Gm2012 -2.3 -1.1 1.2 
X 26099903 26129764 Gm14525 -2.3 -1.1 1.2 
X 34985928 34990666 Rhox2f -2.3 -1.1 1.2 
X 35061008 35065834 Rhox4g -2.3 -1.1 1.2 
X 35367085 35371992 4930525M21Rik -2.3 -1.1 1.2 
X 70479027 70488469 Xlr4c -2.3 -1.1 1.2 
X 132567906 132569485 6530401D17Rik -2.3 -1.1 1.2 
X 146219016 146261237 Gm15097 -2.3 -1.1 1.2 
X 149357996 149358303 7SK.4 -2.3 -1.1 1.2 
X 99261883 99266643 Rgag4 3.6 4.8 1.2 
X 91780813 91787482 Maged1 2.8 4.1 1.2 
X 53443004 53466058 Gm773 1.8 3.1 1.2 
X 7471645 7476395 Pqbp1 3.2 4.4 1.2 
X 8828054 8834025 Gm14862 1.4 2.6 1.2 
X 35542970 35550223 Zbtb33 1.3 2.5 1.2 
X 98624657 98643932 Nono 2.3 3.5 1.2 
X 160508637 160514425 Siah1b 2.4 3.6 1.2 
X 66609771 66614444 Gm14705 1.8 3.0 1.2 
X 34622515 34625397 Rpl39 1.3 2.4 1.2 
X 96654364 96656092 Gm14808 0.3 1.4 1.2 
X 7215597 7230382 Syp 3.7 4.8 1.2 
X 71259253 71269257 Irak1 2.1 3.2 1.2 
X 131743226 131745226 Tceal6 0.0 1.2 1.2 
X 50144377 50152645 Ccdc160 1.5 2.6 1.2 
X 34138201 34146074 Pgrmc1 2.7 3.8 1.2 
X 7581326 7595618 Glod5 2.6 3.7 1.2 
X 20889336 20911853 Gm6938 0.7 1.8 1.1 
X 159198334 159217024 Rbbp7 1.8 3.0 1.1 
X 8681688 8683468 4930402K13Rik 0.5 1.6 1.1 
X 135868222 135872708 Trap1a 2.1 3.2 1.1 
X 136991152 137010679 Prps1 2.1 3.2 1.1 
X 6948402 6952956 Usp27x 2.8 4.0 1.1 
X 71558372 71565488 Fam50a 1.9 3.0 1.1 
X 51080295 51100883 Xlr -0.7 0.4 1.1 
X 133527694 133533011 Zcchc18 0.8 2.0 1.1 
X 138661313 138674235 Nxt2 1.1 2.2 1.1 
X 138145541 138159806 Irs4 3.5 4.6 1.1 
X 144200534 144267999 Gm15128 0.5 1.6 1.1 
X 7762455 7770638 Ebp 2.8 3.8 1.1 
X 34666790 34690741 Nkap 2.7 3.7 1.1 
X 7638297 7651886 Suv39h1 3.8 4.8 1.1 
X 71167460 71176189 Renbp 2.8 3.8 1.1 
X 102695111 102695978 Cypt2-ps -1.3 -0.3 1.0 
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X 139173543 139173640 Mir652 -1.3 -0.3 1.0 
X 54636707 54646213 Rbmx 2.5 3.6 1.0 
X 7305565 7308190 Praf2 1.6 2.6 1.0 
X 70918489 70927841 Slc6a8 2.9 3.9 1.0 
X 45694535 45761226 Bcorl1 5.6 6.7 1.0 
X 35252274 35254947 Rhox9 0.8 1.9 1.0 
X 156560141 156576345 Pdha1 3.1 4.1 1.0 
X 58294916 58329243 Gm14664 1.5 2.5 1.0 
X 72817385 72823570 Rab39b 1.5 2.5 1.0 
X 35184863 35194450 Rhox7 0.5 1.5 1.0 
X 56162537 56173481 4930550L24Rik 1.3 2.3 1.0 
X 71630058 71638611 Fam3a 2.0 3.0 1.0 
X 58144545 58146605 Sox3 3.1 4.1 1.0 
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Appendix 4 




LSH & G9a LSH & SmcHD1 G9a & SmcHD1 LSH & G9a & SmcHD1 
1700071K01Rik B020018G12Rik Cxcl10 4930479M11Rik 
4922502D21Rik Cldn17 Ferd3l Olfr370 
Abca15 Ifng Hax1 Slitrk1 
Adcyap1 Krtap8-2   
Asz1 Olfr1423   
AU015228 Olfr214   
BC050811    
C6.1AL    
Ccdc42    
Cd2    
Cetn1    
Cox8c    
Crisp2    
Dgkg    
Gm740    
Gucy2c    
Gykl1    
Hemt1    
Lcp1    
LOC621852    
Myf5    
Oasl2    
Odz3    
Olfr1349    
Olfr281    
Psors1c2    
Spata16    
Tcf21    
Tmprss3    
Wdr20    
              229
References 
Amir RE, Van den Veyver IB, Wan M, Tran CQ, Francke U, Zoghbi HY (1999) Rett syndrome is 
caused by mutations in X-linked MECP2, encoding methyl-CpG-binding protein 2. Nature 
genetics 23: 185-188 
Arita K, Ariyoshi M, Tochio H, Nakamura Y, Shirakawa M (2008) Recognition of hemi-
methylated DNA by the SRA protein UHRF1 by a base-flipping mechanism. Nature 455: 818-
821 
Arnaud P (2010) Genomic imprinting in germ cells: imprints are under control. Reproduction 
140: 411-423 
Athanasiadou R, de Sousa D, Myant K, Merusi C, Stancheva I, Bird A (2010) Targeting of de 
novo DNA methylation throughout the Oct-4 gene regulatory region in differentiating 
embryonic stem cells. PloS one 5: e9937 
Avner P, Heard E (2001) X-chromosome inactivation: counting, choice and initiation. Nat 
Rev Genet 2: 59-67 
Azuara V, Perry P, Sauer S, Spivakov M, Jorgensen HF, John RM, Gouti M, Casanova M, 
Warnes G, Merkenschlager M, Fisher AG (2006) Chromatin signatures of pluripotent cell 
lines. Nat Cell Biol 8: 532-538 
Bacher CP, Guggiari M, Brors B, Augui S, Clerc P, Avner P, Eils R, Heard E (2006) Transient 
colocalization of X-inactivation centres accompanies the initiation of X inactivation. Nat Cell 
Biol 8: 293-299 
Bacolla A, Pradhan S, Roberts RJ, Wells RD (1999) Recombinant human DNA (cytosine-5) 
methyltransferase. II. Steady-state kinetics reveal allosteric activation by methylated dna. J 
Biol Chem 274: 33011-33019 
Barakat TS, Gunhanlar N, Pardo CG, Achame EM, Ghazvini M, Boers R, Kenter A, 
Rentmeester E, Grootegoed JA, Gribnau J (2011) RNF12 activates Xist and is essential for X 
chromosome inactivation. PLoS genetics 7: e1002001 
Barbisan F, Mazzucchelli R, Santinelli A, Stramazzotti D, Scarpelli M, Lopez-Beltran A, Cheng 
L, Montironi R (2008) Immunohistochemical evaluation of global DNA methylation and 
histone acetylation in papillary urothelial neoplasm of low malignant potential. 
International journal of immunopathology and pharmacology 21: 615-623 
Barlesi F, Giaccone G, Gallegos-Ruiz MI, Loundou A, Span SW, Lefesvre P, Kruyt FA, 
Rodriguez JA (2007) Global histone modifications predict prognosis of resected non small-
cell lung cancer. Journal of clinical oncology : official journal of the American Society of 
Clinical Oncology 25: 4358-4364 
Bartolomei MS, Ferguson-Smith AC (2011) Mammalian genomic imprinting. Cold Spring 
Harbor perspectives in biology 3 
Barton SC, Surani MA, Norris ML (1984) Role of paternal and maternal genomes in mouse 
development. Nature 311: 374-376 
Beard C, Li E, Jaenisch R (1995) Loss of methylation activates Xist in somatic but not in 
embryonic cells. Genes Dev 9: 2325-2334 
              230
Bednar J, Horowitz RA, Grigoryev SA, Carruthers LM, Hansen JC, Koster AJ, Woodcock CL 
(1998) Nucleosomes, linker DNA, and linker histone form a unique structural motif that 
directs the higher-order folding and compaction of chromatin. Proc Natl Acad Sci U S A 95: 
14173-14178 
Bellacosa A, Cicchillitti L, Schepis F, Riccio A, Yeung AT, Matsumoto Y, Golemis EA, Genuardi 
M, Neri G (1999) MED1, a novel human methyl-CpG-binding endonuclease, interacts with 
DNA mismatch repair protein MLH1. Proc Natl Acad Sci U S A 96: 3969-3974 
Bernstein BE, Kamal M, Lindblad-Toh K, Bekiranov S, Bailey DK, Huebert DJ, McMahon S, 
Karlsson EK, Kulbokas EJ, 3rd, Gingeras TR, Schreiber SL, Lander ES (2005) Genomic maps 
and comparative analysis of histone modifications in human and mouse. Cell 120: 169-181 
Bernstein BE, Mikkelsen TS, Xie X, Kamal M, Huebert DJ, Cuff J, Fry B, Meissner A, Wernig 
M, Plath K, Jaenisch R, Wagschal A, Feil R, Schreiber SL, Lander ES (2006) A bivalent 
chromatin structure marks key developmental genes in embryonic stem cells. Cell 125: 315-
326 
Bestor T, Laudano A, Mattaliano R, Ingram V (1988) Cloning and sequencing of a cDNA 
encoding DNA methyltransferase of mouse cells. The carboxyl-terminal domain of the 
mammalian enzymes is related to bacterial restriction methyltransferases. Journal of 
molecular biology 203: 971-983 
Bian Q, Belmont AS (2012) Revisiting higher-order and large-scale chromatin organization. 
Current opinion in cell biology 24: 359-366 
Bibel M, Richter J, Schrenk K, Tucker KL, Staiger V, Korte M, Goetz M, Barde YA (2004) 
Differentiation of mouse embryonic stem cells into a defined neuronal lineage. Nature 
neuroscience 7: 1003-1009 
Bird A (2002) DNA methylation patterns and epigenetic memory. Genes Dev 16: 6-21 
Bird A, Taggart M, Frommer M, Miller OJ, Macleod D (1985) A fraction of the mouse 
genome that is derived from islands of nonmethylated, CpG-rich DNA. Cell 40: 91-99 
Bird AP (1980) DNA methylation and the frequency of CpG in animal DNA. Nucleic Acids Res 
8: 1499-1504 
Bird AP (1986) CpG-rich islands and the function of DNA methylation. Nature 321: 209-213 
Blewitt ME, Gendrel AV, Pang Z, Sparrow DB, Whitelaw N, Craig JM, Apedaile A, Hilton DJ, 
Dunwoodie SL, Brockdorff N, Kay GF, Whitelaw E (2008) SmcHD1, containing a structural-
maintenance-of-chromosomes hinge domain, has a critical role in X inactivation. Nature 
genetics 40: 663-669 
Borgel J, Guibert S, Li Y, Chiba H, Schubeler D, Sasaki H, Forne T, Weber M (2010) Targets 
and dynamics of promoter DNA methylation during early mouse development. Nature 
genetics 42: 1093-1100 
Bostick M, Kim JK, Esteve PO, Clark A, Pradhan S, Jacobsen SE (2007) UHRF1 plays a role in 
maintaining DNA methylation in mammalian cells. Science 317: 1760-1764 
Bourc'his D, Bestor TH (2004) Meiotic catastrophe and retrotransposon reactivation in male 
germ cells lacking Dnmt3L. Nature 431: 96-99 
              231
Bowman GD (2010) Mechanisms of ATP-dependent nucleosome sliding. Current opinion in 
structural biology 20: 73-81 
Boyer LA, Latek RR, Peterson CL (2004) The SANT domain: a unique histone-tail-binding 
module? Nature reviews Molecular cell biology 5: 158-163 
Bracken AP, Helin K (2009) Polycomb group proteins: navigators of lineage pathways led 
astray in cancer. Nature reviews Cancer 9: 773-784 
Brasher SV, Smith BO, Fogh RH, Nietlispach D, Thiru A, Nielsen PR, Broadhurst RW, Ball LJ, 
Murzina NV, Laue ED (2000) The structure of mouse HP1 suggests a unique mode of single 
peptide recognition by the shadow chromo domain dimer. EMBO J 19: 1587-1597 
Brockdorff N, Ashworth A, Kay GF, Cooper P, Smith S, McCabe VM, Norris DP, Penny GD, 
Patel D, Rastan S (1991) Conservation of position and exclusive expression of mouse Xist 
from the inactive X chromosome. Nature 351: 329-331 
Brockdorff N, Ashworth A, Kay GF, McCabe VM, Norris DP, Cooper PJ, Swift S, Rastan S 
(1992) The product of the mouse Xist gene is a 15 kb inactive X-specific transcript 
containing no conserved ORF and located in the nucleus. Cell 71: 515-526 
Bruno M, Flaus A, Stockdale C, Rencurel C, Ferreira H, Owen-Hughes T (2003) Histone 
H2A/H2B dimer exchange by ATP-dependent chromatin remodeling activities. Mol Cell 12: 
1599-1606 
Brzeski J, Jerzmanowski A (2003) Deficient in DNA methylation 1 (DDM1) defines a novel 
family of chromatin-remodeling factors. J Biol Chem 278: 823-828 
Cairns BR (2007) Chromatin remodeling: insights and intrigue from single-molecule studies. 
Nat Struct Mol Biol 14: 989-996 
Cao R, Wang L, Wang H, Xia L, Erdjument-Bromage H, Tempst P, Jones RS, Zhang Y (2002) 
Role of histone H3 lysine 27 methylation in Polycomb-group silencing. Science 298: 1039-
1043 
Carlone DL, Lee JH, Young SR, Dobrota E, Butler JS, Ruiz J, Skalnik DG (2005) Reduced 
genomic cytosine methylation and defective cellular differentiation in embryonic stem cells 
lacking CpG binding protein. Molecular and cellular biology 25: 4881-4891 
Carlone DL, Skalnik DG (2001) CpG binding protein is crucial for early embryonic 
development. Molecular and cellular biology 21: 7601-7606 
Carrozza MJ, Li B, Florens L, Suganuma T, Swanson SK, Lee KK, Shia WJ, Anderson S, Yates J, 
Washburn MP, Workman JL (2005) Histone H3 methylation by Set2 directs deacetylation of 
coding regions by Rpd3S to suppress spurious intragenic transcription. Cell 123: 581-592 
Caterino TL, Hayes JJ (2011) Structure of the H1 C-terminal domain and function in 
chromatin condensation. Biochem Cell Biol 89: 35-44 
Cervoni N, Szyf M (2001) Demethylase activity is directed by histone acetylation. J Biol 
Chem 276: 40778-40787 
Chahrour M, Jung SY, Shaw C, Zhou X, Wong ST, Qin J, Zoghbi HY (2008) MeCP2, a key 
contributor to neurological disease, activates and represses transcription. Science 320: 
1224-1229 
              232
Chang SC, Tucker T, Thorogood NP, Brown CJ (2006) Mechanisms of X-chromosome 
inactivation. Frontiers in bioscience : a journal and virtual library 11: 852-866 
Chase A, Cross NC (2011) Aberrations of EZH2 in cancer. Clinical cancer research : an official 
journal of the American Association for Cancer Research 17: 2613-2618 
Chaturvedi CP, Hosey AM, Palii C, Perez-Iratxeta C, Nakatani Y, Ranish JA, Dilworth FJ, Brand 
M (2009) Dual role for the methyltransferase G9a in the maintenance of beta-globin gene 
transcription in adult erythroid cells. Proc Natl Acad Sci U S A 106: 18303-18308 
Cheadle JP, Gill H, Fleming N, Maynard J, Kerr A, Leonard H, Krawczak M, Cooper DN, Lynch 
S, Thomas N, Hughes H, Hulten M, Ravine D, Sampson JR, Clarke A (2000) Long-read 
sequence analysis of the MECP2 gene in Rett syndrome patients: correlation of disease 
severity with mutation type and location. Human molecular genetics 9: 1119-1129 
Chedin F, Lieber MR, Hsieh CL (2002) The DNA methyltransferase-like protein DNMT3L 
stimulates de novo methylation by Dnmt3a. Proc Natl Acad Sci U S A 99: 16916-16921 
Chen T, Hevi S, Gay F, Tsujimoto N, He T, Zhang B, Ueda Y, Li E (2007) Complete inactivation 
of DNMT1 leads to mitotic catastrophe in human cancer cells. Nature genetics 39: 391-396 
Cheng X (1995) DNA modification by methyltransferases. Current opinion in structural 
biology 5: 4-10 
Cheng X, Blumenthal RM (2008) Mammalian DNA methyltransferases: a structural 
perspective. Structure 16: 341-350 
Chu C, Qu K, Zhong FL, Artandi SE, Chang HY (2011) Genomic maps of long noncoding RNA 
occupancy reveal principles of RNA-chromatin interactions. Mol Cell 44: 667-678 
Ciccone DN, Su H, Hevi S, Gay F, Lei H, Bajko J, Xu G, Li E, Chen T (2009) KDM1B is a histone 
H3K4 demethylase required to establish maternal genomic imprints. Nature 461: 415-418 
Clapier CR, Cairns BR (2009) The biology of chromatin remodeling complexes. Annual 
review of biochemistry 78: 273-304 
Cohen JF, Leis A, Lecarpentier T, Raymond J, Gendrel D, Chalumeau M (2012) Procalcitonin 
predicts response to beta-lactam treatment in hospitalized children with community-
acquired pneumonia. PloS one 7: e36927 
Collins RE, Northrop JP, Horton JR, Lee DY, Zhang X, Stallcup MR, Cheng X (2008) The 
ankyrin repeats of G9a and GLP histone methyltransferases are mono- and dimethyllysine 
binding modules. Nat Struct Mol Biol 15: 245-250 
Coulondre C, Miller JH (1978) Analysis of base substitutions induced by ultraviolet radiation 
in Escherichia coli. National Cancer Institute monograph: 115-119 
Coulondre C, Miller JH, Farabaugh PJ, Gilbert W (1978) Molecular basis of base substitution 
hotspots in Escherichia coli. Nature 274: 775-780 
Cowieson NP, Partridge JF, Allshire RC, McLaughlin PJ (2000) Dimerisation of a chromo 
shadow domain and distinctions from the chromodomain as revealed by structural analysis. 
Curr Biol 10: 517-525 
Crawford DC, Acuna JM, Sherman SL (2001) FMR1 and the fragile X syndrome: human 
genome epidemiology review. Genetics in medicine : official journal of the American College 
of Medical Genetics 3: 359-371 
              233
Cross SH, Charlton JA, Nan X, Bird AP (1994) Purification of CpG islands using a methylated 
DNA binding column. Nature genetics 6: 236-244 
da Rocha ST, Edwards CA, Ito M, Ogata T, Ferguson-Smith AC (2008) Genomic imprinting at 
the mammalian Dlk1-Dio3 domain. Trends Genet 24: 306-316 
Dang W, Bartholomew B (2007) Domain architecture of the catalytic subunit in the ISW2-
nucleosome complex. Molecular and cellular biology 27: 8306-8317 
Dang W, Kagalwala MN, Bartholomew B (2006) Regulation of ISW2 by concerted action of 
histone H4 tail and extranucleosomal DNA. Molecular and cellular biology 26: 7388-7396 
De La Fuente R, Baumann C, Fan T, Schmidtmann A, Dobrinski I, Muegge K (2006) Lsh is 
required for meiotic chromosome synapsis and retrotransposon silencing in female germ 
cells. Nat Cell Biol 8: 1448-1454 
Dean W, Bowden L, Aitchison A, Klose J, Moore T, Meneses JJ, Reik W, Feil R (1998) Altered 
imprinted gene methylation and expression in completely ES cell-derived mouse fetuses: 
association with aberrant phenotypes. Development 125: 2273-2282 
Deaton AM, Bird A (2011) CpG islands and the regulation of transcription. Genes Dev 25: 
1010-1022 
Dechassa ML, Sabri A, Pondugula S, Kassabov SR, Chatterjee N, Kladde MP, Bartholomew B 
(2010) SWI/SNF has intrinsic nucleosome disassembly activity that is dependent on 
adjacent nucleosomes. Mol Cell 38: 590-602 
Dechassa ML, Zhang B, Horowitz-Scherer R, Persinger J, Woodcock CL, Peterson CL, 
Bartholomew B (2008) Architecture of the SWI/SNF-nucleosome complex. Molecular and 
cellular biology 28: 6010-6021 
Deleris A, Greenberg MV, Ausin I, Law RW, Moissiard G, Schubert D, Jacobsen SE (2010) 
Involvement of a Jumonji-C domain-containing histone demethylase in DRM2-mediated 
maintenance of DNA methylation. EMBO reports 11: 950-955 
Dennis K, Fan T, Geiman T, Yan Q, Muegge K (2001) Lsh, a member of the SNF2 family, is 
required for genome-wide methylation. Genes Dev 15: 2940-2944 
Ding F, Chaillet JR (2002) In vivo stabilization of the Dnmt1 (cytosine-5)- methyltransferase 
protein. Proc Natl Acad Sci U S A 99: 14861-14866 
Dong KB, Maksakova IA, Mohn F, Leung D, Appanah R, Lee S, Yang HW, Lam LL, Mager DL, 
Schubeler D, Tachibana M, Shinkai Y, Lorincz MC (2008) DNA methylation in ES cells 
requires the lysine methyltransferase G9a but not its catalytic activity. EMBO J 27: 2691-
2701 
Donohoe ME, Silva SS, Pinter SF, Xu N, Lee JT (2009) The pluripotency factor Oct4 interacts 
with Ctcf and also controls X-chromosome pairing and counting. Nature 460: 128-132 
Easwaran HP, Schermelleh L, Leonhardt H, Cardoso MC (2004) Replication-independent 
chromatin loading of Dnmt1 during G2 and M phases. EMBO reports 5: 1181-1186 
Eden A, Gaudet F, Waghmare A, Jaenisch R (2003) Chromosomal instability and tumors 
promoted by DNA hypomethylation. Science 300: 455 
Eissenberg JC, Elgin SC (2000) The HP1 protein family: getting a grip on chromatin. Curr 
Opin Genet Dev 10: 204-210 
              234
Elgin SC, Grewal SI (2003) Heterochromatin: silence is golden. Curr Biol 13: R895-898 
Engemann S, Strodicke M, Paulsen M, Franck O, Reinhardt R, Lane N, Reik W, Walter J 
(2000) Sequence and functional comparison in the Beckwith-Wiedemann region: 
implications for a novel imprinting centre and extended imprinting. Human molecular 
genetics 9: 2691-2706 
Epsztejn-Litman S, Feldman N, Abu-Remaileh M, Shufaro Y, Gerson A, Ueda J, Deplus R, 
Fuks F, Shinkai Y, Cedar H, Bergman Y (2008) De novo DNA methylation promoted by G9a 
prevents reprogramming of embryonically silenced genes. Nat Struct Mol Biol 15: 1176-
1183 
Esteller M (2005) DNA methylation and cancer therapy: new developments and 
expectations. Current opinion in oncology 17: 55-60 
Esteve PO, Chin HG, Smallwood A, Feehery GR, Gangisetty O, Karpf AR, Carey MF, Pradhan S 
(2006) Direct interaction between DNMT1 and G9a coordinates DNA and histone 
methylation during replication. Genes Dev 20: 3089-3103 
Fan T, Hagan JP, Kozlov SV, Stewart CL, Muegge K (2005) Lsh controls silencing of the 
imprinted Cdkn1c gene. Development 132: 635-644 
Fan T, Schmidtmann A, Xi S, Briones V, Zhu H, Suh HC, Gooya J, Keller JR, Xu H, Roayaei J, 
Anver M, Ruscetti S, Muegge K (2008) DNA hypomethylation caused by Lsh deletion 
promotes erythroleukemia development. Epigenetics 3: 134-142 
Fan T, Yan Q, Huang J, Austin S, Cho E, Ferris D, Muegge K (2003) Lsh-deficient murine 
embryonal fibroblasts show reduced proliferation with signs of abnormal mitosis. Cancer 
research 63: 4677-4683 
Fatemi M, Hermann A, Gowher H, Jeltsch A (2002) Dnmt3a and Dnmt1 functionally 
cooperate during de novo methylation of DNA. European journal of biochemistry / FEBS 
269: 4981-4984 
Fatemi M, Hermann A, Pradhan S, Jeltsch A (2001) The activity of the murine DNA 
methyltransferase Dnmt1 is controlled by interaction of the catalytic domain with the N-
terminal part of the enzyme leading to an allosteric activation of the enzyme after binding 
to methylated DNA. Journal of molecular biology 309: 1189-1199 
Feinberg AP, Vogelstein B (1983) Hypomethylation distinguishes genes of some human 
cancers from their normal counterparts. Nature 301: 89-92 
Feldman N, Gerson A, Fang J, Li E, Zhang Y, Shinkai Y, Cedar H, Bergman Y (2006) G9a-
mediated irreversible epigenetic inactivation of Oct-3/4 during early embryogenesis. Nat 
Cell Biol 8: 188-194 
Felle M, Hoffmeister H, Rothammer J, Fuchs A, Exler JH, Langst G (2011) Nucleosomes 
protect DNA from DNA methylation in vivo and in vitro. Nucleic Acids Res 39: 6956-6969 
Feng S, Jacobsen SE, Reik W (2010) Epigenetic reprogramming in plant and animal 
development. Science 330: 622-627 
Fernandez AF, Assenov Y, Martin-Subero JI, Balint B, Siebert R, Taniguchi H, Yamamoto H, 
Hidalgo M, Tan AC, Galm O, Ferrer I, Sanchez-Cespedes M, Villanueva A, Carmona J, 
Sanchez-Mut JV, Berdasco M, Moreno V, Capella G, Monk D, Ballestar E, Ropero S, Martinez 
R, Sanchez-Carbayo M, Prosper F, Agirre X, Fraga MF, Grana O, Perez-Jurado L, Mora J, Puig 
              235
S, Prat J, Badimon L, Puca AA, Meltzer SJ, Lengauer T, Bridgewater J, Bock C, Esteller M 
(2012) A DNA methylation fingerprint of 1628 human samples. Genome research 22: 407-
419 
Filion GJ, Zhenilo S, Salozhin S, Yamada D, Prokhortchouk E, Defossez PA (2006) A family of 
human zinc finger proteins that bind methylated DNA and repress transcription. Molecular 
and cellular biology 26: 169-181 
Finch JT, Klug A (1976) Solenoidal model for superstructure in chromatin. Proc Natl Acad Sci 
U S A 73: 1897-1901 
Fischle W, Tseng BS, Dormann HL, Ueberheide BM, Garcia BA, Shabanowitz J, Hunt DF, 
Funabiki H, Allis CD (2005) Regulation of HP1-chromatin binding by histone H3 methylation 
and phosphorylation. Nature 438: 1116-1122 
Fisscher U, Weisbeek P, Smeekens S (1996) A tobacco nuclear protein that preferentially 
binds to unmethylated CpG-rich DNA. European journal of biochemistry / FEBS 235: 585-592 
Fitzpatrick GV, Soloway PD, Higgins MJ (2002) Regional loss of imprinting and growth 
deficiency in mice with a targeted deletion of KvDMR1. Nature genetics 32: 426-431 
Flaus A, Martin DM, Barton GJ, Owen-Hughes T (2006) Identification of multiple distinct 
Snf2 subfamilies with conserved structural motifs. Nucleic Acids Res 34: 2887-2905 
Foster CT, Dovey OM, Lezina L, Luo JL, Gant TW, Barlev N, Bradley A, Cowley SM (2010) 
Lysine-specific demethylase 1 regulates the embryonic transcriptome and CoREST stability. 
Molecular and cellular biology 30: 4851-4863 
Fraga MF, Ballestar E, Villar-Garea A, Boix-Chornet M, Espada J, Schotta G, Bonaldi T, 
Haydon C, Ropero S, Petrie K, Iyer NG, Perez-Rosado A, Calvo E, Lopez JA, Cano A, Calasanz 
MJ, Colomer D, Piris MA, Ahn N, Imhof A, Caldas C, Jenuwein T, Esteller M (2005) Loss of 
acetylation at Lys16 and trimethylation at Lys20 of histone H4 is a common hallmark of 
human cancer. Nature genetics 37: 391-400 
Fraga MF, Herranz M, Espada J, Ballestar E, Paz MF, Ropero S, Erkek E, Bozdogan O, Peinado 
H, Niveleau A, Mao JH, Balmain A, Cano A, Esteller M (2004) A mouse skin multistage 
carcinogenesis model reflects the aberrant DNA methylation patterns of human tumors. 
Cancer research 64: 5527-5534 
Franchina M, Kay PH (2000) Evidence that cytosine residues within 5'-CCTGG-3' 
pentanucleotides can be methylated in human DNA independently of the methylating 
system that modifies 5'-CG-3' dinucleotides. DNA and cell biology 19: 521-526 
Fuks F, Hurd PJ, Deplus R, Kouzarides T (2003) The DNA methyltransferases associate with 
HP1 and the SUV39H1 histone methyltransferase. Nucleic Acids Res 31: 2305-2312 
Gangaraju VK, Bartholomew B (2007) Dependency of ISW1a chromatin remodeling on 
extranucleosomal DNA. Molecular and cellular biology 27: 3217-3225 
Geiman TM, Durum SK, Muegge K (1998) Characterization of gene expression, genomic 
structure, and chromosomal localization of Hells (Lsh). Genomics 54: 477-483 
Geiman TM, Tessarollo L, Anver MR, Kopp JB, Ward JM, Muegge K (2001) Lsh, a SNF2 family 
member, is required for normal murine development. Biochimica et biophysica acta 1526: 
211-220 
              236
Gendrel AV, Apedaile A, Coker H, Termanis A, Zvetkova I, Godwin J, Tang YA, Huntley D, 
Montana G, Taylor S, Giannoulatou E, Heard E, Stancheva I, Brockdorff N (2012) Smchd1-
dependent and -independent pathways determine developmental dynamics of CpG island 
methylation on the inactive X chromosome. Developmental cell 23: 265-279 
Gendrel AV, Lippman Z, Yordan C, Colot V, Martienssen RA (2002) Dependence of 
heterochromatic histone H3 methylation patterns on the Arabidopsis gene DDM1. Science 
297: 1871-1873 
Gendrel D (2012) [Anti-meningococcal vaccines: diversity of vaccination policies and 
recommendations]. Archives de pediatrie : organe officiel de la Societe francaise de 
pediatrie 19 Suppl 2: S70-76 
Gendrel D, Cohen R (2012) [Meningococcal vaccine. Editorial]. Archives de pediatrie : 
organe officiel de la Societe francaise de pediatrie 19 Suppl 2: S47-48 
Georgel PT, Horowitz-Scherer RA, Adkins N, Woodcock CL, Wade PA, Hansen JC (2003) 
Chromatin compaction by human MeCP2. Assembly of novel secondary chromatin 
structures in the absence of DNA methylation. J Biol Chem 278: 32181-32188 
Gibbons RJ, McDowell TL, Raman S, O'Rourke DM, Garrick D, Ayyub H, Higgs DR (2000) 
Mutations in ATRX, encoding a SWI/SNF-like protein, cause diverse changes in the pattern 
of DNA methylation. Nature genetics 24: 368-371 
Gowher H, Jeltsch A (2001) Enzymatic properties of recombinant Dnmt3a DNA 
methyltransferase from mouse: the enzyme modifies DNA in a non-processive manner and 
also methylates non-CpG [correction of non-CpA] sites. Journal of molecular biology 309: 
1201-1208 
Gowher H, Liebert K, Hermann A, Xu G, Jeltsch A (2005a) Mechanism of stimulation of 
catalytic activity of Dnmt3A and Dnmt3B DNA-(cytosine-C5)-methyltransferases by Dnmt3L. 
J Biol Chem 280: 13341-13348 
Gowher H, Stockdale CJ, Goyal R, Ferreira H, Owen-Hughes T, Jeltsch A (2005b) De novo 
methylation of nucleosomal DNA by the mammalian Dnmt1 and Dnmt3A DNA 
methyltransferases. Biochemistry 44: 9899-9904 
Grigoryev SA, Arya G, Correll S, Woodcock CL, Schlick T (2009) Evidence for heteromorphic 
chromatin fibers from analysis of nucleosome interactions. Proc Natl Acad Sci U S A 106: 
13317-13322 
Gruenbaum Y, Cedar H, Razin A (1982) Substrate and sequence specificity of a eukaryotic 
DNA methylase. Nature 295: 620-622 
Guenther MG, Levine SS, Boyer LA, Jaenisch R, Young RA (2007) A chromatin landmark and 
transcription initiation at most promoters in human cells. Cell 130: 77-88 
Guttman M, Amit I, Garber M, French C, Lin MF, Feldser D, Huarte M, Zuk O, Carey BW, 
Cassady JP, Cabili MN, Jaenisch R, Mikkelsen TS, Jacks T, Hacohen N, Bernstein BE, Kellis M, 
Regev A, Rinn JL, Lander ES (2009) Chromatin signature reveals over a thousand highly 
conserved large non-coding RNAs in mammals. Nature 458: 223-227 
Haas DL, Lutzko C, Logan AC, Cho GJ, Skelton D, Jin Yu X, Pepper KA, Kohn DB (2003) The 
Moloney murine leukemia virus repressor binding site represses expression in murine and 
human hematopoietic stem cells. Journal of virology 77: 9439-9450 
              237
Haig D, Graham C (1991) Genomic imprinting and the strange case of the insulin-like growth 
factor II receptor. Cell 64: 1045-1046 
Han H, Cortez CC, Yang X, Nichols PW, Jones PA, Liang G (2011) DNA methylation directly 
silences genes with non-CpG island promoters and establishes a nucleosome occupied 
promoter. Human molecular genetics 20: 4299-4310 
Hanahan D, Weinberg RA (2011) Hallmarks of cancer: the next generation. Cell 144: 646-
674 
Hansen RS, Wijmenga C, Luo P, Stanek AM, Canfield TK, Weemaes CM, Gartler SM (1999) 
The DNMT3B DNA methyltransferase gene is mutated in the ICF immunodeficiency 
syndrome. Proc Natl Acad Sci U S A 96: 14412-14417 
Hashimoto H, Horton JR, Zhang X, Bostick M, Jacobsen SE, Cheng X (2008) The SRA domain 
of UHRF1 flips 5-methylcytosine out of the DNA helix. Nature 455: 826-829 
Hata K, Okano M, Lei H, Li E (2002) Dnmt3L cooperates with the Dnmt3 family of de novo 
DNA methyltransferases to establish maternal imprints in mice. Development 129: 1983-
1993 
He J, Yang Q, Chang LJ (2005) Dynamic DNA methylation and histone modifications 
contribute to lentiviral transgene silencing in murine embryonic carcinoma cells. Journal of 
virology 79: 13497-13508 
Heard E, Rougeulle C, Arnaud D, Avner P, Allis CD, Spector DL (2001) Methylation of histone 
H3 at Lys-9 is an early mark on the X chromosome during X inactivation. Cell 107: 727-738 
Hendrich B, Bird A (1998) Identification and characterization of a family of mammalian 
methyl-CpG binding proteins. Molecular and cellular biology 18: 6538-6547 
Hendrich B, Hardeland U, Ng HH, Jiricny J, Bird A (1999) The thymine glycosylase MBD4 can 
bind to the product of deamination at methylated CpG sites. Nature 401: 301-304 
Hermann A, Schmitt S, Jeltsch A (2003) The human Dnmt2 has residual DNA-(cytosine-C5) 
methyltransferase activity. J Biol Chem 278: 31717-31721 
Hirasawa R, Chiba H, Kaneda M, Tajima S, Li E, Jaenisch R, Sasaki H (2008) Maternal and 
zygotic Dnmt1 are necessary and sufficient for the maintenance of DNA methylation 
imprints during preimplantation development. Genes Dev 22: 1607-1616 
Hirota T, Lipp JJ, Toh BH, Peters JM (2005) Histone H3 serine 10 phosphorylation by Aurora 
B causes HP1 dissociation from heterochromatin. Nature 438: 1176-1180 
Ho L, Crabtree GR (2010) Chromatin remodelling during development. Nature 463: 474-484 
Ho L, Jothi R, Ronan JL, Cui K, Zhao K, Crabtree GR (2009a) An embryonic stem cell 
chromatin remodeling complex, esBAF, is an essential component of the core pluripotency 
transcriptional network. Proc Natl Acad Sci U S A 106: 5187-5191 
Ho L, Ronan JL, Wu J, Staahl BT, Chen L, Kuo A, Lessard J, Nesvizhskii AI, Ranish J, Crabtree 
GR (2009b) An embryonic stem cell chromatin remodeling complex, esBAF, is essential for 
embryonic stem cell self-renewal and pluripotency. Proc Natl Acad Sci U S A 106: 5181-5186 
Hong YK, Ontiveros SD, Chen C, Strauss WM (1999) A new structure for the murine Xist 
gene and its relationship to chromosome choice/counting during X-chromosome 
inactivation. Proc Natl Acad Sci U S A 96: 6829-6834 
              238
Horowitz RA, Agard DA, Sedat JW, Woodcock CL (1994) The three-dimensional architecture 
of chromatin in situ: electron tomography reveals fibers composed of a continuously 
variable zig-zag nucleosomal ribbon. J Cell Biol 125: 1-10 
Hota SK, Bartholomew B (2011) Diversity of operation in ATP-dependent chromatin 
remodelers. Biochimica et biophysica acta 1809: 476-487 
Howell CY, Bestor TH, Ding F, Latham KE, Mertineit C, Trasler JM, Chaillet JR (2001) Genomic 
imprinting disrupted by a maternal effect mutation in the Dnmt1 gene. Cell 104: 829-838 
Huang J, Fan T, Yan Q, Zhu H, Fox S, Issaq HJ, Best L, Gangi L, Munroe D, Muegge K (2004) 
Lsh, an epigenetic guardian of repetitive elements. Nucleic Acids Res 32: 5019-5028 
Ideraabdullah FY, Vigneau S, Bartolomei MS (2008) Genomic imprinting mechanisms in 
mammals. Mutation research 647: 77-85 
Iida T, Suetake I, Tajima S, Morioka H, Ohta S, Obuse C, Tsurimoto T (2002) PCNA clamp 
facilitates action of DNA cytosine methyltransferase 1 on hemimethylated DNA. Genes to 
cells : devoted to molecular & cellular mechanisms 7: 997-1007 
Ikegami K, Iwatani M, Suzuki M, Tachibana M, Shinkai Y, Tanaka S, Greally JM, Yagi S, 
Hattori N, Shiota K (2007) Genome-wide and locus-specific DNA hypomethylation in G9a 
deficient mouse embryonic stem cells. Genes to cells : devoted to molecular & cellular 
mechanisms 12: 1-11 
Illingworth R, Kerr A, Desousa D, Jorgensen H, Ellis P, Stalker J, Jackson D, Clee C, Plumb R, 
Rogers J, Humphray S, Cox T, Langford C, Bird A (2008) A novel CpG island set identifies 
tissue-specific methylation at developmental gene loci. PLoS biology 6: e22 
Illingworth RS, Gruenewald-Schneider U, Webb S, Kerr AR, James KD, Turner DJ, Smith C, 
Harrison DJ, Andrews R, Bird AP (2010) Orphan CpG islands identify numerous conserved 
promoters in the mammalian genome. PLoS genetics 6 
Irizarry RA, Ladd-Acosta C, Wen B, Wu Z, Montano C, Onyango P, Cui H, Gabo K, Rongione 
M, Webster M, Ji H, Potash JB, Sabunciyan S, Feinberg AP (2009) The human colon cancer 
methylome shows similar hypo- and hypermethylation at conserved tissue-specific CpG 
island shores. Nature genetics 41: 178-186 
Isagawa T, Nagae G, Shiraki N, Fujita T, Sato N, Ishikawa S, Kume S, Aburatani H (2011) DNA 
methylation profiling of embryonic stem cell differentiation into the three germ layers. PloS 
one 6: e26052 
Jarvis CD, Geiman T, Vila-Storm MP, Osipovich O, Akella U, Candeias S, Nathan I, Durum SK, 
Muegge K (1996) A novel putative helicase produced in early murine lymphocytes. Gene 
169: 203-207 
Jeddeloh JA, Stokes TL, Richards EJ (1999) Maintenance of genomic methylation requires a 
SWI2/SNF2-like protein. Nature genetics 22: 94-97 
Jeltsch A (2002) Beyond Watson and Crick: DNA methylation and molecular enzymology of 
DNA methyltransferases. Chembiochem : a European journal of chemical biology 3: 274-293 
Jeon Y, Sarma K, Lee JT (2012) New and Xisting regulatory mechanisms of X chromosome 
inactivation. Curr Opin Genet Dev 22: 62-71 
              239
Johnson LM, Bostick M, Zhang X, Kraft E, Henderson I, Callis J, Jacobsen SE (2007) The SRA 
methyl-cytosine-binding domain links DNA and histone methylation. Curr Biol 17: 379-384 
Jonkers I, Barakat TS, Achame EM, Monkhorst K, Kenter A, Rentmeester E, Grosveld F, 
Grootegoed JA, Gribnau J (2009) RNF12 is an X-Encoded dose-dependent activator of X 
chromosome inactivation. Cell 139: 999-1011 
Jonkers I, Monkhorst K, Rentmeester E, Grootegoed JA, Grosveld F, Gribnau J (2008) Xist 
RNA is confined to the nuclear territory of the silenced X chromosome throughout the cell 
cycle. Molecular and cellular biology 28: 5583-5594 
Jonsson ZO, Jha S, Wohlschlegel JA, Dutta A (2004) Rvb1p/Rvb2p recruit Arp5p and 
assemble a functional Ino80 chromatin remodeling complex. Mol Cell 16: 465-477 
Jorgensen HF, Ben-Porath I, Bird AP (2004) Mbd1 is recruited to both methylated and 
nonmethylated CpGs via distinct DNA binding domains. Molecular and cellular biology 24: 
3387-3395 
Joshi AA, Struhl K (2005) Eaf3 chromodomain interaction with methylated H3-K36 links 
histone deacetylation to Pol II elongation. Mol Cell 20: 971-978 
Jurkowska RZ, Jurkowski TP, Jeltsch A (2011) Structure and function of mammalian DNA 
methyltransferases. Chembiochem : a European journal of chemical biology 12: 206-222 
Jurkowski TP, Meusburger M, Phalke S, Helm M, Nellen W, Reuter G, Jeltsch A (2008) 
Human DNMT2 methylates tRNA(Asp) molecules using a DNA methyltransferase-like 
catalytic mechanism. Rna 14: 1663-1670 
Kageyama S, Liu H, Kaneko N, Ooga M, Nagata M, Aoki F (2007) Alterations in epigenetic 
modifications during oocyte growth in mice. Reproduction 133: 85-94 
Kaneda M, Hirasawa R, Chiba H, Okano M, Li E, Sasaki H (2010) Genetic evidence for 
Dnmt3a-dependent imprinting during oocyte growth obtained by conditional knockout with 
Zp3-Cre and complete exclusion of Dnmt3b by chimera formation. Genes to cells : devoted 
to molecular & cellular mechanisms 
Kaneda M, Okano M, Hata K, Sado T, Tsujimoto N, Li E, Sasaki H (2004) Essential role for de 
novo DNA methyltransferase Dnmt3a in paternal and maternal imprinting. Nature 429: 
900-903 
Kanhere A, Viiri K, Araujo CC, Rasaiyaah J, Bouwman RD, Whyte WA, Pereira CF, Brookes E, 
Walker K, Bell GW, Pombo A, Fisher AG, Young RA, Jenner RG (2010) Short RNAs are 
transcribed from repressed polycomb target genes and interact with polycomb repressive 
complex-2. Mol Cell 38: 675-688 
Karagianni P, Amazit L, Qin J, Wong J (2008) ICBP90, a novel methyl K9 H3 binding protein 
linking protein ubiquitination with heterochromatin formation. Molecular and cellular 
biology 28: 705-717 
Kassabov SR, Zhang B, Persinger J, Bartholomew B (2003) SWI/SNF unwraps, slides, and 
rewraps the nucleosome. Mol Cell 11: 391-403 
Kawasaki H, Kosugi I, Arai Y, Iwashita T, Tsutsui Y (2011) Mouse embryonic stem cells inhibit 
murine cytomegalovirus infection through a multi-step process. PloS one 6: e17492 
              240
Keogh MC, Kurdistani SK, Morris SA, Ahn SH, Podolny V, Collins SR, Schuldiner M, Chin K, 
Punna T, Thompson NJ, Boone C, Emili A, Weissman JS, Hughes TR, Strahl BD, Grunstein M, 
Greenblatt JF, Buratowski S, Krogan NJ (2005) Cotranscriptional set2 methylation of histone 
H3 lysine 36 recruits a repressive Rpd3 complex. Cell 123: 593-605 
Keohane AM, O'Neill L P, Belyaev ND, Lavender JS, Turner BM (1996) X-Inactivation and 
histone H4 acetylation in embryonic stem cells. Developmental biology 180: 618-630 
Khalil AM, Guttman M, Huarte M, Garber M, Raj A, Rivea Morales D, Thomas K, Presser A, 
Bernstein BE, van Oudenaarden A, Regev A, Lander ES, Rinn JL (2009) Many human large 
intergenic noncoding RNAs associate with chromatin-modifying complexes and affect gene 
expression. Proc Natl Acad Sci U S A 106: 11667-11672 
Kirmizis A, Bartley SM, Kuzmichev A, Margueron R, Reinberg D, Green R, Farnham PJ (2004) 
Silencing of human polycomb target genes is associated with methylation of histone H3 Lys 
27. Genes Dev 18: 1592-1605 
Kizer KO, Phatnani HP, Shibata Y, Hall H, Greenleaf AL, Strahl BD (2005) A novel domain in 
Set2 mediates RNA polymerase II interaction and couples histone H3 K36 methylation with 
transcript elongation. Molecular and cellular biology 25: 3305-3316 
Kobayashi H, Sakurai T, Imai M, Takahashi N, Fukuda A, Yayoi O, Sato S, Nakabayashi K, Hata 
K, Sotomaru Y, Suzuki Y, Kono T (2012) Contribution of intragenic DNA methylation in 
mouse gametic DNA methylomes to establish oocyte-specific heritable marks. PLoS genetics 
8: e1002440 
Kondo Y, Shen L, Ahmed S, Boumber Y, Sekido Y, Haddad BR, Issa JP (2008) Downregulation 
of histone H3 lysine 9 methyltransferase G9a induces centrosome disruption and 
chromosome instability in cancer cells. PloS one 3: e2037 
Kornberg RD (1974) Chromatin structure: a repeating unit of histones and DNA. Science 
184: 868-871 
Kron K, Pethe V, Briollais L, Sadikovic B, Ozcelik H, Sunderji A, Venkateswaran V, Pinthus J, 
Fleshner N, van der Kwast T, Bapat B (2009) Discovery of novel hypermethylated genes in 
prostate cancer using genomic CpG island microarrays. PloS one 4: e4830 
Kurihara Y, Kawamura Y, Uchijima Y, Amamo T, Kobayashi H, Asano T, Kurihara H (2008) 
Maintenance of genomic methylation patterns during preimplantation development 
requires the somatic form of DNA methyltransferase 1. Developmental biology 313: 335-
346 
Lagarou A, Mohd-Sarip A, Moshkin YM, Chalkley GE, Bezstarosti K, Demmers JA, Verrijzer CP 
(2008) dKDM2 couples histone H2A ubiquitylation to histone H3 demethylation during 
Polycomb group silencing. Genes Dev 22: 2799-2810 
Larsen F, Gundersen G, Lopez R, Prydz H (1992) CpG islands as gene markers in the human 
genome. Genomics 13: 1095-1107 
Laurent L, Wong E, Li G, Huynh T, Tsirigos A, Ong CT, Low HM, Kin Sung KW, Rigoutsos I, 
Loring J, Wei CL (2010) Dynamic changes in the human methylome during differentiation. 
Genome research 20: 320-331 
Lechner MS, Schultz DC, Negorev D, Maul GG, Rauscher FJ, 3rd (2005) The mammalian 
heterochromatin protein 1 binds diverse nuclear proteins through a common motif that 
              241
targets the chromoshadow domain. Biochemical and biophysical research communications 
331: 929-937 
Lee DW, Zhang K, Ning ZQ, Raabe EH, Tintner S, Wieland R, Wilkins BJ, Kim JM, Blough RI, 
Arceci RJ (2000) Proliferation-associated SNF2-like gene (PASG): a SNF2 family member 
altered in leukemia. Cancer research 60: 3612-3622 
Lee DY, Northrop JP, Kuo MH, Stallcup MR (2006) Histone H3 lysine 9 methyltransferase 
G9a is a transcriptional coactivator for nuclear receptors. J Biol Chem 281: 8476-8485 
Lee JT (2011) Gracefully ageing at 50, X-chromosome inactivation becomes a paradigm for 
RNA and chromatin control. Nature reviews Molecular cell biology 12: 815-826 
Lee JT, Davidow LS, Warshawsky D (1999) Tsix, a gene antisense to Xist at the X-inactivation 
centre. Nature genetics 21: 400-404 
Lee JT, Lu N (1999) Targeted mutagenesis of Tsix leads to nonrandom X inactivation. Cell 99: 
47-57 
Lee MG, Norman J, Shilatifard A, Shiekhattar R (2007) Physical and functional association of 
a trimethyl H3K4 demethylase and Ring6a/MBLR, a polycomb-like protein. Cell 128: 877-
887 
Lehnertz B, Northrop JP, Antignano F, Burrows K, Hadidi S, Mullaly SC, Rossi FM, Zaph C 
(2010) Activating and inhibitory functions for the histone lysine methyltransferase G9a in T 
helper cell differentiation and function. The Journal of experimental medicine 207: 915-922 
Lehnertz B, Ueda Y, Derijck AA, Braunschweig U, Perez-Burgos L, Kubicek S, Chen T, Li E, 
Jenuwein T, Peters AH (2003) Suv39h-mediated histone H3 lysine 9 methylation directs 
DNA methylation to major satellite repeats at pericentric heterochromatin. Curr Biol 13: 
1192-1200 
Leonhardt H, Page AW, Weier HU, Bestor TH (1992) A targeting sequence directs DNA 
methyltransferase to sites of DNA replication in mammalian nuclei. Cell 71: 865-873 
Leung DC, Dong KB, Maksakova IA, Goyal P, Appanah R, Lee S, Tachibana M, Shinkai Y, 
Lehnertz B, Mager DL, Rossi F, Lorincz MC (2011) Lysine methyltransferase G9a is required 
for de novo DNA methylation and the establishment, but not the maintenance, of proviral 
silencing. Proc Natl Acad Sci U S A 108: 5718-5723 
Li E, Beard C, Jaenisch R (1993) Role for DNA methylation in genomic imprinting. Nature 
366: 362-365 
Li E, Bestor TH, Jaenisch R (1992) Targeted mutation of the DNA methyltransferase gene 
results in embryonic lethality. Cell 69: 915-926 
Li L, Keverne EB, Aparicio SA, Ishino F, Barton SC, Surani MA (1999) Regulation of maternal 
behavior and offspring growth by paternally expressed Peg3. Science 284: 330-333 
Li SS, Yu SL, Singh S (2010) Epigenetic states and expression of imprinted genes in human 
embryonic stem cells. World journal of stem cells 2: 97-102 
Li X, Ito M, Zhou F, Youngson N, Zuo X, Leder P, Ferguson-Smith AC (2008) A maternal-
zygotic effect gene, Zfp57, maintains both maternal and paternal imprints. Developmental 
cell 15: 547-557 
              242
Liang G, Chan MF, Tomigahara Y, Tsai YC, Gonzales FA, Li E, Laird PW, Jones PA (2002) 
Cooperativity between DNA methyltransferases in the maintenance methylation of 
repetitive elements. Molecular and cellular biology 22: 480-491 
Liang G, Lin JC, Wei V, Yoo C, Cheng JC, Nguyen CT, Weisenberger DJ, Egger G, Takai D, 
Gonzales FA, Jones PA (2004) Distinct localization of histone H3 acetylation and H3-K4 
methylation to the transcription start sites in the human genome. Proc Natl Acad Sci U S A 
101: 7357-7362 
Lienert F, Wirbelauer C, Som I, Dean A, Mohn F, Schubeler D (2011) Identification of genetic 
elements that autonomously determine DNA methylation states. Nature genetics 43: 1091-
1097 
Lin SP, Youngson N, Takada S, Seitz H, Reik W, Paulsen M, Cavaille J, Ferguson-Smith AC 
(2003) Asymmetric regulation of imprinting on the maternal and paternal chromosomes at 
the Dlk1-Gtl2 imprinted cluster on mouse chromosome 12. Nature genetics 35: 97-102 
Lock LF, Takagi N, Martin GR (1987) Methylation of the Hprt gene on the inactive X occurs 
after chromosome inactivation. Cell 48: 39-46 
Lorincz MC, Schubeler D, Groudine M (2001) Methylation-mediated proviral silencing is 
associated with MeCP2 recruitment and localized histone H3 deacetylation. Molecular and 
cellular biology 21: 7913-7922 
Lorkovic ZJ, Naumann U, Matzke AJ, Matzke M (2012) Involvement of a GHKL ATPase in 
RNA-directed DNA methylation in Arabidopsis thaliana. Curr Biol 22: 933-938 
Losada A, Hirano T (2005) Dynamic molecular linkers of the genome: the first decade of 
SMC proteins. Genes Dev 19: 1269-1287 
Lu X, Klonoski JM, Resch MG, Hansen JC (2006) In vitro chromatin self-association and its 
relevance to genome architecture. Biochem Cell Biol 84: 411-417 
Luger K, Mader AW, Richmond RK, Sargent DF, Richmond TJ (1997) Crystal structure of the 
nucleosome core particle at 2.8 A resolution. Nature 389: 251-260 
Maclean JA, 2nd, Chen MA, Wayne CM, Bruce SR, Rao M, Meistrich ML, Macleod C, 
Wilkinson MF (2005) Rhox: a new homeobox gene cluster. Cell 120: 369-382 
Malone CS, Miner MD, Doerr JR, Jackson JP, Jacobsen SE, Wall R, Teitell M (2001) 
CmC(A/T)GG DNA methylation in mature B cell lymphoma gene silencing. Proc Natl Acad Sci 
U S A 98: 10404-10409 
Mancini-Dinardo D, Steele SJ, Levorse JM, Ingram RS, Tilghman SM (2006) Elongation of the 
Kcnq1ot1 transcript is required for genomic imprinting of neighboring genes. Genes Dev 20: 
1268-1282 
Margot JB, Cardoso MC, Leonhardt H (2001) Mammalian DNA methyltransferases show 
different subnuclear distributions. Journal of cellular biochemistry 83: 373-379 
McGrath J, Solter D (1984) Completion of mouse embryogenesis requires both the maternal 
and paternal genomes. Cell 37: 179-183 
Meissner A (2011) Guiding DNA methylation. Cell stem cell 9: 388-390 
              243
Meissner A, Mikkelsen TS, Gu H, Wernig M, Hanna J, Sivachenko A, Zhang X, Bernstein BE, 
Nusbaum C, Jaffe DB, Gnirke A, Jaenisch R, Lander ES (2008) Genome-scale DNA 
methylation maps of pluripotent and differentiated cells. Nature 454: 766-770 
Melamed-Bessudo C, Levy AA (2012) Deficiency in DNA methylation increases meiotic 
crossover rates in euchromatic but not in heterochromatic regions in Arabidopsis. Proc Natl 
Acad Sci U S A 109: E981-988 
Messerschmidt DM (2012) Should I stay or should I go: Protection and maintenance of DNA 
methylation at imprinted genes. Epigenetics 7 
Mikkelsen TS, Ku M, Jaffe DB, Issac B, Lieberman E, Giannoukos G, Alvarez P, Brockman W, 
Kim TK, Koche RP, Lee W, Mendenhall E, O'Donovan A, Presser A, Russ C, Xie X, Meissner A, 
Wernig M, Jaenisch R, Nusbaum C, Lander ES, Bernstein BE (2007) Genome-wide maps of 
chromatin state in pluripotent and lineage-committed cells. Nature 448: 553-560 
Millar CB, Guy J, Sansom OJ, Selfridge J, MacDougall E, Hendrich B, Keightley PD, Bishop SM, 
Clarke AR, Bird A (2002) Enhanced CpG mutability and tumorigenesis in MBD4-deficient 
mice. Science 297: 403-405 
Mittelsten Scheid O, Paszkowski J (2000) Transcriptional gene silencing mutants. Plant 
molecular biology 43: 235-241 
Mohn F, Weber M, Rebhan M, Roloff TC, Richter J, Stadler MB, Bibel M, Schubeler D (2008) 
Lineage-specific polycomb targets and de novo DNA methylation define restriction and 
potential of neuronal progenitors. Mol Cell 30: 755-766 
Morey L, Helin K (2010) Polycomb group protein-mediated repression of transcription. 
Trends Biochem Sci 35: 323-332 
Mori Y, Cai K, Cheng Y, Wang S, Paun B, Hamilton JP, Jin Z, Sato F, Berki AT, Kan T, Ito T, 
Mantzur C, Abraham JM, Meltzer SJ (2006) A genome-wide search identifies epigenetic 
silencing of somatostatin, tachykinin-1, and 5 other genes in colon cancer. 
Gastroenterology 131: 797-808 
Morton JP, Myant KB, Sansom OJ (2011) A FAK-PI-3K-mTOR axis is required for Wnt-Myc 
driven intestinal regeneration and tumorigenesis. Cell Cycle 10: 173-175 
Muller-Tidow C, Klein HU, Hascher A, Isken F, Tickenbrock L, Thoennissen N, Agrawal-Singh 
S, Tschanter P, Disselhoff C, Wang Y, Becker A, Thiede C, Ehninger G, zur Stadt U, 
Koschmieder S, Seidl M, Muller FU, Schmitz W, Schlenke P, McClelland M, Berdel WE, Dugas 
M, Serve H, Study Alliance L (2010) Profiling of histone H3 lysine 9 trimethylation levels 
predicts transcription factor activity and survival in acute myeloid leukemia. Blood 116: 
3564-3571 
Munshi A, Shafi G, Aliya N, Jyothy A (2009) Histone modifications dictate specific biological 
readouts. Journal of genetics and genomics = Yi chuan xue bao 36: 75-88 
Myant K, Sansom O (2011) Efficient Wnt mediated intestinal hyperproliferation requires the 
cyclin D2-CDK4/6 complex. Cell division 6: 3 
Myant K, Stancheva I (2008) LSH cooperates with DNA methyltransferases to repress 
transcription. Molecular and cellular biology 28: 215-226 
              244
Myant K, Termanis A, Sundaram AY, Boe T, Li C, Merusi C, Burrage J, de Las Heras JI, 
Stancheva I (2011) LSH and G9a/GLP complex are required for developmentally 
programmed DNA methylation. Genome research 21: 83-94 
Nady N, Lemak A, Walker JR, Avvakumov GV, Kareta MS, Achour M, Xue S, Duan S, Allali-
Hassani A, Zuo X, Wang YX, Bronner C, Chedin F, Arrowsmith CH, Dhe-Paganon S (2011) 
Recognition of multivalent histone states associated with heterochromatin by UHRF1 
protein. J Biol Chem 286: 24300-24311 
Nakamura T, Arai Y, Umehara H, Masuhara M, Kimura T, Taniguchi H, Sekimoto T, Ikawa M, 
Yoneda Y, Okabe M, Tanaka S, Shiota K, Nakano T (2007) PGC7/Stella protects against DNA 
demethylation in early embryogenesis. Nat Cell Biol 9: 64-71 
Nakamura T, Liu YJ, Nakashima H, Umehara H, Inoue K, Matoba S, Tachibana M, Ogura A, 
Shinkai Y, Nakano T (2012) PGC7 binds histone H3K9me2 to protect against conversion of 
5mC to 5hmC in early embryos. Nature 486: 415-419 
Navarro P, Chambers I, Karwacki-Neisius V, Chureau C, Morey C, Rougeulle C, Avner P 
(2008) Molecular coupling of Xist regulation and pluripotency. Science 321: 1693-1695 
Navarro P, Oldfield A, Legoupi J, Festuccia N, Dubois A, Attia M, Schoorlemmer J, Rougeulle 
C, Chambers I, Avner P (2010) Molecular coupling of Tsix regulation and pluripotency. 
Nature 468: 457-460 
Nimura K, Ishida C, Koriyama H, Hata K, Yamanaka S, Li E, Ura K, Kaneda Y (2006) Dnmt3a2 
targets endogenous Dnmt3L to ES cell chromatin and induces regional DNA methylation. 
Genes to cells : devoted to molecular & cellular mechanisms 11: 1225-1237 
Nishino Y, Eltsov M, Joti Y, Ito K, Takata H, Takahashi Y, Hihara S, Frangakis AS, Imamoto N, 
Ishikawa T, Maeshima K (2012) Human mitotic chromosomes consist predominantly of 
irregularly folded nucleosome fibres without a 30-nm chromatin structure. EMBO J 31: 
1644-1653 
Nishioka K, Chuikov S, Sarma K, Erdjument-Bromage H, Allis CD, Tempst P, Reinberg D 
(2002) Set9, a novel histone H3 methyltransferase that facilitates transcription by 
precluding histone tail modifications required for heterochromatin formation. Genes Dev 
16: 479-489 
Oberle I, Rousseau F, Heitz D, Kretz C, Devys D, Hanauer A, Boue J, Bertheas MF, Mandel JL 
(1991) Instability of a 550-base pair DNA segment and abnormal methylation in fragile X 
syndrome. Science 252: 1097-1102 
Oda M, Yamagiwa A, Yamamoto S, Nakayama T, Tsumura A, Sasaki H, Nakao K, Li E, Okano 
M (2006) DNA methylation regulates long-range gene silencing of an X-linked homeobox 
gene cluster in a lineage-specific manner. Genes Dev 20: 3382-3394 
Ogawa Y, Lee JT (2003) Xite, X-inactivation intergenic transcription elements that regulate 
the probability of choice. Mol Cell 11: 731-743 
Ohta T, Gray TA, Rogan PK, Buiting K, Gabriel JM, Saitoh S, Muralidhar B, Bilienska B, 
Krajewska-Walasek M, Driscoll DJ, Horsthemke B, Butler MG, Nicholls RD (1999) Imprinting-
mutation mechanisms in Prader-Willi syndrome. American journal of human genetics 64: 
397-413 
Okano M, Bell DW, Haber DA, Li E (1999) DNA methyltransferases Dnmt3a and Dnmt3b are 
essential for de novo methylation and mammalian development. Cell 99: 247-257 
              245
Okano M, Xie S, Li E (1998a) Cloning and characterization of a family of novel mammalian 
DNA (cytosine-5) methyltransferases. Nature genetics 19: 219-220 
Okano M, Xie S, Li E (1998b) Dnmt2 is not required for de novo and maintenance 
methylation of viral DNA in embryonic stem cells. Nucleic Acids Res 26: 2536-2540 
Okitsu CY, Hsieh CL (2007) DNA methylation dictates histone H3K4 methylation. Molecular 
and cellular biology 27: 2746-2757 
Ooi SK, Qiu C, Bernstein E, Li K, Jia D, Yang Z, Erdjument-Bromage H, Tempst P, Lin SP, Allis 
CD, Cheng X, Bestor TH (2007) DNMT3L connects unmethylated lysine 4 of histone H3 to de 
novo methylation of DNA. Nature 448: 714-717 
Ooi SK, Wolf D, Hartung O, Agarwal S, Daley GQ, Goff SP, Bestor TH (2010) Dynamic 
instability of genomic methylation patterns in pluripotent stem cells. Epigenetics & 
chromatin 3: 17 
Pasini D, Hansen KH, Christensen J, Agger K, Cloos PA, Helin K (2008) Coordinated 
regulation of transcriptional repression by the RBP2 H3K4 demethylase and Polycomb-
Repressive Complex 2. Genes Dev 22: 1345-1355 
Perez-Torrado R, Yamada D, Defossez PA (2006) Born to bind: the BTB protein-protein 
interaction domain. BioEssays : news and reviews in molecular, cellular and developmental 
biology 28: 1194-1202 
Perisic O, Collepardo-Guevara R, Schlick T (2010) Modeling studies of chromatin fiber 
structure as a function of DNA linker length. Journal of molecular biology 403: 777-802 
Perpelescu M, Nozaki N, Obuse C, Yang H, Yoda K (2009) Active establishment of 
centromeric CENP-A chromatin by RSF complex. J Cell Biol 185: 397-407 
Peters AH, Kubicek S, Mechtler K, O'Sullivan RJ, Derijck AA, Perez-Burgos L, Kohlmaier A, 
Opravil S, Tachibana M, Shinkai Y, Martens JH, Jenuwein T (2003) Partitioning and plasticity 
of repressive histone methylation states in mammalian chromatin. Mol Cell 12: 1577-1589 
Picketts DJ, Higgs DR, Bachoo S, Blake DJ, Quarrell OW, Gibbons RJ (1996) ATRX encodes a 
novel member of the SNF2 family of proteins: mutations point to a common mechanism 
underlying the ATR-X syndrome. Human molecular genetics 5: 1899-1907 
Plusa B, Frankenberg S, Chalmers A, Hadjantonakis AK, Moore CA, Papalopulu N, 
Papaioannou VE, Glover DM, Zernicka-Goetz M (2005) Downregulation of Par3 and aPKC 
function directs cells towards the ICM in the preimplantation mouse embryo. Journal of cell 
science 118: 505-515 
Pradhan S, Bacolla A, Wells RD, Roberts RJ (1999) Recombinant human DNA (cytosine-5) 
methyltransferase. I. Expression, purification, and comparison of de novo and maintenance 
methylation. J Biol Chem 274: 33002-33010 
Prinapori R, Guinaud J, Khalil A, Lecuyer H, Gendrel D, Lortholary O, Nassif X, Viscoli C, Zahar 
JR (2012) Risk associated with a systematic search of extended-spectrum beta-lactamase-
producing Enterobacteriaceae. American journal of infection control 
Purcell DJ, Jeong KW, Bittencourt D, Gerke DS, Stallcup MR (2011) A distinct mechanism for 
coactivator versus corepressor function by histone methyltransferase G9a in transcriptional 
regulation. J Biol Chem 286: 41963-41971 
              246
Qin C, Wang Z, Shang J, Bekkari K, Liu R, Pacchione S, McNulty KA, Ng A, Barnum JE, Storer 
RD (2010) Intracisternal A particle genes: Distribution in the mouse genome, active 
subtypes, and potential roles as species-specific mediators of susceptibility to cancer. 
Molecular carcinogenesis 49: 54-67 
Quenneville S, Verde G, Corsinotti A, Kapopoulou A, Jakobsson J, Offner S, Baglivo I, Pedone 
PV, Grimaldi G, Riccio A, Trono D (2011) In embryonic stem cells, ZFP57/KAP1 recognize a 
methylated hexanucleotide to affect chromatin and DNA methylation of imprinting control 
regions. Mol Cell 44: 361-372 
Raabe EH, Abdurrahman L, Behbehani G, Arceci RJ (2001) An SNF2 factor involved in 
mammalian development and cellular proliferation. Dev Dyn 221: 92-105 
Racki LR, Yang JG, Naber N, Partensky PD, Acevedo A, Purcell TJ, Cooke R, Cheng Y, Narlikar 
GJ (2009) The chromatin remodeller ACF acts as a dimeric motor to space nucleosomes. 
Nature 462: 1016-1021 
Ramsahoye BH (2002) Measurement of genome-wide DNA cytosine-5 methylation by 
reversed-phase high-pressure liquid chromatography. Methods in molecular biology 200: 
17-27 
Ramsahoye BH, Biniszkiewicz D, Lyko F, Clark V, Bird AP, Jaenisch R (2000) Non-CpG 
methylation is prevalent in embryonic stem cells and may be mediated by DNA 
methyltransferase 3a. Proc Natl Acad Sci U S A 97: 5237-5242 
Rea S, Eisenhaber F, O'Carroll D, Strahl BD, Sun ZW, Schmid M, Opravil S, Mechtler K, 
Ponting CP, Allis CD, Jenuwein T (2000) Regulation of chromatin structure by site-specific 
histone H3 methyltransferases. Nature 406: 593-599 
Redrup L, Branco MR, Perdeaux ER, Krueger C, Lewis A, Santos F, Nagano T, Cobb BS, Fraser 
P, Reik W (2009) The long noncoding RNA Kcnq1ot1 organises a lineage-specific nuclear 
domain for epigenetic gene silencing. Development 136: 525-530 
Reik W, Constancia M, Fowden A, Anderson N, Dean W, Ferguson-Smith A, Tycko B, Sibley C 
(2003) Regulation of supply and demand for maternal nutrients in mammals by imprinted 
genes. The Journal of physiology 547: 35-44 
Riccio A, Sparago A, Verde G, De Crescenzo A, Citro V, Cubellis MV, Ferrero GB, Silengo MC, 
Russo S, Larizza L, Cerrato F (2009) Inherited and Sporadic Epimutations at the IGF2-H19 
locus in Beckwith-Wiedemann syndrome and Wilms' tumor. Endocrine development 14: 1-9 
Rice JC, Briggs SD, Ueberheide B, Barber CM, Shabanowitz J, Hunt DF, Shinkai Y, Allis CD 
(2003) Histone methyltransferases direct different degrees of methylation to define distinct 
chromatin domains. Mol Cell 12: 1591-1598 
Richardson B, Scheinbart L, Strahler J, Gross L, Hanash S, Johnson M (1990) Evidence for 
impaired T cell DNA methylation in systemic lupus erythematosus and rheumatoid arthritis. 
Arthritis and rheumatism 33: 1665-1673 
Rideout WM, 3rd, Coetzee GA, Olumi AF, Jones PA (1990) 5-Methylcytosine as an 
endogenous mutagen in the human LDL receptor and p53 genes. Science 249: 1288-1290 
Ringrose L, Paro R (2007) Polycomb/Trithorax response elements and epigenetic memory of 
cell identity. Development 134: 223-232 
              247
Rinn JL, Kertesz M, Wang JK, Squazzo SL, Xu X, Brugmann SA, Goodnough LH, Helms JA, 
Farnham PJ, Segal E, Chang HY (2007) Functional demarcation of active and silent 
chromatin domains in human HOX loci by noncoding RNAs. Cell 129: 1311-1323 
Rius M, Lyko F (2012) Epigenetic cancer therapy: rationales, targets and drugs. Oncogene 
31: 4257-4265 
Robertson KD (2005) DNA methylation and human disease. Nat Rev Genet 6: 597-610 
Robertson KD, Keyomarsi K, Gonzales FA, Velicescu M, Jones PA (2000) Differential mRNA 
expression of the human DNA methyltransferases (DNMTs) 1, 3a and 3b during the 
G(0)/G(1) to S phase transition in normal and tumor cells. Nucleic Acids Res 28: 2108-2113 
Robertson KD, Uzvolgyi E, Liang G, Talmadge C, Sumegi J, Gonzales FA, Jones PA (1999) The 
human DNA methyltransferases (DNMTs) 1, 3a and 3b: coordinate mRNA expression in 
normal tissues and overexpression in tumors. Nucleic Acids Res 27: 2291-2298 
Roopra A, Qazi R, Schoenike B, Daley TJ, Morrison JF (2004) Localized domains of G9a-
mediated histone methylation are required for silencing of neuronal genes. Mol Cell 14: 
727-738 
Rossant J, Tam PP (2009) Blastocyst lineage formation, early embryonic asymmetries and 
axis patterning in the mouse. Development 136: 701-713 
Routh A, Sandin S, Rhodes D (2008) Nucleosome repeat length and linker histone 
stoichiometry determine chromatin fiber structure. Proc Natl Acad Sci U S A 105: 8872-8877 
Ryu B, Kim DS, Deluca AM, Alani RM (2007) Comprehensive expression profiling of tumor 
cell lines identifies molecular signatures of melanoma progression. PloS one 2: e594 
Sado T, Fenner MH, Tan SS, Tam P, Shioda T, Li E (2000) X inactivation in the mouse embryo 
deficient for Dnmt1: distinct effect of hypomethylation on imprinted and random X 
inactivation. Developmental biology 225: 294-303 
Sado T, Okano M, Li E, Sasaki H (2004) De novo DNA methylation is dispensable for the 
initiation and propagation of X chromosome inactivation. Development 131: 975-982 
Saha A, Wittmeyer J, Cairns BR (2002) Chromatin remodeling by RSC involves ATP-
dependent DNA translocation. Genes Dev 16: 2120-2134 
Saha A, Wittmeyer J, Cairns BR (2005) Chromatin remodeling through directional DNA 
translocation from an internal nucleosomal site. Nat Struct Mol Biol 12: 747-755 
Saitou M, Kagiwada S, Kurimoto K (2012) Epigenetic reprogramming in mouse pre-
implantation development and primordial germ cells. Development 139: 15-31 
Santos F, Hendrich B, Reik W, Dean W (2002) Dynamic reprogramming of DNA methylation 
in the early mouse embryo. Developmental biology 241: 172-182 
Sasai N, Defossez PA (2009) Many paths to one goal? The proteins that recognize 
methylated DNA in eukaryotes. The International journal of developmental biology 53: 323-
334 
Sasai N, Nakao M, Defossez PA (2010) Sequence-specific recognition of methylated DNA by 
human zinc-finger proteins. Nucleic Acids Res 38: 5015-5022 
              248
Sato M, Kimura T, Kurokawa K, Fujita Y, Abe K, Masuhara M, Yasunaga T, Ryo A, Yamamoto 
M, Nakano T (2002) Identification of PGC7, a new gene expressed specifically in 
preimplantation embryos and germ cells. Mechanisms of development 113: 91-94 
Saxonov S, Berg P, Brutlag DL (2006) A genome-wide analysis of CpG dinucleotides in the 
human genome distinguishes two distinct classes of promoters. Proc Natl Acad Sci U S A 
103: 1412-1417 
Schaniel C, Ang YS, Ratnakumar K, Cormier C, James T, Bernstein E, Lemischka IR, Paddison 
PJ (2009) Smarcc1/Baf155 couples self-renewal gene repression with changes in chromatin 
structure in mouse embryonic stem cells. Stem cells 27: 2979-2991 
Schotta G, Lachner M, Sarma K, Ebert A, Sengupta R, Reuter G, Reinberg D, Jenuwein T 
(2004) A silencing pathway to induce H3-K9 and H4-K20 trimethylation at constitutive 
heterochromatin. Genes Dev 18: 1251-1262 
Schultz DC, Ayyanathan K, Negorev D, Maul GG, Rauscher FJ, 3rd (2002) SETDB1: a novel 
KAP-1-associated histone H3, lysine 9-specific methyltransferase that contributes to HP1-
mediated silencing of euchromatic genes by KRAB zinc-finger proteins. Genes Dev 16: 919-
932 
Seligson DB, Horvath S, Shi T, Yu H, Tze S, Grunstein M, Kurdistani SK (2005) Global histone 
modification patterns predict risk of prostate cancer recurrence. Nature 435: 1262-1266 
Shaked H, Avivi-Ragolsky N, Levy AA (2006) Involvement of the Arabidopsis SWI2/SNF2 
chromatin remodeling gene family in DNA damage response and recombination. Genetics 
173: 985-994 
Sharif J, Muto M, Takebayashi S, Suetake I, Iwamatsu A, Endo TA, Shinga J, Mizutani-Koseki 
Y, Toyoda T, Okamura K, Tajima S, Mitsuya K, Okano M, Koseki H (2007) The SRA protein 
Np95 mediates epigenetic inheritance by recruiting Dnmt1 to methylated DNA. Nature 450: 
908-912 
Sharma S, Gerke DS, Han HF, Jeong S, Stallcup MR, Jones PA, Liang G (2012) Lysine 
methyltransferase G9a is not required for DNMT3A/3B anchoring to methylated 
nucleosomes and maintenance of DNA methylation in somatic cells. Epigenetics & 
chromatin 5: 3 
Shen X, Ranallo R, Choi E, Wu C (2003) Involvement of actin-related proteins in ATP-
dependent chromatin remodeling. Mol Cell 12: 147-155 
Shinkai Y, Tachibana M (2011) H3K9 methyltransferase G9a and the related molecule GLP. 
Genes Dev 25: 781-788 
Shogren-Knaak M, Ishii H, Sun JM, Pazin MJ, Davie JR, Peterson CL (2006) Histone H4-K16 
acetylation controls chromatin structure and protein interactions. Science 311: 844-847 
Sing A, Pannell D, Karaiskakis A, Sturgeon K, Djabali M, Ellis J, Lipshitz HD, Cordes SP (2009) 
A vertebrate Polycomb response element governs segmentation of the posterior hindbrain. 
Cell 138: 885-897 
Smallwood SA, Tomizawa S, Krueger F, Ruf N, Carli N, Segonds-Pichon A, Sato S, Hata K, 
Andrews SR, Kelsey G (2011) Dynamic CpG island methylation landscape in oocytes and 
preimplantation embryos. Nature genetics 43: 811-814 
              249
Smiraglia DJ, Kazhiyur-Mannar R, Oakes CC, Wu YZ, Liang P, Ansari T, Su J, Rush LJ, Smith LT, 
Yu L, Liu C, Dai Z, Chen SS, Wang SH, Costello J, Ioshikhes I, Dawson DW, Hong JS, Teitell 
MA, Szafranek A, Camoriano M, Song F, Elliott R, Held W, Trasler JM, Plass C, Wenger R 
(2007) Restriction landmark genomic scanning (RLGS) spot identification by second 
generation virtual RLGS in multiple genomes with multiple enzyme combinations. BMC 
genomics 8: 446 
Smith FM, Garfield AS, Ward A (2006) Regulation of growth and metabolism by imprinted 
genes. Cytogenetic and genome research 113: 279-291 
Smith ZD, Chan MM, Mikkelsen TS, Gu H, Gnirke A, Regev A, Meissner A (2012) A unique 
regulatory phase of DNA methylation in the early mammalian embryo. Nature 484: 339-344 
Sorge F, Gendrel D, le Groupe de pediatrie t (2013) [Counselling child traveller]. Archives de 
pediatrie : organe officiel de la Societe francaise de pediatrie 20: 95-99 
Soubry A, Staes K, Parthoens E, Noppen S, Stove C, Bogaert P, van Hengel J, van Roy F 
(2010) The transcriptional repressor Kaiso localizes at the mitotic spindle and is a 
constituent of the pericentriolar material. PloS one 5: e9203 
Stockdale C, Flaus A, Ferreira H, Owen-Hughes T (2006) Analysis of nucleosome 
repositioning by yeast ISWI and Chd1 chromatin remodeling complexes. J Biol Chem 281: 
16279-16288 
Strogantsev R, Ferguson-Smith AC (2012) Proteins involved in establishment and 
maintenance of imprinted methylation marks. Brief Funct Genomics 11: 227-239 
Sun LQ, Lee DW, Zhang Q, Xiao W, Raabe EH, Meeker A, Miao D, Huso DL, Arceci RJ (2004) 
Growth retardation and premature aging phenotypes in mice with disruption of the SNF2-
like gene, PASG. Genes Dev 18: 1035-1046 
Surani MA, Barton SC, Norris ML (1984) Development of reconstituted mouse eggs suggests 
imprinting of the genome during gametogenesis. Nature 308: 548-550 
Suzuki T, Farrar JE, Yegnasubramanian S, Zahed M, Suzuki N, Arceci RJ (2008) Stable 
knockdown of PASG enhances DNA demethylation but does not accelerate cellular 
senescence in TIG-7 human fibroblasts. Epigenetics 3: 281-291 
Swindle CS, Klug CA (2002) Mechanisms that regulate silencing of gene expression from 
retroviral vectors. Journal of hematotherapy & stem cell research 11: 449-456 
Szerlong H, Hinata K, Viswanathan R, Erdjument-Bromage H, Tempst P, Cairns BR (2008) 
The HSA domain binds nuclear actin-related proteins to regulate chromatin-remodeling 
ATPases. Nat Struct Mol Biol 15: 469-476 
Szyf M (2001) The role of DNA methyltransferase 1 in growth control. Frontiers in 
bioscience : a journal and virtual library 6: D599-609 
Tachibana M, Sugimoto K, Fukushima T, Shinkai Y (2001) Set domain-containing protein, 
G9a, is a novel lysine-preferring mammalian histone methyltransferase with hyperactivity 
and specific selectivity to lysines 9 and 27 of histone H3. J Biol Chem 276: 25309-25317 
Tachibana M, Sugimoto K, Nozaki M, Ueda J, Ohta T, Ohki M, Fukuda M, Takeda N, Niida H, 
Kato H, Shinkai Y (2002) G9a histone methyltransferase plays a dominant role in 
euchromatic histone H3 lysine 9 methylation and is essential for early embryogenesis. 
Genes Dev 16: 1779-1791 
              250
Tachibana M, Ueda J, Fukuda M, Takeda N, Ohta T, Iwanari H, Sakihama T, Kodama T, 
Hamakubo T, Shinkai Y (2005) Histone methyltransferases G9a and GLP form heteromeric 
complexes and are both crucial for methylation of euchromatin at H3-K9. Genes Dev 19: 
815-826 
Tang LY, Reddy MN, Rasheva V, Lee TL, Lin MJ, Hung MS, Shen CK (2003) The eukaryotic 
DNMT2 genes encode a new class of cytosine-5 DNA methyltransferases. J Biol Chem 278: 
33613-33616 
Tao Y, Xi S, Shan J, Maunakea A, Che A, Briones V, Lee EY, Geiman T, Huang J, Stephens R, 
Leighty RM, Zhao K, Muegge K (2011) Lsh, chromatin remodeling family member, 
modulates genome-wide cytosine methylation patterns at nonrepeat sequences. Proc Natl 
Acad Sci U S A 108: 5626-5631 
Terzi N, Churchman LS, Vasiljeva L, Weissman J, Buratowski S (2011) H3K4 trimethylation by 
Set1 promotes efficient termination by the Nrd1-Nab3-Sen1 pathway. Molecular and 
cellular biology 31: 3569-3583 
Tian D, Sun S, Lee JT (2010) The long noncoding RNA, Jpx, is a molecular switch for X 
chromosome inactivation. Cell 143: 390-403 
Tomizawa S, Kobayashi H, Watanabe T, Andrews S, Hata K, Kelsey G, Sasaki H (2011) 
Dynamic stage-specific changes in imprinted differentially methylated regions during early 
mammalian development and prevalence of non-CpG methylation in oocytes. Development 
138: 811-820 
Torok MS, Grant PA (2006) The generation and recognition of histone methylation. Results 
and problems in cell differentiation 41: 25-46 
Trojer P, Reinberg D (2007) Facultative heterochromatin: is there a distinctive molecular 
signature? Mol Cell 28: 1-13 
Trojer P, Zhang J, Yonezawa M, Schmidt A, Zheng H, Jenuwein T, Reinberg D (2009) Dynamic 
Histone H1 Isotype 4 Methylation and Demethylation by Histone Lysine Methyltransferase 
G9a/KMT1C and the Jumonji Domain-containing JMJD2/KDM4 Proteins. J Biol Chem 284: 
8395-8405 
Tryndyak VP, Kovalchuk O, Pogribny IP (2006) Loss of DNA methylation and histone H4 
lysine 20 trimethylation in human breast cancer cells is associated with aberrant expression 
of DNA methyltransferase 1, Suv4-20h2 histone methyltransferase and methyl-binding 
proteins. Cancer biology & therapy 5: 65-70 
Tsai CE, Lin SP, Ito M, Takagi N, Takada S, Ferguson-Smith AC (2002) Genomic imprinting 
contributes to thyroid hormone metabolism in the mouse embryo. Curr Biol 12: 1221-1226 
Tsumura A, Hayakawa T, Kumaki Y, Takebayashi S, Sakaue M, Matsuoka C, Shimotohno K, 
Ishikawa F, Li E, Ueda HR, Nakayama J, Okano M (2006) Maintenance of self-renewal ability 
of mouse embryonic stem cells in the absence of DNA methyltransferases Dnmt1, Dnmt3a 
and Dnmt3b. Genes to cells : devoted to molecular & cellular mechanisms 11: 805-814 
Tuck-Muller CM, Narayan A, Tsien F, Smeets DF, Sawyer J, Fiala ES, Sohn OS, Ehrlich M 
(2000) DNA hypomethylation and unusual chromosome instability in cell lines from ICF 
syndrome patients. Cytogenetics and cell genetics 89: 121-128 
              251
Tudor M, Akbarian S, Chen RZ, Jaenisch R (2002) Transcriptional profiling of a mouse model 
for Rett syndrome reveals subtle transcriptional changes in the brain. Proc Natl Acad Sci U S 
A 99: 15536-15541 
Udugama M, Sabri A, Bartholomew B (2011) The INO80 ATP-dependent chromatin 
remodeling complex is a nucleosome spacing factor. Molecular and cellular biology 31: 662-
673 
Ueda J, Tachibana M, Ikura T, Shinkai Y (2006) Zinc finger protein Wiz links G9a/GLP histone 
methyltransferases to the co-repressor molecule CtBP. J Biol Chem 281: 20120-20128 
Uemura T, Kubo E, Kanari Y, Ikemura T, Tatsumi K, Muto M (2000) Temporal and spatial 
localization of novel nuclear protein NP95 in mitotic and meiotic cells. Cell structure and 
function 25: 149-159 
Underhill C, Qutob MS, Yee SP, Torchia J (2000) A novel nuclear receptor corepressor 
complex, N-CoR, contains components of the mammalian SWI/SNF complex and the 
corepressor KAP-1. J Biol Chem 275: 40463-40470 
Vakoc CR, Mandat SA, Olenchock BA, Blobel GA (2005) Histone H3 lysine 9 methylation and 
HP1gamma are associated with transcription elongation through mammalian chromatin. 
Mol Cell 19: 381-391 
Vakoc CR, Sachdeva MM, Wang H, Blobel GA (2006) Profile of histone lysine methylation 
across transcribed mammalian chromatin. Molecular and cellular biology 26: 9185-9195 
Van den Wyngaert I, Sprengel J, Kass SU, Luyten WH (1998) Cloning and analysis of a novel 
human putative DNA methyltransferase. FEBS letters 426: 283-289 
Venkatesh S, Smolle M, Li H, Gogol MM, Saint M, Kumar S, Natarajan K, Workman JL (2012) 
Set2 methylation of histone H3 lysine 36 suppresses histone exchange on transcribed 
genes. Nature 
Vire E, Brenner C, Deplus R, Blanchon L, Fraga M, Didelot C, Morey L, Van Eynde A, Bernard 
D, Vanderwinden JM, Bollen M, Esteller M, Di Croce L, de Launoit Y, Fuks F (2006) The 
Polycomb group protein EZH2 directly controls DNA methylation. Nature 439: 871-874 
Vongs A, Kakutani T, Martienssen RA, Richards EJ (1993) Arabidopsis thaliana DNA 
methylation mutants. Science 260: 1926-1928 
Wagschal A, Sutherland HG, Woodfine K, Henckel A, Chebli K, Schulz R, Oakey RJ, Bickmore 
WA, Feil R (2008) G9a histone methyltransferase contributes to imprinting in the mouse 
placenta. Molecular and cellular biology 28: 1104-1113 
Wang C, Shen J, Yang Z, Chen P, Zhao B, Hu W, Lan W, Tong X, Wu H, Li G, Cao C (2011) 
Structural basis for site-specific reading of unmodified R2 of histone H3 tail by UHRF1 PHD 
finger. Cell research 21: 1379-1382 
Wang J, Hevi S, Kurash JK, Lei H, Gay F, Bajko J, Su H, Sun W, Chang H, Xu G, Gaudet F, Li E, 
Chen T (2009) The lysine demethylase LSD1 (KDM1) is required for maintenance of global 
DNA methylation. Nature genetics 41: 125-129 
Wang X, Zhang J (2006) Remarkable expansions of an X-linked reproductive homeobox gene 
cluster in rodent evolution. Genomics 88: 34-43 
              252
Wang Y, Jia S (2009) Degrees make all the difference: the multifunctionality of histone H4 
lysine 20 methylation. Epigenetics 4: 273-276 
Watanabe S, Ichimura T, Fujita N, Tsuruzoe S, Ohki I, Shirakawa M, Kawasuji M, Nakao M 
(2003) Methylated DNA-binding domain 1 and methylpurine-DNA glycosylase link 
transcriptional repression and DNA repair in chromatin. Proc Natl Acad Sci U S A 100: 
12859-12864 
Watanabe T, Tomizawa S, Mitsuya K, Totoki Y, Yamamoto Y, Kuramochi-Miyagawa S, Iida N, 
Hoki Y, Murphy PJ, Toyoda A, Gotoh K, Hiura H, Arima T, Fujiyama A, Sado T, Shibata T, 
Nakano T, Lin H, Ichiyanagi K, Soloway PD, Sasaki H (2011) Role for piRNAs and noncoding 
RNA in de novo DNA methylation of the imprinted mouse Rasgrf1 locus. Science 332: 848-
852 
Weber M, Davies JJ, Wittig D, Oakeley EJ, Haase M, Lam WL, Schubeler D (2005) 
Chromosome-wide and promoter-specific analyses identify sites of differential DNA 
methylation in normal and transformed human cells. Nature genetics 37: 853-862 
Weber M, Hellmann I, Stadler MB, Ramos L, Paabo S, Rebhan M, Schubeler D (2007) 
Distribution, silencing potential and evolutionary impact of promoter DNA methylation in 
the human genome. Nature genetics 39: 457-466 
Weiss T, Hergeth S, Zeissler U, Izzo A, Tropberger P, Zee BM, Dundr M, Garcia BA, Daujat S, 
Schneider R (2010) Histone H1 variant-specific lysine methylation by G9a/KMT1C and 
Glp1/KMT1D. Epigenetics & chromatin 3: 7 
Whitehouse I, Stockdale C, Flaus A, Szczelkun MD, Owen-Hughes T (2003) Evidence for DNA 
translocation by the ISWI chromatin-remodeling enzyme. Molecular and cellular biology 23: 
1935-1945 
Williams SK, Truong D, Tyler JK (2008) Acetylation in the globular core of histone H3 on 
lysine-56 promotes chromatin disassembly during transcriptional activation. Proc Natl Acad 
Sci U S A 105: 9000-9005 
Wong E, Yang K, Kuraguchi M, Werling U, Avdievich E, Fan K, Fazzari M, Jin B, Brown AM, 
Lipkin M, Edelmann W (2002) Mbd4 inactivation increases Cright-arrowT transition 
mutations and promotes gastrointestinal tumor formation. Proc Natl Acad Sci U S A 99: 
14937-14942 
Woo CJ, Kharchenko PV, Daheron L, Park PJ, Kingston RE (2010) A region of the human 
HOXD cluster that confers polycomb-group responsiveness. Cell 140: 99-110 
Woodcock CL, Frado LL, Rattner JB (1984) The higher-order structure of chromatin: 
evidence for a helical ribbon arrangement. J Cell Biol 99: 42-52 
Woodcock CL, Sweetman HE, Frado LL (1976) Structural repeating units in chromatin. II. 
Their isolation and partial characterization. Exp Cell Res 97: 111-119 
Wu H, Chen X, Xiong J, Li Y, Li H, Ding X, Liu S, Chen S, Gao S, Zhu B (2011) Histone 
methyltransferase G9a contributes to H3K27 methylation in vivo. Cell research 21: 365-367 
Wutz A, Jaenisch R (2000) A shift from reversible to irreversible X inactivation is triggered 
during ES cell differentiation. Mol Cell 5: 695-705 
Xi S, Zhu H, Xu H, Schmidtmann A, Geiman TM, Muegge K (2007) Lsh controls Hox gene 
silencing during development. Proc Natl Acad Sci U S A 104: 14366-14371 
              253
Xiao A, Li H, Shechter D, Ahn SH, Fabrizio LA, Erdjument-Bromage H, Ishibe-Murakami S, 
Wang B, Tempst P, Hofmann K, Patel DJ, Elledge SJ, Allis CD (2009) WSTF regulates the 
H2A.X DNA damage response via a novel tyrosine kinase activity. Nature 457: 57-62 
Xie S, Jakoncic J, Qian C (2012) UHRF1 double tudor domain and the adjacent PHD finger act 
together to recognize K9me3-containing histone H3 tail. Journal of molecular biology 415: 
318-328 
Xin Z, Tachibana M, Guggiari M, Heard E, Shinkai Y, Wagstaff J (2003) Role of histone 
methyltransferase G9a in CpG methylation of the Prader-Willi syndrome imprinting center. 
J Biol Chem 278: 14996-15000 
Xu GL, Bestor TH, Bourc'his D, Hsieh CL, Tommerup N, Bugge M, Hulten M, Qu X, Russo JJ, 
Viegas-Pequignot E (1999) Chromosome instability and immunodeficiency syndrome 
caused by mutations in a DNA methyltransferase gene. Nature 402: 187-191 
Xu N, Donohoe ME, Silva SS, Lee JT (2007) Evidence that homologous X-chromosome 
pairing requires transcription and Ctcf protein. Nature genetics 39: 1390-1396 
Yamamizu K, Fujihara M, Tachibana M, Katayama S, Takahashi A, Hara E, Imai H, Shinkai Y, 
Yamashita JK (2012) Protein kinase A determines timing of early differentiation through 
epigenetic regulation with G9a. Cell stem cell 10: 759-770 
Yan Q, Cho E, Lockett S, Muegge K (2003a) Association of Lsh, a regulator of DNA 
methylation, with pericentromeric heterochromatin is dependent on intact 
heterochromatin. Molecular and cellular biology 23: 8416-8428 
Yan Q, Huang J, Fan T, Zhu H, Muegge K (2003b) Lsh, a modulator of CpG methylation, is 
crucial for normal histone methylation. EMBO J 22: 5154-5162 
Yao Y, Bilichak A, Golubov A, Kovalchuk I (2012) ddm1 plants are sensitive to methyl 
methane sulfonate and NaCl stresses and are deficient in DNA repair. Plant cell reports 31: 
1549-1561 
Yasui DH, Peddada S, Bieda MC, Vallero RO, Hogart A, Nagarajan RP, Thatcher KN, Farnham 
PJ, Lasalle JM (2007) Integrated epigenomic analyses of neuronal MeCP2 reveal a role for 
long-range interaction with active genes. Proc Natl Acad Sci U S A 104: 19416-19421 
Yoder JA, Bestor TH (1998) A candidate mammalian DNA methyltransferase related to 
pmt1p of fission yeast. Human molecular genetics 7: 279-284 
Yokochi T, Poduch K, Ryba T, Lu J, Hiratani I, Tachibana M, Shinkai Y, Gilbert DM (2009) G9a 
selectively represses a class of late-replicating genes at the nuclear periphery. Proc Natl 
Acad Sci U S A 106: 19363-19368 
Young JI, Hong EP, Castle JC, Crespo-Barreto J, Bowman AB, Rose MF, Kang D, Richman R, 
Johnson JM, Berget S, Zoghbi HY (2005) Regulation of RNA splicing by the methylation-
dependent transcriptional repressor methyl-CpG binding protein 2. Proc Natl Acad Sci U S A 
102: 17551-17558 
Yu S, Castle A, Chen M, Lee R, Takeda K, Weinstein LS (2001) Increased insulin sensitivity in 
Gsalpha knockout mice. J Biol Chem 276: 19994-19998 
Zegerman P, Canas B, Pappin D, Kouzarides T (2002) Histone H3 lysine 4 methylation 
disrupts binding of nucleosome remodeling and deacetylase (NuRD) repressor complex. J 
Biol Chem 277: 11621-11624 
              254
Zemach A, Zilberman D (2010) Evolution of eukaryotic DNA methylation and the pursuit of 
safer sex. Curr Biol 20: R780-785 
Zhang J, Gao Q, Li P, Liu X, Jia Y, Wu W, Li J, Dong S, Koseki H, Wong J (2011) S phase-
dependent interaction with DNMT1 dictates the role of UHRF1 but not UHRF2 in DNA 
methylation maintenance. Cell research 21: 1723-1739 
Zhao J, Ohsumi TK, Kung JT, Ogawa Y, Grau DJ, Sarma K, Song JJ, Kingston RE, Borowsky M, 
Lee JT (2010) Genome-wide identification of polycomb-associated RNAs by RIP-seq. Mol 
Cell 40: 939-953 
Zhao J, Sun BK, Erwin JA, Song JJ, Lee JT (2008) Polycomb proteins targeted by a short 
repeat RNA to the mouse X chromosome. Science 322: 750-756 
Zhu H, Geiman TM, Xi S, Jiang Q, Schmidtmann A, Chen T, Li E, Muegge K (2006) Lsh is 
involved in de novo methylation of DNA. EMBO J 25: 335-345 
Zhu J, He F, Hu S, Yu J (2008) On the nature of human housekeeping genes. Trends Genet 
24: 481-484 
Zofall M, Persinger J, Kassabov SR, Bartholomew B (2006) Chromatin remodeling by ISW2 
and SWI/SNF requires DNA translocation inside the nucleosome. Nat Struct Mol Biol 13: 
339-346 
Zuo X, Sheng J, Lau HT, McDonald CM, Andrade M, Cullen DE, Bell FT, Iacovino M, Kyba M, 
Xu G, Li X (2012) Zinc finger protein ZFP57 requires its co-factor to recruit DNA 
methyltransferases and maintains DNA methylation imprint in embryonic stem cells via its 
transcriptional repression domain. J Biol Chem 287: 2107-2118 
Zvetkova I, Apedaile A, Ramsahoye B, Mermoud JE, Crompton LA, John R, Feil R, Brockdorff 
N (2005) Global hypomethylation of the genome in XX embryonic stem cells. Nature 
genetics 37: 1274-1279 
 
 
              255
